data_2n9y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n9y _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 114.857 1.429 . . . . 1.99 114.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -58.15 8.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.356 -0.538 . . . . 1.1399999999999999 111.413 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -56.55 -39.4 73.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.189 0.811 . . . . 3.9399999999999999 113.189 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.89 -45.88 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.116 -1.034 . . . . 1.51 108.375 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.47 -44.09 97.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.349 -1.296 . . . . 2.1800000000000002 110.696 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.31 -45.36 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.604 0.24 . . . . 1.3200000000000001 111.441 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.44 92.54 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.838 -1.173 . . . . 0.25 111.324 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.51 -44.84 99.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 121.043 -0.263 . . . . 1.1200000000000001 110.72 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.88 -42.07 95.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 1.78 112.374 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.84 84.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.132 -0.556 . . . . 0.23000000000000001 112.014 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.24 99.36 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.528 -1.029 . . . . 0.16 110.528 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.6 -40.84 89.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 120.767 -0.373 . . . . 2.23 110.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.9 -43.19 99.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.857 -0.794 . . . . 2.1299999999999999 108.857 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.5 -41.86 95.18 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.518 -1.273 . . . . 2.1699999999999999 109.752 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 60.3 mt -60.03 -38.77 83.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.843 -0.743 . . . . 2.0099999999999998 111.063 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -61.22 -47.71 84.85 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.646 -0.822 . . . . 1.3600000000000001 110.564 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.41 -42.8 95.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.341 -0.544 . . . . 1.8899999999999999 110.63 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.0 -43.63 95.1 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.583 -0.447 . . . . 2.1800000000000002 110.891 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.32 -44.82 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.667 -0.413 . . . . 1.3200000000000001 111.234 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.89 -43.29 99.2 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 1.4199999999999999 109.934 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.88 97.31 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.77 -0.372 . . . . 1.1299999999999999 111.743 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 44.6 mtt -64.0 -42.91 97.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 2.21 110.472 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -63.48 -46.34 86.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.09 -0.708 . . . . 1.3999999999999999 109.09 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.18 -35.63 77.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.651 0.611 . . . . 1.45 112.651 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 990' ' ' VAL . 71.5 t -78.04 -1.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.74 -0.784 . . . . 1.5700000000000001 108.965 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 74.36 5.2 71.58 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 108.18 -1.968 . . . . 0.35999999999999999 108.18 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.526 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -47.82 -44.93 29.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 120.024 1.912 . . . . 1.1100000000000001 110.444 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 114.361 -1.29 . . . . 2.1299999999999999 110.545 178.569 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.44 -0.971 0 CA-C-O 121.545 0.688 . . . . 1.6000000000000001 110.074 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.73 -44.53 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 1.5700000000000001 111.865 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 69.3 mt -62.27 -41.94 98.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 1.8999999999999999 110.428 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.49 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 1.3799999999999999 111.031 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.448 ' O ' ' OG ' ' B' ' 699' ' ' SER . 92.4 t -62.92 -45.65 98.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 1.7 110.009 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.71 -43.01 98.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 1.8700000000000001 111.542 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.13 -41.59 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 1.45 110.166 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 13.4 p -61.79 -42.59 99.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.319 -0.4 . . . . 0.27000000000000002 111.179 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.15 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 120.649 -0.421 . . . . 1.26 109.926 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 88.1 mtp -60.79 -39.05 87.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 1.54 109.9 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.11 -41.38 95.05 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.635 -0.986 . . . . 0.20000000000000001 110.635 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.07 89.12 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.954 0.407 . . . . 1.0800000000000001 110.021 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.85 -42.27 88.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 118.938 -1.105 . . . . 1.1399999999999999 109.366 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.11 -45.99 89.47 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.64 -0.255 . . . . 2.29 110.599 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.29 -42.98 99.14 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.331 -0.548 . . . . 2.3500000000000001 110.561 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.63 -46.21 95.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.426 -0.51 . . . . 1.4299999999999999 110.863 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.19 -39.47 94.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.639 -0.791 . . . . 0.26000000000000001 111.615 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.47 -28.68 62.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.676 1.362 . . . . 1.9399999999999999 114.676 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.1 -54.86 51.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.969 0.804 . . . . 1.0800000000000001 111.405 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.07 -44.9 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.513 1.475 . . . . 0.48999999999999999 111.333 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.59 -42.21 87.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 1.7 110.799 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.88 -41.91 99.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.886 -0.326 . . . . 1.6299999999999999 111.092 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.91 -44.5 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 109.064 -0.717 . . . . 2.1499999999999999 109.064 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.81 -50.11 74.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.584 -0.525 . . . . 0.87 109.584 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -59.84 -43.49 94.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 1.6499999999999999 110.919 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 19.4 tp -62.88 -47.51 83.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 2.3900000000000001 110.514 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.85 -41.9 96.76 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.789 -0.364 . . . . 1.3899999999999999 110.836 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -45.61 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 109.522 -0.547 . . . . 2.1699999999999999 109.522 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.7 m -55.01 -47.41 74.72 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.774 -0.77 . . . . 1.7 109.851 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 35.9 mt -64.96 -44.0 96.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.999 0.74 . . . . 1.8799999999999999 112.999 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 55.5 m80 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 108.452 -0.944 . . . . 1.54 108.452 177.383 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . 0.419 ' CG2' ' CE3' ' A' ' 967' ' ' TRP . 20.8 tt . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . 0.419 ' CE3' ' CG2' ' A' ' 966' ' ' ILE . 0.0 OUTLIER -53.98 -52.23 61.36 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.47 0.544 . . . . 1.0 112.47 -176.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -58.41 -40.01 81.29 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.765 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 119.796 -0.762 . . . . 1.0 109.223 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.45 -42.93 99.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.678 -1.146 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.17 -45.15 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.638 0.256 . . . . 1.0 111.327 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.31 -38.95 96.54 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.728 -0.749 . . . . 1.0 111.273 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 121.078 -0.249 . . . . 1.0 110.503 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.18 -42.49 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.468 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.21 93.39 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.816 -0.707 . . . . 1.0 111.8 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.61 98.61 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.26 -41.7 99.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.743 -0.269 . . . . 1.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.89 -42.12 98.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.022 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.05 -40.94 95.54 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.152 -1.019 . . . . 1.0 109.764 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.21 -39.0 91.33 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.5 m -63.0 -47.1 84.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.084 -0.647 . . . . 1.0 110.205 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 982' ' ' ILE . 97.4 mt -61.68 -42.5 94.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 120.919 -0.312 . . . . 1.0 111.14 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.62 -42.45 91.53 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.526 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.76 -44.29 99.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.143 0.497 . . . . 1.0 110.938 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.87 -41.43 95.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.12 98.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.776 -0.77 . . . . 1.0 111.305 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.425 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.5 t90 -63.0 -43.05 99.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.41 -34.1 76.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.136 0.493 . . . . 1.0 111.349 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.14 -2.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.78 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.97 8.73 69.64 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.336 -1.505 . . . . 1.0 109.336 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.463 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.77 -45.18 78.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.294 -1.002 . . . . 1.0 108.294 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--N 1.33 -0.26 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.355 177.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.14 0.495 . . . . 1.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.3 mt -62.33 -43.56 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.626 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.16 -42.0 98.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.168 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 -45.19 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.796 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.461 ' O ' ' OG ' ' B' ' 699' ' ' SER . 67.7 t -63.59 -45.27 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.0 110.664 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . 0.437 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.1 tt -62.64 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.449 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.77 -42.37 97.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.035 0.445 . . . . 1.0 110.346 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 52.1 p -62.22 -36.82 83.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.99 -44.87 97.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.094 0.473 . . . . 1.0 109.922 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.0 mtp -61.54 -39.51 91.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.992 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.84 96.89 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.43 89.22 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.677 0.275 . . . . 1.0 110.51 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.9 mm -62.74 -43.08 98.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.025 -0.67 . . . . 1.0 109.451 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.26 -44.16 97.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.298 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.1 -43.29 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . 0.419 HG21 HD12 ' B' ' 707' ' ' ILE . 94.1 mt -63.94 -44.24 97.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.523 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.35 -41.9 76.44 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.6 -36.17 81.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.74 -57.84 11.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.4 0.519 . . . . 1.0 112.4 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.35 -40.23 60.18 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.086 1.191 . . . . 1.0 111.901 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.17 -42.7 93.45 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.3 -41.82 98.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . 0.41 HD12 HG21 ' B' ' 714' ' ' ILE . 95.2 mt -63.63 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.295 -0.562 . . . . 1.0 109.652 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.421 ' NE1' ' CD1' ' B' ' 719' ' ' ILE . 8.8 t90 -62.37 -48.17 80.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.165 0.507 . . . . 1.0 109.863 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -61.03 -42.54 98.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.004 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.24 -44.49 95.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.5 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.76 -41.79 98.15 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.286 0.565 . . . . 1.0 110.346 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.421 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 95.8 mt -62.51 -46.96 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.165 -1.014 . . . . 1.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 89.2 m -57.74 -46.01 85.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.454 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.57 -43.4 96.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.186 -0.606 . . . . 1.0 110.852 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 64.9 m80 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 178.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 114.165 1.172 . . . . 1.0 114.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -52.94 54.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.73 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -58.09 -39.22 78.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.751 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.27 -45.22 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.629 0.728 . . . . 1.0 109.156 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.46 -42.86 99.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.645 -1.161 . . . . 1.0 110.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.28 -44.49 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.847 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.44 93.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.447 -0.882 . . . . 1.0 110.913 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.46 -46.03 97.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.804 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.24 -42.62 99.24 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.8 93.34 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.807 -0.711 . . . . 1.0 111.454 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.13 -42.49 99.73 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.07 -42.12 99.6 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.837 -0.214 . . . . 1.0 110.791 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.17 -41.27 98.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.196 -0.601 . . . . 1.0 109.9 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.97 -41.43 98.0 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.231 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -43.19 99.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.981 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.2 m -61.84 -47.02 86.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.601 -0.44 . . . . 1.0 111.219 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.29 -43.92 98.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.605 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.33 -43.27 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.1 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.351 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.21 -42.31 99.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.47 99.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.321 -0.552 . . . . 1.0 111.566 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 65.7 mtt -65.21 -42.39 93.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 1.0 111.37 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.72 -43.69 95.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.232 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -34.06 76.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.07 0.462 . . . . 1.0 111.893 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.28 -1.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.535 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 69.83 10.44 64.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.79 -1.724 . . . . 1.0 108.79 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -44.43 72.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.8 m-85 . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 119.816 -0.754 . . . . 1.0 110.705 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.959 0.409 . . . . 1.0 110.328 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.69 -43.68 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 1.0 112.305 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.42 -42.15 99.22 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.497 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.35 -45.2 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.6 t -63.79 -44.69 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.019 0.438 . . . . 1.0 110.453 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.04 -43.43 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.0 mt -64.14 -42.27 96.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.117 0.484 . . . . 1.0 110.663 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 48.6 p -62.27 -39.52 93.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 1.0 112.203 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.42 -45.87 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 1.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.49 -39.38 94.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.797 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.14 97.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.04 90.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.02 0.438 . . . . 1.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.84 -42.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.329 -0.948 . . . . 1.0 108.82 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.2 -44.18 97.69 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.831 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -44.02 95.78 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.136 -0.626 . . . . 1.0 110.227 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.26 98.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.581 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.89 89.65 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.43 -37.82 83.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.33 -56.58 20.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 120.187 -0.605 . . . . 1.0 112.313 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -53.83 -44.35 49.97 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.192 1.261 . . . . 1.0 111.734 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.73 -42.46 95.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.852 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.96 -39.75 94.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 1.0 110.173 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -46.93 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.461 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.421 ' NE1' ' CD1' ' B' ' 719' ' ' ILE . 9.2 t90 -63.43 -47.29 82.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.282 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -44.12 95.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.816 0.302 . . . . 1.0 111.816 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . 0.406 HD22 ' N ' ' B' ' 717' ' ' LEU . 1.5 mm? -63.29 -42.09 99.04 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.473 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.0 -41.61 98.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.421 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 92.2 mt -63.23 -45.05 99.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.213 -0.595 . . . . 1.0 110.234 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.3 m -60.35 -47.14 87.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.864 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.53 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.388 . . . . 1.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 . . . . . 0 C--N 1.325 -0.496 0 C-N-CA 120.183 -0.607 . . . . 1.0 109.519 179.516 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 113.715 1.006 . . . . 1.0 113.715 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -51.84 66.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.699 -0.801 . . . . 1.0 111.181 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -57.38 -37.9 73.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.244 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.11 -44.74 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.24 -42.49 99.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.024 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.27 -44.76 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.0 110.948 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.56 95.73 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.11 -45.2 99.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.345 -0.242 . . . . 1.0 110.345 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.03 -42.49 99.79 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.284 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.63 96.1 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.768 -0.73 . . . . 1.0 111.298 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -41.83 99.61 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.93 -40.94 99.15 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.746 -0.267 . . . . 1.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.37 -42.11 99.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.202 -0.599 . . . . 1.0 110.582 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.05 -41.16 97.84 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.52 -41.19 96.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 1.0 110.677 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.7 m -61.5 -47.13 87.02 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.471 -0.492 . . . . 1.0 111.469 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 982' ' ' ILE . 94.8 mt -63.17 -44.23 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.64 -42.44 98.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.134 -0.626 . . . . 1.0 111.468 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.07 -45.65 98.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.881 -0.327 . . . . 1.0 111.105 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.14 -42.11 99.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.52 99.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.55 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.1 mtt -65.17 -42.38 93.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 111.355 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.427 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.9 t90 -63.12 -43.42 98.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 1.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.57 -34.7 77.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.118 0.485 . . . . 1.0 111.417 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 52.1 t -76.96 -3.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 1.0 109.856 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.68 73.28 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.402 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.26 -45.45 76.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.277 -1.008 . . . . 1.0 108.277 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.408 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.5 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.354 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.804 0.335 . . . . 1.0 111.594 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . 0.404 HD12 HG23 ' B' ' 693' ' ' ILE . 95.6 mt -62.06 -43.69 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.335 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.97 -42.05 99.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.951 -0.299 . . . . 1.0 110.977 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.09 -44.95 99.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.969 0.414 . . . . 1.0 111.053 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.2 t -64.19 -43.79 97.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.404 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.47 -43.4 98.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.751 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.1 -41.34 95.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.19 0.519 . . . . 1.0 110.349 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 30.7 p -62.37 -37.11 84.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.165 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.43 -44.9 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.353 -0.539 . . . . 1.0 109.916 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.7 mtp -61.92 -40.0 93.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.197 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.04 -41.51 97.17 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.27 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 1.0 110.409 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.3 mm -62.95 -43.18 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.447 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 52.5 tp -59.5 -47.7 84.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.331 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.96 -42.5 99.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.206 -0.598 . . . . 1.0 111.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.56 -44.38 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.726 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.33 94.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 713' ' ' LEU . 86.2 mt -67.02 -37.56 84.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.65 -57.23 16.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.008 -0.677 . . . . 1.0 112.092 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.24 -45.14 42.61 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.917 1.078 . . . . 1.0 111.331 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.35 -41.87 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.448 -0.797 . . . . 1.0 110.86 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 709' ' ' LEU . 35.6 mt -62.8 -41.43 99.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.961 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.5 -44.34 98.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.408 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.8 t90 -63.04 -48.6 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 1.0 109.803 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.68 -45.73 93.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.555 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.81 -46.14 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.036 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.35 -43.11 98.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.617 0.599 . . . . 1.0 112.617 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 6.9 tt -67.19 -41.37 86.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.896 -0.722 . . . . 1.0 109.924 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 88.8 m -60.66 -44.83 95.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.819 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . 0.414 HD13 HG22 ' B' ' 721' ' ' ILE . 93.9 mt -62.29 -43.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.062 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.04 -0.664 . . . . 1.0 109.625 178.694 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -49.84 74.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 119.573 -0.851 . . . . 1.0 111.334 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -57.72 -39.12 76.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.279 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.19 -45.28 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 119.826 -0.749 . . . . 1.0 109.083 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.59 -42.17 99.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.652 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.8 -44.63 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.821 0.344 . . . . 1.0 110.86 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.97 96.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.98 -45.19 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 121.158 -0.217 . . . . 1.0 110.529 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.22 -42.5 99.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.806 0.336 . . . . 1.0 111.479 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.49 -43.54 94.55 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.23 -43.02 99.69 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.45 -41.95 98.65 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.756 -0.261 . . . . 1.0 110.951 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.14 -42.11 98.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 1.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.51 -41.25 97.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.859 -0.736 . . . . 1.0 109.492 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.05 -41.95 98.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.304 -0.559 . . . . 1.0 111.238 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.1 m -61.72 -47.4 85.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.896 -0.321 . . . . 1.0 111.211 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.32 -43.76 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.554 -0.459 . . . . 1.0 111.326 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.71 -43.05 97.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.89 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 1.0 111.273 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.31 -42.56 99.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.28 94.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.022 0.378 . . . . 1.0 112.022 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.66 -42.45 91.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.411 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -64.42 -41.92 96.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.869 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.59 -33.48 75.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.24 0.543 . . . . 1.0 110.44 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 -2.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.261 -0.882 . . . . 1.0 109.95 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.85 8.21 72.31 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.273 -1.531 . . . . 1.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -56.11 -45.95 79.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.76 176.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 121.949 0.881 . . . . 1.0 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . 0.404 HD12 HG23 ' B' ' 693' ' ' ILE . 88.0 mt -62.13 -44.73 99.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.199 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' B' ' 694' ' ' LEU . 4.1 mm? -61.17 -42.05 97.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.948 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.23 -43.9 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.647 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.4 t -65.31 -43.71 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 1.0 110.799 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.95 -42.7 99.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.699 0.761 . . . . 1.0 111.637 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.81 -42.71 94.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.554 0.692 . . . . 1.0 110.697 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 58.0 p -61.27 -37.67 83.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.75 -45.32 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.8 mtp -62.07 -39.91 94.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.408 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.31 95.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.36 87.59 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.755 0.312 . . . . 1.0 110.378 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.0 mm -63.01 -42.78 97.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.65 -45.66 93.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.493 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.11 -42.53 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.377 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.68 -43.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.65 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.67 -38.71 93.41 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.533 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.93 -38.23 85.79 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.21 -56.96 18.83 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.242 -0.583 . . . . 1.0 112.271 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -54.67 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.067 1.178 . . . . 1.0 111.612 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.23 -41.89 93.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.905 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.18 -41.71 98.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.121 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.44 -44.15 98.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.414 ' NE1' ' CD1' ' B' ' 719' ' ' ILE . 7.1 t90 -60.89 -48.91 79.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.332 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.38 -42.87 96.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.573 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.1 -44.06 97.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.521 -0.471 . . . . 1.0 110.373 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.36 -42.11 99.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.269 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.414 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 94.5 mt -62.85 -44.68 99.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.953 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.6 m -59.64 -46.69 88.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.971 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.59 -43.82 98.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 1.0 112.23 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.1 m80 . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.451 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -52.36 50.97 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.459 -0.496 . . . . 1.0 111.532 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -57.62 -39.21 76.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.349 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.1 -45.5 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.65 -41.8 99.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.414 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.14 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.887 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.85 96.52 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.87 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.298 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.32 -43.22 98.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.15 91.58 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.894 -0.669 . . . . 1.0 111.949 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.78 -41.36 99.61 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 120.365 -0.922 . . . . 1.0 110.804 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.86 -41.44 99.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.82 -41.58 99.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.052 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.35 -41.17 98.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.353 -0.939 . . . . 1.0 109.641 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.96 -41.31 97.86 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.007 0.908 . . . . 1.0 110.972 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 37.0 m -61.37 -46.51 89.9 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 118.596 -1.242 . . . . 1.0 111.018 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.83 -42.62 97.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.042 -0.663 . . . . 1.0 110.555 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.03 -41.81 97.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.363 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.65 -44.87 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 123.328 0.393 . . . . 1.0 110.6 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.89 -42.03 97.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.27 99.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.884 0.849 . . . . 1.0 111.437 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.86 -40.98 97.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -64.6 -45.44 86.96 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.349 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.88 -33.55 74.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 10.9 m -85.57 0.87 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.82 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 74.19 15.07 80.15 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.347 -1.297 . . . . 1.0 110.967 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.512 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.88 -45.18 67.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.565 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 45.5 m-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.564 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.795 0.331 . . . . 1.0 111.013 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.58 -43.58 98.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.98 -41.7 99.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.053 -0.259 . . . . 1.0 111.137 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.8 -46.41 96.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' B' ' 699' ' ' SER . 18.9 m -65.54 -40.38 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.134 -0.627 . . . . 1.0 110.235 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.98 -43.97 97.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.727 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.103 0.478 . . . . 1.0 110.695 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.27 -38.1 88.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.902 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.48 -45.14 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.125 0.488 . . . . 1.0 110.388 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.11 -38.98 90.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.22 -41.6 96.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.279 -1.129 . . . . 1.0 110.279 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.89 86.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 1.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.6 mm -62.61 -43.07 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.376 -0.601 . . . . 1.0 109.376 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.16 -44.46 97.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.332 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.82 -43.33 99.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.908 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.64 98.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.64 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.13 88.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.23 -38.07 84.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.769 1.025 . . . . 1.0 113.769 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.34 -57.01 18.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.024 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -54.65 -44.65 47.57 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.14 1.227 . . . . 1.0 111.604 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.93 -41.64 95.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.585 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.59 -41.46 98.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.196 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.12 -44.22 99.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.565 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.6 t90 -62.36 -48.77 78.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.595 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.5 OUTLIER -60.53 -45.02 95.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.446 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.58 -42.34 98.31 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.988 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.98 -42.46 99.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.706 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 3.9 mm -63.84 -44.26 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.19 -0.604 . . . . 1.0 109.709 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.6 m -60.37 -45.78 92.3 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.81 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.08 -43.69 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.868 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.8 m80 . . . . . 0 C--N 1.331 -0.206 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.686 178.538 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 114.141 1.164 . . . . 1.0 114.141 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.45 52.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.694 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -57.75 -37.76 74.19 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.622 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.1 -44.74 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.45 -42.38 99.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.706 -1.134 . . . . 1.0 110.173 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.44 -44.8 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.071 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.11 -38.33 95.4 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.86 -45.07 99.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.09 -42.68 99.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.811 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.87 -43.26 96.32 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.319 -0.713 . . . . 1.0 111.319 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.67 99.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.45 -42.05 98.65 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.523 -0.398 . . . . 1.0 111.135 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.51 -41.33 98.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.196 -0.601 . . . . 1.0 110.726 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.9 -41.49 97.97 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.673 -0.811 . . . . 1.0 109.797 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.21 -41.53 98.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.359 -0.536 . . . . 1.0 111.176 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.88 -46.97 87.11 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.542 -0.463 . . . . 1.0 111.16 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.05 -43.66 99.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.27 -42.46 99.14 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.733 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.46 -45.57 98.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.683 0.278 . . . . 1.0 111.123 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.06 -42.24 99.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.284 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.52 98.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.985 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.86 -41.98 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.878 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.429 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.0 t90 -64.11 -43.82 94.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.297 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.31 -34.3 76.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.052 0.454 . . . . 1.0 111.465 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.32 -1.62 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.57 11.59 68.85 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -45.06 70.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.51 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 62.4 m-85 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.231 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.297 0.57 . . . . 1.0 110.767 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.9 -41.51 89.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.516 -0.766 . . . . 1.0 111.192 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.68 -41.43 98.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 1.0 110.791 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.27 -45.28 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.354 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' B' ' 699' ' ' SER . 77.3 t -64.04 -45.43 96.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.078 0.466 . . . . 1.0 110.707 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.71 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.873 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.14 -42.67 96.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 1.0 110.591 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.6 p -61.85 -38.95 90.16 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.67 -45.41 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.231 0.539 . . . . 1.0 110.094 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.3 mtp -62.61 -40.28 96.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.655 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.32 -41.99 97.95 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.501 -1.04 . . . . 1.0 110.501 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.46 86.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.957 0.408 . . . . 1.0 110.174 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.17 -42.31 94.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.765 -0.774 . . . . 1.0 109.576 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.73 -44.05 97.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.617 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.06 -43.62 98.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.751 -0.779 . . . . 1.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.07 -47.92 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 1.0 111.673 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.47 -39.22 80.07 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.862 -0.685 . . . . 1.0 111.546 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.13 -37.4 81.05 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.526 0.935 . . . . 1.0 113.526 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.17 -56.32 23.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.955 -176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.29 -43.07 60.43 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.125 1.217 . . . . 1.0 112.187 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.28 -41.49 94.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.218 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.07 -41.34 99.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.38 -43.98 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.51 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 8.6 t90 -60.77 -48.49 81.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.314 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.36 94.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.482 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.1 -45.14 94.8 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.431 -0.507 . . . . 1.0 110.645 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . 0.518 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 87.0 mt -61.5 -42.28 98.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.683 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.42 -44.11 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.513 -0.475 . . . . 1.0 110.567 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -59.84 -46.61 88.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.834 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.03 -43.04 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.966 -0.294 . . . . 1.0 111.621 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 47.1 m80 . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.789 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -52.2 50.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.384 -176.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -57.67 -38.59 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.572 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.12 -45.35 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.098 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.57 -42.69 99.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.303 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.28 -44.72 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.04 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.52 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.308 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 64.2 t -61.55 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 1.0 110.225 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.32 -42.63 99.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.769 0.319 . . . . 1.0 111.644 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.39 -45.41 90.61 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.97 -43.03 99.74 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.15 -41.89 99.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.806 -0.232 . . . . 1.0 110.518 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.11 -41.97 98.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.535 -0.466 . . . . 1.0 109.78 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.7 -41.55 97.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.756 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.87 -41.65 98.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.677 -0.409 . . . . 1.0 111.074 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.1 m -61.46 -46.98 87.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.952 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 982' ' ' ILE . 94.8 mt -63.12 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.0 -43.06 99.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.645 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.79 -45.75 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.708 0.289 . . . . 1.0 111.028 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.28 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.52 -42.97 99.86 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.399 -0.52 . . . . 1.0 111.226 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.72 -42.75 95.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.877 0.37 . . . . 1.0 111.476 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.432 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.7 t90 -63.25 -43.55 97.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.23 -35.38 78.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.007 0.432 . . . . 1.0 111.569 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.53 -2.57 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.441 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.33 10.87 70.73 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.175 -1.57 . . . . 1.0 109.175 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -45.23 73.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.409 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.0 m-85 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.786 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 1.0 110.623 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.0 mt -62.15 -43.66 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 1.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.39 -42.14 99.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.249 -0.58 . . . . 1.0 110.399 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.43 -45.07 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.419 . . . . 1.0 110.604 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' B' ' 699' ' ' SER . 61.2 t -63.99 -44.22 97.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.07 -43.52 98.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.248 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.41 -42.4 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.0 110.869 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 45.1 p -62.45 -37.45 85.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.751 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.64 -44.9 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 1.0 110.651 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 89.9 mtp -62.97 -39.09 93.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.907 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.59 -42.2 95.69 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.6 84.36 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.808 0.337 . . . . 1.0 111.02 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.8 -42.4 92.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.528 -0.915 . . . . 1.0 108.528 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.64 -45.71 91.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.895 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.92 -42.31 99.75 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.884 -0.726 . . . . 1.0 111.481 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . 0.407 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 31.7 mm -63.69 -45.61 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.803 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.77 -41.02 84.74 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.722 -0.752 . . . . 1.0 111.448 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.49 -37.8 85.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.99 -57.13 19.27 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.201 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' B' ' 707' ' ' ILE . 43.9 Cg_exo -53.85 -43.67 55.97 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.085 1.19 . . . . 1.0 111.337 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.28 -41.82 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.758 -0.656 . . . . 1.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.86 -41.44 99.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.928 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.75 -44.22 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.409 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.0 t90 -62.36 -48.07 81.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -44.61 92.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' B' ' 720' ' ' THR . 50.7 tp -64.03 -45.54 88.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.258 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.99 -43.24 99.32 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.59 -40.88 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.483 -0.887 . . . . 1.0 110.27 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 720' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 40.6 p -57.72 -44.34 85.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.319 -0.553 . . . . 1.0 110.649 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.38 -43.35 98.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.669 -0.413 . . . . 1.0 111.268 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 65.9 m80 . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.006 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 113.588 0.959 . . . . 1.0 113.588 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -51.48 45.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.261 -0.575 . . . . 1.0 111.074 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -57.14 -37.84 72.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.254 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.39 -45.0 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 1.0 109.223 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.75 -41.68 99.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.744 -1.117 . . . . 1.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.3 -44.3 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.543 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.02 -39.73 96.07 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.86 -45.78 97.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.606 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.31 -42.78 99.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.5 -46.25 78.68 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.029 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.75 -42.17 99.33 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.649 -0.981 . . . . 1.0 110.649 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.74 -40.86 97.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.939 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.99 -42.25 98.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.18 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.5 -40.78 95.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 119.058 -1.057 . . . . 1.0 109.76 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.88 -41.31 95.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.281 -0.568 . . . . 1.0 110.508 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.4 m -60.96 -46.76 89.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.462 0.648 . . . . 1.0 110.629 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -44.13 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 119.479 -0.888 . . . . 1.0 111.996 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.27 -41.76 99.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.315 -0.954 . . . . 1.0 111.264 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.86 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.46 -41.7 96.37 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.369 -0.532 . . . . 1.0 110.658 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.036 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.5 mtt -65.28 -42.41 93.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.137 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.431 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -64.26 -42.94 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.889 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.62 -34.5 77.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.117 0.484 . . . . 1.0 111.331 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.05 -1.91 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.678 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.66 8.82 68.42 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.113 -1.595 . . . . 1.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -56.05 -44.24 78.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 117.233 0.516 . . . . 1.0 109.785 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.495 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 36.7 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.492 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.035 0.445 . . . . 1.0 110.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.28 -43.49 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.34 -42.27 99.25 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.43 -0.508 . . . . 1.0 109.978 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.0 -44.81 99.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.941 0.4 . . . . 1.0 110.189 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.449 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.8 t -63.39 -44.31 98.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.24 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.63 -43.92 97.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.92 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.44 -41.89 96.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.949 0.404 . . . . 1.0 110.661 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 44.7 p -62.41 -37.91 87.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 67.5 t -64.06 -44.77 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.008 0.432 . . . . 1.0 110.245 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 53.6 mtt -63.19 -39.06 93.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.729 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.99 -42.23 92.75 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.32 94.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.225 0.536 . . . . 1.0 110.987 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 23.8 mm -60.0 -42.18 88.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.553 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.94 -44.62 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.338 0.399 . . . . 1.0 110.234 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.35 -41.72 98.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.76 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.04 -45.17 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.374 -0.531 . . . . 1.0 111.188 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.35 -39.73 87.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.526 -0.845 . . . . 1.0 111.117 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . 0.407 HD21 ' N ' ' B' ' 709' ' ' LEU . 1.8 mm? -66.73 -37.88 85.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.44 -56.38 25.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.547 -0.461 . . . . 1.0 112.056 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -53.86 -43.25 59.74 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.097 1.198 . . . . 1.0 111.379 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.31 -41.21 90.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.169 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 37.7 mt -63.05 -42.37 99.71 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 41.5 pt -66.28 -41.75 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.005 -0.678 . . . . 1.0 110.046 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -59.92 -48.84 80.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 110.109 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -42.37 98.44 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.248 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.36 -44.0 96.04 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.38 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.592 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -43.12 95.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.31 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.0 m -59.07 -45.8 89.88 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 119.702 -0.799 . . . . 1.0 110.612 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.79 -43.26 97.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.975 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.7 m80 . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.78 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.6 mt . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -55.67 7.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.379 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -57.64 -40.23 78.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 119.347 -0.359 . . . . 1.0 111.814 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.44 -46.2 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.135 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.86 -43.37 98.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.056 -0.974 . . . . 1.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.45 -44.3 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.71 -0.223 . . . . 1.0 110.747 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.11 92.71 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.188 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.77 -46.36 96.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.726 -0.39 . . . . 1.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.43 -43.15 98.27 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.592 0.589 . . . . 1.0 112.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.4 -45.24 91.28 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.921 -0.657 . . . . 1.0 111.734 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.01 99.79 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.75 -41.8 99.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.615 -0.344 . . . . 1.0 110.632 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.26 -42.38 99.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.583 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.27 -40.33 89.97 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.754 -1.178 . . . . 1.0 109.134 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.59 -41.52 99.0 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.645 -0.822 . . . . 1.0 112.075 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.96 -47.02 86.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.706 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 43.6 pt -64.74 -41.95 93.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.877 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.99 -42.83 99.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.22 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 121.103 -0.239 . . . . 1.0 111.179 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.32 -42.26 98.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.308 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.89 99.77 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.746 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.6 mtp -65.37 -42.35 92.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 1.0 111.252 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.44 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.3 t90 -62.53 -42.5 99.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.83 -33.44 74.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.167 0.508 . . . . 1.0 110.975 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.45 -2.97 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.444 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.28 10.1 73.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.513 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.48 -45.25 77.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 -177.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.573 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 49.7 m-85 . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 120.16 -0.616 . . . . 1.0 110.49 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 109.911 -0.404 . . . . 1.0 109.911 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 44.8 pt -62.66 -41.85 93.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.994 -0.548 . . . . 1.0 112.132 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.16 -42.55 99.37 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.4 t -62.32 -44.84 99.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.133 0.492 . . . . 1.0 110.266 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 75.6 t -63.23 -43.74 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.642 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.33 -44.03 97.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.782 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.16 -42.42 96.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.048 0.452 . . . . 1.0 110.686 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 46.1 p -62.21 -39.05 91.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.58 -44.89 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.119 0.485 . . . . 1.0 110.8 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.87 -39.35 94.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.33 95.47 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.62 80.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.1 mm -61.84 -42.46 94.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.436 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.01 -45.67 93.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.665 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 -42.15 99.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.867 -0.733 . . . . 1.0 111.126 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -45.22 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.965 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.26 64.42 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.869 -0.681 . . . . 1.0 111.984 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 10.4 mp -68.66 -37.8 79.91 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.19 -55.58 32.68 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.303 -0.559 . . . . 1.0 112.24 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.34 -43.14 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.283 1.322 . . . . 1.0 112.424 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.89 -43.16 93.81 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.343 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -40.66 97.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.413 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.15 -44.48 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.573 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.5 t90 -63.43 -48.61 77.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 1.0 110.044 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.614 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' B' ' 720' ' ' THR . 53.3 tp -62.27 -44.36 96.7 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.583 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.81 -42.61 99.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.856 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.25 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 720' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 22.6 p -59.08 -44.19 91.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.608 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.89 -44.43 98.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.504 -0.878 . . . . 1.0 111.203 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.0 m80 . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.27 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 114.221 1.193 . . . . 1.0 114.221 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -53.07 47.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 1.0 111.691 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -57.09 -39.05 74.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.586 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.75 -45.29 97.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.702 -0.799 . . . . 1.0 109.48 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.061 -0.972 . . . . 1.0 110.479 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.29 -45.12 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.616 -0.266 . . . . 1.0 111.158 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.64 96.07 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.82 -46.0 97.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.506 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.13 -42.78 99.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.791 0.329 . . . . 1.0 111.848 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.01 -46.82 78.62 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.005 -0.617 . . . . 1.0 112.011 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.04 98.31 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.65 -41.43 98.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.97 0.414 . . . . 1.0 110.502 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.88 -42.9 99.62 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.654 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.32 -40.85 95.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.623 -0.831 . . . . 1.0 109.897 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.91 -40.45 95.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.181 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 99.3 m -60.85 -48.2 82.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.209 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -44.15 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 120.275 -0.57 . . . . 1.0 111.769 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.68 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 79.1 t -61.9 -46.18 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 123.158 0.286 . . . . 1.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.26 -42.42 99.16 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.85 97.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.752 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.2 mtt -64.52 -42.47 95.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.263 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -62.97 -44.37 96.24 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -60.95 -32.66 72.18 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.876 -0.515 . . . . 1.0 111.628 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.9 -1.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 68.54 12.81 64.6 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.828 -1.709 . . . . 1.0 108.828 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.51 -44.1 68.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.613 -1.254 . . . . 1.0 107.613 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.456 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 59.2 m-85 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.553 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.963 0.411 . . . . 1.0 110.352 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.51 -43.63 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.112 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.16 -46.19 97.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' B' ' 699' ' ' SER . 22.3 m -65.47 -40.68 89.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.945 -0.702 . . . . 1.0 110.597 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.92 -43.74 98.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.535 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.12 -42.19 96.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.197 0.522 . . . . 1.0 110.73 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.91 -38.89 92.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.003 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.78 -45.27 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.413 -0.515 . . . . 1.0 110.306 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.57 -39.24 93.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.69 97.97 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.91 86.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.831 0.348 . . . . 1.0 110.534 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 25.8 mm -62.65 -42.45 96.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.52 -43.8 98.21 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.427 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.82 -43.07 99.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.89 -44.33 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.691 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.95 -40.4 73.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.917 -0.658 . . . . 1.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 80.5 mt -66.71 -38.14 86.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.86 -56.96 20.0 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.909 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.09 -44.97 44.52 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.908 1.072 . . . . 1.0 111.774 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.27 -41.77 93.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.595 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.58 -41.46 98.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -63.77 -44.1 98.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.408 -0.59 . . . . 1.0 109.408 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.456 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 10.4 t90 -62.36 -48.53 79.38 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -43.95 97.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.559 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.97 -42.77 99.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.89 -42.12 98.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.509 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.452 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 94.1 mt -63.9 -44.71 98.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.057 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 96.7 m -59.51 -46.52 88.6 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.779 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.73 -43.58 98.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.163 0.506 . . . . 1.0 110.659 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 8.0 m80 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.927 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -52.04 50.73 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.456 -0.497 . . . . 1.0 111.723 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -57.96 -38.58 76.27 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 121.138 -0.225 . . . . 1.0 111.53 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.2 -45.05 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.49 -42.79 99.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.546 -1.206 . . . . 1.0 110.405 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.86 -44.71 99.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.205 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.55 93.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.614 -0.803 . . . . 1.0 111.163 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.92 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.765 -0.256 . . . . 1.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.96 -41.99 99.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.934 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.57 -43.84 93.85 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.785 -0.721 . . . . 1.0 111.304 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.58 99.66 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.4 tp -63.84 -42.86 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.944 0.372 . . . . 1.0 111.582 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.34 -42.57 99.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.875 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.7 -41.3 97.42 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.904 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 980' ' ' LEU . 1.4 mm? -62.76 -41.03 99.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.036 -0.266 . . . . 1.0 111.536 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 17.9 m -60.52 -45.81 92.47 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.625 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.85 -43.92 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.646 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.89 -44.32 93.38 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.18 -40.62 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.817 -0.753 . . . . 1.0 111.027 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.0 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.04 99.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.513 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.64 -42.06 91.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.052 0.453 . . . . 1.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -64.05 -42.4 97.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.752 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.12 -33.46 75.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.032 0.444 . . . . 1.0 111.291 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.27 -0.42 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.476 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.67 10.14 66.68 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -44.33 65.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.733 -1.21 . . . . 1.0 107.733 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.502 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 57.6 m-85 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.428 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.87 0.366 . . . . 1.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.28 -43.69 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.035 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.36 -41.98 99.03 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.826 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -45.32 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.743 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.1 t -63.55 -44.96 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 1.0 110.707 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.41 -43.01 99.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.644 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.92 -42.28 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 1.0 110.564 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 55.3 p -62.2 -40.05 94.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.69 -45.59 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.729 0.299 . . . . 1.0 110.209 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.5 mtp -63.57 -39.43 94.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.33 99.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.989 -1.244 . . . . 1.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.09 -36.57 80.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.031 0.443 . . . . 1.0 110.184 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.97 -41.88 90.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.56 -45.81 92.54 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.943 -0.703 . . . . 1.0 110.814 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.08 -42.91 99.75 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.276 -0.57 . . . . 1.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.2 -44.63 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.269 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.77 -40.57 75.66 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.39 -38.16 84.27 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.25 -56.77 20.84 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.908 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.71 -45.3 42.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.174 1.249 . . . . 1.0 111.455 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.09 -41.6 90.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.188 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.08 -41.5 99.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . 0.402 HD11 HG21 ' B' ' 714' ' ' ILE . 94.6 mt -63.5 -44.27 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.502 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 9.5 t90 -62.3 -48.29 80.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.794 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -44.09 96.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.71 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.88 -43.2 99.44 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.47 -42.13 98.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.422 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 94.3 mt -63.56 -44.06 98.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.095 -0.642 . . . . 1.0 109.511 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.8 m -60.26 -47.44 85.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.795 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.18 -43.51 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.175 -0.61 . . . . 1.0 111.47 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.7 m80 . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 178.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -52.24 50.32 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.418 -0.513 . . . . 1.0 111.615 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -57.74 -37.94 74.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.963 -0.295 . . . . 1.0 111.511 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.97 -44.72 97.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.39 -41.78 98.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.695 -1.139 . . . . 1.0 110.211 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.28 -45.08 99.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.114 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.25 -38.64 95.99 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.03 -45.17 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 121.167 -0.213 . . . . 1.0 110.492 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.28 -42.31 99.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.73 0.3 . . . . 1.0 111.535 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.35 -44.43 93.46 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.323 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.85 99.59 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.93 -41.38 99.46 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.79 -0.241 . . . . 1.0 110.353 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.99 -42.57 99.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.235 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.92 -41.51 98.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.155 -1.018 . . . . 1.0 110.081 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.97 -42.18 98.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.95 -0.7 . . . . 1.0 111.228 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.2 m -61.83 -48.05 82.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.635 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.374 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.01 -43.46 98.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.574 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.65 -45.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.603 0.239 . . . . 1.0 111.158 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.76 -42.48 97.8 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.756 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.41 -41.84 98.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.311 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 62.4 mtt -65.14 -42.3 93.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.688 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.435 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.8 t90 -63.65 -42.65 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.64 -34.02 76.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.218 0.533 . . . . 1.0 111.224 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.7 t -77.36 -2.39 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.22 68.4 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.043 -1.623 . . . . 1.0 109.043 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -56.13 -44.17 78.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.095 0.448 . . . . 1.0 109.946 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 . . . . . 0 C--O 1.232 0.148 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.6 177.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 C--O 1.227 -0.127 0 CA-C-O 121.142 0.496 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.35 -44.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.85 -43.78 95.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.91 -41.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.357 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 699' ' ' SER . 64.3 t -63.56 -45.97 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . 0.431 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.2 tt -62.98 -42.65 99.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.802 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.84 -42.43 97.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.092 0.472 . . . . 1.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 53.6 p -62.06 -37.94 86.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.181 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.62 -45.14 98.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.068 0.461 . . . . 1.0 110.109 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.7 mtp -61.77 -40.0 93.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.591 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.94 98.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.047 -1.221 . . . . 1.0 110.047 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.51 80.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.742 0.306 . . . . 1.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.54 -42.11 94.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.27 -43.93 96.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.489 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.32 -44.32 91.93 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.25 -41.76 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 119.775 -0.77 . . . . 1.0 110.775 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.74 93.12 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.99 -38.29 85.77 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.68 -56.03 27.0 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 112.408 0.522 . . . . 1.0 112.408 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -53.37 -41.96 69.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.293 1.329 . . . . 1.0 111.594 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.26 -41.49 89.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.381 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.47 -41.9 98.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 7.8 tt -65.69 -38.99 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 119.945 -0.702 . . . . 1.0 109.523 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.21 -49.11 79.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -42.71 99.28 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.87 -46.31 89.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.214 -0.594 . . . . 1.0 110.91 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.62 -41.83 99.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.335 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.74 -42.77 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 30.7 m -58.63 -45.74 88.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.501 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.89 -43.83 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.058 0.456 . . . . 1.0 111.077 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.4 m80 . . . . . 0 C--N 1.328 -0.355 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.209 178.664 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 113.315 0.858 . . . . 1.0 113.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -54.63 10.77 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.888 -177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -58.4 -39.41 79.61 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.59 -43.19 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 119.239 -0.985 . . . . 1.0 109.241 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.39 -42.61 99.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.749 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -44.54 99.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.688 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.84 -39.26 95.19 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.54 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.522 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.23 -42.83 99.28 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.65 -44.86 91.82 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.101 -0.571 . . . . 1.0 111.709 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.05 -41.53 99.48 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.06 -40.79 98.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.977 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.16 -42.62 99.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.656 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.7 -40.96 96.86 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.396 -0.922 . . . . 1.0 109.729 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.77 -41.63 99.33 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.815 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -62.52 -47.6 83.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.423 -0.511 . . . . 1.0 112.007 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.49 -40.85 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.726 -0.79 . . . . 1.0 111.286 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.05 -43.81 97.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.71 -45.07 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.121 -0.231 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.68 -41.71 99.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.197 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.63 98.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.537 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 987' ' ' MET . . . . . 0.479 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 96.2 mmm -63.9 -43.62 95.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.894 0.378 . . . . 1.0 111.804 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.415 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -63.16 -43.32 98.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.291 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.03 -34.35 76.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 1.0 111.593 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.85 -2.19 4.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.065 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.81 8.28 63.52 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.479 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -56.41 -44.86 80.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 C--N 1.329 -0.319 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.092 177.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.584 0.231 . . . . 1.0 110.436 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.8 mt -62.64 -44.02 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.478 0.547 . . . . 1.0 112.478 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.51 -43.02 99.85 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.49 -45.41 98.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.978 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.5 t -63.42 -44.23 98.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 1.0 110.172 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.41 -43.87 98.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.961 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.75 -42.23 95.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 1.0 110.814 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.0 p -61.87 -39.98 93.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.458 -0.792 . . . . 1.0 112.085 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 66.7 t -64.21 -45.03 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.076 0.465 . . . . 1.0 110.871 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -63.27 -39.09 93.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.274 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.37 -41.34 96.59 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.613 -0.995 . . . . 1.0 110.613 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.11 88.07 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 120.685 0.278 . . . . 1.0 110.677 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.6 mm -60.41 -43.21 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.651 -0.819 . . . . 1.0 109.692 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.28 -43.23 99.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.467 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.81 -44.39 96.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.619 -0.832 . . . . 1.0 111.197 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . 0.4 HG23 HD12 ' B' ' 707' ' ' ILE . 95.9 mt -62.74 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.77 -39.98 65.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.491 -0.862 . . . . 1.0 111.169 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.59 -37.39 82.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.36 -56.92 19.46 Favored Pre-proline 0 N--CA 1.462 0.137 0 C-N-CA 120.04 -0.664 . . . . 1.0 111.593 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -54.27 -44.37 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 120.837 1.024 . . . . 1.0 111.489 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.13 -42.13 94.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.64 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.59 -41.85 99.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.813 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.6 -44.05 98.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.544 -0.463 . . . . 1.0 109.964 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -62.33 -48.16 81.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.958 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -43.27 98.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.189 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.33 -44.56 96.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.133 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 84.9 mt -61.14 -42.1 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.89 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.5 -44.11 98.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 120.068 -0.653 . . . . 1.0 110.242 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.5 m -59.79 -46.95 87.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.6 -45.11 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.494 0.664 . . . . 1.0 111.198 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 51.2 m80 . . . . . 0 C--N 1.321 -0.656 0 C-N-CA 119.865 -0.734 . . . . 1.0 109.438 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -50.27 67.78 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.857 -0.737 . . . . 1.0 111.306 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -57.69 -38.07 74.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.335 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.46 -46.38 93.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.964 -1.094 . . . . 1.0 109.468 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.56 -44.58 93.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.856 -1.066 . . . . 1.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.88 -39.35 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 119.729 -0.788 . . . . 1.0 110.508 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.24 96.34 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.88 -45.28 99.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.211 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.11 -42.64 99.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 1.0 111.658 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.62 85.03 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -42.82 98.08 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.66 -42.52 98.07 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.391 -0.476 . . . . 1.0 111.951 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.44 -44.95 93.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.426 0.528 . . . . 1.0 112.426 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.22 -42.07 99.21 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.471 -0.891 . . . . 1.0 110.988 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 980' ' ' LEU . 2.1 mm? -63.19 -40.59 97.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.98 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.8 m -62.0 -45.29 94.26 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.569 -0.452 . . . . 1.0 110.203 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -41.34 89.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.3 99.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.963 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.76 -46.04 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.505 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.36 -41.81 98.86 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.334 -0.546 . . . . 1.0 110.521 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.53 98.75 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.207 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.39 -42.88 95.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.537 -0.302 . . . . 1.0 110.815 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.452 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 9.9 t90 -61.71 -42.03 98.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.11 -33.95 75.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.078 0.466 . . . . 1.0 111.176 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.27 -3.18 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.689 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.47 10.81 71.23 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.53 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.6 OUTLIER -55.29 -45.29 76.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 -178.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.48 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.7 m-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.645 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.901 0.381 . . . . 1.0 110.269 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . 0.532 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.9 mt -62.6 -43.51 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 1.0 112.309 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.3 -42.47 99.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.208 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.74 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.5 t -63.26 -44.12 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.808 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.25 -43.39 98.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.06 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.8 -42.31 95.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.176 0.512 . . . . 1.0 110.812 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 35.4 p -62.27 -42.84 99.69 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.18 -42.32 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.9 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.5 mtp -62.38 -39.26 92.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.347 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.66 -40.42 97.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 1.0 110.367 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.36 -42.54 95.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.6 -44.54 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.743 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.05 -43.2 99.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.128 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.35 -43.9 98.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.311 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.905 -0.664 . . . . 1.0 112.029 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.18 -34.89 78.51 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.11 10.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.347 -0.541 . . . . 1.0 112.334 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.12 -39.83 46.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.374 1.383 . . . . 1.0 112.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.6 -42.08 92.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . 0.412 HD21 ' N ' ' B' ' 713' ' ' LEU . 0.7 OUTLIER -63.26 -41.25 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.933 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.31 -44.07 98.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.382 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.48 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 8.1 t90 -62.72 -48.52 78.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.369 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.81 -43.62 97.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.021 -178.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.69 -43.36 99.0 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.24 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.66 -41.3 97.33 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.23 -0.588 . . . . 1.0 110.132 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.432 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.55 -44.15 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.679 -0.808 . . . . 1.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 92.1 m -59.17 -45.35 91.24 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.335 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.51 -43.92 97.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.128 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 67.4 m80 . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.076 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -53.66 53.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.49 -39.32 79.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.419 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.18 -44.96 97.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.699 0.762 . . . . 1.0 108.971 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.53 -42.64 99.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.51 -45.74 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.776 0.322 . . . . 1.0 111.248 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.52 96.82 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.268 -0.733 . . . . 1.0 111.268 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.73 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.605 0.24 . . . . 1.0 110.447 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.21 -42.61 99.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.497 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.99 -45.13 93.27 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.079 -0.581 . . . . 1.0 111.883 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.19 99.71 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.31 -41.6 98.96 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.644 -0.327 . . . . 1.0 110.82 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.99 -42.39 99.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.47 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.91 -41.68 98.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.009 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.57 -41.06 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.104 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -59.88 -45.65 91.84 Favored 'General case' 0 C--O 1.253 1.262 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.477 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.35 -47.69 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 119.904 -0.718 . . . . 1.0 111.344 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.92 -42.65 98.54 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.833 -0.747 . . . . 1.0 111.655 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.18 -47.11 95.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.66 -0.816 . . . . 1.0 111.459 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.12 -42.63 99.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.531 -0.467 . . . . 1.0 110.141 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.85 -43.3 99.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.987 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 98.6 mtp -65.84 -41.95 91.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 1.0 111.773 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.1 t90 -62.7 -43.6 98.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.44 -33.46 73.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.138 0.494 . . . . 1.0 110.897 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.33 -2.8 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.688 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.19 7.09 81.67 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.608 ' CD1' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.82 -45.16 78.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.444 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 50.4 m-85 . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 119.825 -0.75 . . . . 1.0 111.231 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.271 0.558 . . . . 1.0 111.262 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.7 -43.52 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.53 -41.78 99.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.663 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.9 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.319 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.46 ' O ' ' OG ' ' B' ' 699' ' ' SER . 65.5 t -63.51 -45.38 97.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.958 0.409 . . . . 1.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.1 tt -62.6 -43.03 99.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.655 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.69 -42.12 98.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 1.0 110.457 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.2 p -62.01 -36.73 82.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.037 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.95 -44.63 97.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.061 0.458 . . . . 1.0 110.14 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.69 -39.73 92.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.134 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.89 96.9 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.017 -1.233 . . . . 1.0 110.017 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.77 89.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 1.0 110.357 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.87 -43.22 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.233 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.1 -44.22 97.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.163 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.59 -44.12 97.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.669 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 95.0 mt -63.85 -44.47 98.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.876 -0.329 . . . . 1.0 111.428 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.26 -41.14 69.56 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.87 -38.45 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.507 0.928 . . . . 1.0 113.507 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.03 18.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.208 -0.597 . . . . 1.0 112.122 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' B' ' 707' ' ' ILE . 32.3 Cg_exo -54.63 -44.28 51.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.091 1.194 . . . . 1.0 111.359 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.29 -42.15 93.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.715 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.62 -41.77 99.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.52 -44.19 98.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.199 -0.601 . . . . 1.0 109.449 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.444 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 11.3 t90 -63.0 -48.25 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 1.0 109.783 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.608 ' NZ ' ' CD1' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.51 -44.21 96.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.729 -178.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -42.86 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.667 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . 0.498 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 83.8 mt -62.12 -42.77 99.57 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.897 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.78 -44.32 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.909 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 82.9 m -60.31 -45.8 92.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.512 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.37 -43.21 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.385 -0.526 . . . . 1.0 110.42 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 43.3 m80 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.457 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.94 47.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.759 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -58.01 -39.2 77.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.682 0.252 . . . . 1.0 111.682 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.1 -45.06 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.26 -42.64 99.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.79 -44.36 99.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.06 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.79 -38.26 94.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.443 -0.884 . . . . 1.0 111.155 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.8 t -61.98 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.975 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.19 -42.09 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.846 -0.341 . . . . 1.0 111.876 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.26 92.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.372 -0.691 . . . . 1.0 111.372 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.39 99.73 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.146 -1.181 . . . . 1.0 110.146 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.44 -42.08 98.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.953 0.377 . . . . 1.0 111.999 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.76 -43.62 98.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.457 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -40.39 96.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.103 -1.039 . . . . 1.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 980' ' ' LEU . 1.8 mm? -62.5 -39.92 95.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 94.8 m -61.89 -45.53 93.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.807 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.63 -43.63 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.97 -0.692 . . . . 1.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.19 -43.45 98.79 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.379 -0.826 . . . . 1.0 111.355 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 68.4 t -60.63 -44.73 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.081 -0.387 . . . . 1.0 110.82 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.45 -41.43 98.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.175 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.388 -0.525 . . . . 1.0 112.191 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 987' ' ' MET . . . . . 0.481 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 95.6 mmm -64.29 -42.81 96.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 111.201 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.457 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.1 t90 -62.53 -42.6 99.63 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.051 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.33 -34.4 76.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.832 0.349 . . . . 1.0 111.396 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.09 -2.49 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.792 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 68.27 12.17 62.85 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 108.548 -1.821 . . . . 1.0 108.548 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.481 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -54.9 -44.13 73.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -178.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 119.838 -0.745 . . . . 1.0 109.859 177.537 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 . . . . . 0 C--O 1.243 0.734 0 CA-C-O 120.917 0.389 . . . . 1.0 111.83 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.54 -42.69 96.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.856 -0.737 . . . . 1.0 112.351 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.36 -41.58 98.85 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.003 -0.436 . . . . 1.0 111.451 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.6 -45.32 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.846 0.355 . . . . 1.0 111.646 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' B' ' 699' ' ' SER . 58.6 t -64.18 -45.23 96.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . 0.428 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.2 tt -63.29 -43.03 99.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.833 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.3 -42.02 96.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 1.0 110.553 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.5 p -62.38 -38.26 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.361 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.86 -44.83 98.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.137 0.494 . . . . 1.0 110.054 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -63.03 -39.55 95.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.54 -40.54 97.72 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.94 78.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.1 mm -62.59 -42.65 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.43 -44.9 96.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.833 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.28 -43.9 96.61 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.043 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.29 -44.85 97.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.52 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.11 -42.4 67.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.206 -0.521 . . . . 1.0 111.801 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.12 -38.38 85.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.27 -55.56 30.31 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.59 -41.42 68.59 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.299 1.333 . . . . 1.0 111.778 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.24 -41.89 93.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.722 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.33 -42.37 98.97 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.29 -41.71 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.503 -0.879 . . . . 1.0 110.147 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -63.44 -48.77 76.39 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -42.7 95.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.681 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.18 -44.45 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.623 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.73 -41.91 98.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.997 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.55 -42.98 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 120.321 -0.552 . . . . 1.0 109.825 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 98.0 m -59.61 -45.88 90.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.384 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.73 -43.67 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.921 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.2 m80 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.679 178.625 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.028 0.381 . . . . 1.0 112.028 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -50.86 61.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.7 m0 -58.09 -43.54 87.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 119.299 -0.381 . . . . 1.0 111.671 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.78 -43.61 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 118.819 -1.152 . . . . 1.0 110.457 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.15 -42.81 99.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.0 -44.98 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.707 0.289 . . . . 1.0 111.387 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.48 -38.39 94.77 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.116 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.61 -45.1 99.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 121.16 -0.216 . . . . 1.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.3 -42.14 99.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.898 0.333 . . . . 1.0 111.898 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.54 -43.43 94.64 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 120.676 -0.773 . . . . 1.0 111.735 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.1 99.95 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 120.435 -0.888 . . . . 1.0 111.133 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.8 -40.31 96.97 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.539 -0.389 . . . . 1.0 110.098 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.0 -42.7 99.43 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.48 -42.6 99.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.687 -0.805 . . . . 1.0 110.213 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 24.4 mt -62.39 -42.74 99.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.824 0.345 . . . . 1.0 110.779 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 24.1 p -61.93 -45.1 95.2 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.508 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.71 -43.28 97.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.672 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.7 -42.72 97.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.394 -0.522 . . . . 1.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.45 -45.48 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.063 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.83 97.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.931 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.28 99.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.644 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 64.4 mtt -64.77 -42.46 95.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.018 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.46 -33.79 74.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.125 0.488 . . . . 1.0 111.387 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.68 -3.36 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.64 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.56 11.04 72.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.333 -1.507 . . . . 1.0 109.333 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.524 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.48 -45.42 76.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.435 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 48.6 m-85 . . . . . 0 C--N 1.33 -0.248 0 C-N-CA 119.986 -0.686 . . . . 1.0 110.734 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 66.4 t0 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.915 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . 0.563 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 93.2 mt -61.98 -44.42 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 113.095 0.776 . . . . 1.0 113.095 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.35 99.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.717 0.294 . . . . 1.0 111.204 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.21 -45.39 98.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.819 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' B' ' 699' ' ' SER . 66.6 t -63.1 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 1.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.554 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.75 -42.88 94.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.439 . . . . 1.0 110.668 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 54.6 p -62.52 -39.56 93.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.829 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 69.6 t -64.24 -43.79 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.39 0.614 . . . . 1.0 109.381 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.6 mtp -63.29 -39.96 96.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.878 -1.056 . . . . 1.0 110.173 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.93 -47.12 48.74 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.07 83.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.675 0.274 . . . . 1.0 111.631 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.87 -37.61 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.651 -0.82 . . . . 1.0 108.849 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 62.3 tp -60.83 -44.95 96.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.31 -41.37 98.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.141 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.7 -43.85 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.43 -39.25 95.63 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.5 -37.24 82.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.11 -56.48 21.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 112.299 -176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.66 -43.91 53.69 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.06 1.173 . . . . 1.0 112.017 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.17 -41.99 94.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.22 -41.66 99.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.082 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.64 -44.31 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.435 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 7.9 t90 -62.16 -47.31 85.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.29 0.567 . . . . 1.0 109.578 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.53 -44.01 96.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.747 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.51 -46.28 89.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.632 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . 0.489 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 8.2 mp -63.26 -41.01 98.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.545 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 4.5 mm -63.58 -44.65 98.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.965 -0.694 . . . . 1.0 109.994 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -45.37 94.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.1 -43.53 98.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.319 -0.552 . . . . 1.0 111.366 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 44.5 m80 . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -51.94 57.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.1 m0 -57.18 -40.81 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.143 -0.223 . . . . 1.0 110.779 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.42 -46.45 92.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 119.419 -0.912 . . . . 1.0 110.263 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.26 -42.65 99.18 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.681 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.93 -44.58 98.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.443 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.77 -37.91 95.07 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.292 -0.956 . . . . 1.0 111.533 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.25 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.437 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.29 -42.92 99.12 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.08 89.24 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.88 -0.676 . . . . 1.0 111.614 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.67 -41.37 98.91 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.91 -42.78 97.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.133 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.96 -44.33 96.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.557 -0.457 . . . . 1.0 111.654 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.61 -42.12 99.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.64 -0.824 . . . . 1.0 110.366 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . 0.507 HD21 ' N ' ' A' ' 980' ' ' LEU . 4.1 mm? -63.14 -39.65 95.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.846 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 84.6 m -61.2 -45.13 95.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.515 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.82 -44.17 99.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.586 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.94 -42.0 99.67 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.349 -0.54 . . . . 1.0 110.899 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.45 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 1.0 111.011 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.24 -41.73 99.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.9 99.94 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.284 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.27 -40.54 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.373 0.606 . . . . 1.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.6 t90 -65.35 -44.7 86.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.578 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.67 -33.98 76.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.96 2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.176 -1.01 . . . . 1.0 109.296 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.16 84.5 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.38 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.417 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.9 -44.34 66.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.468 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.4 m-85 . . . . . 0 C--N 1.328 -0.355 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.857 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 CA--C 1.522 -0.108 0 N-CA-C 109.997 -0.371 . . . . 1.0 109.997 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.02 -44.46 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.88 -43.37 96.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.34 -47.24 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.91 0.707 . . . . 1.0 112.91 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' B' ' 699' ' ' SER . 11.0 p -65.26 -41.65 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.76 -43.45 98.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.86 -41.84 95.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 1.0 110.665 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 36.8 p -62.55 -40.98 98.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.582 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.56 -45.26 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.266 0.555 . . . . 1.0 110.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -63.5 -39.76 95.3 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.035 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.44 -41.13 99.41 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.99 -0.844 . . . . 1.0 110.99 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.58 80.87 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.05 -41.27 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.63 -46.26 90.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.868 -0.333 . . . . 1.0 111.166 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.24 -42.42 99.2 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.55 -44.21 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.563 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.59 -40.86 94.24 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.64 -37.57 85.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.92 -57.18 17.2 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 119.998 -0.681 . . . . 1.0 112.32 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -54.46 -45.38 41.41 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.158 1.239 . . . . 1.0 111.934 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.86 -40.57 91.79 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.259 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.42 -41.32 98.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.085 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.63 -44.75 98.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.389 -0.525 . . . . 1.0 109.735 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.468 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.2 t90 -63.11 -49.19 75.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.18 0.514 . . . . 1.0 109.702 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.64 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.104 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . 0.421 ' O ' ' OG1' ' B' ' 720' ' ' THR . 55.1 tp -63.35 -45.39 91.43 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.738 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . 0.455 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 82.7 mt -62.76 -42.9 99.9 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.676 0.621 . . . . 1.0 112.676 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' B' ' 720' ' ' THR . 5.6 tp -65.87 -41.26 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 119.611 -0.836 . . . . 1.0 109.871 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 720' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 30.6 p -58.69 -45.3 89.76 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.758 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.05 -41.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 O-C-N 121.849 -0.532 . . . . 1.0 110.676 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 59.2 m80 . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.211 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.0 tt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 113.431 0.9 . . . . 1.0 113.431 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -45.4 80.54 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.272 -0.971 . . . . 1.0 110.822 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . 0.522 ' NE1' ' CD1' ' B' ' 693' ' ' ILE . 35.5 m0 -57.23 -46.13 83.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.78 -0.191 . . . . 1.0 110.786 -177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -63.74 -46.82 93.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 119.329 -0.948 . . . . 1.0 110.941 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.31 -44.26 95.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.113 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.77 -44.95 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.07 -39.32 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.183 -1.008 . . . . 1.0 111.118 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.065 0.394 . . . . 1.0 112.065 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.72 -42.84 97.85 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.58 95.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.494 -0.86 . . . . 1.0 111.2 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.93 -42.85 99.77 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.63 -41.94 99.31 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.732 -0.275 . . . . 1.0 110.659 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.83 -41.79 98.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.47 -41.26 96.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.469 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.61 -42.07 99.36 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.953 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 96.6 m -62.29 -48.66 78.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.01 -41.38 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.453 -0.899 . . . . 1.0 111.626 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.39 -43.48 97.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.541 -0.464 . . . . 1.0 110.696 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.52 -45.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.722 0.296 . . . . 1.0 111.19 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.08 -42.28 99.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.64 98.38 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.336 -0.545 . . . . 1.0 111.811 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.74 -42.62 90.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.144 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -62.67 -42.79 99.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.88 -32.45 73.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.282 0.563 . . . . 1.0 110.509 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.37 -3.79 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.904 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.17 72.86 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.198 -1.561 . . . . 1.0 109.198 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.499 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.88 -46.09 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -178.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.529 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 39.2 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.836 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.767 0.318 . . . . 1.0 110.507 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . 0.522 ' CD1' ' NE1' ' A' ' 968' ' ' TRP . 9.4 tt -62.78 -41.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.461 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.46 -42.43 99.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.412 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.29 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' B' ' 699' ' ' SER . 71.1 t -62.77 -44.77 99.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 1.0 110.485 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.05 -41.99 98.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.572 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.55 -43.32 94.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 1.0 110.398 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.8 p -62.47 -41.44 98.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.848 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.59 -44.88 98.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.316 0.579 . . . . 1.0 109.8 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 55.9 mtt -62.85 -39.46 94.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.499 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.25 -41.69 94.59 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.78 89.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.144 0.497 . . . . 1.0 110.759 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.24 -41.68 93.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.379 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.42 -46.84 87.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.018 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.17 -43.11 99.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.602 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.88 -44.09 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.19 -41.07 92.48 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.244 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.11 -35.36 76.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.2 24.01 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 119.588 -0.845 . . . . 1.0 111.422 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -54.19 -42.43 67.36 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.296 1.331 . . . . 1.0 111.351 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.16 -42.82 96.59 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . 0.4 ' N ' HD21 ' B' ' 713' ' ' LEU . 0.8 OUTLIER -62.47 -41.36 98.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.916 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.96 98.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.053 -0.659 . . . . 1.0 109.349 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.529 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -61.84 -49.27 76.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.922 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.56 -42.64 97.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.316 -0.24 . . . . 1.0 110.656 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.16 -42.62 99.45 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.48 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.91 -40.44 93.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.377 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . 0.401 HD13 ' HE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.97 -46.72 93.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.799 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 21.6 m -60.86 -48.19 82.95 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 34.1 mm -63.14 -43.78 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.788 0.662 . . . . 1.0 112.788 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . 0.455 ' CD2' ' C ' ' B' ' 722' ' ' HIS . 1.8 p-80 . . . . . 0 C--N 1.324 -0.523 0 C-N-CA 119.522 -0.871 . . . . 1.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . 0.445 ' CD2' ' N ' ' A' ' 967' ' ' TRP . 0.0 OUTLIER -58.13 -50.71 72.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.457 -0.497 . . . . 1.0 112.285 -176.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 21.7 m0 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.193 -177.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.36 -46.46 93.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.806 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.23 -43.74 97.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 1.0 111.686 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 67.0 t -63.36 -45.1 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.585 -0.279 . . . . 1.0 111.664 -178.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.66 -37.69 94.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.095 -1.05 . . . . 1.0 111.586 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.0 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.854 -0.339 . . . . 1.0 110.595 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.46 -43.08 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.85 97.58 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.746 -0.74 . . . . 1.0 111.26 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.72 99.7 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.12 -42.95 99.63 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.139 -0.624 . . . . 1.0 111.816 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.42 -41.93 98.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.344 -0.543 . . . . 1.0 111.839 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.46 -42.45 99.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.711 -0.795 . . . . 1.0 110.234 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . 0.464 HD21 ' N ' ' A' ' 980' ' ' LEU . 3.5 mm? -64.52 -41.05 96.63 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.338 0.496 . . . . 1.0 112.338 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 20.3 m -62.14 -47.15 85.84 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.496 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 42.0 pt -63.09 -41.35 92.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.757 -0.777 . . . . 1.0 111.617 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -43.17 99.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.474 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.7 -45.0 99.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.87 0.367 . . . . 1.0 110.699 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.71 -41.5 99.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.22 98.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 1.0 111.206 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.98 -42.03 94.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.773 0.32 . . . . 1.0 111.505 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -63.06 -43.29 99.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.47 -33.77 75.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.076 0.465 . . . . 1.0 111.587 -178.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.65 -3.07 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.81 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.88 9.63 71.06 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.41 -1.476 . . . . 1.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.06 -43.81 78.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.236 0.518 . . . . 1.0 109.652 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.6 m-85 . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.22 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.878 0.37 . . . . 1.0 111.269 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.03 -43.85 98.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 1.0 112.284 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 694' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' B' ' 694' ' ' LEU . 3.9 mm? -62.78 -43.38 98.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.981 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.18 -45.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.328 . . . . 1.0 111.467 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.3 t -63.7 -44.75 98.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.067 0.461 . . . . 1.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.03 -43.16 99.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.781 -0.645 . . . . 1.0 112.05 -178.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.3 -42.35 96.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.1 0.476 . . . . 1.0 110.428 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 50.8 p -62.38 -41.37 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.57 -0.741 . . . . 1.0 112.871 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.45 -45.78 94.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.286 -0.565 . . . . 1.0 110.288 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.36 -39.6 94.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.565 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.24 98.0 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.002 -1.239 . . . . 1.0 110.002 177.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.76 89.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.403 0.621 . . . . 1.0 109.908 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -61.04 -41.8 90.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 118.479 -1.289 . . . . 1.0 109.053 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.36 -43.87 92.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.534 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.753 -0.779 . . . . 1.0 110.743 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.07 -44.16 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.94 -38.85 94.57 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 709' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 713' ' ' LEU . 85.7 mt -67.46 -38.19 84.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.957 1.095 . . . . 1.0 113.957 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.97 -57.11 17.54 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.759 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.5 -45.48 39.38 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.306 1.145 . . . . 1.0 111.448 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.308 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 713' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' B' ' 709' ' ' LEU . 33.5 mt -62.98 -41.08 99.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.784 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.18 -46.39 95.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.397 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 715' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 4.3 t90 -61.03 -49.36 77.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.648 178.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -45.83 91.17 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.786 -0.366 . . . . 1.0 111.037 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.1 -44.43 92.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.032 -0.667 . . . . 1.0 111.114 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.28 -43.42 97.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt -68.33 -40.93 83.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.579 -0.848 . . . . 1.0 109.964 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 94.6 m -59.15 -45.64 90.45 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.38 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.92 -43.14 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.622 -178.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.3 m80 . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 178.105 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.885 -1.286 . . . . 12.09 109.885 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 173.14 -87.62 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.331 -2.84 . . . . 10.779999999999999 103.331 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.724 ' C ' ' H ' ' A' ' 961' ' ' GLU . 2.2 mt -85.0 108.64 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 102.328 -3.212 . . . . 10.300000000000001 102.328 171.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -54.88 -6.96 0.14 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.901 -1.518 . . . . 8.5299999999999994 106.901 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . 0.792 ' O ' ' SG ' ' B' ' 690' ' ' CYS . 1.2 tt0 61.3 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.865 -2.642 . . . . 6.75 103.865 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 964' ' ' ILE . 8.5 mtm-85 -57.8 125.91 25.11 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 123.835 1.779 . . . . 8.4499999999999993 113.515 -173.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' B' ' 689' ' ' LYS 0.273 73.7 m -78.52 6.82 7.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 110.091 -3.231 . . . . 2.6299999999999999 108.962 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 962' ' ' ARG . 0.0 OUTLIER -157.46 64.71 3.25 Favored Pre-proline 0 N--CA 1.425 -1.716 0 CA-C-N 112.071 -2.332 . . . . 3.3300000000000001 107.536 -176.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.84 148.39 88.57 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 106.149 -2.289 . . . . 1.8200000000000001 106.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.9 -42.46 92.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 114.857 1.429 . . . . 1.99 114.857 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -58.15 8.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.356 -0.538 . . . . 1.1399999999999999 111.413 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -56.55 -39.4 73.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.189 0.811 . . . . 3.9399999999999999 113.189 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.89 -45.88 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.116 -1.034 . . . . 1.51 108.375 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.47 -44.09 97.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.349 -1.296 . . . . 2.1800000000000002 110.696 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 91.4 t -63.31 -45.36 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.604 0.24 . . . . 1.3200000000000001 111.441 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.44 92.54 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.838 -1.173 . . . . 0.25 111.324 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.51 -44.84 99.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 121.043 -0.263 . . . . 1.1200000000000001 110.72 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.88 -42.07 95.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 1.78 112.374 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.84 84.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.132 -0.556 . . . . 0.23000000000000001 112.014 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.24 99.36 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.528 -1.029 . . . . 0.16 110.528 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.6 -40.84 89.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 120.767 -0.373 . . . . 2.23 110.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.9 -43.19 99.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.857 -0.794 . . . . 2.1299999999999999 108.857 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.5 -41.86 95.18 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.518 -1.273 . . . . 2.1699999999999999 109.752 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 60.3 mt -60.03 -38.77 83.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.843 -0.743 . . . . 2.0099999999999998 111.063 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -61.22 -47.71 84.85 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.646 -0.822 . . . . 1.3600000000000001 110.564 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.41 -42.8 95.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.341 -0.544 . . . . 1.8899999999999999 110.63 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.0 -43.63 95.1 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.583 -0.447 . . . . 2.1800000000000002 110.891 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 70.3 t -62.32 -44.82 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.667 -0.413 . . . . 1.3200000000000001 111.234 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.89 -43.29 99.2 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 1.4199999999999999 109.934 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.88 97.31 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.77 -0.372 . . . . 1.1299999999999999 111.743 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 44.6 mtt -64.0 -42.91 97.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 2.21 110.472 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.514 ' HE1' ' CE ' ' A' ' 994' ' ' LYS . 17.1 t90 -63.48 -46.34 86.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.09 -0.708 . . . . 1.3999999999999999 109.09 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.18 -35.63 77.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.651 0.611 . . . . 1.45 112.651 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 990' ' ' VAL . 71.5 t -78.04 -1.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.74 -0.784 . . . . 1.5700000000000001 108.965 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 74.36 5.2 71.58 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 108.18 -1.968 . . . . 0.35999999999999999 108.18 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.526 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -47.82 -44.93 29.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 120.024 1.912 . . . . 1.1100000000000001 110.444 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -84.33 -19.18 34.13 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.361 -1.29 . . . . 2.1299999999999999 110.545 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.514 ' CE ' ' HE1' ' A' ' 988' ' ' TRP . 84.5 mttt -76.33 -29.95 57.48 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.559 -2.385 . . . . 3.1400000000000001 104.559 174.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 991' ' ' GLY . 55.6 ttt-85 -67.25 108.81 2.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.33 -2.47 . . . . 3.3300000000000001 104.33 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 996' ' ' ASN . 1.7 p-10 -112.86 -18.23 12.32 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.0 -2.593 . . . . 5.7800000000000002 104.0 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 163.3 154.78 0.05 OUTLIER Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 110.823 -2.899 . . . . 8.9800000000000004 106.111 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 121.293 1.329 . . . . 7.4000000000000004 112.427 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 119.664 -0.52 . . . . 10.720000000000001 112.017 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . 0.44 ' C ' ' HG ' ' B' ' 687' ' ' SER . 1.4 mp0 -120.63 17.63 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 118.214 1.007 . . . . 12.119999999999999 112.967 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.45 ' HG ' ' CD ' ' B' ' 688' ' ' PRO . 0.0 OUTLIER 172.95 -58.38 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 102.794 -3.039 . . . . 7.6100000000000003 102.794 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . 0.696 ' C ' ' N ' ' B' ' 690' ' ' CYS . 18.7 Cg_endo -71.7 59.28 2.7 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.35 -1.827 . . . . 6.7800000000000002 107.35 171.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 963' ' ' CYS . 11.8 mttt -46.29 -18.35 0.05 Allowed 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.017 -2.216 . . . . 6.4000000000000004 105.017 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . 0.792 ' SG ' ' O ' ' A' ' 961' ' ' GLU . 47.0 m -109.49 103.24 52.35 Favored Pre-proline 0 N--CA 1.419 -2.004 0 CA-C-N 110.445 -3.071 . . . . 2.2000000000000002 108.394 175.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.81 158.02 5.0 Favored 'Trans proline' 0 CA--C 1.507 -0.874 0 N-CA-C 108.097 -1.54 . . . . 1.1200000000000001 108.097 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.85 136.21 57.75 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.18 -1.008 . . . . 1.6000000000000001 110.074 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.73 -44.53 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 1.5700000000000001 111.865 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 69.3 mt -62.27 -41.94 98.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 1.8999999999999999 110.428 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.49 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 1.3799999999999999 111.031 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.448 ' O ' ' OG ' ' B' ' 699' ' ' SER . 92.4 t -62.92 -45.65 98.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 1.7 110.009 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.71 -43.01 98.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 1.8700000000000001 111.542 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.13 -41.59 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 1.45 110.166 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 13.4 p -61.79 -42.59 99.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.319 -0.4 . . . . 0.27000000000000002 111.179 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.15 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 120.649 -0.421 . . . . 1.26 109.926 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 88.1 mtp -60.79 -39.05 87.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 1.54 109.9 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.11 -41.38 95.05 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.635 -0.986 . . . . 0.20000000000000001 110.635 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.07 89.12 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.954 0.407 . . . . 1.0800000000000001 110.021 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.85 -42.27 88.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 118.938 -1.105 . . . . 1.1399999999999999 109.366 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.11 -45.99 89.47 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.64 -0.255 . . . . 2.29 110.599 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.29 -42.98 99.14 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.331 -0.548 . . . . 2.3500000000000001 110.561 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.63 -46.21 95.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.426 -0.51 . . . . 1.4299999999999999 110.863 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.19 -39.47 94.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.639 -0.791 . . . . 0.26000000000000001 111.615 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.47 -28.68 62.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.676 1.362 . . . . 1.9399999999999999 114.676 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -60.1 -54.86 51.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.969 0.804 . . . . 1.0800000000000001 111.405 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.07 -44.9 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.513 1.475 . . . . 0.48999999999999999 111.333 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.59 -42.21 87.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 1.7 110.799 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.88 -41.91 99.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.886 -0.326 . . . . 1.6299999999999999 111.092 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.91 -44.5 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 109.064 -0.717 . . . . 2.1499999999999999 109.064 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.81 -50.11 74.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.584 -0.525 . . . . 0.87 109.584 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -59.84 -43.49 94.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 1.6499999999999999 110.919 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 19.4 tp -62.88 -47.51 83.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 2.3900000000000001 110.514 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.85 -41.9 96.76 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.789 -0.364 . . . . 1.3899999999999999 110.836 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -45.61 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 109.522 -0.547 . . . . 2.1699999999999999 109.522 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 720' ' ' THR . . . . . 0.619 ' O ' ' N ' ' B' ' 724' ' ' ARG . 18.7 m -55.01 -47.41 74.72 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.774 -0.77 . . . . 1.7 109.851 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' B' ' 725' ' ' LYS . 35.9 mt -64.96 -44.0 96.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.999 0.74 . . . . 1.8799999999999999 112.999 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -63.38 -34.02 76.82 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.452 -0.944 . . . . 1.54 108.452 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.592 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 56.5 t0 -82.89 -46.98 12.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.244 -1.343 . . . . 1.8100000000000001 112.429 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . 0.619 ' N ' ' O ' ' B' ' 720' ' ' THR . 0.2 OUTLIER -78.58 -47.66 16.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.027 0.38 . . . . 5.1399999999999997 112.027 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.484 ' O ' ' CD1' ' B' ' 727' ' ' PHE . 5.2 tttt -43.06 109.11 0.12 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.338 -0.545 . . . . 5.4400000000000004 109.851 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.56 112.53 7.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.479 0.657 . . . . 6.8899999999999997 111.79 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 725' ' ' LYS . 25.2 m-85 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 114.847 -1.07 . . . . 10.960000000000001 109.753 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . 0.456 ' H2 ' ' H ' ' A' ' 958' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . 0.456 ' H ' ' H2 ' ' A' ' 957' ' ' GLY . . . -63.76 -37.89 89.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.701 0.286 . . . . 1.0 110.533 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.09 126.37 55.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.486 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.94 -38.8 89.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 51.44 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -75.01 143.2 43.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.743 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.26 -36.63 77.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.748 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.51 82.56 53.42 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.609 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.61 145.89 98.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.051 1.834 . . . . 1.0 111.13 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . 0.419 ' CG2' ' CE3' ' A' ' 967' ' ' TRP . 20.8 tt -66.97 -37.84 80.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.419 ' CE3' ' CG2' ' A' ' 966' ' ' ILE . 0.0 OUTLIER -53.98 -52.23 61.36 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.47 0.544 . . . . 1.0 112.47 -176.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -58.41 -40.01 81.29 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.765 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 119.796 -0.762 . . . . 1.0 109.223 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.45 -42.93 99.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.678 -1.146 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.17 -45.15 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.638 0.256 . . . . 1.0 111.327 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.31 -38.95 96.54 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.728 -0.749 . . . . 1.0 111.273 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 121.078 -0.249 . . . . 1.0 110.503 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.18 -42.49 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.468 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.21 93.39 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.816 -0.707 . . . . 1.0 111.8 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.61 98.61 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.26 -41.7 99.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.743 -0.269 . . . . 1.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.89 -42.12 98.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.022 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.05 -40.94 95.54 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.152 -1.019 . . . . 1.0 109.764 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.21 -39.0 91.33 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.5 m -63.0 -47.1 84.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.084 -0.647 . . . . 1.0 110.205 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 982' ' ' ILE . 97.4 mt -61.68 -42.5 94.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 120.919 -0.312 . . . . 1.0 111.14 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.62 -42.45 91.53 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.526 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.76 -44.29 99.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.143 0.497 . . . . 1.0 110.938 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.87 -41.43 95.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.12 98.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.776 -0.77 . . . . 1.0 111.305 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.425 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.5 t90 -63.0 -43.05 99.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.41 -34.1 76.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.136 0.493 . . . . 1.0 111.349 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.9 t -77.14 -2.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.78 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.97 8.73 69.64 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.336 -1.505 . . . . 1.0 109.336 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.463 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.77 -45.18 78.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.294 -1.002 . . . . 1.0 108.294 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.4 -22.86 37.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.355 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.83 -39.46 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 118.695 -1.202 . . . . 1.0 108.44 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.482 HH12 ' CG ' ' B' ' 723' ' ' ASP . 78.3 ttt-85 -66.58 121.54 15.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.87 -0.732 . . . . 1.0 110.739 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -155.94 106.83 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.198 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 41.25 74.17 0.78 Allowed Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.727 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 122.823 2.349 . . . . 1.0 112.229 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.96 90.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.0 110.527 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.415 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.4 OUTLIER -169.39 -62.98 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.041 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 36.5 Cg_endo -63.73 145.68 91.3 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.119 1.88 . . . . 1.0 112.19 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -44.44 96.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.642 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.55 165.68 25.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.575 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.29 156.35 63.61 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.393 2.062 . . . . 1.0 111.841 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 -61.76 138.87 58.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.294 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.3 mt -62.33 -43.56 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.626 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.16 -42.0 98.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.168 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 -45.19 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.796 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.461 ' O ' ' OG ' ' B' ' 699' ' ' SER . 67.7 t -63.59 -45.27 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.0 110.664 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . 0.437 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.1 tt -62.64 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.449 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.77 -42.37 97.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.035 0.445 . . . . 1.0 110.346 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 52.1 p -62.22 -36.82 83.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 68.1 t -63.99 -44.87 97.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.094 0.473 . . . . 1.0 109.922 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.0 mtp -61.54 -39.51 91.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.992 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.84 96.89 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.43 89.22 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.677 0.275 . . . . 1.0 110.51 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.9 mm -62.74 -43.08 98.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.025 -0.67 . . . . 1.0 109.451 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.26 -44.16 97.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.298 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.1 -43.29 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . 0.419 HG21 HD12 ' B' ' 707' ' ' ILE . 94.1 mt -63.94 -44.24 97.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.523 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.35 -41.9 76.44 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.6 -36.17 81.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.74 -57.84 11.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.4 0.519 . . . . 1.0 112.4 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.35 -40.23 60.18 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.086 1.191 . . . . 1.0 111.901 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.17 -42.7 93.45 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.3 -41.82 98.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . 0.41 HD12 HG21 ' B' ' 714' ' ' ILE . 95.2 mt -63.63 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.295 -0.562 . . . . 1.0 109.652 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.421 ' NE1' ' CD1' ' B' ' 719' ' ' ILE . 8.8 t90 -62.37 -48.17 80.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.165 0.507 . . . . 1.0 109.863 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -61.03 -42.54 98.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.004 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.24 -44.49 95.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.5 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.76 -41.79 98.15 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.286 0.565 . . . . 1.0 110.346 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.421 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 95.8 mt -62.51 -46.96 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.165 -1.014 . . . . 1.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 89.2 m -57.74 -46.01 85.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.454 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.57 -43.4 96.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.186 -0.606 . . . . 1.0 110.852 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.32 -36.33 83.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.482 ' CG ' HH12 ' A' ' 995' ' ' ARG . 8.0 m-20 -68.2 -39.79 82.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.38 -39.89 95.76 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.299 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.06 133.95 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.42 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.3 125.13 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.546 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.501 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.98 89.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 1.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.96 140.81 43.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.486 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.25 135.95 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . 0.522 ' CD ' ' HZ3' ' B' ' 689' ' ' LYS . 97.3 mt-10 -119.03 128.13 54.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.252 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -129.09 142.72 50.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.42 151.91 35.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.888 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 18.1 mt 57.01 78.96 0.35 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.419 -0.809 . . . . 1.0 111.711 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -62.25 149.68 89.73 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.52 2.147 . . . . 1.0 111.255 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.07 -42.94 98.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.165 1.172 . . . . 1.0 114.165 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -52.94 54.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.73 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -58.09 -39.22 78.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.751 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.27 -45.22 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.629 0.728 . . . . 1.0 109.156 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.46 -42.86 99.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.645 -1.161 . . . . 1.0 110.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.28 -44.49 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.847 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.44 93.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.447 -0.882 . . . . 1.0 110.913 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.46 -46.03 97.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.804 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.24 -42.62 99.24 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.8 93.34 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.807 -0.711 . . . . 1.0 111.454 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.13 -42.49 99.73 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.07 -42.12 99.6 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.837 -0.214 . . . . 1.0 110.791 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.17 -41.27 98.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.196 -0.601 . . . . 1.0 109.9 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.97 -41.43 98.0 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.231 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -43.19 99.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.981 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.2 m -61.84 -47.02 86.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.601 -0.44 . . . . 1.0 111.219 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.29 -43.92 98.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.605 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.33 -43.27 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.1 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.351 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.21 -42.31 99.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.47 99.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.321 -0.552 . . . . 1.0 111.566 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 65.7 mtt -65.21 -42.39 93.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 1.0 111.37 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.72 -43.69 95.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.232 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -34.06 76.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.07 0.462 . . . . 1.0 111.893 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.28 -1.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.535 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 69.83 10.44 64.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.79 -1.724 . . . . 1.0 108.79 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -44.43 72.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.8 m-85 -82.81 -12.25 57.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.816 -0.754 . . . . 1.0 110.705 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.27 -11.37 59.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.756 -1.202 . . . . 1.0 107.756 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.538 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.6 ttt-85 -66.48 131.26 45.66 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.057 -0.657 . . . . 1.0 109.698 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 64.8 t30 56.39 38.32 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.167 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -160.48 66.86 2.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--N 1.305 -1.729 0 C-N-CA 122.803 2.335 . . . . 1.0 112.106 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.501 -1.44 . . . . 1.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 55.21 30.51 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 1.0 110.607 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 20.5 p -172.72 72.67 0.42 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.626 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.61 145.3 97.75 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.883 2.389 . . . . 1.0 111.937 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . 0.522 ' HZ3' ' CD ' ' A' ' 961' ' ' GLU . 98.8 mttt -63.05 -42.01 99.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.618 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . 0.463 ' CB ' ' CD ' ' B' ' 691' ' ' PRO . 0.0 OUTLIER -85.75 -178.36 1.13 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.371 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' B' ' 690' ' ' CYS . 12.1 Cg_exo -67.58 154.46 73.47 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.545 2.163 . . . . 1.0 110.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.25 139.32 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.328 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.69 -43.68 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 1.0 112.305 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.42 -42.15 99.22 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.497 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.35 -45.2 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.6 t -63.79 -44.69 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.019 0.438 . . . . 1.0 110.453 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.04 -43.43 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.0 mt -64.14 -42.27 96.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.117 0.484 . . . . 1.0 110.663 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 48.6 p -62.27 -39.52 93.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 1.0 112.203 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.42 -45.87 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 1.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.49 -39.38 94.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.797 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.14 97.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.04 90.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.02 0.438 . . . . 1.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.2 mm -60.84 -42.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.329 -0.948 . . . . 1.0 108.82 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.2 -44.18 97.69 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.831 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -44.02 95.78 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.136 -0.626 . . . . 1.0 110.227 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.26 98.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.581 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.51 -41.89 89.65 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.43 -37.82 83.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.33 -56.58 20.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 120.187 -0.605 . . . . 1.0 112.313 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -53.83 -44.35 49.97 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.192 1.261 . . . . 1.0 111.734 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.73 -42.46 95.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.852 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.96 -39.75 94.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 1.0 110.173 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -46.93 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.461 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.421 ' NE1' ' CD1' ' B' ' 719' ' ' ILE . 9.2 t90 -63.43 -47.29 82.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.282 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -44.12 95.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.816 0.302 . . . . 1.0 111.816 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . 0.406 HD22 ' N ' ' B' ' 717' ' ' LEU . 1.5 mm? -63.29 -42.09 99.04 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.473 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.0 -41.61 98.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.421 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 92.2 mt -63.23 -45.05 99.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.213 -0.595 . . . . 1.0 110.234 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.3 m -60.35 -47.14 87.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.864 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.53 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.388 . . . . 1.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 725' ' ' LYS . 7.6 m80 -58.98 -41.57 87.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.183 -0.607 . . . . 1.0 109.519 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.538 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 3.0 m-20 -65.68 -38.14 88.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.136 -0.484 . . . . 1.0 112.146 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.78 -39.33 93.43 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.411 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' B' ' 722' ' ' HIS . 68.8 mttm -103.12 145.85 29.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.992 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 138.44 58.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.572 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.59 179.79 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.531 -1.428 . . . . 1.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.97 89.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.784 0.326 . . . . 1.0 110.536 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.97 -42.12 99.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.87 -39.38 90.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.44 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.93 138.7 58.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -128.33 145.31 51.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.436 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.46 148.43 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 60.3 mt 56.15 79.69 0.32 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.278 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -60.77 149.25 88.89 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.445 2.097 . . . . 1.0 111.21 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.99 -39.17 82.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 113.715 1.006 . . . . 1.0 113.715 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -51.84 66.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.699 -0.801 . . . . 1.0 111.181 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -57.38 -37.9 73.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.244 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.11 -44.74 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.24 -42.49 99.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.024 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.27 -44.76 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.0 110.948 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.56 95.73 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.11 -45.2 99.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.345 -0.242 . . . . 1.0 110.345 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.03 -42.49 99.79 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.284 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.63 96.1 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.768 -0.73 . . . . 1.0 111.298 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -41.83 99.61 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.93 -40.94 99.15 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.746 -0.267 . . . . 1.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.37 -42.11 99.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.202 -0.599 . . . . 1.0 110.582 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.05 -41.16 97.84 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.52 -41.19 96.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 1.0 110.677 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.7 m -61.5 -47.13 87.02 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.471 -0.492 . . . . 1.0 111.469 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 982' ' ' ILE . 94.8 mt -63.17 -44.23 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.64 -42.44 98.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.134 -0.626 . . . . 1.0 111.468 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.07 -45.65 98.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.881 -0.327 . . . . 1.0 111.105 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.14 -42.11 99.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.52 99.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.55 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.1 mtt -65.17 -42.38 93.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 111.355 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.581 ' CD1' ' NZ ' ' A' ' 994' ' ' LYS . 10.9 t90 -63.12 -43.42 98.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 1.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.57 -34.7 77.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.118 0.485 . . . . 1.0 111.417 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 52.1 t -76.96 -3.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 1.0 109.856 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.68 73.28 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.402 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.26 -45.45 76.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.277 -1.008 . . . . 1.0 108.277 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.408 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.5 m-85 -79.86 -24.31 41.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.354 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.581 ' NZ ' ' CD1' ' A' ' 988' ' ' TRP . 56.1 mttp -64.3 -39.55 94.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.816 -1.154 . . . . 1.0 108.704 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.526 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.1 ttt-85 -66.13 132.0 47.48 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.147 -0.621 . . . . 1.0 110.555 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 997' ' ' ARG . 52.3 p-10 -146.51 -28.84 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 996' ' ' ASN . 3.8 ttm180 -174.05 74.49 0.35 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.699 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 C--N 1.307 -1.622 0 C-N-CA 122.597 2.198 . . . . 1.0 112.146 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.539 -1.424 . . . . 1.0 109.539 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 147.0 50.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 1.0 110.563 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 2.7 m 42.51 70.38 1.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.515 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.89 -37.63 85.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.014 2.476 . . . . 1.0 112.092 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.71 -41.81 99.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.481 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.58 173.07 8.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.906 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.51 142.81 96.29 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.968 1.779 . . . . 1.0 112.047 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -67.7 140.97 56.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.594 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . 0.404 HD12 HG23 ' B' ' 693' ' ' ILE . 95.6 mt -62.06 -43.69 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.335 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.97 -42.05 99.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.951 -0.299 . . . . 1.0 110.977 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.09 -44.95 99.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.969 0.414 . . . . 1.0 111.053 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.2 t -64.19 -43.79 97.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.404 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.47 -43.4 98.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.751 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.1 -41.34 95.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.19 0.519 . . . . 1.0 110.349 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 30.7 p -62.37 -37.11 84.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.165 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.43 -44.9 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.353 -0.539 . . . . 1.0 109.916 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.7 mtp -61.92 -40.0 93.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.197 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.04 -41.51 97.17 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.27 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 1.0 110.409 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.3 mm -62.95 -43.18 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.447 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 52.5 tp -59.5 -47.7 84.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.331 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.96 -42.5 99.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.206 -0.598 . . . . 1.0 111.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.56 -44.38 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.726 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.33 94.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 713' ' ' LEU . 86.2 mt -67.02 -37.56 84.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.65 -57.23 16.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.008 -0.677 . . . . 1.0 112.092 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.24 -45.14 42.61 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.917 1.078 . . . . 1.0 111.331 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.35 -41.87 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.448 -0.797 . . . . 1.0 110.86 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 709' ' ' LEU . 35.6 mt -62.8 -41.43 99.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.961 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.5 -44.34 98.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.408 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.8 t90 -63.04 -48.6 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 1.0 109.803 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.68 -45.73 93.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.555 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.81 -46.14 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.036 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.35 -43.11 98.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.617 0.599 . . . . 1.0 112.617 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 6.9 tt -67.19 -41.37 86.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.896 -0.722 . . . . 1.0 109.924 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 88.8 m -60.66 -44.83 95.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.819 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . 0.414 HD13 HG22 ' B' ' 721' ' ' ILE . 93.9 mt -62.29 -43.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.062 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -60.08 -40.85 90.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.04 -0.664 . . . . 1.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 62.9 t0 -65.67 -41.07 92.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.354 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.78 -39.28 93.35 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.729 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.54 133.35 50.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.728 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.48 138.93 57.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.452 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.065 -0.969 . . . . 1.0 110.571 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.504 -1.438 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -150.88 152.17 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.713 0.292 . . . . 1.0 110.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.4 mt -109.82 130.84 55.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.359 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.35 138.52 58.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.662 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.26 146.76 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.446 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -129.21 145.55 51.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.69 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.401 ' O ' ' CG2' ' A' ' 964' ' ' ILE . 1.6 m -104.86 109.79 21.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.272 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.401 ' CG2' ' O ' ' A' ' 963' ' ' CYS . 1.3 pt -159.19 70.36 3.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.39 145.9 97.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.157 1.905 . . . . 1.0 110.812 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.91 -25.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -49.84 74.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 119.573 -0.851 . . . . 1.0 111.334 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -57.72 -39.12 76.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.279 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.19 -45.28 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 119.826 -0.749 . . . . 1.0 109.083 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.59 -42.17 99.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.652 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.8 -44.63 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.821 0.344 . . . . 1.0 110.86 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.97 96.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.4 t -61.98 -45.19 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 121.158 -0.217 . . . . 1.0 110.529 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.22 -42.5 99.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.806 0.336 . . . . 1.0 111.479 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.49 -43.54 94.55 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.23 -43.02 99.69 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.45 -41.95 98.65 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.756 -0.261 . . . . 1.0 110.951 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.14 -42.11 98.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 1.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.51 -41.25 97.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.859 -0.736 . . . . 1.0 109.492 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.05 -41.95 98.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.304 -0.559 . . . . 1.0 111.238 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.1 m -61.72 -47.4 85.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.896 -0.321 . . . . 1.0 111.211 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.32 -43.76 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.554 -0.459 . . . . 1.0 111.326 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.71 -43.05 97.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.89 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 1.0 111.273 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.31 -42.56 99.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.28 94.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.022 0.378 . . . . 1.0 112.022 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.66 -42.45 91.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.411 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -64.42 -41.92 96.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.869 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.59 -33.48 75.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.24 0.543 . . . . 1.0 110.44 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 62.0 t -77.31 -2.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.261 -0.882 . . . . 1.0 109.95 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.85 8.21 72.31 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.273 -1.531 . . . . 1.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -56.11 -45.95 79.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -72.53 -32.01 65.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.76 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.3 95.38 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 118.494 -1.282 . . . . 1.0 109.1 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.597 HH12 ' CG ' ' B' ' 723' ' ' ASP . 7.4 mmt180 -145.11 148.5 33.7 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.176 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' B' ' 720' ' ' THR . 57.4 t30 -93.46 107.63 19.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.399 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 998' ' ' PRO . 0.1 OUTLIER 178.76 -49.25 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.103 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 997' ' ' ARG . 51.9 Cg_exo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.146 1.897 . . . . 1.0 112.066 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.91 137.25 54.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.724 0.297 . . . . 1.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.5 OUTLIER 70.06 179.89 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 23.3 Cg_exo -61.84 145.16 97.26 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.289 1.993 . . . . 1.0 111.758 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.86 -42.21 97.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.701 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 48.7 t -137.69 82.01 27.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.363 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.22 144.79 98.99 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.844 2.363 . . . . 1.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -65.79 138.68 58.08 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.949 0.881 . . . . 1.0 111.995 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . 0.404 HD12 HG23 ' B' ' 693' ' ' ILE . 88.0 mt -62.13 -44.73 99.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.199 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . 0.448 ' N ' ' CD2' ' B' ' 694' ' ' LEU . 4.1 mm? -61.17 -42.05 97.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.948 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.23 -43.9 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.647 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.4 t -65.31 -43.71 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 1.0 110.799 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.95 -42.7 99.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.699 0.761 . . . . 1.0 111.637 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.81 -42.71 94.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.554 0.692 . . . . 1.0 110.697 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 58.0 p -61.27 -37.67 83.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.595 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.75 -45.32 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.8 mtp -62.07 -39.91 94.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.408 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.31 95.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.36 87.59 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.755 0.312 . . . . 1.0 110.378 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.0 mm -63.01 -42.78 97.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.65 -45.66 93.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.493 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.11 -42.53 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.377 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.68 -43.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.65 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.67 -38.71 93.41 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.533 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.93 -38.23 85.79 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.21 -56.96 18.83 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.242 -0.583 . . . . 1.0 112.271 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -54.67 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.067 1.178 . . . . 1.0 111.612 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.23 -41.89 93.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.905 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.18 -41.71 98.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.121 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.44 -44.15 98.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.414 ' NE1' ' CD1' ' B' ' 719' ' ' ILE . 7.1 t90 -60.89 -48.91 79.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.332 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.38 -42.87 96.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.573 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.1 -44.06 97.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.521 -0.471 . . . . 1.0 110.373 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.36 -42.11 99.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.269 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.414 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 94.5 mt -62.85 -44.68 99.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.953 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 720' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 996' ' ' ASN . 99.6 m -59.64 -46.69 88.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.971 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.59 -43.82 98.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 1.0 112.23 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -64.73 -41.12 96.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.597 ' CG ' HH12 ' A' ' 995' ' ' ARG . 46.3 m-20 -68.05 -40.64 82.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.086 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' B' ' 727' ' ' PHE . 72.7 ttt180 -123.44 114.81 20.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.8 -41.01 98.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.454 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.6 -39.18 93.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.494 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . 0.414 ' H ' ' HG2' ' B' ' 724' ' ' ARG . 83.3 t80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.065 -0.969 . . . . 1.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.87 88.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.749 0.309 . . . . 1.0 110.617 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.1 131.42 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.499 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -117.48 134.88 54.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.149 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -134.95 149.34 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.994 0.426 . . . . 1.0 110.457 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.04 -42.4 98.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.094 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.5 m -53.54 -34.11 57.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.894 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.09 83.99 45.2 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.318 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.57 147.75 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.391 2.061 . . . . 1.0 112.334 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.42 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.772 -1.104 . . . . 1.0 113.904 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -52.36 50.97 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.459 -0.496 . . . . 1.0 111.532 -176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -57.62 -39.21 76.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.349 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.1 -45.5 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.65 -41.8 99.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.414 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 67.8 t -63.14 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.887 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.85 96.52 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.87 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.298 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.32 -43.22 98.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.15 91.58 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.894 -0.669 . . . . 1.0 111.949 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.78 -41.36 99.61 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 120.365 -0.922 . . . . 1.0 110.804 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.86 -41.44 99.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.82 -41.58 99.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.052 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.35 -41.17 98.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.353 -0.939 . . . . 1.0 109.641 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.96 -41.31 97.86 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.007 0.908 . . . . 1.0 110.972 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 37.0 m -61.37 -46.51 89.9 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 118.596 -1.242 . . . . 1.0 111.018 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.83 -42.62 97.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.042 -0.663 . . . . 1.0 110.555 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.03 -41.81 97.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.363 -178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.65 -44.87 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 123.328 0.393 . . . . 1.0 110.6 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.89 -42.03 97.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.27 99.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.884 0.849 . . . . 1.0 111.437 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.86 -40.98 97.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -64.6 -45.44 86.96 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.349 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.88 -33.55 74.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 10.9 m -85.57 0.87 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.82 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 74.19 15.07 80.15 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.347 -1.297 . . . . 1.0 110.967 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.512 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.88 -45.18 67.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.565 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 45.5 m-85 -81.82 -3.31 53.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.564 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 991' ' ' GLY . 75.5 mmtt -105.78 11.77 31.63 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.521 ' NH1' ' OD1' ' A' ' 996' ' ' ASN . 78.2 ttt-85 -66.47 130.99 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.061 -0.656 . . . . 1.0 109.739 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . 0.521 ' OD1' ' NH1' ' A' ' 995' ' ' ARG . 11.8 m120 55.81 35.1 24.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.343 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -170.61 69.35 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.536 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.305 -1.739 0 C-N-CA 122.684 2.256 . . . . 1.0 112.175 179.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.02 138.08 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.1 OUTLIER -66.25 -179.95 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.194 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 22.9 Cg_exo -61.76 145.29 97.4 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.108 1.872 . . . . 1.0 111.891 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.07 -41.92 99.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.648 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.54 171.17 6.72 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.24 143.25 98.25 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.563 1.508 . . . . 1.0 111.638 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.82 140.26 57.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.013 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.58 -43.58 98.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.98 -41.7 99.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.053 -0.259 . . . . 1.0 111.137 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.8 -46.41 96.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' B' ' 699' ' ' SER . 18.9 m -65.54 -40.38 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.134 -0.627 . . . . 1.0 110.235 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.98 -43.97 97.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.727 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.103 0.478 . . . . 1.0 110.695 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.27 -38.1 88.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.902 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.48 -45.14 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.125 0.488 . . . . 1.0 110.388 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.11 -38.98 90.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.22 -41.6 96.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.279 -1.129 . . . . 1.0 110.279 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.89 86.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 1.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.6 mm -62.61 -43.07 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.376 -0.601 . . . . 1.0 109.376 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.16 -44.46 97.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.332 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.82 -43.33 99.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.908 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.64 98.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.64 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.13 88.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.23 -38.07 84.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.769 1.025 . . . . 1.0 113.769 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.34 -57.01 18.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.024 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -54.65 -44.65 47.57 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.14 1.227 . . . . 1.0 111.604 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.93 -41.64 95.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.585 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.59 -41.46 98.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.196 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.12 -44.22 99.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.565 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.6 t90 -62.36 -48.77 78.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.595 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.5 OUTLIER -60.53 -45.02 95.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.446 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.58 -42.34 98.31 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.988 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.98 -42.46 99.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.706 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 3.9 mm -63.84 -44.26 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.19 -0.604 . . . . 1.0 109.709 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.6 m -60.37 -45.78 92.3 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.81 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.08 -43.69 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.868 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -62.35 -40.52 96.68 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.686 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.441 ' OD1' ' OD1' ' A' ' 996' ' ' ASN . 31.6 t70 -66.02 -39.82 90.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.773 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -112.32 102.29 10.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 1.0 110.478 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -41.98 99.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.608 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.07 -38.95 89.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.52 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.38 142.58 56.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.0 110.611 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.94 -41.79 99.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -65.55 135.84 55.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.63 -37.67 85.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.815 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -61.15 -42.98 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.543 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.2 m -90.09 139.43 30.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 1.0 111.032 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 7.9 mt 38.78 69.38 1.6 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 1.0 111.57 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -62.54 150.12 88.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.443 2.095 . . . . 1.0 111.544 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.24 -42.79 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.141 1.164 . . . . 1.0 114.141 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.45 52.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.694 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -57.75 -37.76 74.19 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.622 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.3 t -64.1 -44.74 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.45 -42.38 99.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.706 -1.134 . . . . 1.0 110.173 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.44 -44.8 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.071 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.11 -38.33 95.4 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.5 t -61.86 -45.07 99.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.09 -42.68 99.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.811 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.87 -43.26 96.32 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.319 -0.713 . . . . 1.0 111.319 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.67 99.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.45 -42.05 98.65 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.523 -0.398 . . . . 1.0 111.135 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.51 -41.33 98.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.196 -0.601 . . . . 1.0 110.726 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.9 -41.49 97.97 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.673 -0.811 . . . . 1.0 109.797 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.21 -41.53 98.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.359 -0.536 . . . . 1.0 111.176 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.88 -46.97 87.11 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.542 -0.463 . . . . 1.0 111.16 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.05 -43.66 99.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.27 -42.46 99.14 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.733 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.46 -45.57 98.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.683 0.278 . . . . 1.0 111.123 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.06 -42.24 99.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.284 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.52 98.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.985 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.86 -41.98 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.878 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.429 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.0 t90 -64.11 -43.82 94.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.297 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.31 -34.3 76.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.052 0.454 . . . . 1.0 111.465 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.32 -1.62 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 70.57 11.59 68.85 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -45.06 70.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.51 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 62.4 m-85 -86.99 -10.29 53.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.56 38.15 3.36 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.588 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 62.1 ttp180 -64.63 129.22 39.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -107.7 7.62 28.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.148 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.439 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 32.7 mtp180 -78.54 156.78 77.99 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.364 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 C--N 1.312 -1.388 0 C-N-CA 122.499 2.133 . . . . 1.0 112.218 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.749 0.309 . . . . 1.0 110.4 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 6.3 m -138.38 75.57 38.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.566 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -38.13 86.17 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.749 2.299 . . . . 1.0 112.005 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -127.05 144.92 50.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.7 t 55.41 62.94 6.99 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 121.162 0.506 . . . . 1.0 110.544 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.85 159.66 52.51 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.856 2.371 . . . . 1.0 112.132 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.1 141.88 58.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.297 0.57 . . . . 1.0 110.767 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.9 -41.51 89.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.516 -0.766 . . . . 1.0 111.192 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 11.1 mp -63.68 -41.43 98.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 1.0 110.791 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.27 -45.28 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.354 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' B' ' 699' ' ' SER . 77.3 t -64.04 -45.43 96.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.078 0.466 . . . . 1.0 110.707 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.71 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.873 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.14 -42.67 96.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 1.0 110.591 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.6 p -61.85 -38.95 90.16 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 72.5 t -64.67 -45.41 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.231 0.539 . . . . 1.0 110.094 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.3 mtp -62.61 -40.28 96.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.655 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.32 -41.99 97.95 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.501 -1.04 . . . . 1.0 110.501 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.46 86.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.957 0.408 . . . . 1.0 110.174 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.17 -42.31 94.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.765 -0.774 . . . . 1.0 109.576 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.73 -44.05 97.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.617 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.06 -43.62 98.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.751 -0.779 . . . . 1.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.07 -47.92 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 1.0 111.673 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.47 -39.22 80.07 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.862 -0.685 . . . . 1.0 111.546 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.13 -37.4 81.05 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.526 0.935 . . . . 1.0 113.526 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.17 -56.32 23.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.955 -176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -53.29 -43.07 60.43 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.125 1.217 . . . . 1.0 112.187 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.28 -41.49 94.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.218 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.07 -41.34 99.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.38 -43.98 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.51 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 8.6 t90 -60.77 -48.49 81.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.314 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.36 94.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.482 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.1 -45.14 94.8 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.431 -0.507 . . . . 1.0 110.645 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . 0.518 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 87.0 mt -61.5 -42.28 98.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.683 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.563 ' CG2' ' NH2' ' A' ' 995' ' ' ARG . 92.0 mt -63.42 -44.11 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.513 -0.475 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -59.84 -46.61 88.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.834 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.03 -43.04 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.966 -0.294 . . . . 1.0 111.621 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 47.1 m80 -58.21 -39.97 80.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.789 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.588 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 55.4 m-20 -63.69 -38.78 92.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.304 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.91 -42.71 99.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.21 -0.596 . . . . 1.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 57.2 75.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.434 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.86 -38.82 89.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.242 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . 0.446 ' OXT' ' CD2' ' B' ' 727' ' ' PHE . 89.2 t80 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.666 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . 0.435 ' O ' ' OE2' ' A' ' 961' ' ' GLU . . . -63.93 -38.26 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.686 0.279 . . . . 1.0 110.766 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.03 -41.7 99.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.754 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.28 -35.63 80.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.268 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 958' ' ' ALA . 80.0 mm-40 63.28 33.23 14.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.796 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -129.25 138.66 51.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.795 0.331 . . . . 1.0 110.336 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.3 m -86.41 -31.63 21.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.479 0.548 . . . . 1.0 112.479 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 3.1 tt -140.96 74.04 26.33 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.353 -0.539 . . . . 1.0 112.074 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.36 149.31 91.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.632 2.222 . . . . 1.0 111.356 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.25 -42.73 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -52.2 50.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.384 -176.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -57.67 -38.59 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.572 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 73.1 t -64.12 -45.35 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.098 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.57 -42.69 99.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.303 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 75.9 t -63.28 -44.72 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.04 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.52 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.308 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 64.2 t -61.55 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 1.0 110.225 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.32 -42.63 99.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.769 0.319 . . . . 1.0 111.644 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.39 -45.41 90.61 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.97 -43.03 99.74 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.15 -41.89 99.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.806 -0.232 . . . . 1.0 110.518 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.11 -41.97 98.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.535 -0.466 . . . . 1.0 109.78 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.7 -41.55 97.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.756 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.4 mt -61.87 -41.65 98.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.677 -0.409 . . . . 1.0 111.074 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.1 m -61.46 -46.98 87.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.952 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 982' ' ' ILE . 94.8 mt -63.12 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.155 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.0 -43.06 99.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.645 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.79 -45.75 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.708 0.289 . . . . 1.0 111.028 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.28 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.52 -42.97 99.86 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.399 -0.52 . . . . 1.0 111.226 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.72 -42.75 95.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.877 0.37 . . . . 1.0 111.476 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.432 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.7 t90 -63.25 -43.55 97.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.23 -35.38 78.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.007 0.432 . . . . 1.0 111.569 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.53 -2.57 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.441 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.33 10.87 70.73 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.175 -1.57 . . . . 1.0 109.175 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -45.23 73.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.409 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.0 m-85 -81.26 -16.82 51.47 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.786 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.03 35.99 3.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.628 HH22 ' CB ' ' B' ' 723' ' ' ASP . 54.8 ptt85 -68.45 141.16 55.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.495 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.55 40.93 29.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.623 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.11 162.11 0.15 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.303 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 122.755 2.303 . . . . 1.0 112.063 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 1.0 109.558 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.23 -38.58 88.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 1.0 110.404 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.547 ' N ' ' CD ' ' B' ' 688' ' ' PRO . 0.3 OUTLIER 178.0 -44.73 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.882 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' B' ' 687' ' ' SER . 22.6 Cg_exo -61.86 145.74 96.88 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.219 1.946 . . . . 1.0 111.986 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . 0.499 ' O ' ' SG ' ' B' ' 690' ' ' CYS . 99.2 mttt -77.61 145.88 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' B' ' 689' ' ' LYS . 0.5 OUTLIER 58.34 151.06 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.44 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -71.39 157.3 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.705 2.27 . . . . 1.0 113.327 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.05 157.19 38.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.623 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.0 mt -62.15 -43.66 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 1.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.39 -42.14 99.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.249 -0.58 . . . . 1.0 110.399 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.43 -45.07 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.419 . . . . 1.0 110.604 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' B' ' 699' ' ' SER . 61.2 t -63.99 -44.22 97.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.07 -43.52 98.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.248 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.41 -42.4 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.0 110.869 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 45.1 p -62.45 -37.45 85.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.751 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.64 -44.9 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 1.0 110.651 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 89.9 mtp -62.97 -39.09 93.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.907 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.59 -42.2 95.69 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.6 84.36 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.808 0.337 . . . . 1.0 111.02 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.8 -42.4 92.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.528 -0.915 . . . . 1.0 108.528 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.64 -45.71 91.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.895 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.92 -42.31 99.75 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.884 -0.726 . . . . 1.0 111.481 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . 0.407 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 31.7 mm -63.69 -45.61 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.803 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.77 -41.02 84.74 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.722 -0.752 . . . . 1.0 111.448 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.49 -37.8 85.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.99 -57.13 19.27 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.201 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' B' ' 707' ' ' ILE . 43.9 Cg_exo -53.85 -43.67 55.97 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.085 1.19 . . . . 1.0 111.337 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.28 -41.82 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.758 -0.656 . . . . 1.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.86 -41.44 99.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.928 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.75 -44.22 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.409 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.0 t90 -62.36 -48.07 81.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -44.61 92.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.16 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . 0.411 ' O ' ' OG1' ' B' ' 720' ' ' THR . 50.7 tp -64.03 -45.54 88.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.258 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.99 -43.24 99.32 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.59 -40.88 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.483 -0.887 . . . . 1.0 110.27 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 720' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 40.6 p -57.72 -44.34 85.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.319 -0.553 . . . . 1.0 110.649 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.38 -43.35 98.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.669 -0.413 . . . . 1.0 111.268 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -64.38 -40.19 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.628 ' CB ' HH22 ' A' ' 995' ' ' ARG . 34.8 t70 -65.92 -39.89 90.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.29 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -61.47 -43.0 99.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.937 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.99 134.5 50.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.523 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -110.61 124.13 51.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.995 -1.002 . . . . 1.0 110.704 -179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.27 143.22 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 1.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.77 -41.65 99.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.448 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 57.05 55.33 6.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.655 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.49 -38.74 90.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.66 146.56 50.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.541 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.2 -25.02 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.643 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 93.9 mt -130.91 77.17 75.86 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.611 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -61.93 148.52 92.96 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.752 2.301 . . . . 1.0 112.7 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.7 -42.33 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.886 -1.052 . . . . 1.0 113.588 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.39 -51.48 45.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.261 -0.575 . . . . 1.0 111.074 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -57.14 -37.84 72.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.254 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.39 -45.0 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 1.0 109.223 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.75 -41.68 99.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.744 -1.117 . . . . 1.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.3 -44.3 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.543 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.02 -39.73 96.07 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.86 -45.78 97.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.606 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.31 -42.78 99.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.5 -46.25 78.68 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.029 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.75 -42.17 99.33 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.649 -0.981 . . . . 1.0 110.649 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.74 -40.86 97.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.939 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.99 -42.25 98.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.18 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.0 mp -61.5 -40.78 95.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 119.058 -1.057 . . . . 1.0 109.76 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.88 -41.31 95.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.281 -0.568 . . . . 1.0 110.508 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.4 m -60.96 -46.76 89.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.462 0.648 . . . . 1.0 110.629 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -44.13 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 119.479 -0.888 . . . . 1.0 111.996 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.27 -41.76 99.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.315 -0.954 . . . . 1.0 111.264 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.86 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.46 -41.7 96.37 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.369 -0.532 . . . . 1.0 110.658 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.036 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.5 mtt -65.28 -42.41 93.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.137 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.652 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.7 t90 -64.26 -42.94 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.889 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.62 -34.5 77.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.117 0.484 . . . . 1.0 111.331 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.05 -1.91 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.678 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.66 8.82 68.42 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.113 -1.595 . . . . 1.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -56.05 -44.24 78.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 117.233 0.516 . . . . 1.0 109.785 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.495 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 36.7 m-85 -81.83 -23.07 36.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.492 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.652 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 68.5 mttm -63.65 -39.06 93.39 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 118.736 -1.185 . . . . 1.0 108.731 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.9 ttt-85 -65.62 120.59 13.21 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.125 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.05 -4.78 10.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.666 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 166.25 151.86 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 122.201 1.934 . . . . 1.0 112.098 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.74 -1.344 . . . . 1.0 109.74 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.97 125.26 53.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.836 0.351 . . . . 1.0 110.468 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' B' ' 687' ' ' SER . 1.9 t 172.73 73.26 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.651 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -53.83 -38.61 85.64 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.891 2.394 . . . . 1.0 112.075 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.47 133.87 50.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.618 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m 53.21 78.68 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.435 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.36 145.38 98.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.715 2.277 . . . . 1.0 112.101 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -65.24 142.94 58.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.28 -43.49 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.34 -42.27 99.25 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.43 -0.508 . . . . 1.0 109.978 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.0 -44.81 99.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.941 0.4 . . . . 1.0 110.189 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.449 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.8 t -63.39 -44.31 98.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.24 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.63 -43.92 97.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.92 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.44 -41.89 96.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.949 0.404 . . . . 1.0 110.661 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 44.7 p -62.41 -37.91 87.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 67.5 t -64.06 -44.77 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.008 0.432 . . . . 1.0 110.245 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 53.6 mtt -63.19 -39.06 93.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.729 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.99 -42.23 92.75 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.32 94.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.225 0.536 . . . . 1.0 110.987 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 23.8 mm -60.0 -42.18 88.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.553 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 91.6 mt -58.94 -44.62 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.338 0.399 . . . . 1.0 110.234 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.35 -41.72 98.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.76 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.04 -45.17 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.374 -0.531 . . . . 1.0 111.188 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.35 -39.73 87.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.526 -0.845 . . . . 1.0 111.117 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . 0.407 HD21 ' N ' ' B' ' 709' ' ' LEU . 1.8 mm? -66.73 -37.88 85.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.44 -56.38 25.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.547 -0.461 . . . . 1.0 112.056 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -53.86 -43.25 59.74 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.097 1.198 . . . . 1.0 111.379 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.31 -41.21 90.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.169 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 37.7 mt -63.05 -42.37 99.71 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 41.5 pt -66.28 -41.75 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.005 -0.678 . . . . 1.0 110.046 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -59.92 -48.84 80.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 110.109 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -42.37 98.44 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.248 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.36 -44.0 96.04 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.38 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.592 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -43.12 95.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.31 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.0 m -59.07 -45.8 89.88 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 119.702 -0.799 . . . . 1.0 110.612 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.79 -43.26 97.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.975 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -64.8 -38.77 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 62.1 t0 -67.48 -41.46 84.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.305 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -135.04 118.19 16.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.32 -44.04 97.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.339 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.78 126.74 55.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.451 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . 0.487 ' OXT' ' CG ' ' B' ' 727' ' ' PHE . 89.3 t80 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.017 -0.992 . . . . 1.0 110.704 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.05 143.12 56.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 1.0 110.594 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.38 126.1 54.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.537 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.19 145.92 49.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.491 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.49 147.35 47.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.63 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -102.25 136.83 41.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.403 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.6 m -88.14 126.92 35.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.422 ' O ' ' CG1' ' A' ' 964' ' ' ILE . 1.3 tt -178.72 69.26 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.837 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -60.97 139.32 84.12 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.087 1.858 . . . . 1.0 111.57 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.99 -44.71 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -55.67 7.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.379 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -57.64 -40.23 78.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 119.347 -0.359 . . . . 1.0 111.814 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.44 -46.2 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.135 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.86 -43.37 98.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.056 -0.974 . . . . 1.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.45 -44.3 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.71 -0.223 . . . . 1.0 110.747 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.11 92.71 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.188 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.77 -46.36 96.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.726 -0.39 . . . . 1.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.43 -43.15 98.27 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.592 0.589 . . . . 1.0 112.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.4 -45.24 91.28 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.921 -0.657 . . . . 1.0 111.734 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.01 99.79 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.75 -41.8 99.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.615 -0.344 . . . . 1.0 110.632 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.26 -42.38 99.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.583 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.27 -40.33 89.97 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.754 -1.178 . . . . 1.0 109.134 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.5 mt -62.59 -41.52 99.0 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.645 -0.822 . . . . 1.0 112.075 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.96 -47.02 86.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.706 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 43.6 pt -64.74 -41.95 93.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.877 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.99 -42.83 99.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.22 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 121.103 -0.239 . . . . 1.0 111.179 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.32 -42.26 98.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.308 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.89 99.77 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.746 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.6 mtp -65.37 -42.35 92.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 1.0 111.252 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.545 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.3 t90 -62.53 -42.5 99.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.83 -33.44 74.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.167 0.508 . . . . 1.0 110.975 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.45 -2.97 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.444 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 72.28 10.1 73.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.513 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.48 -45.25 77.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 -177.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.573 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 49.7 m-85 -79.19 -15.84 57.47 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.16 -0.616 . . . . 1.0 110.49 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.545 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 99.1 mttt -112.94 33.71 4.87 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 991' ' ' GLY . 66.1 ttp85 -66.63 120.07 12.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.205 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.84 -41.5 95.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.801 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.515 ' C ' HH11 ' A' ' 995' ' ' ARG . 0.1 OUTLIER -160.43 160.16 26.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.736 -178.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . 0.526 ' N ' ' NH1' ' A' ' 995' ' ' ARG . 29.8 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 122.454 2.103 . . . . 1.0 111.953 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.816 -1.314 . . . . 1.0 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 686' ' ' GLU . 54.9 mp0 -66.4 -38.72 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 1.0 110.146 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 8.5 m -145.8 75.08 13.32 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.43 145.08 98.43 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.596 2.197 . . . . 1.0 112.004 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.1 -41.93 99.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.78 164.03 64.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.194 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -61.84 151.28 81.94 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.791 1.661 . . . . 1.0 110.965 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -62.0 139.39 58.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.911 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 44.8 pt -62.66 -41.85 93.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.994 -0.548 . . . . 1.0 112.132 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.16 -42.55 99.37 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.4 t -62.32 -44.84 99.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.133 0.492 . . . . 1.0 110.266 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 75.6 t -63.23 -43.74 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.642 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.8 tp -61.33 -44.03 97.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.782 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.16 -42.42 96.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.048 0.452 . . . . 1.0 110.686 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 46.1 p -62.21 -39.05 91.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.58 -44.89 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.119 0.485 . . . . 1.0 110.8 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.87 -39.35 94.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.33 95.47 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.62 80.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.1 mm -61.84 -42.46 94.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.436 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.01 -45.67 93.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.665 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 -42.15 99.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.867 -0.733 . . . . 1.0 111.126 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -45.22 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.965 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.26 64.42 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.869 -0.681 . . . . 1.0 111.984 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 10.4 mp -68.66 -37.8 79.91 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.19 -55.58 32.68 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.303 -0.559 . . . . 1.0 112.24 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.34 -43.14 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.283 1.322 . . . . 1.0 112.424 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.89 -43.16 93.81 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.343 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.75 -40.66 97.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.413 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.15 -44.48 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.573 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.5 t90 -63.43 -48.61 77.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 1.0 110.044 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.614 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' B' ' 720' ' ' THR . 53.3 tp -62.27 -44.36 96.7 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.583 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.81 -42.61 99.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.856 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.25 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 720' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 22.6 p -59.08 -44.19 91.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.608 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.89 -44.43 98.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.504 -0.878 . . . . 1.0 111.203 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -61.54 -39.27 90.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.495 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 4.6 m-20 -65.77 -41.3 92.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.725 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -63.48 -39.47 94.54 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.858 0.361 . . . . 1.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.07 -44.7 96.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.618 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.28 -39.86 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.634 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.544 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 144.9 55.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.745 0.307 . . . . 1.0 110.754 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.5 mt -109.04 129.94 55.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.274 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -113.81 123.35 49.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.87 138.14 55.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -140.76 152.4 45.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.493 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.79 168.31 10.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.608 . . . . 1.0 112.174 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 11.3 pt 32.99 75.97 0.41 Allowed Pre-proline 0 N--CA 1.462 0.131 0 CA-C-N 114.706 -1.134 . . . . 1.0 111.956 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -62.15 148.52 93.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 1.0 111.405 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.3 -42.82 97.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 114.221 1.193 . . . . 1.0 114.221 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -53.07 47.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 1.0 111.691 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -57.09 -39.05 74.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.586 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.75 -45.29 97.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.702 -0.799 . . . . 1.0 109.48 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.061 -0.972 . . . . 1.0 110.479 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.29 -45.12 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.616 -0.266 . . . . 1.0 111.158 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.64 96.07 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.82 -46.0 97.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.506 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.13 -42.78 99.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.791 0.329 . . . . 1.0 111.848 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.01 -46.82 78.62 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.005 -0.617 . . . . 1.0 112.011 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.04 98.31 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.65 -41.43 98.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.97 0.414 . . . . 1.0 110.502 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.88 -42.9 99.62 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.654 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.32 -40.85 95.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.623 -0.831 . . . . 1.0 109.897 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.91 -40.45 95.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.181 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 99.3 m -60.85 -48.2 82.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.209 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -44.15 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 120.275 -0.57 . . . . 1.0 111.769 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.68 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 79.1 t -61.9 -46.18 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 123.158 0.286 . . . . 1.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.26 -42.42 99.16 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.85 97.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.752 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.2 mtt -64.52 -42.47 95.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.263 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -62.97 -44.37 96.24 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -60.95 -32.66 72.18 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.876 -0.515 . . . . 1.0 111.628 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 57.7 t -77.9 -1.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 68.54 12.81 64.6 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.828 -1.709 . . . . 1.0 108.828 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.51 -44.1 68.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.613 -1.254 . . . . 1.0 107.613 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.456 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 59.2 m-85 -81.97 -4.5 56.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.553 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 991' ' ' GLY . 99.4 mttt -108.05 14.44 25.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 175.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.456 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 73.4 ttp85 -66.36 131.04 45.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.008 -0.677 . . . . 1.0 110.533 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -110.39 145.74 37.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.661 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.94 161.88 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--N 1.308 -1.563 0 C-N-CA 122.589 2.192 . . . . 1.0 112.375 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -97.16 138.04 35.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.355 . . . . 1.0 110.32 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.96 174.22 4.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.366 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.94 -39.32 79.16 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.128 1.885 . . . . 1.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.2 146.81 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.572 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . 0.471 ' CB ' ' CD ' ' B' ' 691' ' ' PRO . 0.0 OUTLIER -59.82 -178.54 0.14 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.394 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' B' ' 690' ' ' CYS . 12.5 Cg_exo -67.96 154.27 73.19 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.286 1.99 . . . . 1.0 110.497 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.58 139.66 57.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.352 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.51 -43.63 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.112 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.16 -46.19 97.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' B' ' 699' ' ' SER . 22.3 m -65.47 -40.68 89.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.945 -0.702 . . . . 1.0 110.597 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.92 -43.74 98.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.535 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.12 -42.19 96.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.197 0.522 . . . . 1.0 110.73 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.91 -38.89 92.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.003 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 77.4 t -63.78 -45.27 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.413 -0.515 . . . . 1.0 110.306 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.57 -39.24 93.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.69 97.97 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.91 86.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.831 0.348 . . . . 1.0 110.534 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 25.8 mm -62.65 -42.45 96.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.52 -43.8 98.21 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.427 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.82 -43.07 99.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.89 -44.33 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.691 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.95 -40.4 73.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.917 -0.658 . . . . 1.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 80.5 mt -66.71 -38.14 86.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.86 -56.96 20.0 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.909 -177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -54.09 -44.97 44.52 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.908 1.072 . . . . 1.0 111.774 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.27 -41.77 93.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.595 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.58 -41.46 98.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -63.77 -44.1 98.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.408 -0.59 . . . . 1.0 109.408 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.456 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 10.4 t90 -62.36 -48.53 79.38 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -43.95 97.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.559 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.97 -42.77 99.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.89 -42.12 98.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.509 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.452 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 94.1 mt -63.9 -44.71 98.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.057 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 96.7 m -59.51 -46.52 88.6 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.779 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.73 -43.58 98.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.163 0.506 . . . . 1.0 110.659 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.6 -38.64 90.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.927 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.456 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 7.6 m-20 -69.87 -42.65 73.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.832 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -64.71 -36.42 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.909 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 57.68 48.88 13.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.764 0.316 . . . . 1.0 110.252 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.03 138.52 58.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.145 0.497 . . . . 1.0 110.724 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.9 t80 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.989 -1.005 . . . . 1.0 109.602 179.644 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 959' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.324 -1.51 . . . . 1.0 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 40.75 22.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 1.0 110.796 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 957' ' ' GLY . 88.0 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 1.0 110.47 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -36.58 82.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.72 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.16 14.31 9.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.725 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -62.32 -40.64 96.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.667 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 58.9 m -71.75 -27.11 62.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.012 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 964' ' ' ILE . 2.9 tt -135.94 71.27 63.2 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.456 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.35 150.3 87.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.797 2.331 . . . . 1.0 111.971 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.94 -42.58 97.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -52.04 50.73 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.456 -0.497 . . . . 1.0 111.723 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -57.96 -38.58 76.27 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 121.138 -0.225 . . . . 1.0 111.53 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.2 -45.05 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.49 -42.79 99.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.546 -1.206 . . . . 1.0 110.405 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.86 -44.71 99.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.205 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.55 93.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.614 -0.803 . . . . 1.0 111.163 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.92 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.765 -0.256 . . . . 1.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.96 -41.99 99.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.934 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.57 -43.84 93.85 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.785 -0.721 . . . . 1.0 111.304 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.58 99.66 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.4 tp -63.84 -42.86 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.944 0.372 . . . . 1.0 111.582 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.34 -42.57 99.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.875 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.7 -41.3 97.42 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.904 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 980' ' ' LEU . 1.4 mm? -62.76 -41.03 99.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.036 -0.266 . . . . 1.0 111.536 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 17.9 m -60.52 -45.81 92.47 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.625 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.85 -43.92 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.646 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.89 -44.32 93.38 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.18 -40.62 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.817 -0.753 . . . . 1.0 111.027 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.0 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.56 -42.04 99.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.513 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.64 -42.06 91.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.052 0.453 . . . . 1.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -64.05 -42.4 97.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.752 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.12 -33.46 75.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.032 0.444 . . . . 1.0 111.291 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.27 -0.42 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.476 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 70.67 10.14 66.68 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -44.33 65.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.733 -1.21 . . . . 1.0 107.733 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.502 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 57.6 m-85 -83.13 -5.44 59.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.428 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.6 mttt -95.03 -4.01 47.27 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.563 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 73.4 ttp85 -66.62 124.39 22.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.477 -0.889 . . . . 1.0 110.572 -178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -116.41 7.59 13.88 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.267 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.18 75.92 0.6 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.856 2.371 . . . . 1.0 112.103 -179.813 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.77 -39.43 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 16.8 p 45.14 71.4 1.54 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 -37.45 85.73 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.065 2.51 . . . . 1.0 112.177 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.74 -41.52 99.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.645 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.67 76.72 59.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.31 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.98 146.41 96.3 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.103 2.535 . . . . 1.0 112.687 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 145.63 55.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.28 -43.69 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.035 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.36 -41.98 99.03 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.826 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -45.32 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.743 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.1 t -63.55 -44.96 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 1.0 110.707 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.41 -43.01 99.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.644 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.92 -42.28 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 1.0 110.564 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 55.3 p -62.2 -40.05 94.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 71.4 t -62.69 -45.59 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.729 0.299 . . . . 1.0 110.209 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.5 mtp -63.57 -39.43 94.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.33 99.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.989 -1.244 . . . . 1.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.09 -36.57 80.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.031 0.443 . . . . 1.0 110.184 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.97 -41.88 90.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.034 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.56 -45.81 92.54 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.943 -0.703 . . . . 1.0 110.814 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.08 -42.91 99.75 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.276 -0.57 . . . . 1.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.2 -44.63 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.269 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.77 -40.57 75.66 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.39 -38.16 84.27 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.25 -56.77 20.84 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.908 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.71 -45.3 42.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.174 1.249 . . . . 1.0 111.455 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.09 -41.6 90.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.188 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.08 -41.5 99.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . 0.402 HD11 HG21 ' B' ' 714' ' ' ILE . 94.6 mt -63.5 -44.27 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.502 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 9.5 t90 -62.3 -48.29 80.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.794 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -44.09 96.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.71 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.88 -43.2 99.44 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.47 -42.13 98.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.422 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 94.3 mt -63.56 -44.06 98.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.095 -0.642 . . . . 1.0 109.511 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.8 m -60.26 -47.44 85.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.795 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.18 -43.51 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.175 -0.61 . . . . 1.0 111.47 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -63.39 -35.79 81.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.563 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 28.4 m-20 -67.82 -42.89 80.78 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.72 -39.09 93.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.348 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.28 132.72 47.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.804 0.335 . . . . 1.0 110.552 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -117.99 131.58 56.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.561 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.084 -0.96 . . . . 1.0 110.546 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.33 143.17 56.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 1.0 110.543 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.4 mt -110.09 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.418 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.0 -39.0 89.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.584 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.63 125.94 54.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.372 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.02 134.27 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.341 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 96.8 m -98.67 140.99 32.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.528 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.6 mt 54.22 69.78 2.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.61 149.75 90.08 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.65 2.233 . . . . 1.0 112.008 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.36 -42.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -52.24 50.32 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.418 -0.513 . . . . 1.0 111.615 -176.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -57.74 -37.94 74.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.963 -0.295 . . . . 1.0 111.511 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.97 -44.72 97.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.39 -41.78 98.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.695 -1.139 . . . . 1.0 110.211 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.28 -45.08 99.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.114 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.25 -38.64 95.99 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 68.1 t -62.03 -45.17 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 121.167 -0.213 . . . . 1.0 110.492 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.28 -42.31 99.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.73 0.3 . . . . 1.0 111.535 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.35 -44.43 93.46 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.323 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.85 99.59 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.93 -41.38 99.46 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.79 -0.241 . . . . 1.0 110.353 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.99 -42.57 99.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.235 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.92 -41.51 98.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.155 -1.018 . . . . 1.0 110.081 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.97 -42.18 98.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.95 -0.7 . . . . 1.0 111.228 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.2 m -61.83 -48.05 82.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.635 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.374 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.01 -43.46 98.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.574 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.65 -45.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.603 0.239 . . . . 1.0 111.158 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.76 -42.48 97.8 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.756 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.41 -41.84 98.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.311 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 62.4 mtt -65.14 -42.3 93.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.688 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.435 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.8 t90 -63.65 -42.65 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.64 -34.02 76.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.218 0.533 . . . . 1.0 111.224 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 54.7 t -77.36 -2.39 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.22 68.4 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.043 -1.623 . . . . 1.0 109.043 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -56.13 -44.17 78.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.095 0.448 . . . . 1.0 109.946 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -83.59 -21.06 32.71 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.6 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.76 -39.12 93.19 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 118.499 -1.281 . . . . 1.0 108.492 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -65.59 126.84 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.357 -0.937 . . . . 1.0 110.126 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -121.04 -60.31 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.224 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 176.95 62.08 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.541 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 C-N-CA 122.798 2.332 . . . . 1.0 112.112 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.0 -38.86 89.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 1.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 5.3 t 60.52 61.97 3.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.656 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -71.88 152.23 57.66 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.715 2.277 . . . . 1.0 112.473 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.97 84.24 44.66 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.444 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.54 147.06 96.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.583 2.189 . . . . 1.0 112.107 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.98 141.2 58.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 1.0 110.387 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.35 -44.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.85 -43.78 95.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.91 -41.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.357 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' B' ' 699' ' ' SER . 64.3 t -63.56 -45.97 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . 0.431 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.2 tt -62.98 -42.65 99.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.802 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.84 -42.43 97.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.092 0.472 . . . . 1.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 53.6 p -62.06 -37.94 86.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.181 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.62 -45.14 98.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.068 0.461 . . . . 1.0 110.109 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.7 mtp -61.77 -40.0 93.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.591 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.94 98.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.047 -1.221 . . . . 1.0 110.047 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.51 80.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.742 0.306 . . . . 1.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 30.7 mm -62.54 -42.11 94.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.27 -43.93 96.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.489 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.32 -44.32 91.93 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.25 -41.76 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 119.775 -0.77 . . . . 1.0 110.775 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.74 93.12 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.99 -38.29 85.77 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.68 -56.03 27.0 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 112.408 0.522 . . . . 1.0 112.408 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -53.37 -41.96 69.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.293 1.329 . . . . 1.0 111.594 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.5 mt -66.26 -41.49 89.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.381 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.47 -41.9 98.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 7.8 tt -65.69 -38.99 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 119.945 -0.702 . . . . 1.0 109.523 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.21 -49.11 79.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -42.71 99.28 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.87 -46.31 89.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.214 -0.594 . . . . 1.0 110.91 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.62 -41.83 99.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.335 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.74 -42.77 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 30.7 m -58.63 -45.74 88.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.501 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.89 -43.83 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.058 0.456 . . . . 1.0 111.077 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -62.25 -40.98 97.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.209 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' B' ' 725' ' ' LYS . 6.8 m-20 -65.88 -38.48 88.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.523 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 60.6 -4.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.026 0.441 . . . . 1.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' B' ' 723' ' ' ASP . 75.4 mmtt -63.24 -41.99 99.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -117.13 127.74 54.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.55 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.371 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.9 89.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 1.0 110.531 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.65 130.88 55.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -114.62 126.56 55.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.36 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.7 137.33 57.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.637 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -76.28 144.92 39.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.03 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 964' ' ' ILE . 81.6 m -93.77 142.49 27.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.837 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 963' ' ' CYS . 1.2 tt 34.17 69.32 1.0 Allowed Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 121.378 0.609 . . . . 1.0 110.64 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.71 143.35 96.31 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.924 2.416 . . . . 1.0 112.754 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.74 -43.69 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.315 0.858 . . . . 1.0 113.315 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -54.63 10.77 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.888 -177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -58.4 -39.41 79.61 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.59 -43.19 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 119.239 -0.985 . . . . 1.0 109.241 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.9 tp -62.39 -42.61 99.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.749 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.47 -44.54 99.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.688 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.84 -39.26 95.19 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.54 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.522 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.23 -42.83 99.28 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.65 -44.86 91.82 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.101 -0.571 . . . . 1.0 111.709 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.05 -41.53 99.48 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.06 -40.79 98.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.977 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.16 -42.62 99.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.656 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.7 -40.96 96.86 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.396 -0.922 . . . . 1.0 109.729 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.77 -41.63 99.33 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.815 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -62.52 -47.6 83.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.423 -0.511 . . . . 1.0 112.007 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.49 -40.85 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.726 -0.79 . . . . 1.0 111.286 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.05 -43.81 97.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.71 -45.07 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.121 -0.231 . . . . 1.0 111.064 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.68 -41.71 99.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.197 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.63 98.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.537 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 987' ' ' MET . . . . . 0.479 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 96.2 mmm -63.9 -43.62 95.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.894 0.378 . . . . 1.0 111.804 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.656 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.7 t90 -63.16 -43.32 98.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.291 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.03 -34.35 76.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 1.0 111.593 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 60.3 t -76.85 -2.19 4.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.065 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.81 8.28 63.52 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.479 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -56.41 -44.86 80.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -81.48 -22.98 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.092 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.656 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 68.5 mttm -63.67 -39.68 94.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.542 -1.263 . . . . 1.0 108.301 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.503 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.1 ttt-85 -66.45 126.89 30.24 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.643 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -139.34 5.84 2.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.31 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 33.4 mtt-85 -153.04 158.13 32.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.237 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo . . . . . 0 C--N 1.312 -1.394 0 C-N-CA 122.42 2.08 . . . . 1.0 112.193 179.688 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.24 -39.03 89.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.709 0.29 . . . . 1.0 110.506 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 2.6 p -142.42 73.14 20.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.72 145.71 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 1.0 112.005 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.75 145.05 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.343 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 174.84 4.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.12 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -62.25 145.42 96.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.263 1.975 . . . . 1.0 112.324 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.35 143.2 57.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.8 mt -62.64 -44.02 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.478 0.547 . . . . 1.0 112.478 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.51 -43.02 99.85 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.49 -45.41 98.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.978 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.5 t -63.42 -44.23 98.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 1.0 110.172 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.41 -43.87 98.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.961 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.75 -42.23 95.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 1.0 110.814 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.0 p -61.87 -39.98 93.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.458 -0.792 . . . . 1.0 112.085 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 66.7 t -64.21 -45.03 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.076 0.465 . . . . 1.0 110.871 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 93.0 mtp -63.27 -39.09 93.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.274 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.37 -41.34 96.59 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.613 -0.995 . . . . 1.0 110.613 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.11 88.07 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 120.685 0.278 . . . . 1.0 110.677 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.6 mm -60.41 -43.21 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.651 -0.819 . . . . 1.0 109.692 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 9.7 mp -61.28 -43.23 99.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.467 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.81 -44.39 96.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.619 -0.832 . . . . 1.0 111.197 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . 0.4 HG23 HD12 ' B' ' 707' ' ' ILE . 95.9 mt -62.74 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.77 -39.98 65.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.491 -0.862 . . . . 1.0 111.169 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.59 -37.39 82.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.36 -56.92 19.46 Favored Pre-proline 0 N--CA 1.462 0.137 0 C-N-CA 120.04 -0.664 . . . . 1.0 111.593 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -54.27 -44.37 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 120.837 1.024 . . . . 1.0 111.489 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.13 -42.13 94.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.64 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.59 -41.85 99.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.813 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.6 -44.05 98.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.544 -0.463 . . . . 1.0 109.964 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -62.33 -48.16 81.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.958 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -43.27 98.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.189 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.33 -44.56 96.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.133 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 84.9 mt -61.14 -42.1 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.89 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.5 -44.11 98.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 120.068 -0.653 . . . . 1.0 110.242 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.5 m -59.79 -46.95 87.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.6 -45.11 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.494 0.664 . . . . 1.0 111.198 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' B' ' 725' ' ' LYS . 51.2 m80 -59.79 -38.95 83.33 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.865 -0.734 . . . . 1.0 109.438 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 7.4 m-20 -66.33 -39.73 89.43 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 112.39 0.515 . . . . 1.0 112.39 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.1 -38.46 91.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.038 0.447 . . . . 1.0 111.018 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 722' ' ' HIS . 75.6 mmtt -99.46 147.3 25.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -120.96 133.96 55.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.265 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.217 -0.624 0 CA-C-O 117.815 -1.088 . . . . 1.0 110.835 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.24 143.19 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 1.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.9 mt -110.37 130.99 55.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.467 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.69 139.1 58.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.6 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -117.62 134.04 55.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . 0.57 ' NH1' ' CZ2' ' A' ' 967' ' ' TRP . 71.6 ttt180 -67.72 134.88 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.278 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.08 141.27 47.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.662 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 71.5 mt 56.87 69.73 1.62 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.477 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.04 148.35 93.34 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.52 2.147 . . . . 1.0 111.577 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 20.8 tt -65.95 -38.04 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.57 ' CZ2' ' NH1' ' A' ' 962' ' ' ARG . 0.0 OUTLIER -54.33 -50.27 67.78 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.857 -0.737 . . . . 1.0 111.306 -176.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -57.69 -38.07 74.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.335 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 66.6 t -64.46 -46.38 93.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.964 -1.094 . . . . 1.0 109.468 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.56 -44.58 93.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.856 -1.066 . . . . 1.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.88 -39.35 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 119.729 -0.788 . . . . 1.0 110.508 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.24 96.34 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.1 t -61.88 -45.28 99.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.211 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.11 -42.64 99.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 1.0 111.658 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.62 85.03 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -42.82 98.08 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.66 -42.52 98.07 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.391 -0.476 . . . . 1.0 111.951 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.44 -44.95 93.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.426 0.528 . . . . 1.0 112.426 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.22 -42.07 99.21 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.471 -0.891 . . . . 1.0 110.988 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . 0.457 HD23 ' N ' ' A' ' 980' ' ' LEU . 2.1 mm? -63.19 -40.59 97.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.98 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.8 m -62.0 -45.29 94.26 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.569 -0.452 . . . . 1.0 110.203 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -41.34 89.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.3 99.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.963 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.76 -46.04 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.505 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.36 -41.81 98.86 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.334 -0.546 . . . . 1.0 110.521 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.53 98.75 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.207 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.39 -42.88 95.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.537 -0.302 . . . . 1.0 110.815 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.621 ' NE1' ' NZ ' ' A' ' 994' ' ' LYS . 9.9 t90 -61.71 -42.03 98.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.11 -33.95 75.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.078 0.466 . . . . 1.0 111.176 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 51.8 t -78.27 -3.18 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.689 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.47 10.81 71.23 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.53 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.6 OUTLIER -55.29 -45.29 76.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 -178.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.48 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.7 m-85 -78.89 -17.17 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.645 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.621 ' NZ ' ' NE1' ' A' ' 988' ' ' TRP . 63.9 mttp -109.77 29.8 7.26 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 991' ' ' GLY . 75.9 ttt-85 -66.95 124.11 22.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -109.47 2.1 20.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.073 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 173.55 153.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . 0.437 ' CA ' HH21 ' A' ' 995' ' ' ARG . 18.0 Cg_endo . . . . . 0 N--CA 1.495 1.576 0 C-N-CA 122.133 1.889 . . . . 1.0 111.994 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 55.2 30.63 14.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 1.0 110.624 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.451 ' H ' ' HG ' ' B' ' 687' ' ' SER . 0.4 OUTLIER -98.19 -179.9 0.95 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.221 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 22.8 Cg_exo -61.87 145.25 97.13 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.104 1.869 . . . . 1.0 112.017 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.08 -41.91 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 61.4 m -133.31 83.43 50.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.571 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -61.2 149.61 88.48 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.895 2.396 . . . . 1.0 112.011 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 -61.23 139.98 58.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.269 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . 0.532 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.9 mt -62.6 -43.51 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 1.0 112.309 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.3 -42.47 99.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.208 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.74 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.5 t -63.26 -44.12 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.808 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.25 -43.39 98.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.06 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.8 -42.31 95.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.176 0.512 . . . . 1.0 110.812 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 35.4 p -62.27 -42.84 99.69 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.18 -42.32 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.9 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.5 mtp -62.38 -39.26 92.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.347 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.66 -40.42 97.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 1.0 110.367 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.36 -42.54 95.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.6 -44.54 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.743 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.05 -43.2 99.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.128 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.35 -43.9 98.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.311 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.905 -0.664 . . . . 1.0 112.029 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.18 -34.89 78.51 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.11 10.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.347 -0.541 . . . . 1.0 112.334 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.12 -39.83 46.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.374 1.383 . . . . 1.0 112.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.6 -42.08 92.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.933 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . 0.412 HD21 ' N ' ' B' ' 713' ' ' LEU . 0.7 OUTLIER -63.26 -41.25 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.933 -179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.31 -44.07 98.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.382 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.48 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 8.1 t90 -62.72 -48.52 78.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.369 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.81 -43.62 97.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.021 -178.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.69 -43.36 99.0 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.24 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.66 -41.3 97.33 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.23 -0.588 . . . . 1.0 110.132 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.432 ' CD1' ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.55 -44.15 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.679 -0.808 . . . . 1.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 92.1 m -59.17 -45.35 91.24 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.335 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.51 -43.92 97.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.128 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -64.32 -39.44 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.01 -38.76 86.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.954 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.84 -43.24 99.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.8 0.333 . . . . 1.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.44 141.13 45.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.72 127.18 54.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.481 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.567 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.4 142.98 56.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.323 . . . . 1.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.83 -41.95 99.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.611 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 55.67 41.48 30.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -108.19 126.66 53.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.165 0.507 . . . . 1.0 110.643 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.24 -37.67 88.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.505 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.41 -33.88 76.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.479 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.8 mt -141.99 71.13 23.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.424 -0.51 . . . . 1.0 111.59 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.64 149.52 90.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.595 2.197 . . . . 1.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.2 -42.89 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -53.66 53.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.49 -39.32 79.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.419 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.18 -44.96 97.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.699 0.762 . . . . 1.0 108.971 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.53 -42.64 99.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.51 -45.74 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.776 0.322 . . . . 1.0 111.248 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.52 96.82 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.268 -0.733 . . . . 1.0 111.268 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 68.9 t -61.73 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.605 0.24 . . . . 1.0 110.447 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.21 -42.61 99.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.497 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.99 -45.13 93.27 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.079 -0.581 . . . . 1.0 111.883 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.19 99.71 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.31 -41.6 98.96 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.644 -0.327 . . . . 1.0 110.82 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.99 -42.39 99.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.47 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.91 -41.68 98.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.009 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.57 -41.06 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.104 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -59.88 -45.65 91.84 Favored 'General case' 0 C--O 1.253 1.262 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.477 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.35 -47.69 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 119.904 -0.718 . . . . 1.0 111.344 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.92 -42.65 98.54 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.833 -0.747 . . . . 1.0 111.655 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.18 -47.11 95.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.66 -0.816 . . . . 1.0 111.459 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.12 -42.63 99.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.531 -0.467 . . . . 1.0 110.141 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.85 -43.3 99.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.987 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 98.6 mtp -65.84 -41.95 91.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 1.0 111.773 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.572 ' CD1' ' NZ ' ' A' ' 994' ' ' LYS . 10.1 t90 -62.7 -43.6 98.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.44 -33.46 73.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.138 0.494 . . . . 1.0 110.897 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.33 -2.8 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.688 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.19 7.09 81.67 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.608 ' CD1' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.82 -45.16 78.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.444 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 50.4 m-85 -83.2 -17.94 41.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.825 -0.75 . . . . 1.0 111.231 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.572 ' NZ ' ' CD1' ' A' ' 988' ' ' TRP . 62.8 mttp -62.62 -37.76 87.54 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 118.353 -1.339 . . . . 1.0 108.877 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.507 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 68.3 mtp180 -65.17 126.81 29.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.835 -1.146 . . . . 1.0 110.385 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 997' ' ' ARG . 44.7 p-10 -161.95 174.54 12.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.463 -0.789 . . . . 1.0 110.065 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 996' ' ' ASN . 12.5 ttp180 80.25 92.07 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.895 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.492 1.408 0 C-N-CA 122.139 1.893 . . . . 1.0 112.028 -179.767 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.0 -39.08 89.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.743 0.306 . . . . 1.0 110.559 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 10.7 p -176.08 74.44 0.27 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.64 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.41 145.02 98.53 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.86 2.373 . . . . 1.0 112.047 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -79.51 134.19 36.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . 0.401 ' SG ' ' CD ' ' B' ' 691' ' ' PRO . 0.1 OUTLIER -120.21 175.5 2.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.877 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . 0.401 ' CD ' ' SG ' ' B' ' 690' ' ' CYS . 23.3 Cg_exo -61.35 143.8 98.07 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.86 1.706 . . . . 1.0 111.822 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.49 138.62 57.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.271 0.558 . . . . 1.0 111.262 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.7 -43.52 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.53 -41.78 99.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.663 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.9 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.319 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.46 ' O ' ' OG ' ' B' ' 699' ' ' SER . 65.5 t -63.51 -45.38 97.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.958 0.409 . . . . 1.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . 0.43 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.1 tt -62.6 -43.03 99.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.655 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.69 -42.12 98.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 1.0 110.457 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.2 p -62.01 -36.73 82.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.037 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.95 -44.63 97.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.061 0.458 . . . . 1.0 110.14 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.69 -39.73 92.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.134 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.89 96.9 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.017 -1.233 . . . . 1.0 110.017 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.77 89.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 1.0 110.357 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.87 -43.22 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.233 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.1 -44.22 97.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.163 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.59 -44.12 97.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.669 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 95.0 mt -63.85 -44.47 98.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.876 -0.329 . . . . 1.0 111.428 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.26 -41.14 69.56 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.87 -38.45 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.507 0.928 . . . . 1.0 113.507 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.03 18.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.208 -0.597 . . . . 1.0 112.122 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' B' ' 707' ' ' ILE . 32.3 Cg_exo -54.63 -44.28 51.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.091 1.194 . . . . 1.0 111.359 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.29 -42.15 93.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.715 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.62 -41.77 99.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.52 -44.19 98.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.199 -0.601 . . . . 1.0 109.449 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.444 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 11.3 t90 -63.0 -48.25 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 1.0 109.783 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.608 ' NZ ' ' CD1' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.51 -44.21 96.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.729 -178.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -42.86 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.667 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . 0.498 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 83.8 mt -62.12 -42.77 99.57 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.897 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.78 -44.32 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.909 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 82.9 m -60.31 -45.8 92.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.512 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' B' ' 724' ' ' ARG . 95.3 mt -62.37 -43.21 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.385 -0.526 . . . . 1.0 110.42 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 43.3 m80 -61.75 -37.61 84.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.457 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.507 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 47.0 m-20 -67.41 -40.12 85.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.585 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 721' ' ' ILE . 62.1 ttp180 -127.36 116.47 20.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.109 0.48 . . . . 1.0 109.765 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.23 133.64 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.18 127.0 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.337 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.091 -0.957 . . . . 1.0 110.562 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -151.05 152.37 33.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 1.0 110.581 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 94.9 mt -74.57 141.73 44.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.52 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.99 137.75 57.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.631 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.28 -37.62 85.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -64.14 -39.06 93.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.688 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 67.6 m -67.29 -36.75 82.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.83 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.77 71.21 13.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.95 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.11 148.95 92.22 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.63 2.22 . . . . 1.0 112.078 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.3 -42.51 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.94 47.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.759 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -58.01 -39.2 77.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.682 0.252 . . . . 1.0 111.682 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.1 -45.06 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.26 -42.64 99.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.79 -44.36 99.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.06 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.79 -38.26 94.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.443 -0.884 . . . . 1.0 111.155 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.8 t -61.98 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.975 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.19 -42.09 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.846 -0.341 . . . . 1.0 111.876 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.26 92.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.372 -0.691 . . . . 1.0 111.372 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.97 -42.39 99.73 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.146 -1.181 . . . . 1.0 110.146 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.44 -42.08 98.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.953 0.377 . . . . 1.0 111.999 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.76 -43.62 98.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.457 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -40.39 96.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.103 -1.039 . . . . 1.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 980' ' ' LEU . 1.8 mm? -62.5 -39.92 95.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 94.8 m -61.89 -45.53 93.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.807 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.63 -43.63 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.97 -0.692 . . . . 1.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.19 -43.45 98.79 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.379 -0.826 . . . . 1.0 111.355 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 68.4 t -60.63 -44.73 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.081 -0.387 . . . . 1.0 110.82 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.45 -41.43 98.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.175 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.388 -0.525 . . . . 1.0 112.191 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 987' ' ' MET . . . . . 0.481 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 95.6 mmm -64.29 -42.81 96.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 111.201 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.457 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.1 t90 -62.53 -42.6 99.63 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.051 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.33 -34.4 76.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.832 0.349 . . . . 1.0 111.396 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.09 -2.49 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.792 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 68.27 12.17 62.85 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 108.548 -1.821 . . . . 1.0 108.548 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.481 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -54.9 -44.13 73.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -178.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -82.32 -6.39 59.22 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.838 -0.745 . . . . 1.0 109.859 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 991' ' ' GLY . 75.2 mmtt -97.85 1.03 47.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' B' ' 723' ' ' ASP . 77.5 ttt-85 -67.02 134.17 51.39 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.013 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -150.54 171.25 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.451 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -72.72 149.75 90.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.189 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.494 1.52 0 C-N-CA 122.03 1.82 . . . . 1.0 112.135 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.532 -1.427 . . . . 1.0 109.532 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.49 29.72 13.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 1.0 110.447 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 161.19 54.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 152.94 64.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.932 2.422 . . . . 1.0 112.027 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.01 144.74 51.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 21.8 m -140.16 81.77 17.93 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.74 147.51 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.357 2.038 . . . . 1.0 112.361 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 145.65 54.94 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.54 -42.69 96.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.856 -0.737 . . . . 1.0 112.351 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.36 -41.58 98.85 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.003 -0.436 . . . . 1.0 111.451 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.6 -45.32 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.846 0.355 . . . . 1.0 111.646 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' B' ' 699' ' ' SER . 58.6 t -64.18 -45.23 96.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . 0.428 ' C ' ' CD2' ' B' ' 697' ' ' LEU . 8.2 tt -63.29 -43.03 99.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.833 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.3 -42.02 96.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 1.0 110.553 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.5 p -62.38 -38.26 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.361 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 69.2 t -63.86 -44.83 98.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.137 0.494 . . . . 1.0 110.054 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -63.03 -39.55 95.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.54 -40.54 97.72 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.94 78.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.1 mm -62.59 -42.65 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 13.7 mt -61.43 -44.9 96.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.833 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.28 -43.9 96.61 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.043 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.29 -44.85 97.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.52 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.11 -42.4 67.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.206 -0.521 . . . . 1.0 111.801 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.12 -38.38 85.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.27 -55.56 30.31 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -52.59 -41.42 68.59 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.299 1.333 . . . . 1.0 111.778 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.24 -41.89 93.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.722 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.33 -42.37 98.97 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.29 -41.71 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.503 -0.879 . . . . 1.0 110.147 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -63.44 -48.77 76.39 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -42.7 95.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.681 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.18 -44.45 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.623 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.73 -41.91 98.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.997 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.55 -42.98 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 120.321 -0.552 . . . . 1.0 109.825 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 98.0 m -59.61 -45.88 90.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.384 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' B' ' 724' ' ' ARG . 30.5 mm -61.73 -43.67 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.921 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -65.78 -36.53 83.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.679 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 995' ' ' ARG . 23.7 t70 -70.94 -42.27 70.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.686 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' B' ' 721' ' ' ILE . 90.3 mtm180 -130.81 130.31 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' B' ' 727' ' ' PHE . 99.4 mttt -124.07 145.61 49.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.63 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 47.68 -88.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' B' ' 725' ' ' LYS . 96.6 m-85 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.38 143.14 56.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 1.0 110.598 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.9 -41.78 99.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.428 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.33 141.74 58.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.471 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -108.9 125.08 51.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.479 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -126.07 136.9 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.354 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.581 ' SG ' ' N ' ' B' ' 685' ' ' GLY . 74.3 m -88.6 133.93 34.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 964' ' ' ILE . 1.2 tt -174.26 72.0 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 1.0 110.178 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.27 140.84 90.73 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.881 2.387 . . . . 1.0 112.679 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.46 -61.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 1.0 112.028 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -50.86 61.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.7 m0 -58.09 -43.54 87.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 119.299 -0.381 . . . . 1.0 111.671 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.78 -43.61 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 118.819 -1.152 . . . . 1.0 110.457 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.15 -42.81 99.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.491 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.0 -44.98 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.707 0.289 . . . . 1.0 111.387 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.48 -38.39 94.77 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.116 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.61 -45.1 99.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 121.16 -0.216 . . . . 1.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.3 -42.14 99.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.898 0.333 . . . . 1.0 111.898 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.54 -43.43 94.64 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 120.676 -0.773 . . . . 1.0 111.735 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.1 99.95 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 120.435 -0.888 . . . . 1.0 111.133 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.8 -40.31 96.97 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.539 -0.389 . . . . 1.0 110.098 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.0 -42.7 99.43 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.48 -42.6 99.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.687 -0.805 . . . . 1.0 110.213 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 24.4 mt -62.39 -42.74 99.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.824 0.345 . . . . 1.0 110.779 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 24.1 p -61.93 -45.1 95.2 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.508 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.71 -43.28 97.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.672 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.7 -42.72 97.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.394 -0.522 . . . . 1.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.45 -45.48 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.063 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.83 97.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.931 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.28 99.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.644 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 64.4 mtt -64.77 -42.46 95.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.018 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.661 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.4 t90 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.46 -33.79 74.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.125 0.488 . . . . 1.0 111.387 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 60.9 t -78.68 -3.36 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.64 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.56 11.04 72.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.333 -1.507 . . . . 1.0 109.333 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.524 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.48 -45.42 76.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.435 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 48.6 m-85 -79.79 -16.52 55.37 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.986 -0.686 . . . . 1.0 110.734 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.661 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 99.2 mttt -108.96 29.35 7.57 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.397 -1.334 . . . . 1.0 107.397 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.614 HH22 ' CB ' ' B' ' 723' ' ' ASP . 73.1 ttp85 -66.26 131.26 45.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.926 0.394 . . . . 1.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -136.28 113.86 10.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -178.91 64.2 0.16 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 C-N-CA 122.867 2.378 . . . . 1.0 112.167 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . 0.581 ' N ' ' SG ' ' A' ' 963' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.584 -1.407 . . . . 1.0 109.584 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' B' ' 686' ' ' GLU . 55.5 mp0 -66.34 -38.04 86.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.841 0.353 . . . . 1.0 110.871 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 166.66 1.9 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.783 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.77 -38.43 85.11 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.338 2.025 . . . . 1.0 112.815 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.99 147.67 28.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.085 0.469 . . . . 1.0 111.281 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 75.2 m -72.49 151.26 91.69 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.35 162.39 30.61 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.658 2.238 . . . . 1.0 113.37 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 66.4 t0 -60.88 146.15 47.56 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.915 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . 0.563 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 93.2 mt -61.98 -44.42 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 113.095 0.776 . . . . 1.0 113.095 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.35 99.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.717 0.294 . . . . 1.0 111.204 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.21 -45.39 98.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.819 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' B' ' 699' ' ' SER . 66.6 t -63.1 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 1.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.554 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.75 -42.88 94.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.439 . . . . 1.0 110.668 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 54.6 p -62.52 -39.56 93.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.829 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 69.6 t -64.24 -43.79 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.39 0.614 . . . . 1.0 109.381 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.6 mtp -63.29 -39.96 96.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.878 -1.056 . . . . 1.0 110.173 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.93 -47.12 48.74 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.07 83.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.675 0.274 . . . . 1.0 111.631 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.87 -37.61 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.651 -0.82 . . . . 1.0 108.849 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 62.3 tp -60.83 -44.95 96.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.31 -41.37 98.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.141 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.7 -43.85 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.43 -39.25 95.63 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.5 -37.24 82.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.11 -56.48 21.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 112.299 -176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -53.66 -43.91 53.69 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.06 1.173 . . . . 1.0 112.017 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.17 -41.99 94.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.137 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.22 -41.66 99.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.082 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.64 -44.31 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.435 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 7.9 t90 -62.16 -47.31 85.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.29 0.567 . . . . 1.0 109.578 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.53 -44.01 96.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.747 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.51 -46.28 89.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.632 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . 0.489 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 8.2 mp -63.26 -41.01 98.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.545 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 4.5 mm -63.58 -44.65 98.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.965 -0.694 . . . . 1.0 109.994 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -45.37 94.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.1 -43.53 98.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.319 -0.552 . . . . 1.0 111.366 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 44.5 m80 -59.06 -41.11 87.15 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.614 ' CB ' HH22 ' A' ' 995' ' ' ARG . 24.8 t70 -65.24 -40.17 93.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.444 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.73 -40.98 98.07 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.573 -0.451 . . . . 1.0 110.675 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 -42.76 98.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.698 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.13 138.51 55.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.79 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.971 -1.014 . . . . 1.0 110.645 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 963' ' ' CYS . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.41 91.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.745 0.307 . . . . 1.0 110.301 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.577 ' CD1' HH21 ' A' ' 962' ' ' ARG . 92.6 mt -118.88 144.77 46.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.93 -35.13 80.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.833 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 961' ' ' GLU . 59.0 mp0 -63.05 -39.57 95.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.689 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . 0.577 HH21 ' CD1' ' A' ' 959' ' ' LEU . 89.9 mtm180 -101.18 134.51 44.11 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 957' ' ' GLY . 78.7 m -84.81 -66.99 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.542 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 963' ' ' CYS . 9.2 pt 27.73 70.12 0.49 Allowed Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 123.668 0.605 . . . . 1.0 111.348 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.83 140.14 88.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.367 2.045 . . . . 1.0 112.35 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.0 -63.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.433 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -51.94 57.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 -177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.1 m0 -57.18 -40.81 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.143 -0.223 . . . . 1.0 110.779 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.42 -46.45 92.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 119.419 -0.912 . . . . 1.0 110.263 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.26 -42.65 99.18 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.681 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.93 -44.58 98.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.443 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.77 -37.91 95.07 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.292 -0.956 . . . . 1.0 111.533 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.25 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.437 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.29 -42.92 99.12 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.08 89.24 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.88 -0.676 . . . . 1.0 111.614 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.67 -41.37 98.91 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.91 -42.78 97.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.133 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.96 -44.33 96.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.557 -0.457 . . . . 1.0 111.654 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.61 -42.12 99.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.64 -0.824 . . . . 1.0 110.366 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . 0.507 HD21 ' N ' ' A' ' 980' ' ' LEU . 4.1 mm? -63.14 -39.65 95.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.846 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 84.6 m -61.2 -45.13 95.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.515 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.82 -44.17 99.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.586 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.94 -42.0 99.67 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.349 -0.54 . . . . 1.0 110.899 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 63.8 t -62.45 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 1.0 111.011 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.24 -41.73 99.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.9 99.94 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.284 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.27 -40.54 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.373 0.606 . . . . 1.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.6 t90 -65.35 -44.7 86.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.578 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.67 -33.98 76.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.96 2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.176 -1.01 . . . . 1.0 109.296 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 75.47 11.16 84.5 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.38 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.417 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.9 -44.34 66.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.468 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.4 m-85 -83.54 -4.29 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.857 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.0 mttt -92.57 -0.46 57.32 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.533 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 77.6 ttt-85 -65.67 133.56 51.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.768 -0.773 . . . . 1.0 109.413 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . 0.468 ' ND2' ' NH1' ' A' ' 995' ' ' ARG . 98.9 m-20 58.4 33.72 23.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.408 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 996' ' ' ASN . 97.7 mtt180 26.85 78.94 0.24 Allowed Pre-proline 0 N--CA 1.467 0.394 0 O-C-N 123.764 0.665 . . . . 1.0 111.945 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . 0.441 ' CG ' ' O ' ' A' ' 993' ' ' PHE . 71.4 Cg_endo . . . . . 0 C--N 1.306 -1.691 0 C-N-CA 122.678 2.252 . . . . 1.0 112.071 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.628 -1.389 . . . . 1.0 109.628 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.1 -38.83 89.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 1.0 110.525 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 66.0 m 44.83 72.53 1.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.444 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.69 -38.18 84.41 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.953 2.435 . . . . 1.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.55 144.99 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 6.5 m -82.67 161.47 58.68 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.054 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.88 147.54 95.08 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.693 1.595 . . . . 1.0 112.245 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.74 143.81 57.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.997 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.02 -44.46 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.88 -43.37 96.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.34 -47.24 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.91 0.707 . . . . 1.0 112.91 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' B' ' 699' ' ' SER . 11.0 p -65.26 -41.65 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.76 -43.45 98.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.86 -41.84 95.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 1.0 110.665 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 36.8 p -62.55 -40.98 98.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.582 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.56 -45.26 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.266 0.555 . . . . 1.0 110.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -63.5 -39.76 95.3 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.035 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.44 -41.13 99.41 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.99 -0.844 . . . . 1.0 110.99 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.58 80.87 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.05 -41.27 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.63 -46.26 90.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.868 -0.333 . . . . 1.0 111.166 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.24 -42.42 99.2 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.55 -44.21 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.563 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.59 -40.86 94.24 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.64 -37.57 85.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.92 -57.18 17.2 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 119.998 -0.681 . . . . 1.0 112.32 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -54.46 -45.38 41.41 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.158 1.239 . . . . 1.0 111.934 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.86 -40.57 91.79 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.259 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.42 -41.32 98.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.085 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.63 -44.75 98.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.389 -0.525 . . . . 1.0 109.735 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.468 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.2 t90 -63.11 -49.19 75.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.18 0.514 . . . . 1.0 109.702 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.64 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.104 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . 0.421 ' O ' ' OG1' ' B' ' 720' ' ' THR . 55.1 tp -63.35 -45.39 91.43 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.738 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . 0.455 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 82.7 mt -62.76 -42.9 99.9 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.676 0.621 . . . . 1.0 112.676 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' B' ' 720' ' ' THR . 5.6 tp -65.87 -41.26 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 119.611 -0.836 . . . . 1.0 109.871 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 720' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 30.6 p -58.69 -45.3 89.76 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.758 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.05 -41.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 O-C-N 121.849 -0.532 . . . . 1.0 110.676 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 59.2 m80 -61.73 -39.81 92.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.211 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 40.5 t0 -67.25 -37.44 83.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.959 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -62.1 -42.05 98.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 1.0 110.721 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 722' ' ' HIS . 68.9 mttm -102.92 146.66 27.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.708 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.26 -39.27 89.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.738 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.479 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 961' ' ' GLU . . . -150.72 152.26 33.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 1.0 110.602 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.33 99.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -160.25 -21.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.87 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 958' ' ' ALA . 97.5 mt-10 -95.05 120.63 35.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.857 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 p 179.85 77.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.983 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.5 pt -152.2 73.32 7.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.126 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.11 144.39 99.2 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.801 2.334 . . . . 1.0 112.426 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.61 -31.28 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.431 0.9 . . . . 1.0 113.431 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -45.4 80.54 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.272 -0.971 . . . . 1.0 110.822 -177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . 0.522 ' NE1' ' CD1' ' B' ' 693' ' ' ILE . 35.5 m0 -57.23 -46.13 83.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.78 -0.191 . . . . 1.0 110.786 -177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -63.74 -46.82 93.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 119.329 -0.948 . . . . 1.0 110.941 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.31 -44.26 95.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.113 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.77 -44.95 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.07 -39.32 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.183 -1.008 . . . . 1.0 111.118 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.065 0.394 . . . . 1.0 112.065 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.72 -42.84 97.85 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.58 95.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.494 -0.86 . . . . 1.0 111.2 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.93 -42.85 99.77 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.63 -41.94 99.31 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.732 -0.275 . . . . 1.0 110.659 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.83 -41.79 98.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.47 -41.26 96.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.469 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.61 -42.07 99.36 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.953 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 96.6 m -62.29 -48.66 78.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.01 -41.38 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.453 -0.899 . . . . 1.0 111.626 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.39 -43.48 97.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.541 -0.464 . . . . 1.0 110.696 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.52 -45.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.722 0.296 . . . . 1.0 111.19 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.08 -42.28 99.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.64 98.38 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.336 -0.545 . . . . 1.0 111.811 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.74 -42.62 90.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.144 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -62.67 -42.79 99.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.88 -32.45 73.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.282 0.563 . . . . 1.0 110.509 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.37 -3.79 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.904 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.17 72.86 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.198 -1.561 . . . . 1.0 109.198 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.499 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.88 -46.09 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -178.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.529 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 39.2 m-85 -74.26 -30.99 62.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.836 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.73 -42.36 95.26 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 118.663 -1.215 . . . . 1.0 108.952 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.428 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 28.6 tpt85 -146.15 148.54 32.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.624 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.11 -41.12 97.91 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -74.36 156.85 87.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.443 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 122.411 2.074 . . . . 1.0 112.025 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 -38.7 89.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.777 0.322 . . . . 1.0 110.466 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 160.92 8.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.523 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.54 -21.87 65.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.586 2.191 . . . . 1.0 111.596 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.98 -41.09 99.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.106 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.98 156.0 36.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.439 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -72.22 152.99 56.6 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.799 2.333 . . . . 1.0 112.442 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -65.84 143.33 57.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . 0.522 ' CD1' ' NE1' ' A' ' 968' ' ' TRP . 9.4 tt -62.78 -41.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.461 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.46 -42.43 99.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.412 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.29 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.436 ' O ' ' OG ' ' B' ' 699' ' ' SER . 71.1 t -62.77 -44.77 99.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 1.0 110.485 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.05 -41.99 98.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.572 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.55 -43.32 94.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 1.0 110.398 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.8 p -62.47 -41.44 98.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.848 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.59 -44.88 98.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.316 0.579 . . . . 1.0 109.8 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 55.9 mtt -62.85 -39.46 94.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.499 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.25 -41.69 94.59 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.78 89.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.144 0.497 . . . . 1.0 110.759 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 27.6 mm -63.24 -41.68 93.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.379 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.42 -46.84 87.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.018 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.17 -43.11 99.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.602 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.88 -44.09 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.19 -41.07 92.48 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.244 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.11 -35.36 76.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.2 24.01 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 119.588 -0.845 . . . . 1.0 111.422 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -54.19 -42.43 67.36 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.296 1.331 . . . . 1.0 111.351 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.16 -42.82 96.59 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . 0.4 ' N ' HD21 ' B' ' 713' ' ' LEU . 0.8 OUTLIER -62.47 -41.36 98.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.916 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.96 98.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.053 -0.659 . . . . 1.0 109.349 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.529 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -61.84 -49.27 76.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.922 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.56 -42.64 97.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.316 -0.24 . . . . 1.0 110.656 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.16 -42.62 99.45 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.48 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.91 -40.44 93.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.377 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . 0.401 HD13 ' HE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.97 -46.72 93.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.799 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 21.6 m -60.86 -48.19 82.95 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 34.1 mm -63.14 -43.78 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.788 0.662 . . . . 1.0 112.788 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . 0.455 ' CD2' ' C ' ' B' ' 722' ' ' HIS . 1.8 p-80 -68.97 -39.54 79.38 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.522 -0.871 . . . . 1.0 109.874 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.442 ' N ' ' CG ' ' B' ' 722' ' ' HIS . 65.5 t0 -66.88 -37.97 85.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -60.84 -43.08 98.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.765 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 722' ' ' HIS . 99.3 mttt -100.9 146.67 27.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.863 0.364 . . . . 1.0 110.733 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.65 147.48 50.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.375 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.643 -179.978 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 960' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.12 -38.13 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.753 0.311 . . . . 1.0 110.728 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.72 -43.05 99.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.804 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . 0.492 ' OE2' ' SG ' ' A' ' 963' ' ' CYS . 22.1 pt-20 -137.22 144.48 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.734 0.302 . . . . 1.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.36 -41.29 89.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.616 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -149.18 148.06 29.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 1.0 111.176 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . 0.492 ' SG ' ' OE2' ' A' ' 960' ' ' GLU . 1.1 m -76.9 -17.81 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.981 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.48 85.52 16.53 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.063 0.394 . . . . 1.0 112.063 -178.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -61.66 147.5 95.2 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.904 2.403 . . . . 1.0 111.87 178.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.25 -43.91 97.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 -177.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.445 ' CD2' ' N ' ' A' ' 967' ' ' TRP . 0.0 OUTLIER -58.13 -50.71 72.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.457 -0.497 . . . . 1.0 112.285 -176.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . 0.428 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 21.7 m0 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.193 -177.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -64.36 -46.46 93.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.806 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.23 -43.74 97.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 1.0 111.686 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 67.0 t -63.36 -45.1 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.585 -0.279 . . . . 1.0 111.664 -178.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.66 -37.69 94.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.095 -1.05 . . . . 1.0 111.586 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 60.6 t -62.0 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.854 -0.339 . . . . 1.0 110.595 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.46 -43.08 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.85 97.58 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.746 -0.74 . . . . 1.0 111.26 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.72 99.7 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.12 -42.95 99.63 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.139 -0.624 . . . . 1.0 111.816 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.42 -41.93 98.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.344 -0.543 . . . . 1.0 111.839 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.46 -42.45 99.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.711 -0.795 . . . . 1.0 110.234 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . 0.464 HD21 ' N ' ' A' ' 980' ' ' LEU . 3.5 mm? -64.52 -41.05 96.63 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.338 0.496 . . . . 1.0 112.338 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 20.3 m -62.14 -47.15 85.84 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.496 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 42.0 pt -63.09 -41.35 92.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.757 -0.777 . . . . 1.0 111.617 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -43.17 99.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.474 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 70.5 t -61.7 -45.0 99.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.87 0.367 . . . . 1.0 110.699 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.71 -41.5 99.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.22 98.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 1.0 111.206 -179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.98 -42.03 94.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.773 0.32 . . . . 1.0 111.505 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -63.06 -43.29 99.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.47 -33.77 75.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.076 0.465 . . . . 1.0 111.587 -178.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.65 -3.07 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.81 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.88 9.63 71.06 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.41 -1.476 . . . . 1.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.06 -43.81 78.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.236 0.518 . . . . 1.0 109.652 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.6 m-85 -81.28 -18.69 44.99 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.22 177.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -73.95 -10.69 59.91 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.715 -1.194 . . . . 1.0 108.135 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -66.35 131.32 45.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.593 -0.843 . . . . 1.0 110.058 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -140.27 -46.82 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.441 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 723' ' ' ASP . 7.0 mtt180 39.67 72.66 0.95 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.741 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 122.762 2.308 . . . . 1.0 112.131 -179.827 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.77 -38.68 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 687' ' ' SER . . . . . 0.414 ' OG ' ' OE1' ' A' ' 960' ' ' GLU . 54.4 m 53.04 71.4 1.44 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.636 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.37 -35.98 85.95 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.198 2.599 . . . . 1.0 112.156 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.34 -43.01 99.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.844 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 690' ' ' CYS . . . . . 0.4 ' SG ' ' CD ' ' B' ' 691' ' ' PRO . 0.1 OUTLIER -76.62 174.89 5.0 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 179.924 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 691' ' ' PRO . . . . . 0.4 ' CD ' ' SG ' ' B' ' 690' ' ' CYS . 23.9 Cg_exo -60.56 143.34 99.43 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.143 1.896 . . . . 1.0 113.141 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.19 153.29 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.742 . . . . 1.0 111.269 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.03 -43.85 98.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 1.0 112.284 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 694' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' B' ' 694' ' ' LEU . 3.9 mm? -62.78 -43.38 98.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.981 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.18 -45.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.328 . . . . 1.0 111.467 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 696' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.3 t -63.7 -44.75 98.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.067 0.461 . . . . 1.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.03 -43.16 99.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.781 -0.645 . . . . 1.0 112.05 -178.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.3 -42.35 96.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.1 0.476 . . . . 1.0 110.428 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 699' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 50.8 p -62.38 -41.37 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.57 -0.741 . . . . 1.0 112.871 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.45 -45.78 94.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.286 -0.565 . . . . 1.0 110.288 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.36 -39.6 94.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.565 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.24 98.0 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.002 -1.239 . . . . 1.0 110.002 177.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.76 89.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.403 0.621 . . . . 1.0 109.908 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -61.04 -41.8 90.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 118.479 -1.289 . . . . 1.0 109.053 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.36 -43.87 92.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.534 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.753 -0.779 . . . . 1.0 110.743 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.07 -44.16 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.94 -38.85 94.57 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 709' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 713' ' ' LEU . 85.7 mt -67.46 -38.19 84.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.957 1.095 . . . . 1.0 113.957 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 710' ' ' ALA . . . . . . . . . . . . . . . -52.97 -57.11 17.54 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.759 -177.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 711' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.5 -45.48 39.38 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.306 1.145 . . . . 1.0 111.448 178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.308 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 713' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' B' ' 709' ' ' LEU . 33.5 mt -62.98 -41.08 99.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.784 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.18 -46.39 95.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.397 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 715' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 4.3 t90 -61.03 -49.36 77.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.648 178.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -45.83 91.17 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.786 -0.366 . . . . 1.0 111.037 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.1 -44.43 92.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.032 -0.667 . . . . 1.0 111.114 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.28 -43.42 97.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt -68.33 -40.93 83.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.579 -0.848 . . . . 1.0 109.964 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 94.6 m -59.15 -45.64 90.45 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.38 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 721' ' ' ILE . . . . . 0.505 ' CG1' HH21 ' B' ' 724' ' ' ARG . 93.7 mt -61.92 -43.14 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.622 -178.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -64.01 -38.43 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 178.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 723' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 997' ' ' ARG . 29.4 t70 -66.1 -44.55 84.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.03 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 724' ' ' ARG . . . . . 0.505 HH21 ' CG1' ' B' ' 721' ' ' ILE . 88.6 mtm180 -66.04 -39.21 89.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 110.616 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.5 133.61 49.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.536 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.389 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.553 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 114.857 1.429 . . . . 1.45 114.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.56 -58.15 8.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.356 -0.538 . . . . 0.9 111.413 -177.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -56.55 -39.4 73.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.189 0.811 . . . . 3.19 113.189 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.89 -45.88 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.116 -1.034 . . . . 0.82 108.375 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.47 -44.09 97.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.349 -1.296 . . . . 1.68 110.696 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 91.4 t -63.31 -45.36 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.604 0.24 . . . . 0.69 111.441 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.44 92.54 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.838 -1.173 . . . . 0.24 111.324 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.51 -44.84 99.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 121.043 -0.263 . . . . 0.29 110.72 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.88 -42.07 95.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 1.1 112.374 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.84 84.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.132 -0.556 . . . . 0.2 112.014 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.24 99.36 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.528 -1.029 . . . . 0.15 110.528 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.6 -40.84 89.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 120.767 -0.373 . . . . 1.63 110.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.9 -43.19 99.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.857 -0.794 . . . . 1.57 108.857 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.5 -41.86 95.18 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.518 -1.273 . . . . 1.51 109.752 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' B' ' 705' ' ' LEU . 60.3 mt -60.03 -38.77 83.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.843 -0.743 . . . . 1.4 111.063 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -61.22 -47.71 84.85 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.646 -0.822 . . . . 0.61 110.564 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.41 -42.8 95.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.341 -0.544 . . . . 1.3 110.63 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.0 -43.63 95.1 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.583 -0.447 . . . . 1.61 110.891 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.3 t -62.32 -44.82 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.667 -0.413 . . . . 0.62 111.234 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.89 -43.29 99.2 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.76 109.934 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.88 97.31 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.77 -0.372 . . . . 0.3 111.743 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 44.6 mtt -64.0 -42.91 97.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 1.59 110.472 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -63.48 -46.34 86.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.09 -0.708 . . . . 1.17 109.09 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.18 -35.63 77.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.651 0.611 . . . . 0.78 112.651 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 990' ' ' VAL . 71.5 t -78.04 -1.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.74 -0.784 . . . . 0.91 108.965 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 74.36 5.2 71.58 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 108.18 -1.968 . . . . 0.36 108.18 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.526 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -47.82 -44.93 29.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 120.024 1.912 . . . . 0.81 110.444 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 114.361 -1.29 . . . . 1.26 110.545 178.569 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.44 -0.971 0 CA-C-O 121.545 0.688 . . . . 1.6 110.074 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.73 -44.53 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.96 111.865 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 69.3 mt -62.27 -41.94 98.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 1.29 110.428 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.49 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.73 111.031 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 92.4 t -62.92 -45.65 98.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 1.04 110.009 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.71 -43.01 98.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.542 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.13 -41.59 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.84 110.166 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 13.4 p -61.79 -42.59 99.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.319 -0.4 . . . . 0.27 111.179 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.15 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 120.649 -0.421 . . . . 0.57 109.926 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 88.1 mtp -60.79 -39.05 87.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.93 109.9 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.11 -41.38 95.05 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.635 -0.986 . . . . 0.18 110.635 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.07 89.12 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.954 0.407 . . . . 0.24 110.021 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.85 -42.27 88.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 118.938 -1.105 . . . . 0.5 109.366 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.473 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.3 mt -59.11 -45.99 89.47 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.64 -0.255 . . . . 1.69 110.599 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.29 -42.98 99.14 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.331 -0.548 . . . . 1.81 110.561 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.63 -46.21 95.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.426 -0.51 . . . . 0.85 110.863 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.19 -39.47 94.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.639 -0.791 . . . . 0.22 111.615 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.47 -28.68 62.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.676 1.362 . . . . 1.28 114.676 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.675 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -60.1 -54.86 51.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.969 0.804 . . . . 0.23 111.405 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.5 Cg_exo -55.07 -44.9 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.513 1.475 . . . . 0.29 111.333 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.59 -42.21 87.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 1.02 110.799 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.88 -41.91 99.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.886 -0.326 . . . . 1.04 111.092 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.91 -44.5 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 109.064 -0.717 . . . . 1.43 109.064 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.81 -50.11 74.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.584 -0.525 . . . . 0.71 109.584 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -59.84 -43.49 94.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 1.03 110.919 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 717' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 717' ' ' LEU . 19.4 tp -62.88 -47.51 83.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 1.86 110.514 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.85 -41.9 96.76 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.789 -0.364 . . . . 0.69 110.836 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -45.61 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 109.522 -0.547 . . . . 1.59 109.522 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.7 m -55.01 -47.41 74.72 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.774 -0.77 . . . . 1.02 109.851 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 35.9 mt -64.96 -44.0 96.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.999 0.74 . . . . 1.33 112.999 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 55.5 m80 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 108.452 -0.944 . . . . 1.34 108.452 177.383 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 966' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.98 -52.23 61.36 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.47 0.544 . . . . 1.0 112.47 -176.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -58.41 -40.01 81.29 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.765 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.7 t -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 119.796 -0.762 . . . . 1.0 109.223 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.45 -42.93 99.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.678 -1.146 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.2 t -63.17 -45.15 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.638 0.256 . . . . 1.0 111.327 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.31 -38.95 96.54 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.728 -0.749 . . . . 1.0 111.273 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 65.6 t -62.24 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 121.078 -0.249 . . . . 1.0 110.503 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.18 -42.49 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.468 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.21 93.39 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.816 -0.707 . . . . 1.0 111.8 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.61 98.61 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.26 -41.7 99.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.743 -0.269 . . . . 1.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.89 -42.12 98.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.022 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.05 -40.94 95.54 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.152 -1.019 . . . . 1.0 109.764 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' B' ' 705' ' ' LEU . 87.8 mt -62.21 -39.0 91.33 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.367 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.5 m -63.0 -47.1 84.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.084 -0.647 . . . . 1.0 110.205 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.68 -42.5 94.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 120.919 -0.312 . . . . 1.0 111.14 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.62 -42.45 91.53 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.526 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.76 -44.29 99.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.143 0.497 . . . . 1.0 110.938 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.87 -41.43 95.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -63.38 -42.12 98.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.776 -0.77 . . . . 1.0 111.305 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.425 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.5 t90 -63.0 -43.05 99.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.41 -34.1 76.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.136 0.493 . . . . 1.0 111.349 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.9 t -77.14 -2.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.78 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.97 8.73 69.64 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.336 -1.505 . . . . 1.0 109.336 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.463 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.77 -45.18 78.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.294 -1.002 . . . . 1.0 108.294 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--N 1.33 -0.26 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.355 177.882 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 692' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.14 0.495 . . . . 1.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.3 mt -62.33 -43.56 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.626 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.16 -42.0 98.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.168 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 -45.19 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.796 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 700' ' ' VAL . 67.7 t -63.59 -45.27 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.0 110.664 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 697' ' ' LEU . . . . . 0.689 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.1 tt -62.64 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.449 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.77 -42.37 97.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.035 0.445 . . . . 1.0 110.346 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 52.1 p -62.22 -36.82 83.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 696' ' ' VAL . 68.1 t -63.99 -44.87 97.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.094 0.473 . . . . 1.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.0 mtp -61.54 -39.51 91.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.992 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.84 96.89 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.43 89.22 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.677 0.275 . . . . 1.0 110.51 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.9 mm -62.74 -43.08 98.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.025 -0.67 . . . . 1.0 109.451 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.5 mt -61.26 -44.16 97.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.298 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.1 -43.29 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.94 -44.24 97.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.523 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.35 -41.9 76.44 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.6 -36.17 81.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -57.84 11.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.4 0.519 . . . . 1.0 112.4 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 19.0 Cg_endo -60.35 -40.23 60.18 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.086 1.191 . . . . 1.0 111.901 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.17 -42.7 93.45 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.3 -41.82 98.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.63 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.295 -0.562 . . . . 1.0 109.652 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.861 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.8 t90 -62.37 -48.17 80.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.165 0.507 . . . . 1.0 109.863 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -61.03 -42.54 98.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.004 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.24 -44.49 95.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.5 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.76 -41.79 98.15 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.286 0.565 . . . . 1.0 110.346 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.861 HD11 ' NE1' ' B' ' 715' ' ' TRP . 95.8 mt -62.51 -46.96 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.165 -1.014 . . . . 1.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 89.2 m -57.74 -46.01 85.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.454 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.57 -43.4 96.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.186 -0.606 . . . . 1.0 110.852 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 64.9 m80 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 178.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 114.165 1.172 . . . . 1.0 114.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.72 -52.94 54.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.73 -176.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -58.09 -39.22 78.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.751 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.27 -45.22 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.629 0.728 . . . . 1.0 109.156 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.46 -42.86 99.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.645 -1.161 . . . . 1.0 110.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.28 -44.49 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.847 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.44 93.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.447 -0.882 . . . . 1.0 110.913 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.46 -46.03 97.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.804 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.24 -42.62 99.24 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.8 93.34 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.807 -0.711 . . . . 1.0 111.454 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.42 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -62.13 -42.49 99.73 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.07 -42.12 99.6 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.837 -0.214 . . . . 1.0 110.791 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.17 -41.27 98.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.196 -0.601 . . . . 1.0 109.9 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 979' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 705' ' ' LEU . 89.3 mt -61.97 -41.43 98.0 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.231 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.611 HD11 ' HA3' ' B' ' 708' ' ' GLY . 0.8 OUTLIER -61.17 -43.19 99.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.981 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.2 m -61.84 -47.02 86.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.601 -0.44 . . . . 1.0 111.219 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.29 -43.92 98.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.605 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.33 -43.27 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.1 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.351 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.21 -42.31 99.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.49 -42.47 99.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.321 -0.552 . . . . 1.0 111.566 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 65.7 mtt -65.21 -42.39 93.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 1.0 111.37 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.72 -43.69 95.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.232 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -34.06 76.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.07 0.462 . . . . 1.0 111.893 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.4 t -77.28 -1.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.535 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 69.83 10.44 64.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.79 -1.724 . . . . 1.0 108.79 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -44.43 72.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.8 m-85 . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 119.816 -0.754 . . . . 1.0 110.705 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.959 0.409 . . . . 1.0 110.328 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.69 -43.68 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 1.0 112.305 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.42 -42.15 99.22 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.497 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.35 -45.2 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.4 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.6 t -63.79 -44.69 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.019 0.438 . . . . 1.0 110.453 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.04 -43.43 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.0 mt -64.14 -42.27 96.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.117 0.484 . . . . 1.0 110.663 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 48.6 p -62.27 -39.52 93.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 1.0 112.203 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.42 -45.87 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 1.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.49 -39.38 94.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.797 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.14 97.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.04 90.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.02 0.438 . . . . 1.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.443 HG22 HD23 ' A' ' 980' ' ' LEU . 27.2 mm -60.84 -42.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.329 -0.948 . . . . 1.0 108.82 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 979' ' ' LEU . 83.4 mt -61.2 -44.18 97.69 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.831 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -44.02 95.78 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.136 -0.626 . . . . 1.0 110.227 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.26 98.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.581 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 708' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 980' ' ' LEU . . . -67.51 -41.89 89.65 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.43 -37.82 83.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.33 -56.58 20.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 120.187 -0.605 . . . . 1.0 112.313 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.4 Cg_exo -53.83 -44.35 49.97 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.192 1.261 . . . . 1.0 111.734 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.482 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -64.73 -42.46 95.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.852 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.96 -39.75 94.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 1.0 110.173 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -46.93 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.461 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.86 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.2 t90 -63.43 -47.29 82.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.282 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -44.12 95.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.816 0.302 . . . . 1.0 111.816 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.29 -42.09 99.04 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.473 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.0 -41.61 98.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.86 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.2 mt -63.23 -45.05 99.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.213 -0.595 . . . . 1.0 110.234 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.3 m -60.35 -47.14 87.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.864 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.53 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.388 . . . . 1.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 . . . . . 0 C--N 1.325 -0.496 0 C-N-CA 120.183 -0.607 . . . . 1.0 109.519 179.516 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 113.715 1.006 . . . . 1.0 113.715 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.439 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.43 -51.84 66.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.699 -0.801 . . . . 1.0 111.181 -176.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -57.38 -37.9 73.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.244 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 68.6 t -64.11 -44.74 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.24 -42.49 99.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.024 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.1 t -63.27 -44.76 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.0 110.948 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.56 95.73 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.6 t -62.11 -45.2 99.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.345 -0.242 . . . . 1.0 110.345 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.03 -42.49 99.79 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.284 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.63 96.1 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.768 -0.73 . . . . 1.0 111.298 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -41.83 99.61 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.93 -40.94 99.15 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.746 -0.267 . . . . 1.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.37 -42.11 99.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.202 -0.599 . . . . 1.0 110.582 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.05 -41.16 97.84 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.8 mt -61.52 -41.19 96.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 1.0 110.677 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.7 m -61.5 -47.13 87.02 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.471 -0.492 . . . . 1.0 111.469 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.17 -44.23 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.64 -42.44 98.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.134 -0.626 . . . . 1.0 111.468 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 980' ' ' LEU . 62.2 t -62.07 -45.65 98.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.881 -0.327 . . . . 1.0 111.105 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.14 -42.11 99.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.35 -42.52 99.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.55 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.1 mtt -65.17 -42.38 93.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 111.355 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.427 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.9 t90 -63.12 -43.42 98.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 1.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.57 -34.7 77.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.118 0.485 . . . . 1.0 111.417 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 986' ' ' ALA . 52.1 t -76.96 -3.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 1.0 109.856 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.68 73.28 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.402 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.26 -45.45 76.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.277 -1.008 . . . . 1.0 108.277 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.408 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.5 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.354 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.804 0.335 . . . . 1.0 111.594 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.06 -43.69 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.335 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 694' ' ' LEU . . . . . 0.555 ' O ' HD13 ' B' ' 698' ' ' LEU . 98.0 mt -62.97 -42.05 99.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.951 -0.299 . . . . 1.0 110.977 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.09 -44.95 99.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.969 0.414 . . . . 1.0 111.053 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.2 t -64.19 -43.79 97.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.404 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.47 -43.4 98.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.751 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 698' ' ' LEU . . . . . 0.555 HD13 ' O ' ' B' ' 694' ' ' LEU . 9.3 mp -65.1 -41.34 95.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.19 0.519 . . . . 1.0 110.349 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 30.7 p -62.37 -37.11 84.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.165 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.43 -44.9 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.353 -0.539 . . . . 1.0 109.916 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.7 mtp -61.92 -40.0 93.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.197 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.04 -41.51 97.17 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.27 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 1.0 110.409 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 980' ' ' LEU . 27.3 mm -62.95 -43.18 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.447 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.544 ' HA ' HD21 ' A' ' 980' ' ' LEU . 52.5 tp -59.5 -47.7 84.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.331 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.96 -42.5 99.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.206 -0.598 . . . . 1.0 111.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.56 -44.38 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.726 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.33 94.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 709' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 713' ' ' LEU . 86.2 mt -67.02 -37.56 84.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.65 -57.23 16.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.008 -0.677 . . . . 1.0 112.092 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 35.4 Cg_exo -55.24 -45.14 42.61 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.917 1.078 . . . . 1.0 111.331 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.35 -41.87 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.448 -0.797 . . . . 1.0 110.86 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 713' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 709' ' ' LEU . 35.6 mt -62.8 -41.43 99.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.961 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.5 -44.34 98.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.429 ' HE1' HD12 ' B' ' 719' ' ' ILE . 5.8 t90 -63.04 -48.6 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 1.0 109.803 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.68 -45.73 93.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.555 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.81 -46.14 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.036 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.35 -43.11 98.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.617 0.599 . . . . 1.0 112.617 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.429 HD12 ' HE1' ' B' ' 715' ' ' TRP . 6.9 tt -67.19 -41.37 86.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.896 -0.722 . . . . 1.0 109.924 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 88.8 m -60.66 -44.83 95.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.819 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.29 -43.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.04 -0.664 . . . . 1.0 109.625 178.694 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -61.94 -49.84 74.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 119.573 -0.851 . . . . 1.0 111.334 -177.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -57.72 -39.12 76.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.279 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.6 t -64.19 -45.28 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 119.826 -0.749 . . . . 1.0 109.083 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.59 -42.17 99.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.652 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.1 t -63.8 -44.63 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.821 0.344 . . . . 1.0 110.86 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.97 96.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.4 t -61.98 -45.19 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 121.158 -0.217 . . . . 1.0 110.529 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.22 -42.5 99.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.806 0.336 . . . . 1.0 111.479 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.49 -43.54 94.55 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.23 -43.02 99.69 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.45 -41.95 98.65 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.756 -0.261 . . . . 1.0 110.951 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.14 -42.11 98.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 1.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.51 -41.25 97.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.859 -0.736 . . . . 1.0 109.492 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' B' ' 705' ' ' LEU . 85.7 mt -62.05 -41.95 98.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.304 -0.559 . . . . 1.0 111.238 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.1 m -61.72 -47.4 85.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.896 -0.321 . . . . 1.0 111.211 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.32 -43.76 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.554 -0.459 . . . . 1.0 111.326 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.71 -43.05 97.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.7 t -61.89 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 1.0 111.273 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.31 -42.56 99.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.735 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.98 -45.28 94.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.022 0.378 . . . . 1.0 112.022 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.66 -42.45 91.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.411 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -64.42 -41.92 96.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.869 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.59 -33.48 75.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.24 0.543 . . . . 1.0 110.44 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 986' ' ' ALA . 62.0 t -77.31 -2.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.261 -0.882 . . . . 1.0 109.95 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.85 8.21 72.31 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.273 -1.531 . . . . 1.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -56.11 -45.95 79.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.664 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 37.8 m-85 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.76 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 121.949 0.881 . . . . 1.0 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.13 -44.73 99.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.199 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 694' ' ' LEU . . . . . 0.458 ' N ' HD22 ' B' ' 694' ' ' LEU . 4.1 mm? -61.17 -42.05 97.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.948 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.23 -43.9 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.647 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.496 ' O ' HG23 ' B' ' 700' ' ' VAL . 69.4 t -65.31 -43.71 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 1.0 110.799 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.95 -42.7 99.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.699 0.761 . . . . 1.0 111.637 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.81 -42.71 94.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.554 0.692 . . . . 1.0 110.697 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 58.0 p -61.27 -37.67 83.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 696' ' ' VAL . 74.6 t -63.75 -45.32 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.8 mtp -62.07 -39.91 94.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.408 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.31 95.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.36 87.59 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.755 0.312 . . . . 1.0 110.378 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 980' ' ' LEU . 27.0 mm -63.01 -42.78 97.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.568 ' HA ' HD21 ' A' ' 980' ' ' LEU . 53.4 tp -60.65 -45.66 93.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.493 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.11 -42.53 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.377 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.68 -43.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.65 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.67 -38.71 93.41 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.533 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.93 -38.23 85.79 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.21 -56.96 18.83 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.242 -0.583 . . . . 1.0 112.271 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.9 Cg_exo -54.67 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.067 1.178 . . . . 1.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.664 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 97.0 mt -65.23 -41.89 93.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.905 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.18 -41.71 98.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.121 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.44 -44.15 98.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.849 ' NE1' HD11 ' B' ' 719' ' ' ILE . 7.1 t90 -60.89 -48.91 79.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.332 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.38 -42.87 96.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.573 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.1 -44.06 97.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.521 -0.471 . . . . 1.0 110.373 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.36 -42.11 99.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.269 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.849 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.5 mt -62.85 -44.68 99.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.953 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.6 m -59.64 -46.69 88.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.971 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.59 -43.82 98.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 1.0 112.23 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.1 m80 . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.451 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.456 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.98 -52.36 50.97 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.459 -0.496 . . . . 1.0 111.532 -176.451 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -57.62 -39.21 76.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.349 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.1 -45.5 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.65 -41.8 99.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.414 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.8 t -63.14 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.887 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.85 96.52 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.87 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.298 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.32 -43.22 98.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.15 91.58 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.894 -0.669 . . . . 1.0 111.949 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.405 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.78 -41.36 99.61 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 120.365 -0.922 . . . . 1.0 110.804 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.5 OUTLIER -62.86 -41.44 99.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.82 -41.58 99.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.052 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.35 -41.17 98.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.353 -0.939 . . . . 1.0 109.641 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.0 mt -61.96 -41.31 97.86 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.007 0.908 . . . . 1.0 110.972 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 37.0 m -61.37 -46.51 89.9 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 118.596 -1.242 . . . . 1.0 111.018 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.83 -42.62 97.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.042 -0.663 . . . . 1.0 110.555 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 983' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 983' ' ' LEU . 75.1 mt -64.03 -41.81 97.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.363 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.8 t -63.65 -44.87 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 123.328 0.393 . . . . 1.0 110.6 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.89 -42.03 97.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.27 99.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.884 0.849 . . . . 1.0 111.437 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.86 -40.98 97.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -64.6 -45.44 86.96 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.349 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.88 -33.55 74.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 10.9 m -85.57 0.87 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.82 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 74.19 15.07 80.15 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.347 -1.297 . . . . 1.0 110.967 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.512 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.88 -45.18 67.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.565 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 45.5 m-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.564 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.795 0.331 . . . . 1.0 111.013 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.58 -43.58 98.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.98 -41.7 99.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.053 -0.259 . . . . 1.0 111.137 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.8 -46.41 96.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.415 ' O ' HG23 ' B' ' 700' ' ' VAL . 18.9 m -65.54 -40.38 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.134 -0.627 . . . . 1.0 110.235 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.98 -43.97 97.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.727 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.103 0.478 . . . . 1.0 110.695 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.27 -38.1 88.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.902 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.0 t -63.48 -45.14 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.125 0.488 . . . . 1.0 110.388 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.11 -38.98 90.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.22 -41.6 96.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.279 -1.129 . . . . 1.0 110.279 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.89 86.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 1.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.405 HG21 ' C ' ' A' ' 976' ' ' GLY . 26.6 mm -62.61 -43.07 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.376 -0.601 . . . . 1.0 109.376 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.503 ' HA ' HD21 ' A' ' 980' ' ' LEU . 86.8 mt -61.16 -44.46 97.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.332 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.82 -43.33 99.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.908 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.64 98.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.64 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.13 88.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.23 -38.07 84.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.769 1.025 . . . . 1.0 113.769 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.34 -57.01 18.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.024 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 33.0 Cg_exo -54.65 -44.65 47.57 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.14 1.227 . . . . 1.0 111.604 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.93 -41.64 95.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.585 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.59 -41.46 98.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.196 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.12 -44.22 99.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.565 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.6 t90 -62.36 -48.77 78.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.595 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.5 OUTLIER -60.53 -45.02 95.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.446 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.58 -42.34 98.31 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.988 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.98 -42.46 99.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.706 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 3.9 mm -63.84 -44.26 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.19 -0.604 . . . . 1.0 109.709 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.6 m -60.37 -45.78 92.3 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.81 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.08 -43.69 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.868 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.8 m80 . . . . . 0 C--N 1.331 -0.206 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.686 178.538 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 114.141 1.164 . . . . 1.0 114.141 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.432 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.26 -52.45 52.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.694 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -57.75 -37.76 74.19 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.622 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.3 t -64.1 -44.74 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.45 -42.38 99.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.706 -1.134 . . . . 1.0 110.173 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.6 t -63.44 -44.8 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.071 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.11 -38.33 95.4 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.5 t -61.86 -45.07 99.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.09 -42.68 99.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.811 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.87 -43.26 96.32 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.319 -0.713 . . . . 1.0 111.319 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.67 99.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.45 -42.05 98.65 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.523 -0.398 . . . . 1.0 111.135 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 978' ' ' LEU . 85.5 mt -62.51 -41.33 98.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.196 -0.601 . . . . 1.0 110.726 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.9 -41.49 97.97 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.673 -0.811 . . . . 1.0 109.797 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 984' ' ' VAL . 87.0 mt -62.21 -41.53 98.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.359 -0.536 . . . . 1.0 111.176 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.88 -46.97 87.11 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.542 -0.463 . . . . 1.0 111.16 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.05 -43.66 99.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.27 -42.46 99.14 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.733 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.46 -45.57 98.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.683 0.278 . . . . 1.0 111.123 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.06 -42.24 99.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.284 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.652 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.09 -41.52 98.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.985 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.86 -41.98 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.878 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 11.0 t90 -64.11 -43.82 94.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.297 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.31 -34.3 76.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.052 0.454 . . . . 1.0 111.465 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.0 t -77.32 -1.62 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.57 11.59 68.85 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -45.06 70.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.51 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 62.4 m-85 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.231 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.297 0.57 . . . . 1.0 110.767 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.9 -41.51 89.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.516 -0.766 . . . . 1.0 111.192 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 694' ' ' LEU . . . . . 0.528 HD12 ' N ' ' B' ' 694' ' ' LEU . 11.1 mp -63.68 -41.43 98.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 1.0 110.791 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.27 -45.28 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.354 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 700' ' ' VAL . 77.3 t -64.04 -45.43 96.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.078 0.466 . . . . 1.0 110.707 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.71 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.873 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.14 -42.67 96.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 1.0 110.591 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.6 p -61.85 -38.95 90.16 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.5 t -64.67 -45.41 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.231 0.539 . . . . 1.0 110.094 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 701' ' ' MET . . . . . 0.435 ' O ' HD13 ' B' ' 705' ' ' LEU . 86.3 mtp -62.61 -40.28 96.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.32 -41.99 97.95 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.501 -1.04 . . . . 1.0 110.501 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.46 86.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.957 0.408 . . . . 1.0 110.174 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.496 HG22 HD11 ' A' ' 980' ' ' LEU . 26.8 mm -62.17 -42.31 94.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.765 -0.774 . . . . 1.0 109.576 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.0 mp -61.73 -44.05 97.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.617 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.06 -43.62 98.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.751 -0.779 . . . . 1.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.07 -47.92 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 1.0 111.673 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 708' ' ' GLY . . . . . 0.413 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -69.47 -39.22 80.07 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.862 -0.685 . . . . 1.0 111.546 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.13 -37.4 81.05 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.526 0.935 . . . . 1.0 113.526 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.17 -56.32 23.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.955 -176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.4 Cg_exo -53.29 -43.07 60.43 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.125 1.217 . . . . 1.0 112.187 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.488 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.28 -41.49 94.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.218 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.07 -41.34 99.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.38 -43.98 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.684 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.6 t90 -60.77 -48.49 81.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.314 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.36 94.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.482 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.1 -45.14 94.8 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.431 -0.507 . . . . 1.0 110.645 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 718' ' ' LEU . . . . . 0.518 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 87.0 mt -61.5 -42.28 98.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.683 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.684 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.0 mt -63.42 -44.11 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.513 -0.475 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -59.84 -46.61 88.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.834 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.03 -43.04 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.966 -0.294 . . . . 1.0 111.621 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 722' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 47.1 m80 . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.789 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.44 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.76 -52.2 50.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.384 -176.544 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -57.67 -38.59 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.572 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.1 t -64.12 -45.35 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.098 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.57 -42.69 99.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.303 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.9 t -63.28 -44.72 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.04 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.52 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.308 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.2 t -61.55 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 1.0 110.225 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.32 -42.63 99.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.769 0.319 . . . . 1.0 111.644 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.39 -45.41 90.61 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.49 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.97 -43.03 99.74 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.15 -41.89 99.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.806 -0.232 . . . . 1.0 110.518 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.11 -41.97 98.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.535 -0.466 . . . . 1.0 109.78 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.7 -41.55 97.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.756 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.4 mt -61.87 -41.65 98.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.677 -0.409 . . . . 1.0 111.074 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.1 m -61.46 -46.98 87.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.952 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.12 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.155 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.0 -43.06 99.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.645 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 980' ' ' LEU . 69.9 t -61.79 -45.75 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.708 0.289 . . . . 1.0 111.028 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.28 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.52 -42.97 99.86 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.399 -0.52 . . . . 1.0 111.226 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.72 -42.75 95.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.877 0.37 . . . . 1.0 111.476 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.432 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.7 t90 -63.25 -43.55 97.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.23 -35.38 78.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.007 0.432 . . . . 1.0 111.569 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 986' ' ' ALA . 59.5 t -77.53 -2.57 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.441 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.33 10.87 70.73 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.175 -1.57 . . . . 1.0 109.175 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -45.23 73.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.409 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.0 m-85 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.786 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 1.0 110.623 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.0 mt -62.15 -43.66 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 1.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 694' ' ' LEU . . . . . 0.513 ' N ' HD12 ' B' ' 694' ' ' LEU . 11.1 mp -62.39 -42.14 99.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.249 -0.58 . . . . 1.0 110.399 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.43 -45.07 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.419 . . . . 1.0 110.604 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' HG23 ' B' ' 700' ' ' VAL . 61.2 t -63.99 -44.22 97.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.07 -43.52 98.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.248 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.41 -42.4 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.0 110.869 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 45.1 p -62.45 -37.45 85.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.751 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.2 t -63.64 -44.9 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 1.0 110.651 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 89.9 mtp -62.97 -39.09 93.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.907 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.59 -42.2 95.69 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.6 84.36 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.808 0.337 . . . . 1.0 111.02 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.49 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.5 mm -60.8 -42.4 92.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.528 -0.915 . . . . 1.0 108.528 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 980' ' ' LEU . 95.4 mt -59.64 -45.71 91.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.895 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 706' ' ' LEU . . . . . 0.419 ' N ' HD12 ' B' ' 706' ' ' LEU . 11.1 mp -62.92 -42.31 99.75 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.884 -0.726 . . . . 1.0 111.481 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 707' ' ' ILE . . . . . 0.407 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 31.7 mm -63.69 -45.61 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.803 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.77 -41.02 84.74 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.722 -0.752 . . . . 1.0 111.448 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.49 -37.8 85.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.99 -57.13 19.27 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.201 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 43.9 Cg_exo -53.85 -43.67 55.97 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.085 1.19 . . . . 1.0 111.337 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.28 -41.82 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.758 -0.656 . . . . 1.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.86 -41.44 99.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.928 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.75 -44.22 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.409 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.0 t90 -62.36 -48.07 81.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.644 ' O ' HG23 ' B' ' 720' ' ' THR . 0.1 OUTLIER -59.45 -44.61 92.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.16 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 717' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' B' ' 720' ' ' THR . 50.7 tp -64.03 -45.54 88.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.258 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.99 -43.24 99.32 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.59 -40.88 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.483 -0.887 . . . . 1.0 110.27 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 720' ' ' THR . . . . . 0.644 HG23 ' O ' ' B' ' 716' ' ' LYS . 40.6 p -57.72 -44.34 85.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.319 -0.553 . . . . 1.0 110.649 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.38 -43.35 98.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.669 -0.413 . . . . 1.0 111.268 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 65.9 m80 . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.006 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 113.588 0.959 . . . . 1.0 113.588 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.469 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -50.39 -51.48 45.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.261 -0.575 . . . . 1.0 111.074 -176.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -57.14 -37.84 72.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.254 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.39 -45.0 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 1.0 109.223 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.75 -41.68 99.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.744 -1.117 . . . . 1.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.9 t -63.3 -44.3 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.543 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.02 -39.73 96.07 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.86 -45.78 97.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.606 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.31 -42.78 99.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 975' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.5 -46.25 78.68 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.029 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.75 -42.17 99.33 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.649 -0.981 . . . . 1.0 110.649 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.74 -40.86 97.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.939 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.99 -42.25 98.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.18 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 979' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.0 mp -61.5 -40.78 95.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 119.058 -1.057 . . . . 1.0 109.76 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 705' ' ' LEU . 89.6 mt -60.88 -41.31 95.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.281 -0.568 . . . . 1.0 110.508 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.4 m -60.96 -46.76 89.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.462 0.648 . . . . 1.0 110.629 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -44.13 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 119.479 -0.888 . . . . 1.0 111.996 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.27 -41.76 99.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.315 -0.954 . . . . 1.0 111.264 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.1 t -62.86 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.46 -41.7 96.37 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.369 -0.532 . . . . 1.0 110.658 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.88 -42.12 98.68 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.036 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.5 mtt -65.28 -42.41 93.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.137 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.431 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -64.26 -42.94 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.889 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.62 -34.5 77.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.117 0.484 . . . . 1.0 111.331 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.05 -1.91 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.678 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.66 8.82 68.42 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.113 -1.595 . . . . 1.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -56.05 -44.24 78.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 117.233 0.516 . . . . 1.0 109.785 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.495 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 36.7 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.492 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.035 0.445 . . . . 1.0 110.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.28 -43.49 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.34 -42.27 99.25 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.43 -0.508 . . . . 1.0 109.978 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.0 -44.81 99.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.941 0.4 . . . . 1.0 110.189 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.8 t -63.39 -44.31 98.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.24 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.63 -43.92 97.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.92 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.44 -41.89 96.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.949 0.404 . . . . 1.0 110.661 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 44.7 p -62.41 -37.91 87.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.5 t -64.06 -44.77 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.008 0.432 . . . . 1.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 53.6 mtt -63.19 -39.06 93.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.729 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.99 -42.23 92.75 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.32 94.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.225 0.536 . . . . 1.0 110.987 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 980' ' ' LEU . 23.8 mm -60.0 -42.18 88.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.553 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.6 mt -58.94 -44.62 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.338 0.399 . . . . 1.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.35 -41.72 98.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.76 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.04 -45.17 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.374 -0.531 . . . . 1.0 111.188 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.35 -39.73 87.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.526 -0.845 . . . . 1.0 111.117 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.73 -37.88 85.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.44 -56.38 25.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.547 -0.461 . . . . 1.0 112.056 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.8 Cg_exo -53.86 -43.25 59.74 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.097 1.198 . . . . 1.0 111.379 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.31 -41.21 90.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.169 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 37.7 mt -63.05 -42.37 99.71 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 41.5 pt -66.28 -41.75 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.005 -0.678 . . . . 1.0 110.046 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -59.92 -48.84 80.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 110.109 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -42.37 98.44 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.248 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.36 -44.0 96.04 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.38 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.592 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -43.12 95.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.31 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.0 m -59.07 -45.8 89.88 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 119.702 -0.799 . . . . 1.0 110.612 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.79 -43.26 97.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.975 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.7 m80 . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.78 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.6 mt . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -71.47 -55.67 7.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.379 -177.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 968' ' ' TRP . . . . . 0.65 ' CE2' HD12 ' B' ' 693' ' ' ILE . 94.5 m95 -57.64 -40.23 78.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 119.347 -0.359 . . . . 1.0 111.814 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.44 -46.2 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.135 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.86 -43.37 98.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.056 -0.974 . . . . 1.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.1 t -62.45 -44.3 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.71 -0.223 . . . . 1.0 110.747 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.11 92.71 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.188 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.77 -46.36 96.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.726 -0.39 . . . . 1.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.43 -43.15 98.27 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.592 0.589 . . . . 1.0 112.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.4 -45.24 91.28 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.921 -0.657 . . . . 1.0 111.734 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.415 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.87 -43.01 99.79 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.75 -41.8 99.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.615 -0.344 . . . . 1.0 110.632 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.26 -42.38 99.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.583 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.27 -40.33 89.97 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.754 -1.178 . . . . 1.0 109.134 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.5 mt -62.59 -41.52 99.0 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.645 -0.822 . . . . 1.0 112.075 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.96 -47.02 86.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.706 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 43.6 pt -64.74 -41.95 93.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.877 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.99 -42.83 99.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.1 t -62.22 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 121.103 -0.239 . . . . 1.0 111.179 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.32 -42.26 98.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.308 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.39 -42.89 99.77 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.746 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.6 mtp -65.37 -42.35 92.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 1.0 111.252 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.3 t90 -62.53 -42.5 99.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.83 -33.44 74.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.167 0.508 . . . . 1.0 110.975 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -77.45 -2.97 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.444 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.28 10.1 73.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.513 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.48 -45.25 77.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 -177.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.573 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 49.7 m-85 . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 120.16 -0.616 . . . . 1.0 110.49 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 109.911 -0.404 . . . . 1.0 109.911 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 968' ' ' TRP . 44.8 pt -62.66 -41.85 93.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.994 -0.548 . . . . 1.0 112.132 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.16 -42.55 99.37 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.4 t -62.32 -44.84 99.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.133 0.492 . . . . 1.0 110.266 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.413 ' O ' HG23 ' B' ' 700' ' ' VAL . 75.6 t -63.23 -43.74 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.642 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 697' ' ' LEU . . . . . 0.519 HD22 ' CE3' ' A' ' 968' ' ' TRP . 45.8 tp -61.33 -44.03 97.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.782 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.16 -42.42 96.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.048 0.452 . . . . 1.0 110.686 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 46.1 p -62.21 -39.05 91.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.3 t -63.58 -44.89 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.119 0.485 . . . . 1.0 110.8 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.87 -39.35 94.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.33 95.47 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.62 80.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 980' ' ' LEU . 27.1 mm -61.84 -42.46 94.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.436 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.662 ' O ' HD13 ' B' ' 709' ' ' LEU . 92.0 mt -61.01 -45.67 93.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.665 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 -42.15 99.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.867 -0.733 . . . . 1.0 111.126 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -45.22 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.965 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.26 64.42 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.869 -0.681 . . . . 1.0 111.984 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 709' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 705' ' ' LEU . 10.4 mp -68.66 -37.8 79.91 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.19 -55.58 32.68 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.303 -0.559 . . . . 1.0 112.24 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.1 Cg_exo -54.34 -43.14 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.283 1.322 . . . . 1.0 112.424 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.564 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 92.8 mt -64.89 -43.16 93.81 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.343 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 713' ' ' LEU . . . . . 0.438 HD13 ' O ' ' B' ' 709' ' ' LEU . 10.3 mp -63.75 -40.66 97.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.413 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.15 -44.48 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.573 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.5 t90 -63.43 -48.61 77.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 1.0 110.044 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.614 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 717' ' ' LEU . . . . . 0.418 ' O ' ' OG1' ' B' ' 720' ' ' THR . 53.3 tp -62.27 -44.36 96.7 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.583 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.81 -42.61 99.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.856 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.25 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 720' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 22.6 p -59.08 -44.19 91.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.608 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.89 -44.43 98.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.504 -0.878 . . . . 1.0 111.203 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.0 m80 . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.27 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 114.221 1.193 . . . . 1.0 114.221 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.41 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.14 -53.07 47.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 1.0 111.691 -176.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -57.09 -39.05 74.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.586 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.75 -45.29 97.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.702 -0.799 . . . . 1.0 109.48 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.061 -0.972 . . . . 1.0 110.479 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.4 t -63.29 -45.12 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.616 -0.266 . . . . 1.0 111.158 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.64 96.07 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.82 -46.0 97.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.506 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.13 -42.78 99.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.791 0.329 . . . . 1.0 111.848 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.01 -46.82 78.62 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.005 -0.617 . . . . 1.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.426 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -60.09 -42.04 98.31 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.65 -41.43 98.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.97 0.414 . . . . 1.0 110.502 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.88 -42.9 99.62 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.654 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 979' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.2 mp -61.32 -40.85 95.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.623 -0.831 . . . . 1.0 109.897 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.0 mt -61.91 -40.45 95.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.181 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 99.3 m -60.85 -48.2 82.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.209 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -44.15 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 120.275 -0.57 . . . . 1.0 111.769 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.68 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 980' ' ' LEU . 79.1 t -61.9 -46.18 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 123.158 0.286 . . . . 1.0 111.124 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.26 -42.42 99.16 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.34 -43.85 97.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.752 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.2 mtt -64.52 -42.47 95.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.263 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -62.97 -44.37 96.24 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -60.95 -32.66 72.18 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.876 -0.515 . . . . 1.0 111.628 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.9 -1.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 68.54 12.81 64.6 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.828 -1.709 . . . . 1.0 108.828 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.51 -44.1 68.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.613 -1.254 . . . . 1.0 107.613 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.456 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 59.2 m-85 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.553 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.963 0.411 . . . . 1.0 110.352 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.51 -43.63 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.112 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.16 -46.19 97.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.423 ' O ' HG23 ' B' ' 700' ' ' VAL . 22.3 m -65.47 -40.68 89.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.945 -0.702 . . . . 1.0 110.597 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.92 -43.74 98.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.535 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.12 -42.19 96.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.197 0.522 . . . . 1.0 110.73 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 37.5 p -62.91 -38.89 92.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.003 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 696' ' ' VAL . 77.4 t -63.78 -45.27 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.413 -0.515 . . . . 1.0 110.306 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.57 -39.24 93.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.69 97.97 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.91 86.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.831 0.348 . . . . 1.0 110.534 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 976' ' ' GLY . 25.8 mm -62.65 -42.45 96.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.475 ' HA ' HD21 ' A' ' 980' ' ' LEU . 87.3 mt -61.52 -43.8 98.21 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.427 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.82 -43.07 99.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.89 -44.33 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.691 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.95 -40.4 73.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.917 -0.658 . . . . 1.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 80.5 mt -66.71 -38.14 86.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.86 -56.96 20.0 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.909 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.3 Cg_exo -54.09 -44.97 44.52 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.908 1.072 . . . . 1.0 111.774 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.27 -41.77 93.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.595 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.58 -41.46 98.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -63.77 -44.1 98.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.408 -0.59 . . . . 1.0 109.408 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.887 ' NE1' HD11 ' B' ' 719' ' ' ILE . 10.4 t90 -62.36 -48.53 79.38 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -43.95 97.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.559 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.97 -42.77 99.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.89 -42.12 98.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.509 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.887 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.1 mt -63.9 -44.71 98.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.057 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 96.7 m -59.51 -46.52 88.6 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.779 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.73 -43.58 98.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.163 0.506 . . . . 1.0 110.659 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 8.0 m80 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.927 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.458 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.6 -52.04 50.73 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.456 -0.497 . . . . 1.0 111.723 -176.34 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -57.96 -38.58 76.27 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 121.138 -0.225 . . . . 1.0 111.53 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.2 -45.05 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.49 -42.79 99.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.546 -1.206 . . . . 1.0 110.405 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.86 -44.71 99.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.205 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.55 93.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.614 -0.803 . . . . 1.0 111.163 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.92 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.765 -0.256 . . . . 1.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.96 -41.99 99.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.934 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.57 -43.84 93.85 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.785 -0.721 . . . . 1.0 111.304 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.78 -42.58 99.66 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.4 tp -63.84 -42.86 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.944 0.372 . . . . 1.0 111.582 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.34 -42.57 99.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.875 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.7 -41.3 97.42 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.904 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.723 HD21 HD23 ' B' ' 705' ' ' LEU . 1.4 mm? -62.76 -41.03 99.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.036 -0.266 . . . . 1.0 111.536 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 17.9 m -60.52 -45.81 92.47 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.625 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.85 -43.92 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.646 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.89 -44.32 93.38 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.18 -40.62 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.817 -0.753 . . . . 1.0 111.027 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.0 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.56 -42.04 99.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.513 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.64 -42.06 91.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.052 0.453 . . . . 1.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -64.05 -42.4 97.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.752 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.12 -33.46 75.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.032 0.444 . . . . 1.0 111.291 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.5 t -77.27 -0.42 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.476 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.67 10.14 66.68 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -44.33 65.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.733 -1.21 . . . . 1.0 107.733 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.502 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 57.6 m-85 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.428 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.87 0.366 . . . . 1.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.28 -43.69 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.035 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 694' ' ' LEU . . . . . 0.494 ' N ' HD12 ' B' ' 694' ' ' LEU . 11.1 mp -62.36 -41.98 99.03 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -45.32 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.743 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.1 t -63.55 -44.96 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 1.0 110.707 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.41 -43.01 99.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.644 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.92 -42.28 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 1.0 110.564 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 55.3 p -62.2 -40.05 94.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 696' ' ' VAL . 71.4 t -62.69 -45.59 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.729 0.299 . . . . 1.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.5 mtp -63.57 -39.43 94.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.33 99.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.989 -1.244 . . . . 1.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.09 -36.57 80.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.031 0.443 . . . . 1.0 110.184 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.406 HG21 ' C ' ' A' ' 976' ' ' GLY . 31.7 mm -60.97 -41.88 90.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.034 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.723 HD23 HD21 ' A' ' 980' ' ' LEU . 81.4 mt -60.56 -45.81 92.54 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.943 -0.703 . . . . 1.0 110.814 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.08 -42.91 99.75 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.276 -0.57 . . . . 1.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.2 -44.63 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.269 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.77 -40.57 75.66 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.39 -38.16 84.27 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.711 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.25 -56.77 20.84 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.908 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.6 Cg_exo -54.71 -45.3 42.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.174 1.249 . . . . 1.0 111.455 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.09 -41.6 90.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.188 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.08 -41.5 99.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.5 -44.27 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.854 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.5 t90 -62.3 -48.29 80.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.794 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -44.09 96.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.71 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.88 -43.2 99.44 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.47 -42.13 98.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.854 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.3 mt -63.56 -44.06 98.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.095 -0.642 . . . . 1.0 109.511 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.8 m -60.26 -47.44 85.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.795 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.18 -43.51 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.175 -0.61 . . . . 1.0 111.47 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.7 m80 . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 178.241 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.77 -52.24 50.32 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.418 -0.513 . . . . 1.0 111.615 -176.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -57.74 -37.94 74.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.963 -0.295 . . . . 1.0 111.511 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 973' ' ' VAL . 72.5 t -63.97 -44.72 97.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.39 -41.78 98.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.695 -1.139 . . . . 1.0 110.211 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.2 t -63.28 -45.08 99.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.114 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.25 -38.64 95.99 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.1 t -62.03 -45.17 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 121.167 -0.213 . . . . 1.0 110.492 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.28 -42.31 99.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.73 0.3 . . . . 1.0 111.535 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 975' ' ' GLY . . . . . 0.402 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -65.35 -44.43 93.46 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.323 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.464 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.0 -41.85 99.59 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.93 -41.38 99.46 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.79 -0.241 . . . . 1.0 110.353 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.99 -42.57 99.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.235 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 979' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 975' ' ' GLY . 8.6 mp -61.92 -41.51 98.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.155 -1.018 . . . . 1.0 110.081 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.9 mt -61.97 -42.18 98.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.95 -0.7 . . . . 1.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.2 m -61.83 -48.05 82.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.635 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.374 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 983' ' ' LEU . . . . . 0.489 HD11 ' HE2' ' A' ' 987' ' ' MET . 57.2 tp -63.01 -43.46 98.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.574 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 980' ' ' LEU . 59.7 t -62.65 -45.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.603 0.239 . . . . 1.0 111.158 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.76 -42.48 97.8 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.756 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.41 -41.84 98.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.311 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 983' ' ' LEU . 62.4 mtt -65.14 -42.3 93.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.688 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.435 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.8 t90 -63.65 -42.65 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.64 -34.02 76.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.218 0.533 . . . . 1.0 111.224 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.7 t -77.36 -2.39 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.811 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.22 68.4 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.043 -1.623 . . . . 1.0 109.043 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -56.13 -44.17 78.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.095 0.448 . . . . 1.0 109.946 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.672 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 47.3 m-85 . . . . . 0 C--O 1.232 0.148 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.6 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 C--O 1.227 -0.127 0 CA-C-O 121.142 0.496 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.35 -44.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.85 -43.78 95.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.91 -41.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.357 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 64.3 t -63.56 -45.97 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 697' ' ' LEU . . . . . 0.687 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.2 tt -62.98 -42.65 99.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.802 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.84 -42.43 97.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.092 0.472 . . . . 1.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 53.6 p -62.06 -37.94 86.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.181 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.7 t -63.62 -45.14 98.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.068 0.461 . . . . 1.0 110.109 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.7 mtp -61.77 -40.0 93.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.591 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.94 98.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.047 -1.221 . . . . 1.0 110.047 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.51 80.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.742 0.306 . . . . 1.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.464 HG21 ' C ' ' A' ' 976' ' ' GLY . 30.7 mm -62.54 -42.11 94.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.492 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.1 mm? -63.27 -43.93 96.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.489 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.32 -44.32 91.93 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.25 -41.76 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 119.775 -0.77 . . . . 1.0 110.775 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.74 93.12 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.99 -38.29 85.77 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.68 -56.03 27.0 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 112.408 0.522 . . . . 1.0 112.408 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.0 Cg_exo -53.37 -41.96 69.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.293 1.329 . . . . 1.0 111.594 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.672 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 93.5 mt -66.26 -41.49 89.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.381 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.47 -41.9 98.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 7.8 tt -65.69 -38.99 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 119.945 -0.702 . . . . 1.0 109.523 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.21 -49.11 79.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -42.71 99.28 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.87 -46.31 89.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.214 -0.594 . . . . 1.0 110.91 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.62 -41.83 99.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.335 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.74 -42.77 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 30.7 m -58.63 -45.74 88.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.501 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.89 -43.83 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.058 0.456 . . . . 1.0 111.077 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.4 m80 . . . . . 0 C--N 1.328 -0.355 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.209 178.664 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 113.315 0.858 . . . . 1.0 113.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.551 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -70.87 -54.63 10.77 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.888 -177.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -58.4 -39.41 79.61 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 970' ' ' LEU . 9.8 p -65.59 -43.19 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 119.239 -0.985 . . . . 1.0 109.241 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 970' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 969' ' ' VAL . 54.9 tp -62.39 -42.61 99.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.749 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 967' ' ' TRP . 74.5 t -62.47 -44.54 99.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.688 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.84 -39.26 95.19 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.54 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.522 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.23 -42.83 99.28 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.65 -44.86 91.82 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.101 -0.571 . . . . 1.0 111.709 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.481 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.05 -41.53 99.48 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.06 -40.79 98.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.977 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.16 -42.62 99.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.656 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.7 -40.96 96.86 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.396 -0.922 . . . . 1.0 109.729 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 984' ' ' VAL . 89.9 mt -62.77 -41.63 99.33 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.815 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -62.52 -47.6 83.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.423 -0.511 . . . . 1.0 112.007 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.49 -40.85 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.726 -0.79 . . . . 1.0 111.286 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.05 -43.81 97.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 980' ' ' LEU . 73.8 t -60.71 -45.07 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.121 -0.231 . . . . 1.0 111.064 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.68 -41.71 99.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.197 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.96 -43.63 98.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.537 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.479 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 96.2 mmm -63.9 -43.62 95.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.894 0.378 . . . . 1.0 111.804 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.415 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -63.16 -43.32 98.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.291 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.03 -34.35 76.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 1.0 111.593 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.3 t -76.85 -2.19 4.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.065 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.81 8.28 63.52 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.479 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -56.41 -44.86 80.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 C--N 1.329 -0.319 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.092 177.899 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.584 0.231 . . . . 1.0 110.436 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.8 mt -62.64 -44.02 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.478 0.547 . . . . 1.0 112.478 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.51 -43.02 99.85 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.49 -45.41 98.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.978 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.419 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.5 t -63.42 -44.23 98.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 1.0 110.172 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.41 -43.87 98.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.961 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.75 -42.23 95.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 1.0 110.814 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.0 p -61.87 -39.98 93.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.458 -0.792 . . . . 1.0 112.085 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 66.7 t -64.21 -45.03 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.076 0.465 . . . . 1.0 110.871 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 701' ' ' MET . . . . . 0.439 ' O ' HD13 ' B' ' 705' ' ' LEU . 93.0 mtp -63.27 -39.09 93.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.274 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.37 -41.34 96.59 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.613 -0.995 . . . . 1.0 110.613 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.11 88.07 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 120.685 0.278 . . . . 1.0 110.677 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.481 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.6 mm -60.41 -43.21 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.651 -0.819 . . . . 1.0 109.692 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.485 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.7 mp -61.28 -43.23 99.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.467 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.81 -44.39 96.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.619 -0.832 . . . . 1.0 111.197 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.74 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.77 -39.98 65.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.491 -0.862 . . . . 1.0 111.169 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.59 -37.39 82.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.714 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.36 -56.92 19.46 Favored Pre-proline 0 N--CA 1.462 0.137 0 C-N-CA 120.04 -0.664 . . . . 1.0 111.593 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.1 Cg_exo -54.27 -44.37 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 120.837 1.024 . . . . 1.0 111.489 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.13 -42.13 94.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.64 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.59 -41.85 99.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.813 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.6 -44.05 98.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.544 -0.463 . . . . 1.0 109.964 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -62.33 -48.16 81.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.958 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -43.27 98.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.189 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.33 -44.56 96.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.133 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 718' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 84.9 mt -61.14 -42.1 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.89 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.5 -44.11 98.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 120.068 -0.653 . . . . 1.0 110.242 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.5 m -59.79 -46.95 87.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.6 -45.11 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.494 0.664 . . . . 1.0 111.198 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 722' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 51.2 m80 . . . . . 0 C--N 1.321 -0.656 0 C-N-CA 119.865 -0.734 . . . . 1.0 109.438 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 966' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.731 ' O ' HG13 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -54.33 -50.27 67.78 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.857 -0.737 . . . . 1.0 111.306 -176.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -57.69 -38.07 74.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.335 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 973' ' ' VAL . 66.6 t -64.46 -46.38 93.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.964 -1.094 . . . . 1.0 109.468 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.56 -44.58 93.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.856 -1.066 . . . . 1.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 967' ' ' TRP . 3.4 m -64.88 -39.35 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 119.729 -0.788 . . . . 1.0 110.508 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.24 96.34 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.1 t -61.88 -45.28 99.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.211 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.11 -42.64 99.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 1.0 111.658 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.62 85.03 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.476 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -59.69 -42.82 98.08 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.66 -42.52 98.07 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.391 -0.476 . . . . 1.0 111.951 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.44 -44.95 93.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.426 0.528 . . . . 1.0 112.426 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.22 -42.07 99.21 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.471 -0.891 . . . . 1.0 110.988 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' B' ' 705' ' ' LEU . 2.1 mm? -63.19 -40.59 97.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.98 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.8 m -62.0 -45.29 94.26 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.569 -0.452 . . . . 1.0 110.203 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -41.34 89.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.3 99.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.963 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.8 t -61.76 -46.04 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.505 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.36 -41.81 98.86 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.334 -0.546 . . . . 1.0 110.521 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.21 -42.53 98.75 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.207 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.39 -42.88 95.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.537 -0.302 . . . . 1.0 110.815 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.452 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 9.9 t90 -61.71 -42.03 98.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.11 -33.95 75.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.078 0.466 . . . . 1.0 111.176 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 986' ' ' ALA . 51.8 t -78.27 -3.18 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.689 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.47 10.81 71.23 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.53 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.6 OUTLIER -55.29 -45.29 76.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 -178.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 51.7 m-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.645 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 692' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.901 0.381 . . . . 1.0 110.269 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.532 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.9 mt -62.6 -43.51 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 1.0 112.309 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 694' ' ' LEU . 90.1 mt -62.3 -42.47 99.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.208 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.74 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.5 t -63.26 -44.12 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.808 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.25 -43.39 98.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.06 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.8 -42.31 95.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.176 0.512 . . . . 1.0 110.812 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 35.4 p -62.27 -42.84 99.69 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.18 -42.32 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.9 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.5 mtp -62.38 -39.26 92.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.347 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.66 -40.42 97.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 1.0 110.367 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.476 HG21 ' C ' ' A' ' 976' ' ' GLY . 29.4 mm -62.36 -42.54 95.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.513 ' HA ' HD11 ' A' ' 980' ' ' LEU . 5.6 tt -61.6 -44.54 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.743 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.05 -43.2 99.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.128 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.35 -43.9 98.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.311 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.905 -0.664 . . . . 1.0 112.029 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 709' ' ' LEU . . . . . 0.469 HD22 HD21 ' B' ' 705' ' ' LEU . 9.6 mp -67.18 -34.89 78.51 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.598 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -58.11 10.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.347 -0.541 . . . . 1.0 112.334 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 17.8 Cg_endo -62.12 -39.83 46.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.374 1.383 . . . . 1.0 112.045 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 89.5 mt -65.6 -42.08 92.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.933 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -41.25 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.933 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.31 -44.07 98.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.382 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.855 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.1 t90 -62.72 -48.52 78.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.369 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.81 -43.62 97.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.021 -178.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.69 -43.36 99.0 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.24 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.66 -41.3 97.33 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.23 -0.588 . . . . 1.0 110.132 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.855 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.55 -44.15 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.679 -0.808 . . . . 1.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 92.1 m -59.17 -45.35 91.24 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.335 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.51 -43.92 97.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.128 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 67.4 m80 . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.076 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -55.72 -53.66 53.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -176.085 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.49 -39.32 79.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.419 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 69.2 t -64.18 -44.96 97.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.699 0.762 . . . . 1.0 108.971 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.53 -42.64 99.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.0 t -63.51 -45.74 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.776 0.322 . . . . 1.0 111.248 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.52 96.82 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.268 -0.733 . . . . 1.0 111.268 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.9 t -61.73 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.605 0.24 . . . . 1.0 110.447 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.21 -42.61 99.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.497 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.99 -45.13 93.27 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.079 -0.581 . . . . 1.0 111.883 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.19 99.71 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.31 -41.6 98.96 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.644 -0.327 . . . . 1.0 110.82 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.99 -42.39 99.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.47 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.91 -41.68 98.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.009 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' B' ' 705' ' ' LEU . 83.9 mt -60.57 -41.06 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.104 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -59.88 -45.65 91.84 Favored 'General case' 0 C--O 1.253 1.262 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.477 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.35 -47.69 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 119.904 -0.718 . . . . 1.0 111.344 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.92 -42.65 98.54 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.833 -0.747 . . . . 1.0 111.655 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.18 -47.11 95.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.66 -0.816 . . . . 1.0 111.459 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.12 -42.63 99.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.531 -0.467 . . . . 1.0 110.141 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.85 -43.3 99.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.987 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 98.6 mtp -65.84 -41.95 91.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 1.0 111.773 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.1 t90 -62.7 -43.6 98.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.44 -33.46 73.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.138 0.494 . . . . 1.0 110.897 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.8 t -77.33 -2.8 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.688 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.19 7.09 81.67 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.606 ' CD1' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.82 -45.16 78.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.444 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 50.4 m-85 . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 119.825 -0.75 . . . . 1.0 111.231 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.271 0.558 . . . . 1.0 111.262 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.7 -43.52 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.53 -41.78 99.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.663 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.9 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.319 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.458 ' O ' HG23 ' B' ' 700' ' ' VAL . 65.5 t -63.51 -45.38 97.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.958 0.409 . . . . 1.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 697' ' ' LEU . . . . . 0.688 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.1 tt -62.6 -43.03 99.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.655 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.69 -42.12 98.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 1.0 110.457 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.2 p -62.01 -36.73 82.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.037 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.8 t -63.95 -44.63 97.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.061 0.458 . . . . 1.0 110.14 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.69 -39.73 92.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.134 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.89 96.9 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.017 -1.233 . . . . 1.0 110.017 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.77 89.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 1.0 110.357 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.87 -43.22 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.233 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 980' ' ' LEU . 84.6 mt -61.1 -44.22 97.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.163 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.59 -44.12 97.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.669 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 707' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 95.0 mt -63.85 -44.47 98.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.876 -0.329 . . . . 1.0 111.428 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.26 -41.14 69.56 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.87 -38.45 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.507 0.928 . . . . 1.0 113.507 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.26 -57.03 18.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.208 -0.597 . . . . 1.0 112.122 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 32.3 Cg_exo -54.63 -44.28 51.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.091 1.194 . . . . 1.0 111.359 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.29 -42.15 93.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.715 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.62 -41.77 99.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.52 -44.19 98.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.199 -0.601 . . . . 1.0 109.449 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.444 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 11.3 t90 -63.0 -48.25 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 1.0 109.783 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.606 ' NZ ' ' CD1' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.51 -44.21 96.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.729 -178.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -42.86 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.667 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 718' ' ' LEU . . . . . 0.498 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 83.8 mt -62.12 -42.77 99.57 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.897 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.78 -44.32 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.909 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 82.9 m -60.31 -45.8 92.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.512 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.37 -43.21 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.385 -0.526 . . . . 1.0 110.42 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 722' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 43.3 m80 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.457 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.473 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.0 -51.94 47.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.759 -176.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -58.01 -39.2 77.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.682 0.252 . . . . 1.0 111.682 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.1 -45.06 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.26 -42.64 99.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.6 t -62.79 -44.36 99.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.79 -38.26 94.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.443 -0.884 . . . . 1.0 111.155 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.8 t -61.98 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.975 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.19 -42.09 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.846 -0.341 . . . . 1.0 111.876 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.26 92.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.372 -0.691 . . . . 1.0 111.372 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.97 -42.39 99.73 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.146 -1.181 . . . . 1.0 110.146 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.44 -42.08 98.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.953 0.377 . . . . 1.0 111.999 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.76 -43.62 98.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.457 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -40.39 96.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.103 -1.039 . . . . 1.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 976' ' ' GLY . 1.8 mm? -62.5 -39.92 95.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 94.8 m -61.89 -45.53 93.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.807 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.63 -43.63 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.97 -0.692 . . . . 1.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.19 -43.45 98.79 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.379 -0.826 . . . . 1.0 111.355 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 980' ' ' LEU . 68.4 t -60.63 -44.73 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.081 -0.387 . . . . 1.0 110.82 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.45 -41.43 98.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.175 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.388 -0.525 . . . . 1.0 112.191 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.481 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 95.6 mmm -64.29 -42.81 96.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 111.201 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.457 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.1 t90 -62.53 -42.6 99.63 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.051 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.33 -34.4 76.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.832 0.349 . . . . 1.0 111.396 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -78.09 -2.49 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.792 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 68.27 12.17 62.85 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 108.548 -1.821 . . . . 1.0 108.548 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.481 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -54.9 -44.13 73.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -178.068 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 119.838 -0.745 . . . . 1.0 109.859 177.537 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 . . . . . 0 C--O 1.243 0.734 0 CA-C-O 120.917 0.389 . . . . 1.0 111.83 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.54 -42.69 96.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.856 -0.737 . . . . 1.0 112.351 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.36 -41.58 98.85 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.003 -0.436 . . . . 1.0 111.451 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.6 -45.32 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.846 0.355 . . . . 1.0 111.646 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 58.6 t -64.18 -45.23 96.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 697' ' ' LEU . . . . . 0.676 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.2 tt -63.29 -43.03 99.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.833 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.3 -42.02 96.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 1.0 110.553 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 49.5 p -62.38 -38.26 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.361 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.2 t -63.86 -44.83 98.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.137 0.494 . . . . 1.0 110.054 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -63.03 -39.55 95.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.54 -40.54 97.72 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.94 78.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.1 mm -62.59 -42.65 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.416 ' HA ' HD21 ' A' ' 980' ' ' LEU . 13.7 mt -61.43 -44.9 96.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.833 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.28 -43.9 96.61 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.043 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.29 -44.85 97.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.52 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 708' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -70.11 -42.4 67.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.206 -0.521 . . . . 1.0 111.801 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 709' ' ' LEU . . . . . 0.462 ' O ' HD13 ' B' ' 713' ' ' LEU . 82.5 mt -67.12 -38.38 85.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.27 -55.56 30.31 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 44.0 Cg_exo -52.59 -41.42 68.59 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.299 1.333 . . . . 1.0 111.778 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.476 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.24 -41.89 93.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.722 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 713' ' ' LEU . . . . . 0.462 HD13 ' O ' ' B' ' 709' ' ' LEU . 9.4 mp -63.33 -42.37 98.97 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.29 -41.71 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.503 -0.879 . . . . 1.0 110.147 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -63.44 -48.77 76.39 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -42.7 95.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.681 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.18 -44.45 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.623 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.73 -41.91 98.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.997 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.55 -42.98 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 120.321 -0.552 . . . . 1.0 109.825 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 98.0 m -59.61 -45.88 90.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.384 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.73 -43.67 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.921 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.2 m80 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.679 178.625 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.028 0.381 . . . . 1.0 112.028 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.562 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -66.64 -50.86 61.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -177.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 968' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.7 m0 -58.09 -43.54 87.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 119.299 -0.381 . . . . 1.0 111.671 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 970' ' ' LEU . 28.1 m -65.78 -43.61 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 118.819 -1.152 . . . . 1.0 110.457 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 970' ' ' LEU . . . . . 0.444 ' N ' HG23 ' A' ' 969' ' ' VAL . 89.3 mt -63.15 -42.81 99.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.491 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.3 t -64.0 -44.98 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.707 0.289 . . . . 1.0 111.387 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.48 -38.39 94.77 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.116 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.61 -45.1 99.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 121.16 -0.216 . . . . 1.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.3 -42.14 99.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.898 0.333 . . . . 1.0 111.898 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.54 -43.43 94.64 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 120.676 -0.773 . . . . 1.0 111.735 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.1 99.95 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 120.435 -0.888 . . . . 1.0 111.133 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.8 -40.31 96.97 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.539 -0.389 . . . . 1.0 110.098 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.0 -42.7 99.43 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.48 -42.6 99.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.687 -0.805 . . . . 1.0 110.213 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 984' ' ' VAL . 24.4 mt -62.39 -42.74 99.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.824 0.345 . . . . 1.0 110.779 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 24.1 p -61.93 -45.1 95.2 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.508 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.71 -43.28 97.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.672 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.7 -42.72 97.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.394 -0.522 . . . . 1.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.617 HG22 HD21 ' B' ' 712' ' ' LEU . 69.6 t -62.45 -45.48 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.063 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.83 97.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.931 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.37 -43.28 99.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.644 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 64.4 mtt -64.77 -42.46 95.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.018 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.46 -33.79 74.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.125 0.488 . . . . 1.0 111.387 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.9 t -78.68 -3.36 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.64 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.56 11.04 72.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.333 -1.507 . . . . 1.0 109.333 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.524 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.48 -45.42 76.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.435 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 48.6 m-85 . . . . . 0 C--N 1.33 -0.248 0 C-N-CA 119.986 -0.686 . . . . 1.0 110.734 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 692' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 66.4 t0 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.915 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.563 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 93.2 mt -61.98 -44.42 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 113.095 0.776 . . . . 1.0 113.095 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.35 99.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.717 0.294 . . . . 1.0 111.204 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.21 -45.39 98.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.819 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 700' ' ' VAL . 66.6 t -63.1 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 1.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.554 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.75 -42.88 94.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.439 . . . . 1.0 110.668 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 54.6 p -62.52 -39.56 93.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.829 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 700' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.6 t -64.24 -43.79 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.39 0.614 . . . . 1.0 109.381 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.6 mtp -63.29 -39.96 96.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.878 -1.056 . . . . 1.0 110.173 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.93 -47.12 48.74 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.07 83.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.675 0.274 . . . . 1.0 111.631 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.42 HG22 ' O ' ' B' ' 700' ' ' VAL . 10.7 tp -64.87 -37.61 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.651 -0.82 . . . . 1.0 108.849 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 62.3 tp -60.83 -44.95 96.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.31 -41.37 98.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.141 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.7 -43.85 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.43 -39.25 95.63 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.5 -37.24 82.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.694 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.11 -56.48 21.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 112.299 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.5 Cg_exo -53.66 -43.91 53.69 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.06 1.173 . . . . 1.0 112.017 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.617 HD21 HG22 ' A' ' 984' ' ' VAL . 11.1 mp -65.17 -41.99 94.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.137 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.22 -41.66 99.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.082 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.64 -44.31 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.435 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 7.9 t90 -62.16 -47.31 85.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.29 0.567 . . . . 1.0 109.578 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.53 -44.01 96.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.747 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.51 -46.28 89.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.632 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 718' ' ' LEU . . . . . 0.489 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 8.2 mp -63.26 -41.01 98.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.545 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 4.5 mm -63.58 -44.65 98.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.965 -0.694 . . . . 1.0 109.994 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -45.37 94.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.1 -43.53 98.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.319 -0.552 . . . . 1.0 111.366 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 722' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 44.5 m80 . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -65.34 -51.94 57.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 -177.295 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 968' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.1 m0 -57.18 -40.81 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.143 -0.223 . . . . 1.0 110.779 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.42 -46.45 92.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 119.419 -0.912 . . . . 1.0 110.263 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.26 -42.65 99.18 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.681 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.7 t -63.93 -44.58 98.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.443 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.77 -37.91 95.07 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.292 -0.956 . . . . 1.0 111.533 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.25 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.437 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.29 -42.92 99.12 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.2 -45.08 89.24 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.88 -0.676 . . . . 1.0 111.614 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.593 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.67 -41.37 98.91 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.91 -42.78 97.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.133 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.96 -44.33 96.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.557 -0.457 . . . . 1.0 111.654 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 979' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 983' ' ' LEU . 8.4 mp -62.61 -42.12 99.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.64 -0.824 . . . . 1.0 110.366 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' B' ' 705' ' ' LEU . 4.1 mm? -63.14 -39.65 95.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.846 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 84.6 m -61.2 -45.13 95.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.515 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.82 -44.17 99.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.586 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 983' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 979' ' ' LEU . 8.5 mp -62.94 -42.0 99.67 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.349 -0.54 . . . . 1.0 110.899 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 63.8 t -62.45 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 1.0 111.011 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.24 -41.73 99.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.9 99.94 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.284 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.27 -40.54 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.373 0.606 . . . . 1.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.6 t90 -65.35 -44.7 86.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.578 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.67 -33.98 76.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.96 2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.176 -1.01 . . . . 1.0 109.296 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.16 84.5 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.38 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.417 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.9 -44.34 66.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.468 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.4 m-85 . . . . . 0 C--N 1.328 -0.355 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.857 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 CA--C 1.522 -0.108 0 N-CA-C 109.997 -0.371 . . . . 1.0 109.997 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.02 -44.46 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.88 -43.37 96.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.34 -47.24 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.91 0.707 . . . . 1.0 112.91 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' B' ' 699' ' ' SER . 11.0 p -65.26 -41.65 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 697' ' ' LEU . . . . . 0.42 ' N ' HG13 ' B' ' 696' ' ' VAL . 42.9 tp -61.76 -43.45 98.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.852 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.86 -41.84 95.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 1.0 110.665 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 36.8 p -62.55 -40.98 98.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.582 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.56 -45.26 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.266 0.555 . . . . 1.0 110.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -63.5 -39.76 95.3 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.035 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.44 -41.13 99.41 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.99 -0.844 . . . . 1.0 110.99 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.58 80.87 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.05 -41.27 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.673 ' HA ' HD21 ' A' ' 980' ' ' LEU . 47.5 tp -60.63 -46.26 90.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.868 -0.333 . . . . 1.0 111.166 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.24 -42.42 99.2 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.55 -44.21 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.563 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.59 -40.86 94.24 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.64 -37.57 85.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.92 -57.18 17.2 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 119.998 -0.681 . . . . 1.0 112.32 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.7 Cg_exo -54.46 -45.38 41.41 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.158 1.239 . . . . 1.0 111.934 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.493 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -65.86 -40.57 91.79 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.259 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.42 -41.32 98.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.085 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.63 -44.75 98.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.389 -0.525 . . . . 1.0 109.735 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.468 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.2 t90 -63.11 -49.19 75.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.18 0.514 . . . . 1.0 109.702 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.444 ' O ' HG23 ' B' ' 720' ' ' THR . 0.2 OUTLIER -60.64 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.104 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.35 -45.39 91.43 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.738 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 718' ' ' LEU . . . . . 0.455 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 82.7 mt -62.76 -42.9 99.9 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.676 0.621 . . . . 1.0 112.676 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' B' ' 720' ' ' THR . 5.6 tp -65.87 -41.26 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 119.611 -0.836 . . . . 1.0 109.871 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 720' ' ' THR . . . . . 0.444 HG23 ' O ' ' B' ' 716' ' ' LYS . 30.6 p -58.69 -45.3 89.76 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.758 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 721' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' B' ' 721' ' ' ILE . 36.2 mm -62.05 -41.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 O-C-N 121.849 -0.532 . . . . 1.0 110.676 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 722' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 59.2 m80 . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.211 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.0 tt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 113.431 0.9 . . . . 1.0 113.431 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.37 -45.4 80.54 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.272 -0.971 . . . . 1.0 110.822 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 968' ' ' TRP . . . . . 0.599 ' NE1' HD12 ' B' ' 693' ' ' ILE . 35.5 m0 -57.23 -46.13 83.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.78 -0.191 . . . . 1.0 110.786 -177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -63.74 -46.82 93.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 119.329 -0.948 . . . . 1.0 110.941 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.31 -44.26 95.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.113 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 967' ' ' TRP . 64.5 t -63.77 -44.95 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.07 -39.32 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.183 -1.008 . . . . 1.0 111.118 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.065 0.394 . . . . 1.0 112.065 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.72 -42.84 97.85 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.58 95.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.494 -0.86 . . . . 1.0 111.2 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.401 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.93 -42.85 99.77 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.63 -41.94 99.31 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.732 -0.275 . . . . 1.0 110.659 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.83 -41.79 98.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.47 -41.26 96.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.469 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' B' ' 705' ' ' LEU . 91.2 mt -62.61 -42.07 99.36 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.953 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 96.6 m -62.29 -48.66 78.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.01 -41.38 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.453 -0.899 . . . . 1.0 111.626 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.39 -43.48 97.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.541 -0.464 . . . . 1.0 110.696 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.2 t -62.52 -45.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.722 0.296 . . . . 1.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.08 -42.28 99.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.12 -43.64 98.38 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.336 -0.545 . . . . 1.0 111.811 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.74 -42.62 90.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.144 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -62.67 -42.79 99.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.88 -32.45 73.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.282 0.563 . . . . 1.0 110.509 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.4 t -78.37 -3.79 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.904 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.17 72.86 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.198 -1.561 . . . . 1.0 109.198 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.499 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.88 -46.09 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -178.576 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.658 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 39.2 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.836 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.767 0.318 . . . . 1.0 110.507 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.599 HD12 ' NE1' ' A' ' 968' ' ' TRP . 9.4 tt -62.78 -41.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.461 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.46 -42.43 99.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.412 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.29 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 71.1 t -62.77 -44.77 99.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 1.0 110.485 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 697' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 968' ' ' TRP . 86.7 mt -62.05 -41.99 98.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.572 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.55 -43.32 94.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 1.0 110.398 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.8 p -62.47 -41.44 98.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.848 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.59 -44.88 98.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.316 0.579 . . . . 1.0 109.8 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 55.9 mtt -62.85 -39.46 94.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.499 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.25 -41.69 94.59 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.78 89.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.144 0.497 . . . . 1.0 110.759 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 704' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 980' ' ' LEU . 27.6 mm -63.24 -41.68 93.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.379 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.523 ' HA ' HD21 ' A' ' 980' ' ' LEU . 57.5 tp -59.42 -46.84 87.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.018 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.17 -43.11 99.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.602 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.88 -44.09 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.19 -41.07 92.48 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.244 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.11 -35.36 76.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.08 -56.2 24.01 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 119.588 -0.845 . . . . 1.0 111.422 -177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.8 Cg_exo -54.19 -42.43 67.36 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.296 1.331 . . . . 1.0 111.351 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 712' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 90.9 mt -64.16 -42.82 96.59 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.91 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -41.36 98.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.96 98.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.053 -0.659 . . . . 1.0 109.349 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.857 ' NE1' HD11 ' B' ' 719' ' ' ILE . 5.3 t90 -61.84 -49.27 76.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.922 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 716' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.56 -42.64 97.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.316 -0.24 . . . . 1.0 110.656 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.16 -42.62 99.45 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.48 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.91 -40.44 93.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.377 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 719' ' ' ILE . . . . . 0.857 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.97 -46.72 93.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.799 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 21.6 m -60.86 -48.19 82.95 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 34.1 mm -63.14 -43.78 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.788 0.662 . . . . 1.0 112.788 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 722' ' ' HIS . . . . . 0.455 ' CD2' ' C ' ' B' ' 722' ' ' HIS . 1.8 p-80 . . . . . 0 C--N 1.324 -0.523 0 C-N-CA 119.522 -0.871 . . . . 1.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -58.13 -50.71 72.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.457 -0.497 . . . . 1.0 112.285 -176.72 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 968' ' ' TRP . . . . . 0.451 ' CZ2' HD11 ' B' ' 693' ' ' ILE . 21.7 m0 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.193 -177.03 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 973' ' ' VAL . 65.1 t -64.36 -46.46 93.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.806 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.23 -43.74 97.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 1.0 111.686 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.0 t -63.36 -45.1 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.585 -0.279 . . . . 1.0 111.664 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.66 -37.69 94.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.095 -1.05 . . . . 1.0 111.586 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 969' ' ' VAL . 60.6 t -62.0 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.854 -0.339 . . . . 1.0 110.595 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.46 -43.08 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.85 97.58 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.746 -0.74 . . . . 1.0 111.26 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.1 -41.72 99.7 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.12 -42.95 99.63 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.139 -0.624 . . . . 1.0 111.816 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.42 -41.93 98.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.344 -0.543 . . . . 1.0 111.839 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.46 -42.45 99.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.711 -0.795 . . . . 1.0 110.234 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.66 HD11 HD12 ' B' ' 705' ' ' LEU . 3.5 mm? -64.52 -41.05 96.63 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.338 0.496 . . . . 1.0 112.338 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 20.3 m -62.14 -47.15 85.84 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.496 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 42.0 pt -63.09 -41.35 92.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.757 -0.777 . . . . 1.0 111.617 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -43.17 99.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.474 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.5 t -61.7 -45.0 99.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.87 0.367 . . . . 1.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 985' ' ' LEU . 93.0 mt -62.71 -41.5 99.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.49 -42.22 98.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 1.0 111.206 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.98 -42.03 94.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.773 0.32 . . . . 1.0 111.505 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -63.06 -43.29 99.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.47 -33.77 75.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.076 0.465 . . . . 1.0 111.587 -178.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.4 t -77.65 -3.07 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.81 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.88 9.63 71.06 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.41 -1.476 . . . . 1.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.06 -43.81 78.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.236 0.518 . . . . 1.0 109.652 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.6 m-85 . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.22 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.878 0.37 . . . . 1.0 111.269 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 693' ' ' ILE . . . . . 0.451 HD11 ' CZ2' ' A' ' 968' ' ' TRP . 86.8 mt -62.03 -43.85 98.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 1.0 112.284 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 694' ' ' LEU . . . . . 0.482 ' N ' HD22 ' B' ' 694' ' ' LEU . 3.9 mm? -62.78 -43.38 98.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.981 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.18 -45.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.328 . . . . 1.0 111.467 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.3 t -63.7 -44.75 98.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.067 0.461 . . . . 1.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.03 -43.16 99.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.781 -0.645 . . . . 1.0 112.05 -178.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.3 -42.35 96.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.1 0.476 . . . . 1.0 110.428 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 50.8 p -62.38 -41.37 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.57 -0.741 . . . . 1.0 112.871 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.45 -45.78 94.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.286 -0.565 . . . . 1.0 110.288 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.36 -39.6 94.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.565 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.24 98.0 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.002 -1.239 . . . . 1.0 110.002 177.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.76 89.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.403 0.621 . . . . 1.0 109.908 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -61.04 -41.8 90.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 118.479 -1.289 . . . . 1.0 109.053 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 705' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 980' ' ' LEU . 59.5 tp -59.36 -43.87 92.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.534 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.753 -0.779 . . . . 1.0 110.743 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.07 -44.16 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.94 -38.85 94.57 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 709' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 713' ' ' LEU . 85.7 mt -67.46 -38.19 84.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.957 1.095 . . . . 1.0 113.957 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 710' ' ' ALA . . . . . 0.667 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.97 -57.11 17.54 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.759 -177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 711' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.9 Cg_exo -55.5 -45.48 39.38 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.306 1.145 . . . . 1.0 111.448 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.308 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 713' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' B' ' 709' ' ' LEU . 33.5 mt -62.98 -41.08 99.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.784 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.18 -46.39 95.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.397 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 715' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 4.3 t90 -61.03 -49.36 77.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.648 178.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -45.83 91.17 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.786 -0.366 . . . . 1.0 111.037 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.1 -44.43 92.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.032 -0.667 . . . . 1.0 111.114 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.28 -43.42 97.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt -68.33 -40.93 83.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.579 -0.848 . . . . 1.0 109.964 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 94.6 m -59.15 -45.64 90.45 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.38 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.92 -43.14 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.622 -178.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.3 m80 . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 178.105 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.885 -1.286 . . . . 11.73 109.885 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 173.14 -87.62 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.331 -2.84 . . . . 10.34 103.331 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.745 ' C ' ' H ' ' A' ' 961' ' ' GLU . 2.2 mt -85.0 108.64 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 102.328 -3.212 . . . . 10.0 102.328 171.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -54.88 -6.96 0.14 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.901 -1.518 . . . . 8.53 106.901 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 961' ' ' GLU . . . . . 0.792 ' O ' ' SG ' ' B' ' 690' ' ' CYS . 1.2 tt0 61.3 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.865 -2.642 . . . . 6.75 103.865 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 964' ' ' ILE . 8.5 mtm-85 -57.8 125.91 25.11 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 123.835 1.779 . . . . 7.79 113.515 -173.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.466 ' CB ' ' HA ' ' B' ' 690' ' ' CYS 0.273 73.7 m -78.52 6.82 7.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 110.091 -3.231 . . . . 2.63 108.962 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.531 ' H ' ' C ' ' A' ' 962' ' ' ARG . 0.0 OUTLIER -157.46 64.71 3.25 Favored Pre-proline 0 N--CA 1.425 -1.716 0 CA-C-N 112.071 -2.332 . . . . 2.84 107.536 -176.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.84 148.39 88.57 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 106.149 -2.289 . . . . 1.52 106.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.9 -42.46 92.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 114.857 1.429 . . . . 1.45 114.857 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.56 -58.15 8.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.356 -0.538 . . . . 0.9 111.413 -177.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -56.55 -39.4 73.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.189 0.811 . . . . 3.19 113.189 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.89 -45.88 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.116 -1.034 . . . . 0.82 108.375 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.47 -44.09 97.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.349 -1.296 . . . . 1.68 110.696 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 91.4 t -63.31 -45.36 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.604 0.24 . . . . 0.69 111.441 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.44 92.54 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.838 -1.173 . . . . 0.24 111.324 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.51 -44.84 99.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 121.043 -0.263 . . . . 0.29 110.72 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.88 -42.07 95.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 1.1 112.374 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.84 84.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.132 -0.556 . . . . 0.2 112.014 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.24 99.36 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.528 -1.029 . . . . 0.15 110.528 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.6 -40.84 89.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 120.767 -0.373 . . . . 1.63 110.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.9 -43.19 99.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.857 -0.794 . . . . 1.57 108.857 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.5 -41.86 95.18 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.518 -1.273 . . . . 1.51 109.752 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' B' ' 705' ' ' LEU . 60.3 mt -60.03 -38.77 83.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.843 -0.743 . . . . 1.4 111.063 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -61.22 -47.71 84.85 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.646 -0.822 . . . . 0.61 110.564 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.41 -42.8 95.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.341 -0.544 . . . . 1.3 110.63 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.0 -43.63 95.1 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.583 -0.447 . . . . 1.61 110.891 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.3 t -62.32 -44.82 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.667 -0.413 . . . . 0.62 111.234 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.89 -43.29 99.2 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.76 109.934 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.88 97.31 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.77 -0.372 . . . . 0.3 111.743 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 44.6 mtt -64.0 -42.91 97.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 1.59 110.472 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.549 ' HE1' ' CE ' ' A' ' 994' ' ' LYS . 17.1 t90 -63.48 -46.34 86.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.09 -0.708 . . . . 1.17 109.09 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.18 -35.63 77.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.651 0.611 . . . . 0.78 112.651 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 990' ' ' VAL . 71.5 t -78.04 -1.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.74 -0.784 . . . . 0.91 108.965 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 74.36 5.2 71.58 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 108.18 -1.968 . . . . 0.36 108.18 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.526 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -47.82 -44.93 29.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 120.024 1.912 . . . . 0.81 110.444 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -84.33 -19.18 34.13 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.361 -1.29 . . . . 1.26 110.545 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.549 ' CE ' ' HE1' ' A' ' 988' ' ' TRP . 84.5 mttt -76.33 -29.95 57.48 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.559 -2.385 . . . . 2.66 104.559 174.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 991' ' ' GLY . 55.6 ttt-85 -67.25 108.81 2.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.33 -2.47 . . . . 2.52 104.33 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 996' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 996' ' ' ASN . 1.7 p-10 -112.86 -18.23 12.32 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.0 -2.593 . . . . 5.16 104.0 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 163.3 154.78 0.05 OUTLIER Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 110.823 -2.899 . . . . 8.36 106.111 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 121.293 1.329 . . . . 7.21 112.427 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 119.664 -0.52 . . . . 10.54 112.017 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.63 17.63 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 118.214 1.007 . . . . 12.12 112.967 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 687' ' ' SER . . . . . 0.5 ' O ' ' N ' ' B' ' 689' ' ' LYS . 0.0 OUTLIER 172.95 -58.38 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 102.794 -3.039 . . . . 7.44 102.794 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 688' ' ' PRO . . . . . 0.696 ' C ' ' N ' ' B' ' 690' ' ' CYS . 18.7 Cg_endo -71.7 59.28 2.7 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.35 -1.827 . . . . 6.08 107.35 171.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 689' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' B' ' 687' ' ' SER . 11.8 mttt -46.29 -18.35 0.05 Allowed 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.017 -2.216 . . . . 6.05 105.017 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 690' ' ' CYS . . . . . 0.792 ' SG ' ' O ' ' A' ' 961' ' ' GLU . 47.0 m -109.49 103.24 52.35 Favored Pre-proline 0 N--CA 1.419 -2.004 0 CA-C-N 110.445 -3.071 . . . . 1.8 108.394 175.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.81 158.02 5.0 Favored 'Trans proline' 0 CA--C 1.507 -0.874 0 N-CA-C 108.097 -1.54 . . . . 0.9 108.097 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.85 136.21 57.75 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.18 -1.008 . . . . 1.6 110.074 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.73 -44.53 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.96 111.865 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 69.3 mt -62.27 -41.94 98.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 1.29 110.428 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.49 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.73 111.031 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 92.4 t -62.92 -45.65 98.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 1.04 110.009 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.71 -43.01 98.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.542 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.13 -41.59 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.84 110.166 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 13.4 p -61.79 -42.59 99.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.319 -0.4 . . . . 0.27 111.179 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.15 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 120.649 -0.421 . . . . 0.57 109.926 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 88.1 mtp -60.79 -39.05 87.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.93 109.9 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.11 -41.38 95.05 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.635 -0.986 . . . . 0.18 110.635 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.07 89.12 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.954 0.407 . . . . 0.24 110.021 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.85 -42.27 88.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 118.938 -1.105 . . . . 0.5 109.366 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.473 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.3 mt -59.11 -45.99 89.47 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.64 -0.255 . . . . 1.69 110.599 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.29 -42.98 99.14 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.331 -0.548 . . . . 1.81 110.561 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.63 -46.21 95.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.426 -0.51 . . . . 0.85 110.863 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.19 -39.47 94.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.639 -0.791 . . . . 0.22 111.615 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.47 -28.68 62.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.676 1.362 . . . . 1.28 114.676 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.675 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -60.1 -54.86 51.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.969 0.804 . . . . 0.23 111.405 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.5 Cg_exo -55.07 -44.9 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.513 1.475 . . . . 0.29 111.333 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.59 -42.21 87.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 1.02 110.799 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.88 -41.91 99.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.886 -0.326 . . . . 1.04 111.092 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.91 -44.5 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 109.064 -0.717 . . . . 1.43 109.064 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.81 -50.11 74.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.584 -0.525 . . . . 0.71 109.584 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -59.84 -43.49 94.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 1.03 110.919 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 717' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 717' ' ' LEU . 19.4 tp -62.88 -47.51 83.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 1.86 110.514 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.85 -41.9 96.76 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.789 -0.364 . . . . 0.69 110.836 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -45.61 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 109.522 -0.547 . . . . 1.59 109.522 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 720' ' ' THR . . . . . 0.619 ' O ' ' N ' ' B' ' 724' ' ' ARG . 18.7 m -55.01 -47.41 74.72 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.774 -0.77 . . . . 1.02 109.851 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 721' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' B' ' 725' ' ' LYS . 35.9 mt -64.96 -44.0 96.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.999 0.74 . . . . 1.33 112.999 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -63.38 -34.02 76.82 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.452 -0.944 . . . . 1.34 108.452 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.592 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 56.5 t0 -82.89 -46.98 12.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.244 -1.343 . . . . 1.81 112.429 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 724' ' ' ARG . . . . . 0.619 ' N ' ' O ' ' B' ' 720' ' ' THR . 0.2 OUTLIER -78.58 -47.66 16.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.027 0.38 . . . . 4.63 112.027 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.484 ' O ' ' CD1' ' B' ' 727' ' ' PHE . 5.2 tttt -43.06 109.11 0.12 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.338 -0.545 . . . . 4.97 109.851 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.56 112.53 7.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.479 0.657 . . . . 6.89 111.79 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 727' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 725' ' ' LYS . 25.2 m-85 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 114.847 -1.07 . . . . 10.13 109.753 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.89 89.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.701 0.286 . . . . 1.0 110.533 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.09 126.37 55.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.486 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.94 -38.8 89.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 51.44 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -75.01 143.2 43.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.743 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.26 -36.63 77.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.748 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.51 82.56 53.42 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.609 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.61 145.89 98.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.051 1.834 . . . . 1.0 111.13 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt -66.97 -37.84 80.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.98 -52.23 61.36 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.47 0.544 . . . . 1.0 112.47 -176.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -58.41 -40.01 81.29 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.765 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.7 t -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 119.796 -0.762 . . . . 1.0 109.223 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.45 -42.93 99.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.678 -1.146 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.2 t -63.17 -45.15 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.638 0.256 . . . . 1.0 111.327 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.31 -38.95 96.54 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.728 -0.749 . . . . 1.0 111.273 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 65.6 t -62.24 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 121.078 -0.249 . . . . 1.0 110.503 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.18 -42.49 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.468 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.21 93.39 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.816 -0.707 . . . . 1.0 111.8 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.61 98.61 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.26 -41.7 99.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.743 -0.269 . . . . 1.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.89 -42.12 98.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.022 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.05 -40.94 95.54 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.152 -1.019 . . . . 1.0 109.764 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' B' ' 705' ' ' LEU . 87.8 mt -62.21 -39.0 91.33 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.367 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.5 m -63.0 -47.1 84.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.084 -0.647 . . . . 1.0 110.205 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.68 -42.5 94.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 120.919 -0.312 . . . . 1.0 111.14 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.62 -42.45 91.53 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.526 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.76 -44.29 99.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.143 0.497 . . . . 1.0 110.938 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.87 -41.43 95.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -63.38 -42.12 98.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.776 -0.77 . . . . 1.0 111.305 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.425 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.5 t90 -63.0 -43.05 99.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.41 -34.1 76.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.136 0.493 . . . . 1.0 111.349 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.9 t -77.14 -2.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.78 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.97 8.73 69.64 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.336 -1.505 . . . . 1.0 109.336 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.463 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.77 -45.18 78.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.294 -1.002 . . . . 1.0 108.294 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.4 -22.86 37.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.355 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.83 -39.46 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 118.695 -1.202 . . . . 1.0 108.44 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' B' ' 723' ' ' ASP . 78.3 ttt-85 -66.58 121.54 15.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.87 -0.732 . . . . 1.0 110.739 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -155.94 106.83 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.198 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 41.25 74.17 0.78 Allowed Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.727 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 122.823 2.349 . . . . 1.0 112.229 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.96 90.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.0 110.527 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 687' ' ' SER . . . . . 0.415 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.4 OUTLIER -169.39 -62.98 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.041 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 688' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 36.5 Cg_endo -63.73 145.68 91.3 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.119 1.88 . . . . 1.0 112.19 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -44.44 96.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.642 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.55 165.68 25.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.575 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.29 156.35 63.61 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.393 2.062 . . . . 1.0 111.841 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 692' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 -61.76 138.87 58.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.294 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.3 mt -62.33 -43.56 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.626 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.16 -42.0 98.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.168 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 -45.19 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.796 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 700' ' ' VAL . 67.7 t -63.59 -45.27 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.0 110.664 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 697' ' ' LEU . . . . . 0.689 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.1 tt -62.64 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.449 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.77 -42.37 97.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.035 0.445 . . . . 1.0 110.346 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 52.1 p -62.22 -36.82 83.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 696' ' ' VAL . 68.1 t -63.99 -44.87 97.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.094 0.473 . . . . 1.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.0 mtp -61.54 -39.51 91.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.992 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.84 96.89 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.43 89.22 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.677 0.275 . . . . 1.0 110.51 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.9 mm -62.74 -43.08 98.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.025 -0.67 . . . . 1.0 109.451 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.5 mt -61.26 -44.16 97.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.298 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.1 -43.29 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.94 -44.24 97.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.523 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.35 -41.9 76.44 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.6 -36.17 81.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -57.84 11.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.4 0.519 . . . . 1.0 112.4 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 19.0 Cg_endo -60.35 -40.23 60.18 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.086 1.191 . . . . 1.0 111.901 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.17 -42.7 93.45 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.3 -41.82 98.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.63 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.295 -0.562 . . . . 1.0 109.652 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.861 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.8 t90 -62.37 -48.17 80.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.165 0.507 . . . . 1.0 109.863 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -61.03 -42.54 98.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.004 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.24 -44.49 95.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.5 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.76 -41.79 98.15 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.286 0.565 . . . . 1.0 110.346 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.861 HD11 ' NE1' ' B' ' 715' ' ' TRP . 95.8 mt -62.51 -46.96 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.165 -1.014 . . . . 1.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 89.2 m -57.74 -46.01 85.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.454 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.57 -43.4 96.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.186 -0.606 . . . . 1.0 110.852 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.32 -36.33 83.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 995' ' ' ARG . 8.0 m-20 -68.2 -39.79 82.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.38 -39.89 95.76 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.299 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.06 133.95 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.42 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.3 125.13 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.546 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.501 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.98 89.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 1.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.96 140.81 43.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.486 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.25 135.95 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 961' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' B' ' 689' ' ' LYS . 97.3 mt-10 -119.03 128.13 54.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.252 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -129.09 142.72 50.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.42 151.91 35.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.888 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 964' ' ' ILE . 18.1 mt 57.01 78.96 0.35 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.419 -0.809 . . . . 1.0 111.711 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -62.25 149.68 89.73 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.52 2.147 . . . . 1.0 111.255 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.07 -42.94 98.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.165 1.172 . . . . 1.0 114.165 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.72 -52.94 54.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.73 -176.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -58.09 -39.22 78.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.751 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.27 -45.22 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.629 0.728 . . . . 1.0 109.156 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.46 -42.86 99.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.645 -1.161 . . . . 1.0 110.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.28 -44.49 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.847 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.44 93.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.447 -0.882 . . . . 1.0 110.913 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.46 -46.03 97.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.804 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.24 -42.62 99.24 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.8 93.34 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.807 -0.711 . . . . 1.0 111.454 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.42 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -62.13 -42.49 99.73 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.07 -42.12 99.6 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.837 -0.214 . . . . 1.0 110.791 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.17 -41.27 98.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.196 -0.601 . . . . 1.0 109.9 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 979' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 705' ' ' LEU . 89.3 mt -61.97 -41.43 98.0 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.231 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.611 HD11 ' HA3' ' B' ' 708' ' ' GLY . 0.8 OUTLIER -61.17 -43.19 99.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.981 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.2 m -61.84 -47.02 86.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.601 -0.44 . . . . 1.0 111.219 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.29 -43.92 98.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.605 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.33 -43.27 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.1 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.351 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.21 -42.31 99.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.49 -42.47 99.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.321 -0.552 . . . . 1.0 111.566 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 65.7 mtt -65.21 -42.39 93.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 1.0 111.37 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.72 -43.69 95.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.232 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -34.06 76.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.07 0.462 . . . . 1.0 111.893 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.4 t -77.28 -1.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.535 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 69.83 10.44 64.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.79 -1.724 . . . . 1.0 108.79 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -44.43 72.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.8 m-85 -82.81 -12.25 57.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.816 -0.754 . . . . 1.0 110.705 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.27 -11.37 59.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.756 -1.202 . . . . 1.0 107.756 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.539 HH12 ' CG ' ' B' ' 723' ' ' ASP . 78.6 ttt-85 -66.48 131.26 45.66 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.057 -0.657 . . . . 1.0 109.698 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 64.8 t30 56.39 38.32 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.167 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -160.48 66.86 2.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--N 1.305 -1.729 0 C-N-CA 122.803 2.335 . . . . 1.0 112.106 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.501 -1.44 . . . . 1.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 55.21 30.51 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 1.0 110.607 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 20.5 p -172.72 72.67 0.42 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.626 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.61 145.3 97.75 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.883 2.389 . . . . 1.0 111.937 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 689' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 961' ' ' GLU . 98.8 mttt -63.05 -42.01 99.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.618 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 690' ' ' CYS . . . . . 0.463 ' CB ' ' CD ' ' B' ' 691' ' ' PRO . 0.0 OUTLIER -85.75 -178.36 1.13 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.371 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 691' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' B' ' 690' ' ' CYS . 12.1 Cg_exo -67.58 154.46 73.47 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.545 2.163 . . . . 1.0 110.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.25 139.32 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.328 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.69 -43.68 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 1.0 112.305 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.42 -42.15 99.22 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.497 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.35 -45.2 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.4 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.6 t -63.79 -44.69 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.019 0.438 . . . . 1.0 110.453 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.04 -43.43 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.0 mt -64.14 -42.27 96.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.117 0.484 . . . . 1.0 110.663 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 48.6 p -62.27 -39.52 93.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 1.0 112.203 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.42 -45.87 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 1.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.49 -39.38 94.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.797 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.14 97.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.04 90.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.02 0.438 . . . . 1.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.443 HG22 HD23 ' A' ' 980' ' ' LEU . 27.2 mm -60.84 -42.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.329 -0.948 . . . . 1.0 108.82 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 979' ' ' LEU . 83.4 mt -61.2 -44.18 97.69 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.831 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -44.02 95.78 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.136 -0.626 . . . . 1.0 110.227 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.26 98.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.581 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 708' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 980' ' ' LEU . . . -67.51 -41.89 89.65 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.43 -37.82 83.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.33 -56.58 20.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 120.187 -0.605 . . . . 1.0 112.313 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.4 Cg_exo -53.83 -44.35 49.97 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.192 1.261 . . . . 1.0 111.734 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.482 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -64.73 -42.46 95.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.852 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.96 -39.75 94.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 1.0 110.173 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -46.93 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.461 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.86 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.2 t90 -63.43 -47.29 82.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.282 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -44.12 95.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.816 0.302 . . . . 1.0 111.816 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.29 -42.09 99.04 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.473 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.0 -41.61 98.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.86 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.2 mt -63.23 -45.05 99.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.213 -0.595 . . . . 1.0 110.234 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.3 m -60.35 -47.14 87.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.864 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.53 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.388 . . . . 1.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 722' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 725' ' ' LYS . 7.6 m80 -58.98 -41.57 87.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.183 -0.607 . . . . 1.0 109.519 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.539 ' CG ' HH12 ' A' ' 995' ' ' ARG . 3.0 m-20 -65.68 -38.14 88.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.136 -0.484 . . . . 1.0 112.146 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.78 -39.33 93.43 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.411 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' B' ' 722' ' ' HIS . 68.8 mttm -103.12 145.85 29.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.992 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 138.44 58.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.572 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.59 179.79 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.531 -1.428 . . . . 1.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.97 89.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.784 0.326 . . . . 1.0 110.536 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.97 -42.12 99.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.87 -39.38 90.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.44 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.93 138.7 58.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -128.33 145.31 51.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.436 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.46 148.43 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 964' ' ' ILE . 60.3 mt 56.15 79.69 0.32 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.278 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -60.77 149.25 88.89 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.445 2.097 . . . . 1.0 111.21 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.99 -39.17 82.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 113.715 1.006 . . . . 1.0 113.715 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.439 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.43 -51.84 66.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.699 -0.801 . . . . 1.0 111.181 -176.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -57.38 -37.9 73.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.244 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 68.6 t -64.11 -44.74 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.24 -42.49 99.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.024 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.1 t -63.27 -44.76 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.0 110.948 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.56 95.73 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.6 t -62.11 -45.2 99.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.345 -0.242 . . . . 1.0 110.345 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.03 -42.49 99.79 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.284 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.63 96.1 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.768 -0.73 . . . . 1.0 111.298 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -41.83 99.61 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.93 -40.94 99.15 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.746 -0.267 . . . . 1.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.37 -42.11 99.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.202 -0.599 . . . . 1.0 110.582 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.05 -41.16 97.84 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.8 mt -61.52 -41.19 96.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 1.0 110.677 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.7 m -61.5 -47.13 87.02 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.471 -0.492 . . . . 1.0 111.469 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.17 -44.23 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.64 -42.44 98.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.134 -0.626 . . . . 1.0 111.468 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 980' ' ' LEU . 62.2 t -62.07 -45.65 98.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.881 -0.327 . . . . 1.0 111.105 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.14 -42.11 99.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.35 -42.52 99.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.55 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.1 mtt -65.17 -42.38 93.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 111.355 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.579 ' CD1' ' NZ ' ' A' ' 994' ' ' LYS . 10.9 t90 -63.12 -43.42 98.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 1.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.57 -34.7 77.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.118 0.485 . . . . 1.0 111.417 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 986' ' ' ALA . 52.1 t -76.96 -3.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 1.0 109.856 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.68 73.28 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.402 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.26 -45.45 76.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.277 -1.008 . . . . 1.0 108.277 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.408 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.5 m-85 -79.86 -24.31 41.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.354 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.579 ' NZ ' ' CD1' ' A' ' 988' ' ' TRP . 56.1 mttp -64.3 -39.55 94.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.816 -1.154 . . . . 1.0 108.704 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.526 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.1 ttt-85 -66.13 132.0 47.48 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.147 -0.621 . . . . 1.0 110.555 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 996' ' ' ASN . . . . . 0.57 ' CB ' HD11 ' B' ' 719' ' ' ILE . 52.3 p-10 -146.51 -28.84 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 996' ' ' ASN . 3.8 ttm180 -174.05 74.49 0.35 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.699 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 C--N 1.307 -1.622 0 C-N-CA 122.597 2.198 . . . . 1.0 112.146 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.539 -1.424 . . . . 1.0 109.539 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 147.0 50.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 1.0 110.563 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 2.7 m 42.51 70.38 1.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.515 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.89 -37.63 85.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.014 2.476 . . . . 1.0 112.092 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.71 -41.81 99.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.481 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.58 173.07 8.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.906 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.51 142.81 96.29 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.968 1.779 . . . . 1.0 112.047 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -67.7 140.97 56.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.594 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.06 -43.69 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.335 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 694' ' ' LEU . . . . . 0.555 ' O ' HD13 ' B' ' 698' ' ' LEU . 98.0 mt -62.97 -42.05 99.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.951 -0.299 . . . . 1.0 110.977 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.09 -44.95 99.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.969 0.414 . . . . 1.0 111.053 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.2 t -64.19 -43.79 97.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.404 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.47 -43.4 98.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.751 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 698' ' ' LEU . . . . . 0.555 HD13 ' O ' ' B' ' 694' ' ' LEU . 9.3 mp -65.1 -41.34 95.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.19 0.519 . . . . 1.0 110.349 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 30.7 p -62.37 -37.11 84.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.165 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.43 -44.9 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.353 -0.539 . . . . 1.0 109.916 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.7 mtp -61.92 -40.0 93.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.197 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.04 -41.51 97.17 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.27 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 1.0 110.409 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 980' ' ' LEU . 27.3 mm -62.95 -43.18 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.447 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.544 ' HA ' HD21 ' A' ' 980' ' ' LEU . 52.5 tp -59.5 -47.7 84.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.331 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.96 -42.5 99.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.206 -0.598 . . . . 1.0 111.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.56 -44.38 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.726 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.33 94.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 709' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 713' ' ' LEU . 86.2 mt -67.02 -37.56 84.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.65 -57.23 16.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.008 -0.677 . . . . 1.0 112.092 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 35.4 Cg_exo -55.24 -45.14 42.61 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.917 1.078 . . . . 1.0 111.331 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.35 -41.87 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.448 -0.797 . . . . 1.0 110.86 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 713' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 709' ' ' LEU . 35.6 mt -62.8 -41.43 99.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.961 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.5 -44.34 98.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.429 ' HE1' HD12 ' B' ' 719' ' ' ILE . 5.8 t90 -63.04 -48.6 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 1.0 109.803 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.68 -45.73 93.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.555 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.81 -46.14 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.036 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.35 -43.11 98.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.617 0.599 . . . . 1.0 112.617 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 996' ' ' ASN . 6.9 tt -67.19 -41.37 86.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.896 -0.722 . . . . 1.0 109.924 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 88.8 m -60.66 -44.83 95.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.819 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.29 -43.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -60.08 -40.85 90.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.04 -0.664 . . . . 1.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 62.9 t0 -65.67 -41.07 92.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.354 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.78 -39.28 93.35 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.729 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.54 133.35 50.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.728 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.48 138.93 57.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.452 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.065 -0.969 . . . . 1.0 110.571 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.504 -1.438 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -150.88 152.17 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.713 0.292 . . . . 1.0 110.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.4 mt -109.82 130.84 55.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.359 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.35 138.52 58.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.662 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.26 146.76 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.446 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -129.21 145.55 51.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.69 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.51 ' O ' HG23 ' A' ' 964' ' ' ILE . 1.6 m -104.86 109.79 21.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.272 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 963' ' ' CYS . 1.3 pt -159.19 70.36 3.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.39 145.9 97.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.157 1.905 . . . . 1.0 110.812 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.91 -25.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -61.94 -49.84 74.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 119.573 -0.851 . . . . 1.0 111.334 -177.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -57.72 -39.12 76.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.279 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.6 t -64.19 -45.28 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 119.826 -0.749 . . . . 1.0 109.083 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.59 -42.17 99.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.652 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.1 t -63.8 -44.63 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.821 0.344 . . . . 1.0 110.86 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.97 96.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.4 t -61.98 -45.19 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 121.158 -0.217 . . . . 1.0 110.529 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.22 -42.5 99.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.806 0.336 . . . . 1.0 111.479 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.49 -43.54 94.55 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.23 -43.02 99.69 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.45 -41.95 98.65 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.756 -0.261 . . . . 1.0 110.951 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.14 -42.11 98.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 1.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.51 -41.25 97.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.859 -0.736 . . . . 1.0 109.492 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' B' ' 705' ' ' LEU . 85.7 mt -62.05 -41.95 98.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.304 -0.559 . . . . 1.0 111.238 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.1 m -61.72 -47.4 85.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.896 -0.321 . . . . 1.0 111.211 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.32 -43.76 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.554 -0.459 . . . . 1.0 111.326 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.71 -43.05 97.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.7 t -61.89 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 1.0 111.273 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.31 -42.56 99.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.735 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.98 -45.28 94.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.022 0.378 . . . . 1.0 112.022 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.66 -42.45 91.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.7 t90 -64.42 -41.92 96.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.869 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.59 -33.48 75.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.24 0.543 . . . . 1.0 110.44 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 986' ' ' ALA . 62.0 t -77.31 -2.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.261 -0.882 . . . . 1.0 109.95 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.85 8.21 72.31 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.273 -1.531 . . . . 1.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -56.11 -45.95 79.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.664 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 37.8 m-85 -72.53 -32.01 65.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.76 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.3 95.38 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 118.494 -1.282 . . . . 1.0 109.1 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.619 HH12 ' CG ' ' B' ' 723' ' ' ASP . 7.4 mmt180 -145.11 148.5 33.7 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.176 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -93.46 107.63 19.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.399 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 998' ' ' PRO . 0.1 OUTLIER 178.76 -49.25 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.103 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 998' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 997' ' ' ARG . 51.9 Cg_exo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.146 1.897 . . . . 1.0 112.066 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.91 137.25 54.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.724 0.297 . . . . 1.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 687' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.5 OUTLIER 70.06 179.89 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 688' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 23.3 Cg_exo -61.84 145.16 97.26 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.289 1.993 . . . . 1.0 111.758 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.86 -42.21 97.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.701 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 48.7 t -137.69 82.01 27.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.363 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.22 144.79 98.99 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.844 2.363 . . . . 1.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -65.79 138.68 58.08 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.949 0.881 . . . . 1.0 111.995 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.13 -44.73 99.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.199 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 694' ' ' LEU . . . . . 0.458 HD22 ' N ' ' B' ' 694' ' ' LEU . 4.1 mm? -61.17 -42.05 97.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.948 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.23 -43.9 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.647 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.496 ' O ' HG23 ' B' ' 700' ' ' VAL . 69.4 t -65.31 -43.71 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 1.0 110.799 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.95 -42.7 99.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.699 0.761 . . . . 1.0 111.637 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.81 -42.71 94.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.554 0.692 . . . . 1.0 110.697 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 58.0 p -61.27 -37.67 83.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 696' ' ' VAL . 74.6 t -63.75 -45.32 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.8 mtp -62.07 -39.91 94.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.408 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.31 95.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.36 87.59 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.755 0.312 . . . . 1.0 110.378 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 980' ' ' LEU . 27.0 mm -63.01 -42.78 97.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.568 ' HA ' HD21 ' A' ' 980' ' ' LEU . 53.4 tp -60.65 -45.66 93.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.493 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.11 -42.53 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.377 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.68 -43.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.65 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.67 -38.71 93.41 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.533 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.93 -38.23 85.79 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.21 -56.96 18.83 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.242 -0.583 . . . . 1.0 112.271 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.9 Cg_exo -54.67 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.067 1.178 . . . . 1.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.664 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 97.0 mt -65.23 -41.89 93.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.905 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.18 -41.71 98.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.121 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.44 -44.15 98.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.849 ' NE1' HD11 ' B' ' 719' ' ' ILE . 7.1 t90 -60.89 -48.91 79.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.332 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.38 -42.87 96.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.573 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.1 -44.06 97.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.521 -0.471 . . . . 1.0 110.373 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.36 -42.11 99.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.269 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.849 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.5 mt -62.85 -44.68 99.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.953 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.6 m -59.64 -46.69 88.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.971 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.59 -43.82 98.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 1.0 112.23 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -64.73 -41.12 96.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.619 ' CG ' HH12 ' A' ' 995' ' ' ARG . 46.3 m-20 -68.05 -40.64 82.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.086 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 724' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' B' ' 727' ' ' PHE . 72.7 ttt180 -123.44 114.81 20.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.8 -41.01 98.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.454 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.6 -39.18 93.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.494 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 727' ' ' PHE . . . . . 0.414 ' H ' ' HG2' ' B' ' 724' ' ' ARG . 83.3 t80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.065 -0.969 . . . . 1.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.87 88.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.749 0.309 . . . . 1.0 110.617 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.1 131.42 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.499 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -117.48 134.88 54.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.149 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 961' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 963' ' ' CYS . 83.6 tt0 -134.95 149.34 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.994 0.426 . . . . 1.0 110.457 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.04 -42.4 98.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.094 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 961' ' ' GLU . 1.5 m -53.54 -34.11 57.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.894 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.09 83.99 45.2 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.318 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.57 147.75 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.391 2.061 . . . . 1.0 112.334 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.42 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.772 -1.104 . . . . 1.0 113.904 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.456 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.98 -52.36 50.97 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.459 -0.496 . . . . 1.0 111.532 -176.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -57.62 -39.21 76.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.349 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.1 -45.5 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.65 -41.8 99.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.414 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.8 t -63.14 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.887 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.85 96.52 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.87 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.298 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.32 -43.22 98.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.15 91.58 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.894 -0.669 . . . . 1.0 111.949 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.405 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.78 -41.36 99.61 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 120.365 -0.922 . . . . 1.0 110.804 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.5 OUTLIER -62.86 -41.44 99.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.82 -41.58 99.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.052 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.35 -41.17 98.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.353 -0.939 . . . . 1.0 109.641 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.0 mt -61.96 -41.31 97.86 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.007 0.908 . . . . 1.0 110.972 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 37.0 m -61.37 -46.51 89.9 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 118.596 -1.242 . . . . 1.0 111.018 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.83 -42.62 97.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.042 -0.663 . . . . 1.0 110.555 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 983' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 983' ' ' LEU . 75.1 mt -64.03 -41.81 97.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.363 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.8 t -63.65 -44.87 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 123.328 0.393 . . . . 1.0 110.6 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.89 -42.03 97.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.27 99.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.884 0.849 . . . . 1.0 111.437 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.86 -40.98 97.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.434 ' HE1' ' HE3' ' A' ' 994' ' ' LYS . 10.4 t90 -64.6 -45.44 86.96 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.349 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.88 -33.55 74.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 10.9 m -85.57 0.87 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.82 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 74.19 15.07 80.15 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.347 -1.297 . . . . 1.0 110.967 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.512 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.88 -45.18 67.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.565 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 45.5 m-85 -81.82 -3.31 53.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.564 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 991' ' ' GLY . 75.5 mmtt -105.78 11.77 31.63 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.521 ' NH1' ' OD1' ' A' ' 996' ' ' ASN . 78.2 ttt-85 -66.47 130.99 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.061 -0.656 . . . . 1.0 109.739 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 996' ' ' ASN . . . . . 0.521 ' OD1' ' NH1' ' A' ' 995' ' ' ARG . 11.8 m120 55.81 35.1 24.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.343 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -170.61 69.35 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.536 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.305 -1.739 0 C-N-CA 122.684 2.256 . . . . 1.0 112.175 179.885 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.02 138.08 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 687' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.1 OUTLIER -66.25 -179.95 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.194 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 688' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 22.9 Cg_exo -61.76 145.29 97.4 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.108 1.872 . . . . 1.0 111.891 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.07 -41.92 99.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.648 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.54 171.17 6.72 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.24 143.25 98.25 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.563 1.508 . . . . 1.0 111.638 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.82 140.26 57.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.013 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.58 -43.58 98.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.98 -41.7 99.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.053 -0.259 . . . . 1.0 111.137 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.8 -46.41 96.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.415 ' O ' HG23 ' B' ' 700' ' ' VAL . 18.9 m -65.54 -40.38 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.134 -0.627 . . . . 1.0 110.235 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.98 -43.97 97.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.727 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.103 0.478 . . . . 1.0 110.695 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.27 -38.1 88.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.902 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.0 t -63.48 -45.14 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.125 0.488 . . . . 1.0 110.388 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.11 -38.98 90.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.22 -41.6 96.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.279 -1.129 . . . . 1.0 110.279 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.89 86.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 1.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.405 HG21 ' C ' ' A' ' 976' ' ' GLY . 26.6 mm -62.61 -43.07 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.376 -0.601 . . . . 1.0 109.376 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.503 ' HA ' HD21 ' A' ' 980' ' ' LEU . 86.8 mt -61.16 -44.46 97.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.332 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.82 -43.33 99.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.908 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.64 98.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.64 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.13 88.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.23 -38.07 84.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.769 1.025 . . . . 1.0 113.769 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.34 -57.01 18.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.024 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 33.0 Cg_exo -54.65 -44.65 47.57 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.14 1.227 . . . . 1.0 111.604 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.93 -41.64 95.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.585 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.59 -41.46 98.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.196 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.12 -44.22 99.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.565 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.6 t90 -62.36 -48.77 78.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.595 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.5 OUTLIER -60.53 -45.02 95.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.446 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.58 -42.34 98.31 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.988 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.98 -42.46 99.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.706 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 3.9 mm -63.84 -44.26 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.19 -0.604 . . . . 1.0 109.709 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.6 m -60.37 -45.78 92.3 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.81 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.08 -43.69 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.868 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -62.35 -40.52 96.68 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.686 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.443 ' CG ' HH12 ' A' ' 995' ' ' ARG . 31.6 t70 -66.02 -39.82 90.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.773 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -112.32 102.29 10.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 1.0 110.478 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -41.98 99.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.608 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.07 -38.95 89.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.52 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.38 142.58 56.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.0 110.611 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.94 -41.79 99.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 962' ' ' ARG . 83.3 tt0 -65.55 135.84 55.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.527 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.63 -37.67 85.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.815 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.427 ' H ' ' HG2' ' A' ' 960' ' ' GLU . 78.2 ttt-85 -61.15 -42.98 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.543 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.2 m -90.09 139.43 30.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 1.0 111.032 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 964' ' ' ILE . 7.9 mt 38.78 69.38 1.6 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 1.0 111.57 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -62.54 150.12 88.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.443 2.095 . . . . 1.0 111.544 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.24 -42.79 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.141 1.164 . . . . 1.0 114.141 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.432 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.26 -52.45 52.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.694 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -57.75 -37.76 74.19 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.622 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.3 t -64.1 -44.74 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.45 -42.38 99.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.706 -1.134 . . . . 1.0 110.173 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.6 t -63.44 -44.8 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.071 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.11 -38.33 95.4 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.5 t -61.86 -45.07 99.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.09 -42.68 99.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.811 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.87 -43.26 96.32 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.319 -0.713 . . . . 1.0 111.319 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.67 99.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.45 -42.05 98.65 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.523 -0.398 . . . . 1.0 111.135 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 978' ' ' LEU . 85.5 mt -62.51 -41.33 98.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.196 -0.601 . . . . 1.0 110.726 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.9 -41.49 97.97 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.673 -0.811 . . . . 1.0 109.797 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 984' ' ' VAL . 87.0 mt -62.21 -41.53 98.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.359 -0.536 . . . . 1.0 111.176 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.88 -46.97 87.11 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.542 -0.463 . . . . 1.0 111.16 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.05 -43.66 99.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.27 -42.46 99.14 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.733 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.46 -45.57 98.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.683 0.278 . . . . 1.0 111.123 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.06 -42.24 99.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.284 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.652 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.09 -41.52 98.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.985 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.86 -41.98 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.878 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 11.0 t90 -64.11 -43.82 94.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.297 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.31 -34.3 76.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.052 0.454 . . . . 1.0 111.465 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.0 t -77.32 -1.62 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 70.57 11.59 68.85 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -45.06 70.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.51 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 62.4 m-85 -86.99 -10.29 53.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.56 38.15 3.36 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.588 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 62.1 ttp180 -64.63 129.22 39.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -107.7 7.62 28.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.148 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.511 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 32.7 mtp180 -78.54 156.78 77.99 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.364 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 C--N 1.312 -1.388 0 C-N-CA 122.499 2.133 . . . . 1.0 112.218 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.749 0.309 . . . . 1.0 110.4 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 6.3 m -138.38 75.57 38.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.566 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -38.13 86.17 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.749 2.299 . . . . 1.0 112.005 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -127.05 144.92 50.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.7 t 55.41 62.94 6.99 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 121.162 0.506 . . . . 1.0 110.544 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.85 159.66 52.51 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.856 2.371 . . . . 1.0 112.132 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.1 141.88 58.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.297 0.57 . . . . 1.0 110.767 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.9 -41.51 89.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.516 -0.766 . . . . 1.0 111.192 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 694' ' ' LEU . . . . . 0.528 HD12 ' N ' ' B' ' 694' ' ' LEU . 11.1 mp -63.68 -41.43 98.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 1.0 110.791 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.27 -45.28 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.354 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 700' ' ' VAL . 77.3 t -64.04 -45.43 96.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.078 0.466 . . . . 1.0 110.707 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.71 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.873 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.14 -42.67 96.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 1.0 110.591 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.6 p -61.85 -38.95 90.16 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.5 t -64.67 -45.41 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.231 0.539 . . . . 1.0 110.094 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 701' ' ' MET . . . . . 0.435 ' O ' HD13 ' B' ' 705' ' ' LEU . 86.3 mtp -62.61 -40.28 96.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.32 -41.99 97.95 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.501 -1.04 . . . . 1.0 110.501 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.46 86.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.957 0.408 . . . . 1.0 110.174 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.496 HG22 HD11 ' A' ' 980' ' ' LEU . 26.8 mm -62.17 -42.31 94.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.765 -0.774 . . . . 1.0 109.576 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.0 mp -61.73 -44.05 97.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.617 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.06 -43.62 98.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.751 -0.779 . . . . 1.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.07 -47.92 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 1.0 111.673 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 708' ' ' GLY . . . . . 0.413 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -69.47 -39.22 80.07 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.862 -0.685 . . . . 1.0 111.546 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.13 -37.4 81.05 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.526 0.935 . . . . 1.0 113.526 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.17 -56.32 23.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.955 -176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.4 Cg_exo -53.29 -43.07 60.43 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.125 1.217 . . . . 1.0 112.187 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.488 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.28 -41.49 94.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.218 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.07 -41.34 99.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.38 -43.98 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.684 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.6 t90 -60.77 -48.49 81.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.314 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.36 94.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.482 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.1 -45.14 94.8 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.431 -0.507 . . . . 1.0 110.645 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 718' ' ' LEU . . . . . 0.518 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 87.0 mt -61.5 -42.28 98.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.683 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.684 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.0 mt -63.42 -44.11 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.513 -0.475 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -59.84 -46.61 88.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.834 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.03 -43.04 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.966 -0.294 . . . . 1.0 111.621 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 722' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 47.1 m80 -58.21 -39.97 80.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.789 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.588 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 55.4 m-20 -63.69 -38.78 92.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.304 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.91 -42.71 99.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.21 -0.596 . . . . 1.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 57.2 75.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.434 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.86 -38.82 89.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.242 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 727' ' ' PHE . . . . . 0.446 ' CD2' ' OXT' ' B' ' 727' ' ' PHE . 89.2 t80 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.666 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 958' ' ' ALA . . . . . 0.435 ' O ' ' OE2' ' A' ' 961' ' ' GLU . . . -63.93 -38.26 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.686 0.279 . . . . 1.0 110.766 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.03 -41.7 99.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.754 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.28 -35.63 80.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.268 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 961' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 958' ' ' ALA . 80.0 mm-40 63.28 33.23 14.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.796 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -129.25 138.66 51.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.795 0.331 . . . . 1.0 110.336 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.3 m -86.41 -31.63 21.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.479 0.548 . . . . 1.0 112.479 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 964' ' ' ILE . 3.1 tt -140.96 74.04 26.33 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.353 -0.539 . . . . 1.0 112.074 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.36 149.31 91.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.632 2.222 . . . . 1.0 111.356 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.25 -42.73 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.44 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.76 -52.2 50.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.384 -176.544 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -57.67 -38.59 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.572 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.1 t -64.12 -45.35 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.098 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.57 -42.69 99.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.303 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.9 t -63.28 -44.72 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.04 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.52 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.308 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.2 t -61.55 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 1.0 110.225 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.32 -42.63 99.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.769 0.319 . . . . 1.0 111.644 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.39 -45.41 90.61 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.49 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.97 -43.03 99.74 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.15 -41.89 99.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.806 -0.232 . . . . 1.0 110.518 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.11 -41.97 98.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.535 -0.466 . . . . 1.0 109.78 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.7 -41.55 97.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.756 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.4 mt -61.87 -41.65 98.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.677 -0.409 . . . . 1.0 111.074 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.1 m -61.46 -46.98 87.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.952 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.12 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.155 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.0 -43.06 99.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.645 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 980' ' ' LEU . 69.9 t -61.79 -45.75 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.708 0.289 . . . . 1.0 111.028 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.28 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.52 -42.97 99.86 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.399 -0.52 . . . . 1.0 111.226 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.72 -42.75 95.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.877 0.37 . . . . 1.0 111.476 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.432 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 11.7 t90 -63.25 -43.55 97.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.23 -35.38 78.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.007 0.432 . . . . 1.0 111.569 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 986' ' ' ALA . 59.5 t -77.53 -2.57 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.441 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.33 10.87 70.73 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.175 -1.57 . . . . 1.0 109.175 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -45.23 73.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.409 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.0 m-85 -81.26 -16.82 51.47 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.786 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.03 35.99 3.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.649 HH22 ' CB ' ' B' ' 723' ' ' ASP . 54.8 ptt85 -68.45 141.16 55.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.495 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.55 40.93 29.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.623 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.11 162.11 0.15 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.303 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 122.755 2.303 . . . . 1.0 112.063 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 1.0 109.558 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.23 -38.58 88.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 1.0 110.404 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 687' ' ' SER . . . . . 0.547 ' N ' ' CD ' ' B' ' 688' ' ' PRO . 0.3 OUTLIER 178.0 -44.73 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.882 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 688' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' B' ' 687' ' ' SER . 22.6 Cg_exo -61.86 145.74 96.88 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.219 1.946 . . . . 1.0 111.986 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 689' ' ' LYS . . . . . 0.499 ' O ' ' SG ' ' B' ' 690' ' ' CYS . 99.2 mttt -77.61 145.88 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 690' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' B' ' 689' ' ' LYS . 0.5 OUTLIER 58.34 151.06 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.44 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -71.39 157.3 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.705 2.27 . . . . 1.0 113.327 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.05 157.19 38.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.623 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.0 mt -62.15 -43.66 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 1.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 694' ' ' LEU . . . . . 0.513 HD12 ' N ' ' B' ' 694' ' ' LEU . 11.1 mp -62.39 -42.14 99.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.249 -0.58 . . . . 1.0 110.399 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.43 -45.07 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.419 . . . . 1.0 110.604 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' HG23 ' B' ' 700' ' ' VAL . 61.2 t -63.99 -44.22 97.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.07 -43.52 98.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.248 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.41 -42.4 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.0 110.869 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 45.1 p -62.45 -37.45 85.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.751 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.2 t -63.64 -44.9 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 1.0 110.651 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 89.9 mtp -62.97 -39.09 93.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.907 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.59 -42.2 95.69 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.6 84.36 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.808 0.337 . . . . 1.0 111.02 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.49 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.5 mm -60.8 -42.4 92.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.528 -0.915 . . . . 1.0 108.528 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 980' ' ' LEU . 95.4 mt -59.64 -45.71 91.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.895 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 706' ' ' LEU . . . . . 0.419 HD12 ' N ' ' B' ' 706' ' ' LEU . 11.1 mp -62.92 -42.31 99.75 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.884 -0.726 . . . . 1.0 111.481 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 707' ' ' ILE . . . . . 0.407 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 31.7 mm -63.69 -45.61 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.803 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.77 -41.02 84.74 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.722 -0.752 . . . . 1.0 111.448 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.49 -37.8 85.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.99 -57.13 19.27 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.201 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 43.9 Cg_exo -53.85 -43.67 55.97 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.085 1.19 . . . . 1.0 111.337 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.28 -41.82 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.758 -0.656 . . . . 1.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.86 -41.44 99.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.928 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.75 -44.22 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.409 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.0 t90 -62.36 -48.07 81.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.644 ' O ' HG23 ' B' ' 720' ' ' THR . 0.1 OUTLIER -59.45 -44.61 92.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.16 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 717' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' B' ' 720' ' ' THR . 50.7 tp -64.03 -45.54 88.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.258 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.99 -43.24 99.32 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.59 -40.88 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.483 -0.887 . . . . 1.0 110.27 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 720' ' ' THR . . . . . 0.644 HG23 ' O ' ' B' ' 716' ' ' LYS . 40.6 p -57.72 -44.34 85.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.319 -0.553 . . . . 1.0 110.649 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.38 -43.35 98.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.669 -0.413 . . . . 1.0 111.268 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -64.38 -40.19 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.649 ' CB ' HH22 ' A' ' 995' ' ' ARG . 34.8 t70 -65.92 -39.89 90.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.29 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -61.47 -43.0 99.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.937 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.99 134.5 50.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.523 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -110.61 124.13 51.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.995 -1.002 . . . . 1.0 110.704 -179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.27 143.22 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 1.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 959' ' ' LEU . 11.0 mp -62.77 -41.65 99.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.448 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 57.05 55.33 6.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.655 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.49 -38.74 90.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.66 146.56 50.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.541 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.2 -25.02 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.643 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 964' ' ' ILE . 93.9 mt -130.91 77.17 75.86 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.611 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -61.93 148.52 92.96 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.752 2.301 . . . . 1.0 112.7 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.7 -42.33 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.886 -1.052 . . . . 1.0 113.588 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.469 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -50.39 -51.48 45.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.261 -0.575 . . . . 1.0 111.074 -176.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -57.14 -37.84 72.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.254 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.39 -45.0 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 1.0 109.223 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.75 -41.68 99.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.744 -1.117 . . . . 1.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.9 t -63.3 -44.3 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.543 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.02 -39.73 96.07 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.86 -45.78 97.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.606 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.31 -42.78 99.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 975' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.5 -46.25 78.68 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.029 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.75 -42.17 99.33 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.649 -0.981 . . . . 1.0 110.649 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.74 -40.86 97.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.939 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.99 -42.25 98.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.18 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 979' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.0 mp -61.5 -40.78 95.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 119.058 -1.057 . . . . 1.0 109.76 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 705' ' ' LEU . 89.6 mt -60.88 -41.31 95.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.281 -0.568 . . . . 1.0 110.508 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.4 m -60.96 -46.76 89.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.462 0.648 . . . . 1.0 110.629 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -44.13 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 119.479 -0.888 . . . . 1.0 111.996 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.27 -41.76 99.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.315 -0.954 . . . . 1.0 111.264 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.1 t -62.86 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.46 -41.7 96.37 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.369 -0.532 . . . . 1.0 110.658 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.88 -42.12 98.68 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.036 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.5 mtt -65.28 -42.41 93.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.137 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.695 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.7 t90 -64.26 -42.94 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.889 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.62 -34.5 77.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.117 0.484 . . . . 1.0 111.331 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.05 -1.91 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.678 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.66 8.82 68.42 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.113 -1.595 . . . . 1.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -56.05 -44.24 78.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 117.233 0.516 . . . . 1.0 109.785 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.495 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 36.7 m-85 -81.83 -23.07 36.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.492 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.695 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 68.5 mttm -63.65 -39.06 93.39 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 118.736 -1.185 . . . . 1.0 108.731 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.9 ttt-85 -65.62 120.59 13.21 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.125 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.05 -4.78 10.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.666 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 166.25 151.86 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 122.201 1.934 . . . . 1.0 112.098 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.74 -1.344 . . . . 1.0 109.74 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.97 125.26 53.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.836 0.351 . . . . 1.0 110.468 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 1.9 t 172.73 73.26 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.651 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -53.83 -38.61 85.64 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.891 2.394 . . . . 1.0 112.075 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.47 133.87 50.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.618 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m 53.21 78.68 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.435 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.36 145.38 98.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.715 2.277 . . . . 1.0 112.101 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -65.24 142.94 58.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.28 -43.49 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.34 -42.27 99.25 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.43 -0.508 . . . . 1.0 109.978 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.0 -44.81 99.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.941 0.4 . . . . 1.0 110.189 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.8 t -63.39 -44.31 98.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.24 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.63 -43.92 97.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.92 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.44 -41.89 96.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.949 0.404 . . . . 1.0 110.661 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 44.7 p -62.41 -37.91 87.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.5 t -64.06 -44.77 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.008 0.432 . . . . 1.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 53.6 mtt -63.19 -39.06 93.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.729 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.99 -42.23 92.75 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.32 94.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.225 0.536 . . . . 1.0 110.987 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 980' ' ' LEU . 23.8 mm -60.0 -42.18 88.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.553 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.6 mt -58.94 -44.62 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.338 0.399 . . . . 1.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.35 -41.72 98.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.76 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.04 -45.17 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.374 -0.531 . . . . 1.0 111.188 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.35 -39.73 87.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.526 -0.845 . . . . 1.0 111.117 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.73 -37.88 85.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.44 -56.38 25.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.547 -0.461 . . . . 1.0 112.056 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.8 Cg_exo -53.86 -43.25 59.74 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.097 1.198 . . . . 1.0 111.379 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.31 -41.21 90.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.169 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 37.7 mt -63.05 -42.37 99.71 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 41.5 pt -66.28 -41.75 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.005 -0.678 . . . . 1.0 110.046 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -59.92 -48.84 80.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 110.109 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -42.37 98.44 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.248 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.36 -44.0 96.04 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.38 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.592 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -43.12 95.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.31 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.0 m -59.07 -45.8 89.88 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 119.702 -0.799 . . . . 1.0 110.612 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.79 -43.26 97.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.975 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -64.8 -38.77 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 62.1 t0 -67.48 -41.46 84.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.305 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -135.04 118.19 16.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.32 -44.04 97.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.339 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.78 126.74 55.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.451 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 727' ' ' PHE . . . . . 0.487 ' CG ' ' OXT' ' B' ' 727' ' ' PHE . 89.3 t80 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.017 -0.992 . . . . 1.0 110.704 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.05 143.12 56.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 1.0 110.594 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.38 126.1 54.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.537 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.19 145.92 49.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.491 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.49 147.35 47.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.63 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -102.25 136.83 41.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.403 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.6 m -88.14 126.92 35.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 964' ' ' ILE . 1.3 tt -178.72 69.26 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.837 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -60.97 139.32 84.12 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.087 1.858 . . . . 1.0 111.57 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.99 -44.71 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -71.47 -55.67 7.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.379 -177.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 968' ' ' TRP . . . . . 0.65 ' CE2' HD12 ' B' ' 693' ' ' ILE . 94.5 m95 -57.64 -40.23 78.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 119.347 -0.359 . . . . 1.0 111.814 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.44 -46.2 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.135 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.86 -43.37 98.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.056 -0.974 . . . . 1.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.1 t -62.45 -44.3 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.71 -0.223 . . . . 1.0 110.747 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.11 92.71 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.188 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.77 -46.36 96.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.726 -0.39 . . . . 1.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.43 -43.15 98.27 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.592 0.589 . . . . 1.0 112.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.4 -45.24 91.28 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.921 -0.657 . . . . 1.0 111.734 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.415 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.87 -43.01 99.79 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.75 -41.8 99.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.615 -0.344 . . . . 1.0 110.632 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.26 -42.38 99.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.583 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.27 -40.33 89.97 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.754 -1.178 . . . . 1.0 109.134 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.5 mt -62.59 -41.52 99.0 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.645 -0.822 . . . . 1.0 112.075 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.96 -47.02 86.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.706 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 43.6 pt -64.74 -41.95 93.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.877 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.99 -42.83 99.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.1 t -62.22 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 121.103 -0.239 . . . . 1.0 111.179 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.32 -42.26 98.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.308 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.39 -42.89 99.77 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.746 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.6 mtp -65.37 -42.35 92.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 1.0 111.252 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.619 ' HE1' ' HZ2' ' A' ' 994' ' ' LYS . 10.3 t90 -62.53 -42.5 99.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.83 -33.44 74.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.167 0.508 . . . . 1.0 110.975 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -77.45 -2.97 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.444 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 72.28 10.1 73.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.513 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.48 -45.25 77.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 -177.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.573 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 49.7 m-85 -79.19 -15.84 57.47 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.16 -0.616 . . . . 1.0 110.49 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.619 ' HZ2' ' HE1' ' A' ' 988' ' ' TRP . 99.1 mttt -112.94 33.71 4.87 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 991' ' ' GLY . 66.1 ttp85 -66.63 120.07 12.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.205 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.84 -41.5 95.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.801 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.529 ' C ' HH11 ' A' ' 995' ' ' ARG . 0.1 OUTLIER -160.43 160.16 26.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.736 -178.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 998' ' ' PRO . . . . . 0.526 ' N ' ' NH1' ' A' ' 995' ' ' ARG . 29.8 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 122.454 2.103 . . . . 1.0 111.953 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.816 -1.314 . . . . 1.0 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 686' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 686' ' ' GLU . 54.9 mp0 -66.4 -38.72 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 1.0 110.146 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 8.5 m -145.8 75.08 13.32 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.43 145.08 98.43 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.596 2.197 . . . . 1.0 112.004 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.1 -41.93 99.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.78 164.03 64.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.194 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -61.84 151.28 81.94 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.791 1.661 . . . . 1.0 110.965 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -62.0 139.39 58.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.911 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 968' ' ' TRP . 44.8 pt -62.66 -41.85 93.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.994 -0.548 . . . . 1.0 112.132 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.16 -42.55 99.37 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.4 t -62.32 -44.84 99.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.133 0.492 . . . . 1.0 110.266 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.413 ' O ' HG23 ' B' ' 700' ' ' VAL . 75.6 t -63.23 -43.74 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.642 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 697' ' ' LEU . . . . . 0.519 HD22 ' CE3' ' A' ' 968' ' ' TRP . 45.8 tp -61.33 -44.03 97.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.782 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.16 -42.42 96.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.048 0.452 . . . . 1.0 110.686 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 46.1 p -62.21 -39.05 91.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.3 t -63.58 -44.89 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.119 0.485 . . . . 1.0 110.8 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.87 -39.35 94.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.33 95.47 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.62 80.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 980' ' ' LEU . 27.1 mm -61.84 -42.46 94.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.436 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.662 ' O ' HD13 ' B' ' 709' ' ' LEU . 92.0 mt -61.01 -45.67 93.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.665 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 -42.15 99.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.867 -0.733 . . . . 1.0 111.126 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -45.22 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.965 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.26 64.42 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.869 -0.681 . . . . 1.0 111.984 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 709' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 705' ' ' LEU . 10.4 mp -68.66 -37.8 79.91 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.19 -55.58 32.68 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.303 -0.559 . . . . 1.0 112.24 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.1 Cg_exo -54.34 -43.14 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.283 1.322 . . . . 1.0 112.424 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.564 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 92.8 mt -64.89 -43.16 93.81 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.343 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 713' ' ' LEU . . . . . 0.438 HD13 ' O ' ' B' ' 709' ' ' LEU . 10.3 mp -63.75 -40.66 97.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.413 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.15 -44.48 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.573 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.5 t90 -63.43 -48.61 77.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 1.0 110.044 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.614 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 717' ' ' LEU . . . . . 0.418 ' O ' ' OG1' ' B' ' 720' ' ' THR . 53.3 tp -62.27 -44.36 96.7 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.583 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.81 -42.61 99.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.856 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.25 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 720' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 22.6 p -59.08 -44.19 91.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.608 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.89 -44.43 98.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.504 -0.878 . . . . 1.0 111.203 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -61.54 -39.27 90.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.495 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 4.6 m-20 -65.77 -41.3 92.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.725 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -63.48 -39.47 94.54 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.858 0.361 . . . . 1.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.07 -44.7 96.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.618 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.28 -39.86 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.634 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.544 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 144.9 55.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.745 0.307 . . . . 1.0 110.754 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.5 mt -109.04 129.94 55.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.274 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -113.81 123.35 49.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.87 138.14 55.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -140.76 152.4 45.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.493 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.79 168.31 10.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.608 . . . . 1.0 112.174 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 11.3 pt 32.99 75.97 0.41 Allowed Pre-proline 0 N--CA 1.462 0.131 0 CA-C-N 114.706 -1.134 . . . . 1.0 111.956 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -62.15 148.52 93.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 1.0 111.405 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.3 -42.82 97.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 114.221 1.193 . . . . 1.0 114.221 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.41 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.14 -53.07 47.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 1.0 111.691 -176.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -57.09 -39.05 74.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.586 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.75 -45.29 97.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.702 -0.799 . . . . 1.0 109.48 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.061 -0.972 . . . . 1.0 110.479 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.4 t -63.29 -45.12 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.616 -0.266 . . . . 1.0 111.158 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.64 96.07 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.82 -46.0 97.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.506 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.13 -42.78 99.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.791 0.329 . . . . 1.0 111.848 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.01 -46.82 78.62 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.005 -0.617 . . . . 1.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.426 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -60.09 -42.04 98.31 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.65 -41.43 98.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.97 0.414 . . . . 1.0 110.502 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.88 -42.9 99.62 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.654 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 979' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.2 mp -61.32 -40.85 95.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.623 -0.831 . . . . 1.0 109.897 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.0 mt -61.91 -40.45 95.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.181 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 99.3 m -60.85 -48.2 82.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.209 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -44.15 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 120.275 -0.57 . . . . 1.0 111.769 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.68 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 980' ' ' LEU . 79.1 t -61.9 -46.18 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 123.158 0.286 . . . . 1.0 111.124 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.26 -42.42 99.16 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.34 -43.85 97.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.752 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.2 mtt -64.52 -42.47 95.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.263 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -62.97 -44.37 96.24 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -60.95 -32.66 72.18 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.876 -0.515 . . . . 1.0 111.628 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.9 -1.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 68.54 12.81 64.6 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.828 -1.709 . . . . 1.0 108.828 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.51 -44.1 68.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.613 -1.254 . . . . 1.0 107.613 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.456 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 59.2 m-85 -81.97 -4.5 56.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.553 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.4 mttt -108.05 14.44 25.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 175.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.456 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 73.4 ttp85 -66.36 131.04 45.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.008 -0.677 . . . . 1.0 110.533 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -110.39 145.74 37.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.661 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.94 161.88 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--N 1.308 -1.563 0 C-N-CA 122.589 2.192 . . . . 1.0 112.375 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -97.16 138.04 35.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.355 . . . . 1.0 110.32 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.96 174.22 4.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.366 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.94 -39.32 79.16 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.128 1.885 . . . . 1.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.2 146.81 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.572 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 690' ' ' CYS . . . . . 0.471 ' CB ' ' CD ' ' B' ' 691' ' ' PRO . 0.0 OUTLIER -59.82 -178.54 0.14 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.394 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 691' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' B' ' 690' ' ' CYS . 12.5 Cg_exo -67.96 154.27 73.19 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.286 1.99 . . . . 1.0 110.497 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.58 139.66 57.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.352 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.51 -43.63 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.112 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.16 -46.19 97.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.423 ' O ' HG23 ' B' ' 700' ' ' VAL . 22.3 m -65.47 -40.68 89.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.945 -0.702 . . . . 1.0 110.597 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.92 -43.74 98.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.535 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.12 -42.19 96.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.197 0.522 . . . . 1.0 110.73 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 37.5 p -62.91 -38.89 92.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.003 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 696' ' ' VAL . 77.4 t -63.78 -45.27 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.413 -0.515 . . . . 1.0 110.306 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.57 -39.24 93.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.69 97.97 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.91 86.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.831 0.348 . . . . 1.0 110.534 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 976' ' ' GLY . 25.8 mm -62.65 -42.45 96.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.475 ' HA ' HD21 ' A' ' 980' ' ' LEU . 87.3 mt -61.52 -43.8 98.21 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.427 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.82 -43.07 99.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.89 -44.33 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.691 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.95 -40.4 73.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.917 -0.658 . . . . 1.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 80.5 mt -66.71 -38.14 86.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.86 -56.96 20.0 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.909 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.3 Cg_exo -54.09 -44.97 44.52 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.908 1.072 . . . . 1.0 111.774 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.27 -41.77 93.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.595 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.58 -41.46 98.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -63.77 -44.1 98.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.408 -0.59 . . . . 1.0 109.408 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.887 ' NE1' HD11 ' B' ' 719' ' ' ILE . 10.4 t90 -62.36 -48.53 79.38 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -43.95 97.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.559 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.97 -42.77 99.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.89 -42.12 98.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.509 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.887 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.1 mt -63.9 -44.71 98.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.057 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 720' ' ' THR . . . . . 0.407 HG22 ' NE ' ' B' ' 724' ' ' ARG . 96.7 m -59.51 -46.52 88.6 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.779 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.73 -43.58 98.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.163 0.506 . . . . 1.0 110.659 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.6 -38.64 90.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.927 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.456 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 7.6 m-20 -69.87 -42.65 73.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.832 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 724' ' ' ARG . . . . . 0.407 ' NE ' HG22 ' B' ' 720' ' ' THR . 87.7 mtm180 -64.71 -36.42 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 57.68 48.88 13.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.764 0.316 . . . . 1.0 110.252 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.03 138.52 58.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.145 0.497 . . . . 1.0 110.724 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.9 t80 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.989 -1.005 . . . . 1.0 109.602 179.644 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 957' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 959' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.324 -1.51 . . . . 1.0 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 40.75 22.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 1.0 110.796 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 957' ' ' GLY . 88.0 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 1.0 110.47 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -36.58 82.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.72 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.16 14.31 9.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.725 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -62.32 -40.64 96.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.667 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 58.9 m -71.75 -27.11 62.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.012 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 964' ' ' ILE . 2.9 tt -135.94 71.27 63.2 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.456 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.35 150.3 87.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.797 2.331 . . . . 1.0 111.971 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.94 -42.58 97.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.458 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.6 -52.04 50.73 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.456 -0.497 . . . . 1.0 111.723 -176.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -57.96 -38.58 76.27 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 121.138 -0.225 . . . . 1.0 111.53 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.2 -45.05 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.49 -42.79 99.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.546 -1.206 . . . . 1.0 110.405 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.86 -44.71 99.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.205 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.55 93.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.614 -0.803 . . . . 1.0 111.163 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.92 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.765 -0.256 . . . . 1.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.96 -41.99 99.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.934 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.57 -43.84 93.85 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.785 -0.721 . . . . 1.0 111.304 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.78 -42.58 99.66 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.4 tp -63.84 -42.86 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.944 0.372 . . . . 1.0 111.582 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.34 -42.57 99.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.875 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.7 -41.3 97.42 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.904 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.723 HD21 HD23 ' B' ' 705' ' ' LEU . 1.4 mm? -62.76 -41.03 99.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.036 -0.266 . . . . 1.0 111.536 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 17.9 m -60.52 -45.81 92.47 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.625 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.85 -43.92 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.646 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.89 -44.32 93.38 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.18 -40.62 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.817 -0.753 . . . . 1.0 111.027 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.0 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.56 -42.04 99.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.513 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.64 -42.06 91.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.052 0.453 . . . . 1.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -64.05 -42.4 97.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.752 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.12 -33.46 75.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.032 0.444 . . . . 1.0 111.291 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.5 t -77.27 -0.42 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.476 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 70.67 10.14 66.68 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -44.33 65.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.733 -1.21 . . . . 1.0 107.733 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.502 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 57.6 m-85 -83.13 -5.44 59.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.428 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.6 mttt -95.03 -4.01 47.27 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.563 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 73.4 ttp85 -66.62 124.39 22.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.477 -0.889 . . . . 1.0 110.572 -178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -116.41 7.59 13.88 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.267 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.18 75.92 0.6 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.856 2.371 . . . . 1.0 112.103 -179.813 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.77 -39.43 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 16.8 p 45.14 71.4 1.54 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 -37.45 85.73 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.065 2.51 . . . . 1.0 112.177 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.74 -41.52 99.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.645 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.67 76.72 59.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.31 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.98 146.41 96.3 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.103 2.535 . . . . 1.0 112.687 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 145.63 55.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.28 -43.69 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.035 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 694' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 694' ' ' LEU . 11.1 mp -62.36 -41.98 99.03 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -45.32 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.743 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.1 t -63.55 -44.96 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 1.0 110.707 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.41 -43.01 99.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.644 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.92 -42.28 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 1.0 110.564 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 55.3 p -62.2 -40.05 94.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 696' ' ' VAL . 71.4 t -62.69 -45.59 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.729 0.299 . . . . 1.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.5 mtp -63.57 -39.43 94.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.33 99.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.989 -1.244 . . . . 1.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.09 -36.57 80.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.031 0.443 . . . . 1.0 110.184 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.406 HG21 ' C ' ' A' ' 976' ' ' GLY . 31.7 mm -60.97 -41.88 90.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.034 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.723 HD23 HD21 ' A' ' 980' ' ' LEU . 81.4 mt -60.56 -45.81 92.54 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.943 -0.703 . . . . 1.0 110.814 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.08 -42.91 99.75 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.276 -0.57 . . . . 1.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.2 -44.63 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.269 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.77 -40.57 75.66 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.39 -38.16 84.27 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.711 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.25 -56.77 20.84 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.908 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.6 Cg_exo -54.71 -45.3 42.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.174 1.249 . . . . 1.0 111.455 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.09 -41.6 90.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.188 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.08 -41.5 99.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.5 -44.27 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.854 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.5 t90 -62.3 -48.29 80.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.794 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -44.09 96.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.71 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.88 -43.2 99.44 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.47 -42.13 98.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.854 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.3 mt -63.56 -44.06 98.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.095 -0.642 . . . . 1.0 109.511 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.8 m -60.26 -47.44 85.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.795 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.18 -43.51 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.175 -0.61 . . . . 1.0 111.47 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -63.39 -35.79 81.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.563 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 28.4 m-20 -67.82 -42.89 80.78 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.72 -39.09 93.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.348 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.28 132.72 47.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.804 0.335 . . . . 1.0 110.552 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -117.99 131.58 56.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.561 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.084 -0.96 . . . . 1.0 110.546 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.33 143.17 56.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 1.0 110.543 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.4 mt -110.09 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.418 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.0 -39.0 89.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.584 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.63 125.94 54.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.372 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.02 134.27 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.341 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 96.8 m -98.67 140.99 32.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.528 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.455 HD11 ' HG2' ' B' ' 691' ' ' PRO . 5.6 mt 54.22 69.78 2.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.92 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.61 149.75 90.08 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.65 2.233 . . . . 1.0 112.008 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.36 -42.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.77 -52.24 50.32 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.418 -0.513 . . . . 1.0 111.615 -176.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -57.74 -37.94 74.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.963 -0.295 . . . . 1.0 111.511 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 973' ' ' VAL . 72.5 t -63.97 -44.72 97.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.39 -41.78 98.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.695 -1.139 . . . . 1.0 110.211 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.2 t -63.28 -45.08 99.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.114 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.25 -38.64 95.99 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.1 t -62.03 -45.17 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 121.167 -0.213 . . . . 1.0 110.492 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.28 -42.31 99.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.73 0.3 . . . . 1.0 111.535 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 975' ' ' GLY . . . . . 0.402 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -65.35 -44.43 93.46 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.323 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.464 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.0 -41.85 99.59 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.93 -41.38 99.46 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.79 -0.241 . . . . 1.0 110.353 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.99 -42.57 99.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.235 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 979' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 975' ' ' GLY . 8.6 mp -61.92 -41.51 98.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.155 -1.018 . . . . 1.0 110.081 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.9 mt -61.97 -42.18 98.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.95 -0.7 . . . . 1.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.2 m -61.83 -48.05 82.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.635 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.374 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 983' ' ' LEU . . . . . 0.489 HD11 ' HE2' ' A' ' 987' ' ' MET . 57.2 tp -63.01 -43.46 98.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.574 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 980' ' ' LEU . 59.7 t -62.65 -45.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.603 0.239 . . . . 1.0 111.158 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.76 -42.48 97.8 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.756 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.41 -41.84 98.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.311 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 983' ' ' LEU . 62.4 mtt -65.14 -42.3 93.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.688 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.65 -42.65 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.64 -34.02 76.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.218 0.533 . . . . 1.0 111.224 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.7 t -77.36 -2.39 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.811 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.22 68.4 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.043 -1.623 . . . . 1.0 109.043 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -56.13 -44.17 78.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.095 0.448 . . . . 1.0 109.946 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.672 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 47.3 m-85 -83.59 -21.06 32.71 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.6 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.76 -39.12 93.19 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 118.499 -1.281 . . . . 1.0 108.492 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -65.59 126.84 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.357 -0.937 . . . . 1.0 110.126 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 996' ' ' ASN . . . . . 0.539 ' O ' HG23 ' B' ' 719' ' ' ILE . 98.9 m-20 -121.04 -60.31 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.224 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 176.95 62.08 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.541 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 C-N-CA 122.798 2.332 . . . . 1.0 112.112 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.0 -38.86 89.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 1.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 5.3 t 60.52 61.97 3.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.656 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -71.88 152.23 57.66 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.715 2.277 . . . . 1.0 112.473 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.97 84.24 44.66 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.444 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 691' ' ' PRO . . . . . 0.455 ' HG2' HD11 ' A' ' 964' ' ' ILE . 22.3 Cg_exo -61.54 147.06 96.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.583 2.189 . . . . 1.0 112.107 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.98 141.2 58.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 1.0 110.387 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.35 -44.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.85 -43.78 95.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.91 -41.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.357 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 64.3 t -63.56 -45.97 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 697' ' ' LEU . . . . . 0.687 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.2 tt -62.98 -42.65 99.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.802 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.84 -42.43 97.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.092 0.472 . . . . 1.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 53.6 p -62.06 -37.94 86.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.181 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.7 t -63.62 -45.14 98.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.068 0.461 . . . . 1.0 110.109 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.7 mtp -61.77 -40.0 93.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.591 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.94 98.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.047 -1.221 . . . . 1.0 110.047 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.51 80.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.742 0.306 . . . . 1.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.464 HG21 ' C ' ' A' ' 976' ' ' GLY . 30.7 mm -62.54 -42.11 94.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.492 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.1 mm? -63.27 -43.93 96.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.489 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.32 -44.32 91.93 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.25 -41.76 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 119.775 -0.77 . . . . 1.0 110.775 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.74 93.12 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.99 -38.29 85.77 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.68 -56.03 27.0 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 112.408 0.522 . . . . 1.0 112.408 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.0 Cg_exo -53.37 -41.96 69.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.293 1.329 . . . . 1.0 111.594 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.672 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 93.5 mt -66.26 -41.49 89.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.381 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.47 -41.9 98.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 7.8 tt -65.69 -38.99 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 119.945 -0.702 . . . . 1.0 109.523 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.21 -49.11 79.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -42.71 99.28 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.87 -46.31 89.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.214 -0.594 . . . . 1.0 110.91 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.62 -41.83 99.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.335 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 996' ' ' ASN . 33.3 mm -65.74 -42.77 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 30.7 m -58.63 -45.74 88.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.501 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.89 -43.83 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.058 0.456 . . . . 1.0 111.077 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -62.25 -40.98 97.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.209 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' B' ' 725' ' ' LYS . 6.8 m-20 -65.88 -38.48 88.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.523 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 60.6 -4.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.026 0.441 . . . . 1.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' B' ' 723' ' ' ASP . 75.4 mmtt -63.24 -41.99 99.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -117.13 127.74 54.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.55 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.371 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.9 89.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 1.0 110.531 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.65 130.88 55.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -114.62 126.56 55.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.36 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.7 137.33 57.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.637 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -76.28 144.92 39.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.03 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 964' ' ' ILE . 81.6 m -93.77 142.49 27.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.837 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 963' ' ' CYS . 1.2 tt 34.17 69.32 1.0 Allowed Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 121.378 0.609 . . . . 1.0 110.64 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 969' ' ' VAL . 23.4 Cg_exo -61.71 143.35 96.31 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.924 2.416 . . . . 1.0 112.754 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.74 -43.69 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.315 0.858 . . . . 1.0 113.315 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.551 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -70.87 -54.63 10.77 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.888 -177.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -58.4 -39.41 79.61 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 970' ' ' LEU . 9.8 p -65.59 -43.19 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 119.239 -0.985 . . . . 1.0 109.241 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 970' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 969' ' ' VAL . 54.9 tp -62.39 -42.61 99.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.749 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 967' ' ' TRP . 74.5 t -62.47 -44.54 99.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.688 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.84 -39.26 95.19 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.54 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.522 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.23 -42.83 99.28 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.65 -44.86 91.82 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.101 -0.571 . . . . 1.0 111.709 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.481 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.05 -41.53 99.48 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.06 -40.79 98.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.977 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.16 -42.62 99.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.656 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.7 -40.96 96.86 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.396 -0.922 . . . . 1.0 109.729 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 984' ' ' VAL . 89.9 mt -62.77 -41.63 99.33 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.815 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -62.52 -47.6 83.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.423 -0.511 . . . . 1.0 112.007 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.49 -40.85 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.726 -0.79 . . . . 1.0 111.286 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.05 -43.81 97.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 980' ' ' LEU . 73.8 t -60.71 -45.07 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.121 -0.231 . . . . 1.0 111.064 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.68 -41.71 99.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.197 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.96 -43.63 98.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.537 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.479 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 96.2 mmm -63.9 -43.62 95.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.894 0.378 . . . . 1.0 111.804 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.697 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.7 t90 -63.16 -43.32 98.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.291 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.03 -34.35 76.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 1.0 111.593 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.3 t -76.85 -2.19 4.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.065 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.81 8.28 63.52 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.479 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -56.41 -44.86 80.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -81.48 -22.98 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.092 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.697 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 68.5 mttm -63.67 -39.68 94.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.542 -1.263 . . . . 1.0 108.301 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.504 HH12 ' CG ' ' B' ' 723' ' ' ASP . 78.1 ttt-85 -66.45 126.89 30.24 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.643 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -139.34 5.84 2.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.31 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 33.4 mtt-85 -153.04 158.13 32.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.237 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo . . . . . 0 C--N 1.312 -1.394 0 C-N-CA 122.42 2.08 . . . . 1.0 112.193 179.688 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.24 -39.03 89.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.709 0.29 . . . . 1.0 110.506 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 2.6 p -142.42 73.14 20.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.72 145.71 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 1.0 112.005 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.75 145.05 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.343 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 174.84 4.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.12 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -62.25 145.42 96.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.263 1.975 . . . . 1.0 112.324 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.35 143.2 57.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.8 mt -62.64 -44.02 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.478 0.547 . . . . 1.0 112.478 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.51 -43.02 99.85 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.49 -45.41 98.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.978 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.419 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.5 t -63.42 -44.23 98.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 1.0 110.172 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.41 -43.87 98.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.961 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.75 -42.23 95.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 1.0 110.814 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.0 p -61.87 -39.98 93.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.458 -0.792 . . . . 1.0 112.085 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 66.7 t -64.21 -45.03 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.076 0.465 . . . . 1.0 110.871 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 701' ' ' MET . . . . . 0.439 ' O ' HD13 ' B' ' 705' ' ' LEU . 93.0 mtp -63.27 -39.09 93.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.274 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.37 -41.34 96.59 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.613 -0.995 . . . . 1.0 110.613 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.11 88.07 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 120.685 0.278 . . . . 1.0 110.677 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.481 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.6 mm -60.41 -43.21 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.651 -0.819 . . . . 1.0 109.692 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.485 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.7 mp -61.28 -43.23 99.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.467 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.81 -44.39 96.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.619 -0.832 . . . . 1.0 111.197 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.74 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.77 -39.98 65.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.491 -0.862 . . . . 1.0 111.169 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.59 -37.39 82.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.714 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.36 -56.92 19.46 Favored Pre-proline 0 N--CA 1.462 0.137 0 C-N-CA 120.04 -0.664 . . . . 1.0 111.593 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.1 Cg_exo -54.27 -44.37 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 120.837 1.024 . . . . 1.0 111.489 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.13 -42.13 94.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.64 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.59 -41.85 99.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.813 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.6 -44.05 98.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.544 -0.463 . . . . 1.0 109.964 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -62.33 -48.16 81.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.958 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -43.27 98.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.189 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.33 -44.56 96.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.133 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 718' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 84.9 mt -61.14 -42.1 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.89 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.5 -44.11 98.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 120.068 -0.653 . . . . 1.0 110.242 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.5 m -59.79 -46.95 87.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.6 -45.11 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.494 0.664 . . . . 1.0 111.198 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 722' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' B' ' 725' ' ' LYS . 51.2 m80 -59.79 -38.95 83.33 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.865 -0.734 . . . . 1.0 109.438 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.504 ' CG ' HH12 ' A' ' 995' ' ' ARG . 7.4 m-20 -66.33 -39.73 89.43 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 112.39 0.515 . . . . 1.0 112.39 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.1 -38.46 91.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.038 0.447 . . . . 1.0 111.018 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 722' ' ' HIS . 75.6 mmtt -99.46 147.3 25.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -120.96 133.96 55.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.265 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.217 -0.624 0 CA-C-O 117.815 -1.088 . . . . 1.0 110.835 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.24 143.19 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 1.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.9 mt -110.37 130.99 55.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.467 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.69 139.1 58.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.6 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -117.62 134.04 55.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.57 ' NH1' ' CZ2' ' A' ' 967' ' ' TRP . 71.6 ttt180 -67.72 134.88 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.278 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.08 141.27 47.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.662 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 964' ' ' ILE . 71.5 mt 56.87 69.73 1.62 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.04 148.35 93.34 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.52 2.147 . . . . 1.0 111.577 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt -65.95 -38.04 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.731 ' O ' HG13 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -54.33 -50.27 67.78 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.857 -0.737 . . . . 1.0 111.306 -176.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -57.69 -38.07 74.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.335 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 973' ' ' VAL . 66.6 t -64.46 -46.38 93.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.964 -1.094 . . . . 1.0 109.468 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.56 -44.58 93.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.856 -1.066 . . . . 1.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 967' ' ' TRP . 3.4 m -64.88 -39.35 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 119.729 -0.788 . . . . 1.0 110.508 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.24 96.34 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.1 t -61.88 -45.28 99.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.211 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.11 -42.64 99.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 1.0 111.658 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.62 85.03 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.476 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -59.69 -42.82 98.08 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.66 -42.52 98.07 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.391 -0.476 . . . . 1.0 111.951 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.44 -44.95 93.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.426 0.528 . . . . 1.0 112.426 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.22 -42.07 99.21 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.471 -0.891 . . . . 1.0 110.988 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' B' ' 705' ' ' LEU . 2.1 mm? -63.19 -40.59 97.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.98 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.8 m -62.0 -45.29 94.26 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.569 -0.452 . . . . 1.0 110.203 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -41.34 89.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.3 99.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.963 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.8 t -61.76 -46.04 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.505 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.36 -41.81 98.86 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.334 -0.546 . . . . 1.0 110.521 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.21 -42.53 98.75 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.207 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.39 -42.88 95.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.537 -0.302 . . . . 1.0 110.815 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.587 ' NE1' ' NZ ' ' A' ' 994' ' ' LYS . 9.9 t90 -61.71 -42.03 98.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.11 -33.95 75.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.078 0.466 . . . . 1.0 111.176 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 986' ' ' ALA . 51.8 t -78.27 -3.18 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.689 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.47 10.81 71.23 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.53 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.6 OUTLIER -55.29 -45.29 76.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 -178.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 51.7 m-85 -78.89 -17.17 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.645 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.587 ' NZ ' ' NE1' ' A' ' 988' ' ' TRP . 63.9 mttp -109.77 29.8 7.26 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 991' ' ' GLY . 75.9 ttt-85 -66.95 124.11 22.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -109.47 2.1 20.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.073 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 173.55 153.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 998' ' ' PRO . . . . . 0.452 ' CA ' HH21 ' A' ' 995' ' ' ARG . 18.0 Cg_endo . . . . . 0 N--CA 1.495 1.576 0 C-N-CA 122.133 1.889 . . . . 1.0 111.994 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 55.2 30.63 14.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 1.0 110.624 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 687' ' ' SER . . . . . 0.429 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.4 OUTLIER -98.19 -179.9 0.95 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.221 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 688' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 22.8 Cg_exo -61.87 145.25 97.13 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.104 1.869 . . . . 1.0 112.017 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.08 -41.91 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 61.4 m -133.31 83.43 50.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.571 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -61.2 149.61 88.48 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.895 2.396 . . . . 1.0 112.011 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 692' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 -61.23 139.98 58.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.269 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.532 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.9 mt -62.6 -43.51 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 1.0 112.309 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 694' ' ' LEU . 90.1 mt -62.3 -42.47 99.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.208 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.74 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.5 t -63.26 -44.12 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.808 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.25 -43.39 98.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.06 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.8 -42.31 95.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.176 0.512 . . . . 1.0 110.812 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 35.4 p -62.27 -42.84 99.69 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.18 -42.32 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.9 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.5 mtp -62.38 -39.26 92.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.347 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.66 -40.42 97.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 1.0 110.367 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.476 HG21 ' C ' ' A' ' 976' ' ' GLY . 29.4 mm -62.36 -42.54 95.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.513 ' HA ' HD11 ' A' ' 980' ' ' LEU . 5.6 tt -61.6 -44.54 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.743 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.05 -43.2 99.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.128 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.35 -43.9 98.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.311 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.905 -0.664 . . . . 1.0 112.029 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 709' ' ' LEU . . . . . 0.469 HD22 HD21 ' B' ' 705' ' ' LEU . 9.6 mp -67.18 -34.89 78.51 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.598 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -58.11 10.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.347 -0.541 . . . . 1.0 112.334 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 17.8 Cg_endo -62.12 -39.83 46.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.374 1.383 . . . . 1.0 112.045 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 89.5 mt -65.6 -42.08 92.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.933 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -41.25 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.933 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.31 -44.07 98.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.382 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.855 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.1 t90 -62.72 -48.52 78.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.369 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.81 -43.62 97.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.021 -178.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.69 -43.36 99.0 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.24 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.66 -41.3 97.33 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.23 -0.588 . . . . 1.0 110.132 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.855 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.55 -44.15 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.679 -0.808 . . . . 1.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 92.1 m -59.17 -45.35 91.24 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.335 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.51 -43.92 97.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.128 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -64.32 -39.44 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 723' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.01 -38.76 86.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.954 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.84 -43.24 99.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.8 0.333 . . . . 1.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.44 141.13 45.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.72 127.18 54.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.481 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.567 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.4 142.98 56.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.323 . . . . 1.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.83 -41.95 99.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.611 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 55.67 41.48 30.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -108.19 126.66 53.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.165 0.507 . . . . 1.0 110.643 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.24 -37.67 88.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.505 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.41 -33.88 76.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.479 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.8 mt -141.99 71.13 23.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.424 -0.51 . . . . 1.0 111.59 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.64 149.52 90.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.595 2.197 . . . . 1.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.2 -42.89 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -55.72 -53.66 53.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -176.085 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.49 -39.32 79.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.419 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 69.2 t -64.18 -44.96 97.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.699 0.762 . . . . 1.0 108.971 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.53 -42.64 99.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.0 t -63.51 -45.74 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.776 0.322 . . . . 1.0 111.248 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.52 96.82 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.268 -0.733 . . . . 1.0 111.268 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.9 t -61.73 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.605 0.24 . . . . 1.0 110.447 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.21 -42.61 99.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.497 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.99 -45.13 93.27 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.079 -0.581 . . . . 1.0 111.883 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.19 99.71 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.31 -41.6 98.96 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.644 -0.327 . . . . 1.0 110.82 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.99 -42.39 99.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.47 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.91 -41.68 98.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.009 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' B' ' 705' ' ' LEU . 83.9 mt -60.57 -41.06 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.104 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -59.88 -45.65 91.84 Favored 'General case' 0 C--O 1.253 1.262 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.477 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.35 -47.69 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 119.904 -0.718 . . . . 1.0 111.344 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.92 -42.65 98.54 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.833 -0.747 . . . . 1.0 111.655 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.18 -47.11 95.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.66 -0.816 . . . . 1.0 111.459 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.12 -42.63 99.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.531 -0.467 . . . . 1.0 110.141 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.85 -43.3 99.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.987 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 98.6 mtp -65.84 -41.95 91.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 1.0 111.773 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.521 ' CD1' ' NZ ' ' A' ' 994' ' ' LYS . 10.1 t90 -62.7 -43.6 98.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.44 -33.46 73.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.138 0.494 . . . . 1.0 110.897 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.8 t -77.33 -2.8 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.688 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.19 7.09 81.67 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.606 ' CD1' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.82 -45.16 78.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.444 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 50.4 m-85 -83.2 -17.94 41.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.825 -0.75 . . . . 1.0 111.231 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.521 ' NZ ' ' CD1' ' A' ' 988' ' ' TRP . 62.8 mttp -62.62 -37.76 87.54 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 118.353 -1.339 . . . . 1.0 108.877 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.507 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 68.3 mtp180 -65.17 126.81 29.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.835 -1.146 . . . . 1.0 110.385 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 996' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 997' ' ' ARG . 44.7 p-10 -161.95 174.54 12.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.463 -0.789 . . . . 1.0 110.065 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 996' ' ' ASN . 12.5 ttp180 80.25 92.07 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.895 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.492 1.408 0 C-N-CA 122.139 1.893 . . . . 1.0 112.028 -179.767 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.0 -39.08 89.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.743 0.306 . . . . 1.0 110.559 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 10.7 p -176.08 74.44 0.27 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.64 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.41 145.02 98.53 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.86 2.373 . . . . 1.0 112.047 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -79.51 134.19 36.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 690' ' ' CYS . . . . . 0.401 ' SG ' ' CD ' ' B' ' 691' ' ' PRO . 0.1 OUTLIER -120.21 175.5 2.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.877 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 691' ' ' PRO . . . . . 0.401 ' CD ' ' SG ' ' B' ' 690' ' ' CYS . 23.3 Cg_exo -61.35 143.8 98.07 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.86 1.706 . . . . 1.0 111.822 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.49 138.62 57.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.271 0.558 . . . . 1.0 111.262 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.7 -43.52 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.53 -41.78 99.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.663 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.9 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.319 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.458 ' O ' HG23 ' B' ' 700' ' ' VAL . 65.5 t -63.51 -45.38 97.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.958 0.409 . . . . 1.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 697' ' ' LEU . . . . . 0.688 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.1 tt -62.6 -43.03 99.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.655 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.69 -42.12 98.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 1.0 110.457 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.2 p -62.01 -36.73 82.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.037 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.8 t -63.95 -44.63 97.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.061 0.458 . . . . 1.0 110.14 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.69 -39.73 92.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.134 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.89 96.9 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.017 -1.233 . . . . 1.0 110.017 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.77 89.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 1.0 110.357 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.87 -43.22 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.233 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 980' ' ' LEU . 84.6 mt -61.1 -44.22 97.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.163 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.59 -44.12 97.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.669 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 707' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 95.0 mt -63.85 -44.47 98.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.876 -0.329 . . . . 1.0 111.428 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.26 -41.14 69.56 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.87 -38.45 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.507 0.928 . . . . 1.0 113.507 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.26 -57.03 18.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.208 -0.597 . . . . 1.0 112.122 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 32.3 Cg_exo -54.63 -44.28 51.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.091 1.194 . . . . 1.0 111.359 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.29 -42.15 93.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.715 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.62 -41.77 99.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.52 -44.19 98.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.199 -0.601 . . . . 1.0 109.449 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.444 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 11.3 t90 -63.0 -48.25 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 1.0 109.783 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.606 ' NZ ' ' CD1' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.51 -44.21 96.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.729 -178.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -42.86 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.667 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 718' ' ' LEU . . . . . 0.498 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 83.8 mt -62.12 -42.77 99.57 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.897 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.78 -44.32 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.909 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 82.9 m -60.31 -45.8 92.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.512 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 721' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' B' ' 724' ' ' ARG . 95.3 mt -62.37 -43.21 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.385 -0.526 . . . . 1.0 110.42 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 722' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 43.3 m80 -61.75 -37.61 84.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.457 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.507 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 47.0 m-20 -67.41 -40.12 85.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.585 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 724' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 721' ' ' ILE . 62.1 ttp180 -127.36 116.47 20.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.109 0.48 . . . . 1.0 109.765 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.23 133.64 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.18 127.0 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.337 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.091 -0.957 . . . . 1.0 110.562 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -151.05 152.37 33.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 1.0 110.581 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 959' ' ' LEU . 94.9 mt -74.57 141.73 44.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.52 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.99 137.75 57.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.631 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.28 -37.62 85.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -64.14 -39.06 93.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.688 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 67.6 m -67.29 -36.75 82.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.83 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.77 71.21 13.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.95 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.11 148.95 92.22 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.63 2.22 . . . . 1.0 112.078 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.3 -42.51 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.473 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.0 -51.94 47.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.759 -176.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -58.01 -39.2 77.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.682 0.252 . . . . 1.0 111.682 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.1 -45.06 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.26 -42.64 99.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.6 t -62.79 -44.36 99.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.79 -38.26 94.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.443 -0.884 . . . . 1.0 111.155 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.8 t -61.98 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.975 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.19 -42.09 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.846 -0.341 . . . . 1.0 111.876 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.26 92.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.372 -0.691 . . . . 1.0 111.372 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.97 -42.39 99.73 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.146 -1.181 . . . . 1.0 110.146 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.44 -42.08 98.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.953 0.377 . . . . 1.0 111.999 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.76 -43.62 98.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.457 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -40.39 96.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.103 -1.039 . . . . 1.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 976' ' ' GLY . 1.8 mm? -62.5 -39.92 95.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 94.8 m -61.89 -45.53 93.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.807 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.63 -43.63 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.97 -0.692 . . . . 1.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.19 -43.45 98.79 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.379 -0.826 . . . . 1.0 111.355 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 980' ' ' LEU . 68.4 t -60.63 -44.73 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.081 -0.387 . . . . 1.0 110.82 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.45 -41.43 98.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.175 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.388 -0.525 . . . . 1.0 112.191 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.481 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 95.6 mmm -64.29 -42.81 96.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 111.201 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.1 t90 -62.53 -42.6 99.63 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.051 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.33 -34.4 76.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.832 0.349 . . . . 1.0 111.396 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -78.09 -2.49 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.792 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 68.27 12.17 62.85 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 108.548 -1.821 . . . . 1.0 108.548 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.481 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -54.9 -44.13 73.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -178.068 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -82.32 -6.39 59.22 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.838 -0.745 . . . . 1.0 109.859 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 991' ' ' GLY . 75.2 mmtt -97.85 1.03 47.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.539 HH12 ' CG ' ' B' ' 723' ' ' ASP . 77.5 ttt-85 -67.02 134.17 51.39 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.013 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -150.54 171.25 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.451 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -72.72 149.75 90.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.189 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.494 1.52 0 C-N-CA 122.03 1.82 . . . . 1.0 112.135 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.532 -1.427 . . . . 1.0 109.532 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.49 29.72 13.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 1.0 110.447 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 161.19 54.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 152.94 64.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.932 2.422 . . . . 1.0 112.027 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.01 144.74 51.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 21.8 m -140.16 81.77 17.93 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.74 147.51 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.357 2.038 . . . . 1.0 112.361 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 145.65 54.94 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.54 -42.69 96.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.856 -0.737 . . . . 1.0 112.351 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.36 -41.58 98.85 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.003 -0.436 . . . . 1.0 111.451 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.6 -45.32 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.846 0.355 . . . . 1.0 111.646 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 58.6 t -64.18 -45.23 96.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 697' ' ' LEU . . . . . 0.676 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.2 tt -63.29 -43.03 99.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.833 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.3 -42.02 96.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 1.0 110.553 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 49.5 p -62.38 -38.26 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.361 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.2 t -63.86 -44.83 98.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.137 0.494 . . . . 1.0 110.054 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -63.03 -39.55 95.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.54 -40.54 97.72 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.94 78.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.1 mm -62.59 -42.65 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.416 ' HA ' HD21 ' A' ' 980' ' ' LEU . 13.7 mt -61.43 -44.9 96.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.833 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.28 -43.9 96.61 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.043 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.29 -44.85 97.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.52 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 708' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -70.11 -42.4 67.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.206 -0.521 . . . . 1.0 111.801 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 709' ' ' LEU . . . . . 0.462 ' O ' HD13 ' B' ' 713' ' ' LEU . 82.5 mt -67.12 -38.38 85.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.27 -55.56 30.31 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 44.0 Cg_exo -52.59 -41.42 68.59 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.299 1.333 . . . . 1.0 111.778 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.476 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.24 -41.89 93.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.722 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 713' ' ' LEU . . . . . 0.462 HD13 ' O ' ' B' ' 709' ' ' LEU . 9.4 mp -63.33 -42.37 98.97 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.29 -41.71 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.503 -0.879 . . . . 1.0 110.147 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -63.44 -48.77 76.39 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -42.7 95.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.681 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.18 -44.45 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.623 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.73 -41.91 98.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.997 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.55 -42.98 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 120.321 -0.552 . . . . 1.0 109.825 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 98.0 m -59.61 -45.88 90.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.384 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 721' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' B' ' 724' ' ' ARG . 30.5 mm -61.73 -43.67 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.921 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -65.78 -36.53 83.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.679 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.539 ' CG ' HH12 ' A' ' 995' ' ' ARG . 23.7 t70 -70.94 -42.27 70.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.686 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 724' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' B' ' 721' ' ' ILE . 90.3 mtm180 -130.81 130.31 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' B' ' 727' ' ' PHE . 99.4 mttt -124.07 145.61 49.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.63 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 47.68 -88.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 727' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' B' ' 725' ' ' LYS . 96.6 m-85 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.38 143.14 56.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 1.0 110.598 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.9 -41.78 99.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.428 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.33 141.74 58.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.471 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -108.9 125.08 51.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.479 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -126.07 136.9 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.354 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.581 ' SG ' ' N ' ' B' ' 685' ' ' GLY . 74.3 m -88.6 133.93 34.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 964' ' ' ILE . 1.2 tt -174.26 72.0 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 1.0 110.178 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.45 ' O ' HG22 ' A' ' 969' ' ' VAL . 20.3 Cg_exo -61.27 140.84 90.73 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.881 2.387 . . . . 1.0 112.679 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.46 -61.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 1.0 112.028 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.562 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -66.64 -50.86 61.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -177.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 968' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.7 m0 -58.09 -43.54 87.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 119.299 -0.381 . . . . 1.0 111.671 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 965' ' ' PRO . 28.1 m -65.78 -43.61 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 118.819 -1.152 . . . . 1.0 110.457 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 970' ' ' LEU . . . . . 0.444 ' N ' HG23 ' A' ' 969' ' ' VAL . 89.3 mt -63.15 -42.81 99.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.491 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.3 t -64.0 -44.98 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.707 0.289 . . . . 1.0 111.387 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.48 -38.39 94.77 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.116 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.61 -45.1 99.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 121.16 -0.216 . . . . 1.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.3 -42.14 99.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.898 0.333 . . . . 1.0 111.898 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.54 -43.43 94.64 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 120.676 -0.773 . . . . 1.0 111.735 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.1 99.95 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 120.435 -0.888 . . . . 1.0 111.133 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.8 -40.31 96.97 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.539 -0.389 . . . . 1.0 110.098 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.0 -42.7 99.43 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.48 -42.6 99.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.687 -0.805 . . . . 1.0 110.213 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 984' ' ' VAL . 24.4 mt -62.39 -42.74 99.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.824 0.345 . . . . 1.0 110.779 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 24.1 p -61.93 -45.1 95.2 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.508 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.71 -43.28 97.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.672 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.7 -42.72 97.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.394 -0.522 . . . . 1.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.617 HG22 HD21 ' B' ' 712' ' ' LEU . 69.6 t -62.45 -45.48 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.063 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.83 97.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.931 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.37 -43.28 99.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.644 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 64.4 mtt -64.77 -42.46 95.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.018 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.684 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.4 t90 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.46 -33.79 74.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.125 0.488 . . . . 1.0 111.387 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.9 t -78.68 -3.36 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.64 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.56 11.04 72.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.333 -1.507 . . . . 1.0 109.333 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.524 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.48 -45.42 76.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.435 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 48.6 m-85 -79.79 -16.52 55.37 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.986 -0.686 . . . . 1.0 110.734 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.684 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 99.2 mttt -108.96 29.35 7.57 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.397 -1.334 . . . . 1.0 107.397 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.633 HH22 ' CB ' ' B' ' 723' ' ' ASP . 73.1 ttp85 -66.26 131.26 45.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.926 0.394 . . . . 1.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -136.28 113.86 10.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -178.91 64.2 0.16 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 C-N-CA 122.867 2.378 . . . . 1.0 112.167 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 685' ' ' GLY . . . . . 0.581 ' N ' ' SG ' ' A' ' 963' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.584 -1.407 . . . . 1.0 109.584 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 686' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' B' ' 686' ' ' GLU . 55.5 mp0 -66.34 -38.04 86.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.841 0.353 . . . . 1.0 110.871 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 166.66 1.9 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.783 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.77 -38.43 85.11 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.338 2.025 . . . . 1.0 112.815 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.99 147.67 28.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.085 0.469 . . . . 1.0 111.281 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 75.2 m -72.49 151.26 91.69 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.35 162.39 30.61 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.658 2.238 . . . . 1.0 113.37 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 692' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 66.4 t0 -60.88 146.15 47.56 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.915 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.563 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 93.2 mt -61.98 -44.42 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 113.095 0.776 . . . . 1.0 113.095 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.35 99.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.717 0.294 . . . . 1.0 111.204 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.21 -45.39 98.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.819 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 700' ' ' VAL . 66.6 t -63.1 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 1.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.554 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.75 -42.88 94.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.439 . . . . 1.0 110.668 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 54.6 p -62.52 -39.56 93.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.829 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 700' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.6 t -64.24 -43.79 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.39 0.614 . . . . 1.0 109.381 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.6 mtp -63.29 -39.96 96.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.878 -1.056 . . . . 1.0 110.173 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.93 -47.12 48.74 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.07 83.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.675 0.274 . . . . 1.0 111.631 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.42 HG22 ' O ' ' B' ' 700' ' ' VAL . 10.7 tp -64.87 -37.61 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.651 -0.82 . . . . 1.0 108.849 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 62.3 tp -60.83 -44.95 96.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.31 -41.37 98.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.141 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.7 -43.85 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.43 -39.25 95.63 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.5 -37.24 82.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.694 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.11 -56.48 21.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 112.299 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.5 Cg_exo -53.66 -43.91 53.69 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.06 1.173 . . . . 1.0 112.017 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.617 HD21 HG22 ' A' ' 984' ' ' VAL . 11.1 mp -65.17 -41.99 94.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.137 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.22 -41.66 99.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.082 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.64 -44.31 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.435 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 7.9 t90 -62.16 -47.31 85.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.29 0.567 . . . . 1.0 109.578 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.53 -44.01 96.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.747 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.51 -46.28 89.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.632 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 718' ' ' LEU . . . . . 0.489 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 8.2 mp -63.26 -41.01 98.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.545 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 4.5 mm -63.58 -44.65 98.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.965 -0.694 . . . . 1.0 109.994 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -45.37 94.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.1 -43.53 98.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.319 -0.552 . . . . 1.0 111.366 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 722' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 44.5 m80 -59.06 -41.11 87.15 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.633 ' CB ' HH22 ' A' ' 995' ' ' ARG . 24.8 t70 -65.24 -40.17 93.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.444 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.73 -40.98 98.07 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.573 -0.451 . . . . 1.0 110.675 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 -42.76 98.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.698 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.13 138.51 55.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.79 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.971 -1.014 . . . . 1.0 110.645 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 957' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 963' ' ' CYS . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.41 91.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.745 0.307 . . . . 1.0 110.301 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.663 HD12 HH21 ' A' ' 962' ' ' ARG . 92.6 mt -118.88 144.77 46.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.93 -35.13 80.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.833 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -63.05 -39.57 95.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.689 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.663 HH21 HD12 ' A' ' 959' ' ' LEU . 89.9 mtm180 -101.18 134.51 44.11 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 957' ' ' GLY . 78.7 m -84.81 -66.99 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.542 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 963' ' ' CYS . 9.2 pt 27.73 70.12 0.49 Allowed Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 123.668 0.605 . . . . 1.0 111.348 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.83 140.14 88.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.367 2.045 . . . . 1.0 112.35 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.0 -63.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.433 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -65.34 -51.94 57.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 -177.295 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 968' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.1 m0 -57.18 -40.81 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.143 -0.223 . . . . 1.0 110.779 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.42 -46.45 92.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 119.419 -0.912 . . . . 1.0 110.263 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.26 -42.65 99.18 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.681 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.7 t -63.93 -44.58 98.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.443 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.77 -37.91 95.07 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.292 -0.956 . . . . 1.0 111.533 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.25 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.437 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.29 -42.92 99.12 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.2 -45.08 89.24 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.88 -0.676 . . . . 1.0 111.614 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.593 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.67 -41.37 98.91 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.91 -42.78 97.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.133 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.96 -44.33 96.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.557 -0.457 . . . . 1.0 111.654 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 979' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 983' ' ' LEU . 8.4 mp -62.61 -42.12 99.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.64 -0.824 . . . . 1.0 110.366 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' B' ' 705' ' ' LEU . 4.1 mm? -63.14 -39.65 95.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.846 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 84.6 m -61.2 -45.13 95.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.515 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.82 -44.17 99.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.586 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 983' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 979' ' ' LEU . 8.5 mp -62.94 -42.0 99.67 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.349 -0.54 . . . . 1.0 110.899 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 63.8 t -62.45 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 1.0 111.011 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.24 -41.73 99.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.9 99.94 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.284 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.27 -40.54 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.373 0.606 . . . . 1.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.408 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 12.6 t90 -65.35 -44.7 86.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.578 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.67 -33.98 76.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.96 2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.176 -1.01 . . . . 1.0 109.296 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 75.47 11.16 84.5 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.38 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.417 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.9 -44.34 66.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.468 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.4 m-85 -83.54 -4.29 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.857 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.0 mttt -92.57 -0.46 57.32 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.533 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 77.6 ttt-85 -65.67 133.56 51.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.768 -0.773 . . . . 1.0 109.413 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 996' ' ' ASN . . . . . 0.468 ' ND2' ' NH1' ' A' ' 995' ' ' ARG . 98.9 m-20 58.4 33.72 23.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.408 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 996' ' ' ASN . 97.7 mtt180 26.85 78.94 0.24 Allowed Pre-proline 0 N--CA 1.467 0.394 0 O-C-N 123.764 0.665 . . . . 1.0 111.945 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 998' ' ' PRO . . . . . 0.441 ' CG ' ' O ' ' A' ' 993' ' ' PHE . 71.4 Cg_endo . . . . . 0 C--N 1.306 -1.691 0 C-N-CA 122.678 2.252 . . . . 1.0 112.071 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.628 -1.389 . . . . 1.0 109.628 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.1 -38.83 89.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 1.0 110.525 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 66.0 m 44.83 72.53 1.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.444 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.69 -38.18 84.41 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.953 2.435 . . . . 1.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.55 144.99 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 6.5 m -82.67 161.47 58.68 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.054 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.88 147.54 95.08 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.693 1.595 . . . . 1.0 112.245 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.74 143.81 57.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.997 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.02 -44.46 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.88 -43.37 96.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.34 -47.24 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.91 0.707 . . . . 1.0 112.91 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' B' ' 699' ' ' SER . 11.0 p -65.26 -41.65 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 697' ' ' LEU . . . . . 0.42 ' N ' HG13 ' B' ' 696' ' ' VAL . 42.9 tp -61.76 -43.45 98.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.852 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.86 -41.84 95.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 1.0 110.665 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 36.8 p -62.55 -40.98 98.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.582 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.56 -45.26 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.266 0.555 . . . . 1.0 110.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -63.5 -39.76 95.3 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.035 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.44 -41.13 99.41 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.99 -0.844 . . . . 1.0 110.99 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.58 80.87 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.05 -41.27 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.673 ' HA ' HD21 ' A' ' 980' ' ' LEU . 47.5 tp -60.63 -46.26 90.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.868 -0.333 . . . . 1.0 111.166 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.24 -42.42 99.2 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.55 -44.21 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.563 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.59 -40.86 94.24 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.64 -37.57 85.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.92 -57.18 17.2 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 119.998 -0.681 . . . . 1.0 112.32 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.7 Cg_exo -54.46 -45.38 41.41 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.158 1.239 . . . . 1.0 111.934 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.493 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -65.86 -40.57 91.79 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.259 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.42 -41.32 98.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.085 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.63 -44.75 98.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.389 -0.525 . . . . 1.0 109.735 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.468 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.2 t90 -63.11 -49.19 75.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.18 0.514 . . . . 1.0 109.702 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.444 ' O ' HG23 ' B' ' 720' ' ' THR . 0.2 OUTLIER -60.64 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.104 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.35 -45.39 91.43 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.738 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 718' ' ' LEU . . . . . 0.455 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 82.7 mt -62.76 -42.9 99.9 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.676 0.621 . . . . 1.0 112.676 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' B' ' 720' ' ' THR . 5.6 tp -65.87 -41.26 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 119.611 -0.836 . . . . 1.0 109.871 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 720' ' ' THR . . . . . 0.444 HG23 ' O ' ' B' ' 716' ' ' LYS . 30.6 p -58.69 -45.3 89.76 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.758 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 721' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' B' ' 721' ' ' ILE . 36.2 mm -62.05 -41.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 O-C-N 121.849 -0.532 . . . . 1.0 110.676 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 722' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 59.2 m80 -61.73 -39.81 92.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.211 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 40.5 t0 -67.25 -37.44 83.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.959 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -62.1 -42.05 98.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 1.0 110.721 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 722' ' ' HIS . 68.9 mttm -102.92 146.66 27.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.708 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.26 -39.27 89.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.738 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.479 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 958' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 961' ' ' GLU . . . -150.72 152.26 33.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 1.0 110.602 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.33 99.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.401 ' H ' ' H ' ' A' ' 961' ' ' GLU . 83.5 tt0 -160.25 -21.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.87 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 961' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 958' ' ' ALA . 97.5 mt-10 -95.05 120.63 35.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.857 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 p 179.85 77.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.983 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 964' ' ' ILE . 5.5 pt -152.2 73.32 7.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.126 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.11 144.39 99.2 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.801 2.334 . . . . 1.0 112.426 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.61 -31.28 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.431 0.9 . . . . 1.0 113.431 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.37 -45.4 80.54 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.272 -0.971 . . . . 1.0 110.822 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 968' ' ' TRP . . . . . 0.599 ' NE1' HD12 ' B' ' 693' ' ' ILE . 35.5 m0 -57.23 -46.13 83.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.78 -0.191 . . . . 1.0 110.786 -177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -63.74 -46.82 93.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 119.329 -0.948 . . . . 1.0 110.941 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.31 -44.26 95.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.113 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 967' ' ' TRP . 64.5 t -63.77 -44.95 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.07 -39.32 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.183 -1.008 . . . . 1.0 111.118 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.065 0.394 . . . . 1.0 112.065 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.72 -42.84 97.85 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.58 95.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.494 -0.86 . . . . 1.0 111.2 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.401 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.93 -42.85 99.77 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.63 -41.94 99.31 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.732 -0.275 . . . . 1.0 110.659 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.83 -41.79 98.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.47 -41.26 96.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.469 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' B' ' 705' ' ' LEU . 91.2 mt -62.61 -42.07 99.36 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.953 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 96.6 m -62.29 -48.66 78.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.01 -41.38 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.453 -0.899 . . . . 1.0 111.626 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.39 -43.48 97.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.541 -0.464 . . . . 1.0 110.696 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.2 t -62.52 -45.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.722 0.296 . . . . 1.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.08 -42.28 99.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.12 -43.64 98.38 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.336 -0.545 . . . . 1.0 111.811 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.74 -42.62 90.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.144 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -62.67 -42.79 99.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.88 -32.45 73.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.282 0.563 . . . . 1.0 110.509 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.4 t -78.37 -3.79 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.904 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.17 72.86 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.198 -1.561 . . . . 1.0 109.198 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.499 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.88 -46.09 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -178.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.658 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 39.2 m-85 -74.26 -30.99 62.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.836 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.73 -42.36 95.26 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 118.663 -1.215 . . . . 1.0 108.952 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.428 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 28.6 tpt85 -146.15 148.54 32.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.624 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.11 -41.12 97.91 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -74.36 156.85 87.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.443 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 122.411 2.074 . . . . 1.0 112.025 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 -38.7 89.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.777 0.322 . . . . 1.0 110.466 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 160.92 8.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.523 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.54 -21.87 65.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.586 2.191 . . . . 1.0 111.596 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.98 -41.09 99.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.106 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.98 156.0 36.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.439 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -72.22 152.99 56.6 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.799 2.333 . . . . 1.0 112.442 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -65.84 143.33 57.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.599 HD12 ' NE1' ' A' ' 968' ' ' TRP . 9.4 tt -62.78 -41.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.461 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.46 -42.43 99.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.412 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.29 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 71.1 t -62.77 -44.77 99.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 1.0 110.485 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 697' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 968' ' ' TRP . 86.7 mt -62.05 -41.99 98.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.572 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.55 -43.32 94.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 1.0 110.398 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.8 p -62.47 -41.44 98.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.848 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.59 -44.88 98.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.316 0.579 . . . . 1.0 109.8 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 55.9 mtt -62.85 -39.46 94.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.499 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.25 -41.69 94.59 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.78 89.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.144 0.497 . . . . 1.0 110.759 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 704' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 980' ' ' LEU . 27.6 mm -63.24 -41.68 93.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.379 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.523 ' HA ' HD21 ' A' ' 980' ' ' LEU . 57.5 tp -59.42 -46.84 87.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.018 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.17 -43.11 99.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.602 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.88 -44.09 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.19 -41.07 92.48 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.244 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.11 -35.36 76.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.08 -56.2 24.01 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 119.588 -0.845 . . . . 1.0 111.422 -177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.8 Cg_exo -54.19 -42.43 67.36 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.296 1.331 . . . . 1.0 111.351 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 712' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 90.9 mt -64.16 -42.82 96.59 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.91 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -41.36 98.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.96 98.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.053 -0.659 . . . . 1.0 109.349 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.857 ' NE1' HD11 ' B' ' 719' ' ' ILE . 5.3 t90 -61.84 -49.27 76.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.922 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 716' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.56 -42.64 97.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.316 -0.24 . . . . 1.0 110.656 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.16 -42.62 99.45 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.48 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.91 -40.44 93.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.377 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 719' ' ' ILE . . . . . 0.857 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.97 -46.72 93.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.799 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 21.6 m -60.86 -48.19 82.95 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 34.1 mm -63.14 -43.78 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.788 0.662 . . . . 1.0 112.788 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 722' ' ' HIS . . . . . 0.455 ' CD2' ' C ' ' B' ' 722' ' ' HIS . 1.8 p-80 -68.97 -39.54 79.38 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.522 -0.871 . . . . 1.0 109.874 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.442 ' N ' ' CG ' ' B' ' 722' ' ' HIS . 65.5 t0 -66.88 -37.97 85.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -60.84 -43.08 98.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.765 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 725' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 722' ' ' HIS . 99.3 mttt -100.9 146.67 27.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.863 0.364 . . . . 1.0 110.733 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.65 147.48 50.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.375 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.643 -179.978 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 957' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 960' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.12 -38.13 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.753 0.311 . . . . 1.0 110.728 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.72 -43.05 99.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.804 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.492 ' OE2' ' SG ' ' A' ' 963' ' ' CYS . 22.1 pt-20 -137.22 144.48 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.734 0.302 . . . . 1.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.36 -41.29 89.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.616 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 965' ' ' PRO . 34.9 ptt-85 -149.18 148.06 29.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 1.0 111.176 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 963' ' ' CYS . . . . . 0.492 ' SG ' ' OE2' ' A' ' 960' ' ' GLU . 1.1 m -76.9 -17.81 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.981 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.48 85.52 16.53 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.063 0.394 . . . . 1.0 112.063 -178.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.449 ' HA ' ' HE ' ' A' ' 962' ' ' ARG . 23.6 Cg_exo -61.66 147.5 95.2 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.904 2.403 . . . . 1.0 111.87 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.25 -43.91 97.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 -177.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -58.13 -50.71 72.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.457 -0.497 . . . . 1.0 112.285 -176.72 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 968' ' ' TRP . . . . . 0.451 ' CZ2' HD11 ' B' ' 693' ' ' ILE . 21.7 m0 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.193 -177.03 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 973' ' ' VAL . 65.1 t -64.36 -46.46 93.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.806 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.23 -43.74 97.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 1.0 111.686 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.0 t -63.36 -45.1 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.585 -0.279 . . . . 1.0 111.664 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.66 -37.69 94.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.095 -1.05 . . . . 1.0 111.586 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 969' ' ' VAL . 60.6 t -62.0 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.854 -0.339 . . . . 1.0 110.595 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.46 -43.08 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.85 97.58 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.746 -0.74 . . . . 1.0 111.26 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.1 -41.72 99.7 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.12 -42.95 99.63 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.139 -0.624 . . . . 1.0 111.816 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.42 -41.93 98.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.344 -0.543 . . . . 1.0 111.839 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.46 -42.45 99.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.711 -0.795 . . . . 1.0 110.234 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.66 HD11 HD12 ' B' ' 705' ' ' LEU . 3.5 mm? -64.52 -41.05 96.63 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.338 0.496 . . . . 1.0 112.338 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 20.3 m -62.14 -47.15 85.84 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.496 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 42.0 pt -63.09 -41.35 92.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.757 -0.777 . . . . 1.0 111.617 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -43.17 99.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.474 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.5 t -61.7 -45.0 99.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.87 0.367 . . . . 1.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 985' ' ' LEU . 93.0 mt -62.71 -41.5 99.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.49 -42.22 98.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 1.0 111.206 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.98 -42.03 94.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.773 0.32 . . . . 1.0 111.505 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.408 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.4 t90 -63.06 -43.29 99.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.47 -33.77 75.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.076 0.465 . . . . 1.0 111.587 -178.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.4 t -77.65 -3.07 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.81 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.88 9.63 71.06 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.41 -1.476 . . . . 1.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.06 -43.81 78.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.236 0.518 . . . . 1.0 109.652 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.6 m-85 -81.28 -18.69 44.99 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.22 177.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -73.95 -10.69 59.91 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.715 -1.194 . . . . 1.0 108.135 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -66.35 131.32 45.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.593 -0.843 . . . . 1.0 110.058 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -140.27 -46.82 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.441 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 723' ' ' ASP . 7.0 mtt180 39.67 72.66 0.95 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.741 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 122.762 2.308 . . . . 1.0 112.131 -179.827 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.77 -38.68 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 687' ' ' SER . . . . . 0.403 ' OG ' ' OE1' ' A' ' 960' ' ' GLU . 54.4 m 53.04 71.4 1.44 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.636 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.37 -35.98 85.95 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.198 2.599 . . . . 1.0 112.156 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.34 -43.01 99.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.844 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 690' ' ' CYS . . . . . 0.4 ' SG ' ' CD ' ' B' ' 691' ' ' PRO . 0.1 OUTLIER -76.62 174.89 5.0 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 179.924 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 691' ' ' PRO . . . . . 0.4 ' CD ' ' SG ' ' B' ' 690' ' ' CYS . 23.9 Cg_exo -60.56 143.34 99.43 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.143 1.896 . . . . 1.0 113.141 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.19 153.29 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.742 . . . . 1.0 111.269 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 693' ' ' ILE . . . . . 0.451 HD11 ' CZ2' ' A' ' 968' ' ' TRP . 86.8 mt -62.03 -43.85 98.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 1.0 112.284 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 694' ' ' LEU . . . . . 0.482 HD22 ' N ' ' B' ' 694' ' ' LEU . 3.9 mm? -62.78 -43.38 98.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.981 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.18 -45.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.328 . . . . 1.0 111.467 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.3 t -63.7 -44.75 98.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.067 0.461 . . . . 1.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.03 -43.16 99.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.781 -0.645 . . . . 1.0 112.05 -178.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.3 -42.35 96.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.1 0.476 . . . . 1.0 110.428 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 50.8 p -62.38 -41.37 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.57 -0.741 . . . . 1.0 112.871 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.45 -45.78 94.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.286 -0.565 . . . . 1.0 110.288 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.36 -39.6 94.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.565 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.24 98.0 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.002 -1.239 . . . . 1.0 110.002 177.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.76 89.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.403 0.621 . . . . 1.0 109.908 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -61.04 -41.8 90.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 118.479 -1.289 . . . . 1.0 109.053 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 705' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 980' ' ' LEU . 59.5 tp -59.36 -43.87 92.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.534 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.753 -0.779 . . . . 1.0 110.743 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.07 -44.16 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.94 -38.85 94.57 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 709' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 713' ' ' LEU . 85.7 mt -67.46 -38.19 84.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.957 1.095 . . . . 1.0 113.957 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 710' ' ' ALA . . . . . 0.667 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.97 -57.11 17.54 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.759 -177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 711' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.9 Cg_exo -55.5 -45.48 39.38 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.306 1.145 . . . . 1.0 111.448 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.308 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 713' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' B' ' 709' ' ' LEU . 33.5 mt -62.98 -41.08 99.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.784 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.18 -46.39 95.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.397 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 715' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 4.3 t90 -61.03 -49.36 77.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.648 178.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -45.83 91.17 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.786 -0.366 . . . . 1.0 111.037 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.1 -44.43 92.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.032 -0.667 . . . . 1.0 111.114 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.28 -43.42 97.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt -68.33 -40.93 83.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.579 -0.848 . . . . 1.0 109.964 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 720' ' ' THR . . . . . 0.469 HG22 ' NE ' ' B' ' 724' ' ' ARG . 94.6 m -59.15 -45.64 90.45 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.38 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 721' ' ' ILE . . . . . 0.521 ' CG1' HH21 ' B' ' 724' ' ' ARG . 93.7 mt -61.92 -43.14 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.622 -178.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -64.01 -38.43 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 178.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 723' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 997' ' ' ARG . 29.4 t70 -66.1 -44.55 84.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.03 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 724' ' ' ARG . . . . . 0.521 HH21 ' CG1' ' B' ' 721' ' ' ILE . 88.6 mtm180 -66.04 -39.21 89.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 110.616 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.5 133.61 49.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.536 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.389 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.553 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 114.857 1.429 . . . . 1.45 114.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.56 -58.15 8.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.356 -0.538 . . . . 0.90000000000000002 111.413 -177.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -56.55 -39.4 73.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.189 0.811 . . . . 3.1899999999999999 113.189 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.89 -45.88 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.116 -1.034 . . . . 0.81999999999999995 108.375 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.47 -44.09 97.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.349 -1.296 . . . . 1.6799999999999999 110.696 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 91.4 t -63.31 -45.36 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.604 0.24 . . . . 0.68999999999999995 111.441 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.44 92.54 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.838 -1.173 . . . . 0.23999999999999999 111.324 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.51 -44.84 99.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 121.043 -0.263 . . . . 0.28999999999999998 110.72 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.88 -42.07 95.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 1.1000000000000001 112.374 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.84 84.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.132 -0.556 . . . . 0.20000000000000001 112.014 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.24 99.36 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.528 -1.029 . . . . 0.14999999999999999 110.528 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.6 -40.84 89.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 120.767 -0.373 . . . . 1.6299999999999999 110.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.9 -43.19 99.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.857 -0.794 . . . . 1.5700000000000001 108.857 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.5 -41.86 95.18 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.518 -1.273 . . . . 1.51 109.752 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' B' ' 705' ' ' LEU . 60.3 mt -60.03 -38.77 83.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.843 -0.743 . . . . 1.3999999999999999 111.063 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -61.22 -47.71 84.85 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.646 -0.822 . . . . 0.60999999999999999 110.564 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.41 -42.8 95.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.341 -0.544 . . . . 1.3 110.63 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.0 -43.63 95.1 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.583 -0.447 . . . . 1.6100000000000001 110.891 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.3 t -62.32 -44.82 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.667 -0.413 . . . . 0.62 111.234 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.89 -43.29 99.2 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.76000000000000001 109.934 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.88 97.31 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.77 -0.372 . . . . 0.29999999999999999 111.743 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 44.6 mtt -64.0 -42.91 97.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 1.5900000000000001 110.472 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 17.1 t90 -63.48 -46.34 86.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.09 -0.708 . . . . 1.1699999999999999 109.09 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.18 -35.63 77.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.651 0.611 . . . . 0.78000000000000003 112.651 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 990' ' ' VAL . 71.5 t -78.04 -1.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.74 -0.784 . . . . 0.91000000000000003 108.965 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 74.36 5.2 71.58 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 108.18 -1.968 . . . . 0.35999999999999999 108.18 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.526 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -47.82 -44.93 29.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 120.024 1.912 . . . . 0.81000000000000005 110.444 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 114.361 -1.29 . . . . 1.26 110.545 178.569 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.44 -0.971 0 CA-C-O 121.545 0.688 . . . . 1.6000000000000001 110.074 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.73 -44.53 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.95999999999999996 111.865 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 69.3 mt -62.27 -41.94 98.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 1.29 110.428 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.49 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.72999999999999998 111.031 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 92.4 t -62.92 -45.65 98.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 1.04 110.009 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.71 -43.01 98.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.542 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.13 -41.59 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.83999999999999997 110.166 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 13.4 p -61.79 -42.59 99.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.319 -0.4 . . . . 0.27000000000000002 111.179 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.15 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 120.649 -0.421 . . . . 0.56999999999999995 109.926 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 88.1 mtp -60.79 -39.05 87.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.93000000000000005 109.9 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.11 -41.38 95.05 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.635 -0.986 . . . . 0.17999999999999999 110.635 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.07 89.12 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.954 0.407 . . . . 0.23999999999999999 110.021 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.85 -42.27 88.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 118.938 -1.105 . . . . 0.5 109.366 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.473 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.3 mt -59.11 -45.99 89.47 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.64 -0.255 . . . . 1.6899999999999999 110.599 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.29 -42.98 99.14 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.331 -0.548 . . . . 1.8100000000000001 110.561 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.63 -46.21 95.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.426 -0.51 . . . . 0.84999999999999998 110.863 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.19 -39.47 94.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.639 -0.791 . . . . 0.22 111.615 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.47 -28.68 62.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.676 1.362 . . . . 1.28 114.676 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.675 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -60.1 -54.86 51.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.969 0.804 . . . . 0.23000000000000001 111.405 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.5 Cg_exo -55.07 -44.9 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.513 1.475 . . . . 0.28999999999999998 111.333 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.59 -42.21 87.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 1.02 110.799 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.88 -41.91 99.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.886 -0.326 . . . . 1.04 111.092 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.91 -44.5 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 109.064 -0.717 . . . . 1.4299999999999999 109.064 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.81 -50.11 74.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.584 -0.525 . . . . 0.70999999999999996 109.584 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -59.84 -43.49 94.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 1.03 110.919 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 717' ' ' LEU . 19.4 tp -62.88 -47.51 83.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 1.8600000000000001 110.514 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.85 -41.9 96.76 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.789 -0.364 . . . . 0.68999999999999995 110.836 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -45.61 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 109.522 -0.547 . . . . 1.5900000000000001 109.522 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.7 m -55.01 -47.41 74.72 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.774 -0.77 . . . . 1.02 109.851 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 35.9 mt -64.96 -44.0 96.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.999 0.74 . . . . 1.3300000000000001 112.999 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 55.5 m80 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 108.452 -0.944 . . . . 1.3400000000000001 108.452 177.383 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.98 -52.23 61.36 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.47 0.544 . . . . 1.0 112.47 -176.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -58.41 -40.01 81.29 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.765 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.7 t -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 119.796 -0.762 . . . . 1.0 109.223 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.45 -42.93 99.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.678 -1.146 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.2 t -63.17 -45.15 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.638 0.256 . . . . 1.0 111.327 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.31 -38.95 96.54 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.728 -0.749 . . . . 1.0 111.273 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 65.6 t -62.24 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 121.078 -0.249 . . . . 1.0 110.503 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.18 -42.49 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.468 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.21 93.39 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.816 -0.707 . . . . 1.0 111.8 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.61 98.61 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.26 -41.7 99.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.743 -0.269 . . . . 1.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.89 -42.12 98.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.022 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.05 -40.94 95.54 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.152 -1.019 . . . . 1.0 109.764 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' B' ' 705' ' ' LEU . 87.8 mt -62.21 -39.0 91.33 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.367 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.5 m -63.0 -47.1 84.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.084 -0.647 . . . . 1.0 110.205 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.68 -42.5 94.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 120.919 -0.312 . . . . 1.0 111.14 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.62 -42.45 91.53 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.526 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.76 -44.29 99.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.143 0.497 . . . . 1.0 110.938 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.87 -41.43 95.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -63.38 -42.12 98.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.776 -0.77 . . . . 1.0 111.305 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.425 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.5 t90 -63.0 -43.05 99.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.41 -34.1 76.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.136 0.493 . . . . 1.0 111.349 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.9 t -77.14 -2.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.78 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.97 8.73 69.64 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.336 -1.505 . . . . 1.0 109.336 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.463 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.77 -45.18 78.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.294 -1.002 . . . . 1.0 108.294 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--N 1.33 -0.26 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.355 177.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.14 0.495 . . . . 1.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.3 mt -62.33 -43.56 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.626 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.16 -42.0 98.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.168 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 -45.19 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.796 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 700' ' ' VAL . 67.7 t -63.59 -45.27 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.0 110.664 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . 0.689 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.1 tt -62.64 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.449 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.77 -42.37 97.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.035 0.445 . . . . 1.0 110.346 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 52.1 p -62.22 -36.82 83.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 696' ' ' VAL . 68.1 t -63.99 -44.87 97.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.094 0.473 . . . . 1.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.0 mtp -61.54 -39.51 91.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.992 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.84 96.89 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.43 89.22 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.677 0.275 . . . . 1.0 110.51 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.9 mm -62.74 -43.08 98.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.025 -0.67 . . . . 1.0 109.451 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.5 mt -61.26 -44.16 97.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.298 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.1 -43.29 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.94 -44.24 97.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.523 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.35 -41.9 76.44 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.6 -36.17 81.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -57.84 11.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.4 0.519 . . . . 1.0 112.4 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 19.0 Cg_endo -60.35 -40.23 60.18 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.086 1.191 . . . . 1.0 111.901 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.17 -42.7 93.45 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.3 -41.82 98.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.63 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.295 -0.562 . . . . 1.0 109.652 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.861 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.8 t90 -62.37 -48.17 80.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.165 0.507 . . . . 1.0 109.863 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -61.03 -42.54 98.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.004 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.24 -44.49 95.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.5 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.76 -41.79 98.15 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.286 0.565 . . . . 1.0 110.346 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.861 HD11 ' NE1' ' B' ' 715' ' ' TRP . 95.8 mt -62.51 -46.96 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.165 -1.014 . . . . 1.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 89.2 m -57.74 -46.01 85.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.454 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.57 -43.4 96.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.186 -0.606 . . . . 1.0 110.852 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 64.9 m80 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 178.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 114.165 1.172 . . . . 1.0 114.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.72 -52.94 54.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.73 -176.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -58.09 -39.22 78.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.751 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.27 -45.22 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.629 0.728 . . . . 1.0 109.156 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.46 -42.86 99.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.645 -1.161 . . . . 1.0 110.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.28 -44.49 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.847 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.44 93.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.447 -0.882 . . . . 1.0 110.913 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.46 -46.03 97.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.804 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.24 -42.62 99.24 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.8 93.34 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.807 -0.711 . . . . 1.0 111.454 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.42 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -62.13 -42.49 99.73 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.07 -42.12 99.6 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.837 -0.214 . . . . 1.0 110.791 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.17 -41.27 98.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.196 -0.601 . . . . 1.0 109.9 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 705' ' ' LEU . 89.3 mt -61.97 -41.43 98.0 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.231 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.611 HD11 ' HA3' ' B' ' 708' ' ' GLY . 0.8 OUTLIER -61.17 -43.19 99.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.981 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.2 m -61.84 -47.02 86.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.601 -0.44 . . . . 1.0 111.219 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.29 -43.92 98.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.605 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.33 -43.27 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.1 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.351 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.21 -42.31 99.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.49 -42.47 99.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.321 -0.552 . . . . 1.0 111.566 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 65.7 mtt -65.21 -42.39 93.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 1.0 111.37 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.72 -43.69 95.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.232 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -34.06 76.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.07 0.462 . . . . 1.0 111.893 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.4 t -77.28 -1.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.535 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 69.83 10.44 64.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.79 -1.724 . . . . 1.0 108.79 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -44.43 72.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.8 m-85 . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 119.816 -0.754 . . . . 1.0 110.705 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.959 0.409 . . . . 1.0 110.328 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.69 -43.68 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 1.0 112.305 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.42 -42.15 99.22 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.497 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.35 -45.2 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.4 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.6 t -63.79 -44.69 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.019 0.438 . . . . 1.0 110.453 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.04 -43.43 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.0 mt -64.14 -42.27 96.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.117 0.484 . . . . 1.0 110.663 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 48.6 p -62.27 -39.52 93.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 1.0 112.203 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.42 -45.87 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 1.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.49 -39.38 94.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.797 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.14 97.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.04 90.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.02 0.438 . . . . 1.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.443 HG22 HD23 ' A' ' 980' ' ' LEU . 27.2 mm -60.84 -42.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.329 -0.948 . . . . 1.0 108.82 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 979' ' ' LEU . 83.4 mt -61.2 -44.18 97.69 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.831 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -44.02 95.78 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.136 -0.626 . . . . 1.0 110.227 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.26 98.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.581 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 980' ' ' LEU . . . -67.51 -41.89 89.65 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.43 -37.82 83.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.33 -56.58 20.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 120.187 -0.605 . . . . 1.0 112.313 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.4 Cg_exo -53.83 -44.35 49.97 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.192 1.261 . . . . 1.0 111.734 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.482 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -64.73 -42.46 95.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.852 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.96 -39.75 94.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 1.0 110.173 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -46.93 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.461 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.86 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.2 t90 -63.43 -47.29 82.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.282 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -44.12 95.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.816 0.302 . . . . 1.0 111.816 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.29 -42.09 99.04 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.473 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.0 -41.61 98.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.86 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.2 mt -63.23 -45.05 99.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.213 -0.595 . . . . 1.0 110.234 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.3 m -60.35 -47.14 87.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.864 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.53 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.388 . . . . 1.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 7.6 m80 . . . . . 0 C--N 1.325 -0.496 0 C-N-CA 120.183 -0.607 . . . . 1.0 109.519 179.516 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.3 mt . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 113.715 1.006 . . . . 1.0 113.715 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.439 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.43 -51.84 66.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.699 -0.801 . . . . 1.0 111.181 -176.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -57.38 -37.9 73.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.244 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 68.6 t -64.11 -44.74 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.24 -42.49 99.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.024 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.1 t -63.27 -44.76 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.0 110.948 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.56 95.73 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.6 t -62.11 -45.2 99.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.345 -0.242 . . . . 1.0 110.345 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.03 -42.49 99.79 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.284 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.63 96.1 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.768 -0.73 . . . . 1.0 111.298 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -41.83 99.61 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.93 -40.94 99.15 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.746 -0.267 . . . . 1.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.37 -42.11 99.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.202 -0.599 . . . . 1.0 110.582 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.05 -41.16 97.84 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.8 mt -61.52 -41.19 96.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 1.0 110.677 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.7 m -61.5 -47.13 87.02 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.471 -0.492 . . . . 1.0 111.469 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.17 -44.23 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.64 -42.44 98.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.134 -0.626 . . . . 1.0 111.468 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 980' ' ' LEU . 62.2 t -62.07 -45.65 98.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.881 -0.327 . . . . 1.0 111.105 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.14 -42.11 99.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.35 -42.52 99.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.55 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.1 mtt -65.17 -42.38 93.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 111.355 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.427 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.9 t90 -63.12 -43.42 98.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 1.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.57 -34.7 77.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.118 0.485 . . . . 1.0 111.417 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 986' ' ' ALA . 52.1 t -76.96 -3.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 1.0 109.856 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.68 73.28 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.402 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.26 -45.45 76.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.277 -1.008 . . . . 1.0 108.277 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.408 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.5 m-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.354 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.804 0.335 . . . . 1.0 111.594 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.06 -43.69 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.335 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . 0.555 ' O ' HD13 ' B' ' 698' ' ' LEU . 98.0 mt -62.97 -42.05 99.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.951 -0.299 . . . . 1.0 110.977 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.09 -44.95 99.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.969 0.414 . . . . 1.0 111.053 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.2 t -64.19 -43.79 97.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.404 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.47 -43.4 98.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.751 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . 0.555 HD13 ' O ' ' B' ' 694' ' ' LEU . 9.3 mp -65.1 -41.34 95.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.19 0.519 . . . . 1.0 110.349 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 30.7 p -62.37 -37.11 84.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.165 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.43 -44.9 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.353 -0.539 . . . . 1.0 109.916 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.7 mtp -61.92 -40.0 93.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.197 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.04 -41.51 97.17 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.27 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 1.0 110.409 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 980' ' ' LEU . 27.3 mm -62.95 -43.18 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.447 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.544 ' HA ' HD21 ' A' ' 980' ' ' LEU . 52.5 tp -59.5 -47.7 84.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.331 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.96 -42.5 99.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.206 -0.598 . . . . 1.0 111.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.56 -44.38 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.726 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.33 94.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 713' ' ' LEU . 86.2 mt -67.02 -37.56 84.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.65 -57.23 16.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.008 -0.677 . . . . 1.0 112.092 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 35.4 Cg_exo -55.24 -45.14 42.61 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.917 1.078 . . . . 1.0 111.331 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.35 -41.87 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.448 -0.797 . . . . 1.0 110.86 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 709' ' ' LEU . 35.6 mt -62.8 -41.43 99.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.961 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.5 -44.34 98.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.429 ' HE1' HD12 ' B' ' 719' ' ' ILE . 5.8 t90 -63.04 -48.6 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 1.0 109.803 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.68 -45.73 93.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.555 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.81 -46.14 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.036 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.35 -43.11 98.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.617 0.599 . . . . 1.0 112.617 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.429 HD12 ' HE1' ' B' ' 715' ' ' TRP . 6.9 tt -67.19 -41.37 86.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.896 -0.722 . . . . 1.0 109.924 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 88.8 m -60.66 -44.83 95.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.819 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.29 -43.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.04 -0.664 . . . . 1.0 109.625 178.694 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -61.94 -49.84 74.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 119.573 -0.851 . . . . 1.0 111.334 -177.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -57.72 -39.12 76.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.279 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.6 t -64.19 -45.28 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 119.826 -0.749 . . . . 1.0 109.083 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.59 -42.17 99.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.652 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.1 t -63.8 -44.63 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.821 0.344 . . . . 1.0 110.86 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.97 96.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.4 t -61.98 -45.19 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 121.158 -0.217 . . . . 1.0 110.529 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.22 -42.5 99.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.806 0.336 . . . . 1.0 111.479 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.49 -43.54 94.55 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.23 -43.02 99.69 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.45 -41.95 98.65 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.756 -0.261 . . . . 1.0 110.951 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.14 -42.11 98.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 1.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.51 -41.25 97.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.859 -0.736 . . . . 1.0 109.492 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' B' ' 705' ' ' LEU . 85.7 mt -62.05 -41.95 98.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.304 -0.559 . . . . 1.0 111.238 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.1 m -61.72 -47.4 85.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.896 -0.321 . . . . 1.0 111.211 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.32 -43.76 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.554 -0.459 . . . . 1.0 111.326 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.71 -43.05 97.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.7 t -61.89 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 1.0 111.273 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.31 -42.56 99.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.735 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.98 -45.28 94.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.022 0.378 . . . . 1.0 112.022 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.66 -42.45 91.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.411 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -64.42 -41.92 96.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.869 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.59 -33.48 75.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.24 0.543 . . . . 1.0 110.44 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 986' ' ' ALA . 62.0 t -77.31 -2.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.261 -0.882 . . . . 1.0 109.95 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.85 8.21 72.31 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.273 -1.531 . . . . 1.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -56.11 -45.95 79.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.664 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 37.8 m-85 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.76 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 121.949 0.881 . . . . 1.0 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.13 -44.73 99.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.199 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . 0.458 HD22 ' N ' ' B' ' 694' ' ' LEU . 4.1 mm? -61.17 -42.05 97.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.948 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.23 -43.9 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.647 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.496 ' O ' HG23 ' B' ' 700' ' ' VAL . 69.4 t -65.31 -43.71 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 1.0 110.799 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.95 -42.7 99.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.699 0.761 . . . . 1.0 111.637 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.81 -42.71 94.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.554 0.692 . . . . 1.0 110.697 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 58.0 p -61.27 -37.67 83.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 696' ' ' VAL . 74.6 t -63.75 -45.32 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.8 mtp -62.07 -39.91 94.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.408 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.31 95.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.36 87.59 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.755 0.312 . . . . 1.0 110.378 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 980' ' ' LEU . 27.0 mm -63.01 -42.78 97.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.568 ' HA ' HD21 ' A' ' 980' ' ' LEU . 53.4 tp -60.65 -45.66 93.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.493 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.11 -42.53 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.377 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.68 -43.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.65 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.67 -38.71 93.41 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.533 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.93 -38.23 85.79 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.21 -56.96 18.83 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.242 -0.583 . . . . 1.0 112.271 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.9 Cg_exo -54.67 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.067 1.178 . . . . 1.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.664 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 97.0 mt -65.23 -41.89 93.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.905 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.18 -41.71 98.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.121 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.44 -44.15 98.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.849 ' NE1' HD11 ' B' ' 719' ' ' ILE . 7.1 t90 -60.89 -48.91 79.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.332 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.38 -42.87 96.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.573 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.1 -44.06 97.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.521 -0.471 . . . . 1.0 110.373 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.36 -42.11 99.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.269 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.849 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.5 mt -62.85 -44.68 99.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.953 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.6 m -59.64 -46.69 88.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.971 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.59 -43.82 98.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 1.0 112.23 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.1 m80 . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.451 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 113.904 1.075 . . . . 1.0 113.904 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.456 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.98 -52.36 50.97 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.459 -0.496 . . . . 1.0 111.532 -176.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -57.62 -39.21 76.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.349 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.1 -45.5 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.65 -41.8 99.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.414 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.8 t -63.14 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.887 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.85 96.52 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.87 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.298 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.32 -43.22 98.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.15 91.58 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.894 -0.669 . . . . 1.0 111.949 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.405 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.78 -41.36 99.61 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 120.365 -0.922 . . . . 1.0 110.804 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.5 OUTLIER -62.86 -41.44 99.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.82 -41.58 99.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.052 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.35 -41.17 98.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.353 -0.939 . . . . 1.0 109.641 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.0 mt -61.96 -41.31 97.86 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.007 0.908 . . . . 1.0 110.972 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 37.0 m -61.37 -46.51 89.9 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 118.596 -1.242 . . . . 1.0 111.018 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.83 -42.62 97.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.042 -0.663 . . . . 1.0 110.555 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 983' ' ' LEU . 75.1 mt -64.03 -41.81 97.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.363 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.8 t -63.65 -44.87 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 123.328 0.393 . . . . 1.0 110.6 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.89 -42.03 97.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.27 99.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.884 0.849 . . . . 1.0 111.437 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.86 -40.98 97.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -64.6 -45.44 86.96 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.349 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.88 -33.55 74.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 10.9 m -85.57 0.87 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.82 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 74.19 15.07 80.15 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.347 -1.297 . . . . 1.0 110.967 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.512 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.88 -45.18 67.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.565 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 45.5 m-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.564 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.795 0.331 . . . . 1.0 111.013 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.58 -43.58 98.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.98 -41.7 99.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.053 -0.259 . . . . 1.0 111.137 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.8 -46.41 96.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.415 ' O ' HG23 ' B' ' 700' ' ' VAL . 18.9 m -65.54 -40.38 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.134 -0.627 . . . . 1.0 110.235 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.98 -43.97 97.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.727 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.103 0.478 . . . . 1.0 110.695 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.27 -38.1 88.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.902 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.0 t -63.48 -45.14 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.125 0.488 . . . . 1.0 110.388 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.11 -38.98 90.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.22 -41.6 96.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.279 -1.129 . . . . 1.0 110.279 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.89 86.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 1.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.405 HG21 ' C ' ' A' ' 976' ' ' GLY . 26.6 mm -62.61 -43.07 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.376 -0.601 . . . . 1.0 109.376 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.503 ' HA ' HD21 ' A' ' 980' ' ' LEU . 86.8 mt -61.16 -44.46 97.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.332 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.82 -43.33 99.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.908 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.64 98.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.64 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.13 88.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.23 -38.07 84.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.769 1.025 . . . . 1.0 113.769 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.34 -57.01 18.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.024 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 33.0 Cg_exo -54.65 -44.65 47.57 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.14 1.227 . . . . 1.0 111.604 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.93 -41.64 95.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.585 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.59 -41.46 98.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.196 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.12 -44.22 99.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.565 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.6 t90 -62.36 -48.77 78.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.595 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.5 OUTLIER -60.53 -45.02 95.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.446 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.58 -42.34 98.31 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.988 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.98 -42.46 99.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.706 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 3.9 mm -63.84 -44.26 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.19 -0.604 . . . . 1.0 109.709 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.6 m -60.37 -45.78 92.3 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.81 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.08 -43.69 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.868 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.8 m80 . . . . . 0 C--N 1.331 -0.206 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.686 178.538 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 114.141 1.164 . . . . 1.0 114.141 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.432 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.26 -52.45 52.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.694 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -57.75 -37.76 74.19 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.622 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.3 t -64.1 -44.74 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.45 -42.38 99.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.706 -1.134 . . . . 1.0 110.173 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.6 t -63.44 -44.8 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.071 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.11 -38.33 95.4 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.5 t -61.86 -45.07 99.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.09 -42.68 99.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.811 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.87 -43.26 96.32 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.319 -0.713 . . . . 1.0 111.319 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.67 99.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.45 -42.05 98.65 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.523 -0.398 . . . . 1.0 111.135 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 978' ' ' LEU . 85.5 mt -62.51 -41.33 98.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.196 -0.601 . . . . 1.0 110.726 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.9 -41.49 97.97 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.673 -0.811 . . . . 1.0 109.797 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 984' ' ' VAL . 87.0 mt -62.21 -41.53 98.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.359 -0.536 . . . . 1.0 111.176 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.88 -46.97 87.11 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.542 -0.463 . . . . 1.0 111.16 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.05 -43.66 99.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.27 -42.46 99.14 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.733 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.46 -45.57 98.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.683 0.278 . . . . 1.0 111.123 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.06 -42.24 99.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.284 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.652 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.09 -41.52 98.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.985 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.86 -41.98 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.878 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 11.0 t90 -64.11 -43.82 94.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.297 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.31 -34.3 76.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.052 0.454 . . . . 1.0 111.465 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.0 t -77.32 -1.62 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.57 11.59 68.85 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -45.06 70.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.51 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 62.4 m-85 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.231 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.297 0.57 . . . . 1.0 110.767 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.9 -41.51 89.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.516 -0.766 . . . . 1.0 111.192 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . 0.528 ' N ' HD12 ' B' ' 694' ' ' LEU . 11.1 mp -63.68 -41.43 98.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 1.0 110.791 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.27 -45.28 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.354 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 700' ' ' VAL . 77.3 t -64.04 -45.43 96.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.078 0.466 . . . . 1.0 110.707 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.71 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.873 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.14 -42.67 96.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 1.0 110.591 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.6 p -61.85 -38.95 90.16 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.5 t -64.67 -45.41 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.231 0.539 . . . . 1.0 110.094 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . 0.435 ' O ' HD13 ' B' ' 705' ' ' LEU . 86.3 mtp -62.61 -40.28 96.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.32 -41.99 97.95 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.501 -1.04 . . . . 1.0 110.501 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.46 86.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.957 0.408 . . . . 1.0 110.174 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.496 HG22 HD11 ' A' ' 980' ' ' LEU . 26.8 mm -62.17 -42.31 94.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.765 -0.774 . . . . 1.0 109.576 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.0 mp -61.73 -44.05 97.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.617 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.06 -43.62 98.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.751 -0.779 . . . . 1.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.07 -47.92 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 1.0 111.673 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . 0.413 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -69.47 -39.22 80.07 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.862 -0.685 . . . . 1.0 111.546 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.13 -37.4 81.05 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.526 0.935 . . . . 1.0 113.526 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.17 -56.32 23.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.955 -176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.4 Cg_exo -53.29 -43.07 60.43 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.125 1.217 . . . . 1.0 112.187 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.488 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.28 -41.49 94.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.218 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.07 -41.34 99.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.38 -43.98 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.684 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.6 t90 -60.77 -48.49 81.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.314 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.36 94.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.482 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.1 -45.14 94.8 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.431 -0.507 . . . . 1.0 110.645 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . 0.518 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 87.0 mt -61.5 -42.28 98.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.683 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.684 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.0 mt -63.42 -44.11 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.513 -0.475 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -59.84 -46.61 88.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.834 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.03 -43.04 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.966 -0.294 . . . . 1.0 111.621 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 47.1 m80 . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.789 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.44 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.76 -52.2 50.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.384 -176.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -57.67 -38.59 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.572 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.1 t -64.12 -45.35 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.098 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.57 -42.69 99.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.303 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.9 t -63.28 -44.72 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.04 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.52 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.308 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.2 t -61.55 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 1.0 110.225 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.32 -42.63 99.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.769 0.319 . . . . 1.0 111.644 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.39 -45.41 90.61 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.49 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.97 -43.03 99.74 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.15 -41.89 99.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.806 -0.232 . . . . 1.0 110.518 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.11 -41.97 98.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.535 -0.466 . . . . 1.0 109.78 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.7 -41.55 97.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.756 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.4 mt -61.87 -41.65 98.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.677 -0.409 . . . . 1.0 111.074 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.1 m -61.46 -46.98 87.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.952 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.12 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.155 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.0 -43.06 99.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.645 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 980' ' ' LEU . 69.9 t -61.79 -45.75 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.708 0.289 . . . . 1.0 111.028 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.28 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.52 -42.97 99.86 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.399 -0.52 . . . . 1.0 111.226 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.72 -42.75 95.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.877 0.37 . . . . 1.0 111.476 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.432 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.7 t90 -63.25 -43.55 97.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.23 -35.38 78.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.007 0.432 . . . . 1.0 111.569 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 986' ' ' ALA . 59.5 t -77.53 -2.57 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.441 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.33 10.87 70.73 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.175 -1.57 . . . . 1.0 109.175 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -45.23 73.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.409 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.0 m-85 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.786 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 1.0 110.623 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.0 mt -62.15 -43.66 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 1.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . 0.513 HD12 ' N ' ' B' ' 694' ' ' LEU . 11.1 mp -62.39 -42.14 99.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.249 -0.58 . . . . 1.0 110.399 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.43 -45.07 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.419 . . . . 1.0 110.604 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' HG23 ' B' ' 700' ' ' VAL . 61.2 t -63.99 -44.22 97.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.07 -43.52 98.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.248 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.41 -42.4 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.0 110.869 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 45.1 p -62.45 -37.45 85.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.751 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.2 t -63.64 -44.9 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 1.0 110.651 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 89.9 mtp -62.97 -39.09 93.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.907 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.59 -42.2 95.69 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.6 84.36 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.808 0.337 . . . . 1.0 111.02 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.49 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.5 mm -60.8 -42.4 92.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.528 -0.915 . . . . 1.0 108.528 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 980' ' ' LEU . 95.4 mt -59.64 -45.71 91.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.895 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . 0.419 ' N ' HD12 ' B' ' 706' ' ' LEU . 11.1 mp -62.92 -42.31 99.75 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.884 -0.726 . . . . 1.0 111.481 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . 0.407 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 31.7 mm -63.69 -45.61 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.803 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.77 -41.02 84.74 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.722 -0.752 . . . . 1.0 111.448 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.49 -37.8 85.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.99 -57.13 19.27 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.201 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 43.9 Cg_exo -53.85 -43.67 55.97 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.085 1.19 . . . . 1.0 111.337 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.28 -41.82 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.758 -0.656 . . . . 1.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.86 -41.44 99.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.928 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.75 -44.22 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.409 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.0 t90 -62.36 -48.07 81.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.644 ' O ' HG23 ' B' ' 720' ' ' THR . 0.1 OUTLIER -59.45 -44.61 92.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.16 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' B' ' 720' ' ' THR . 50.7 tp -64.03 -45.54 88.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.258 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.99 -43.24 99.32 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.59 -40.88 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.483 -0.887 . . . . 1.0 110.27 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . 0.644 HG23 ' O ' ' B' ' 716' ' ' LYS . 40.6 p -57.72 -44.34 85.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.319 -0.553 . . . . 1.0 110.649 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.38 -43.35 98.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.669 -0.413 . . . . 1.0 111.268 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 65.9 m80 . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.006 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 113.588 0.959 . . . . 1.0 113.588 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.469 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -50.39 -51.48 45.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.261 -0.575 . . . . 1.0 111.074 -176.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -57.14 -37.84 72.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.254 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.39 -45.0 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 1.0 109.223 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.75 -41.68 99.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.744 -1.117 . . . . 1.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.9 t -63.3 -44.3 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.543 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.02 -39.73 96.07 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.86 -45.78 97.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.606 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.31 -42.78 99.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.5 -46.25 78.68 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.029 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.75 -42.17 99.33 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.649 -0.981 . . . . 1.0 110.649 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.74 -40.86 97.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.939 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.99 -42.25 98.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.18 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.0 mp -61.5 -40.78 95.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 119.058 -1.057 . . . . 1.0 109.76 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 705' ' ' LEU . 89.6 mt -60.88 -41.31 95.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.281 -0.568 . . . . 1.0 110.508 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.4 m -60.96 -46.76 89.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.462 0.648 . . . . 1.0 110.629 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -44.13 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 119.479 -0.888 . . . . 1.0 111.996 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.27 -41.76 99.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.315 -0.954 . . . . 1.0 111.264 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.1 t -62.86 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.46 -41.7 96.37 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.369 -0.532 . . . . 1.0 110.658 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.88 -42.12 98.68 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.036 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.5 mtt -65.28 -42.41 93.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.137 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.431 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -64.26 -42.94 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.889 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.62 -34.5 77.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.117 0.484 . . . . 1.0 111.331 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.05 -1.91 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.678 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.66 8.82 68.42 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.113 -1.595 . . . . 1.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -56.05 -44.24 78.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 117.233 0.516 . . . . 1.0 109.785 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.495 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 36.7 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.492 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.035 0.445 . . . . 1.0 110.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.28 -43.49 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.34 -42.27 99.25 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.43 -0.508 . . . . 1.0 109.978 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.0 -44.81 99.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.941 0.4 . . . . 1.0 110.189 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.8 t -63.39 -44.31 98.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.24 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.63 -43.92 97.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.92 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.44 -41.89 96.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.949 0.404 . . . . 1.0 110.661 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 44.7 p -62.41 -37.91 87.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.5 t -64.06 -44.77 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.008 0.432 . . . . 1.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 53.6 mtt -63.19 -39.06 93.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.729 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.99 -42.23 92.75 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.32 94.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.225 0.536 . . . . 1.0 110.987 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 980' ' ' LEU . 23.8 mm -60.0 -42.18 88.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.553 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.6 mt -58.94 -44.62 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.338 0.399 . . . . 1.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.35 -41.72 98.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.76 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.04 -45.17 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.374 -0.531 . . . . 1.0 111.188 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.35 -39.73 87.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.526 -0.845 . . . . 1.0 111.117 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.73 -37.88 85.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.44 -56.38 25.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.547 -0.461 . . . . 1.0 112.056 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.8 Cg_exo -53.86 -43.25 59.74 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.097 1.198 . . . . 1.0 111.379 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.31 -41.21 90.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.169 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 37.7 mt -63.05 -42.37 99.71 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 41.5 pt -66.28 -41.75 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.005 -0.678 . . . . 1.0 110.046 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -59.92 -48.84 80.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 110.109 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -42.37 98.44 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.248 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.36 -44.0 96.04 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.38 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.592 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -43.12 95.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.31 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.0 m -59.07 -45.8 89.88 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 119.702 -0.799 . . . . 1.0 110.612 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.79 -43.26 97.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.975 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.7 m80 . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.78 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.6 mt . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -71.47 -55.67 7.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.379 -177.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . 0.65 ' CE2' HD12 ' B' ' 693' ' ' ILE . 94.5 m95 -57.64 -40.23 78.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 119.347 -0.359 . . . . 1.0 111.814 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.44 -46.2 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.135 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.86 -43.37 98.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.056 -0.974 . . . . 1.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.1 t -62.45 -44.3 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.71 -0.223 . . . . 1.0 110.747 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.11 92.71 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.188 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.77 -46.36 96.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.726 -0.39 . . . . 1.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.43 -43.15 98.27 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.592 0.589 . . . . 1.0 112.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.4 -45.24 91.28 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.921 -0.657 . . . . 1.0 111.734 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.415 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.87 -43.01 99.79 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.75 -41.8 99.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.615 -0.344 . . . . 1.0 110.632 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.26 -42.38 99.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.583 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.27 -40.33 89.97 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.754 -1.178 . . . . 1.0 109.134 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.5 mt -62.59 -41.52 99.0 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.645 -0.822 . . . . 1.0 112.075 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.96 -47.02 86.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.706 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 43.6 pt -64.74 -41.95 93.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.877 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.99 -42.83 99.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.1 t -62.22 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 121.103 -0.239 . . . . 1.0 111.179 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.32 -42.26 98.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.308 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.39 -42.89 99.77 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.746 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.6 mtp -65.37 -42.35 92.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 1.0 111.252 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.44 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.3 t90 -62.53 -42.5 99.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.83 -33.44 74.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.167 0.508 . . . . 1.0 110.975 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -77.45 -2.97 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.444 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.28 10.1 73.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.513 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.48 -45.25 77.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 -177.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.573 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 49.7 m-85 . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 120.16 -0.616 . . . . 1.0 110.49 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 109.911 -0.404 . . . . 1.0 109.911 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 968' ' ' TRP . 44.8 pt -62.66 -41.85 93.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.994 -0.548 . . . . 1.0 112.132 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.16 -42.55 99.37 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.4 t -62.32 -44.84 99.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.133 0.492 . . . . 1.0 110.266 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.413 ' O ' HG23 ' B' ' 700' ' ' VAL . 75.6 t -63.23 -43.74 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.642 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . 0.519 HD22 ' CE3' ' A' ' 968' ' ' TRP . 45.8 tp -61.33 -44.03 97.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.782 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.16 -42.42 96.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.048 0.452 . . . . 1.0 110.686 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 46.1 p -62.21 -39.05 91.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.3 t -63.58 -44.89 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.119 0.485 . . . . 1.0 110.8 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.87 -39.35 94.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.33 95.47 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.62 80.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 980' ' ' LEU . 27.1 mm -61.84 -42.46 94.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.436 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.662 ' O ' HD13 ' B' ' 709' ' ' LEU . 92.0 mt -61.01 -45.67 93.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.665 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 -42.15 99.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.867 -0.733 . . . . 1.0 111.126 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -45.22 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.965 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.26 64.42 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.869 -0.681 . . . . 1.0 111.984 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 705' ' ' LEU . 10.4 mp -68.66 -37.8 79.91 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.19 -55.58 32.68 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.303 -0.559 . . . . 1.0 112.24 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.1 Cg_exo -54.34 -43.14 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.283 1.322 . . . . 1.0 112.424 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.564 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 92.8 mt -64.89 -43.16 93.81 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.343 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . 0.438 HD13 ' O ' ' B' ' 709' ' ' LEU . 10.3 mp -63.75 -40.66 97.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.413 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.15 -44.48 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.573 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.5 t90 -63.43 -48.61 77.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 1.0 110.044 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.614 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . 0.418 ' O ' ' OG1' ' B' ' 720' ' ' THR . 53.3 tp -62.27 -44.36 96.7 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.583 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.81 -42.61 99.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.856 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.25 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 22.6 p -59.08 -44.19 91.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.608 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.89 -44.43 98.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.504 -0.878 . . . . 1.0 111.203 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.0 m80 . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.27 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 114.221 1.193 . . . . 1.0 114.221 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.41 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.14 -53.07 47.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 1.0 111.691 -176.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -57.09 -39.05 74.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.586 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.75 -45.29 97.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.702 -0.799 . . . . 1.0 109.48 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.061 -0.972 . . . . 1.0 110.479 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.4 t -63.29 -45.12 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.616 -0.266 . . . . 1.0 111.158 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.64 96.07 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.82 -46.0 97.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.506 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.13 -42.78 99.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.791 0.329 . . . . 1.0 111.848 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.01 -46.82 78.62 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.005 -0.617 . . . . 1.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.426 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -60.09 -42.04 98.31 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.65 -41.43 98.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.97 0.414 . . . . 1.0 110.502 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.88 -42.9 99.62 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.654 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.2 mp -61.32 -40.85 95.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.623 -0.831 . . . . 1.0 109.897 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.0 mt -61.91 -40.45 95.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.181 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 99.3 m -60.85 -48.2 82.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.209 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -44.15 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 120.275 -0.57 . . . . 1.0 111.769 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.68 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 980' ' ' LEU . 79.1 t -61.9 -46.18 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 123.158 0.286 . . . . 1.0 111.124 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.26 -42.42 99.16 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.34 -43.85 97.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.752 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.2 mtt -64.52 -42.47 95.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.263 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -62.97 -44.37 96.24 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -60.95 -32.66 72.18 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.876 -0.515 . . . . 1.0 111.628 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.9 -1.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 68.54 12.81 64.6 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.828 -1.709 . . . . 1.0 108.828 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.51 -44.1 68.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.613 -1.254 . . . . 1.0 107.613 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.456 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 59.2 m-85 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.553 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.963 0.411 . . . . 1.0 110.352 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.51 -43.63 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.112 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.16 -46.19 97.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.423 ' O ' HG23 ' B' ' 700' ' ' VAL . 22.3 m -65.47 -40.68 89.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.945 -0.702 . . . . 1.0 110.597 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.92 -43.74 98.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.535 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.12 -42.19 96.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.197 0.522 . . . . 1.0 110.73 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 37.5 p -62.91 -38.89 92.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.003 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 696' ' ' VAL . 77.4 t -63.78 -45.27 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.413 -0.515 . . . . 1.0 110.306 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.57 -39.24 93.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.69 97.97 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.91 86.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.831 0.348 . . . . 1.0 110.534 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 976' ' ' GLY . 25.8 mm -62.65 -42.45 96.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.475 ' HA ' HD21 ' A' ' 980' ' ' LEU . 87.3 mt -61.52 -43.8 98.21 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.427 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.82 -43.07 99.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.89 -44.33 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.691 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.95 -40.4 73.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.917 -0.658 . . . . 1.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 80.5 mt -66.71 -38.14 86.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.86 -56.96 20.0 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.909 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.3 Cg_exo -54.09 -44.97 44.52 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.908 1.072 . . . . 1.0 111.774 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.27 -41.77 93.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.595 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.58 -41.46 98.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -63.77 -44.1 98.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.408 -0.59 . . . . 1.0 109.408 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.887 ' NE1' HD11 ' B' ' 719' ' ' ILE . 10.4 t90 -62.36 -48.53 79.38 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -43.95 97.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.559 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.97 -42.77 99.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.89 -42.12 98.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.509 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.887 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.1 mt -63.9 -44.71 98.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.057 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 96.7 m -59.51 -46.52 88.6 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.779 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.73 -43.58 98.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.163 0.506 . . . . 1.0 110.659 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 8.0 m80 . . . . . 0 N--CA 1.447 -0.606 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.927 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.458 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.6 -52.04 50.73 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.456 -0.497 . . . . 1.0 111.723 -176.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -57.96 -38.58 76.27 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 121.138 -0.225 . . . . 1.0 111.53 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.2 -45.05 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.49 -42.79 99.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.546 -1.206 . . . . 1.0 110.405 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.86 -44.71 99.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.205 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.55 93.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.614 -0.803 . . . . 1.0 111.163 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.92 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.765 -0.256 . . . . 1.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.96 -41.99 99.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.934 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.57 -43.84 93.85 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.785 -0.721 . . . . 1.0 111.304 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.78 -42.58 99.66 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.4 tp -63.84 -42.86 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.944 0.372 . . . . 1.0 111.582 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.34 -42.57 99.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.875 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.7 -41.3 97.42 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.904 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.723 HD21 HD23 ' B' ' 705' ' ' LEU . 1.4 mm? -62.76 -41.03 99.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.036 -0.266 . . . . 1.0 111.536 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 17.9 m -60.52 -45.81 92.47 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.625 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.85 -43.92 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.646 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.89 -44.32 93.38 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.18 -40.62 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.817 -0.753 . . . . 1.0 111.027 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.0 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.56 -42.04 99.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.513 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.64 -42.06 91.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.052 0.453 . . . . 1.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -64.05 -42.4 97.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.752 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.12 -33.46 75.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.032 0.444 . . . . 1.0 111.291 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.5 t -77.27 -0.42 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.476 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.67 10.14 66.68 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -44.33 65.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.733 -1.21 . . . . 1.0 107.733 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.502 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 57.6 m-85 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.428 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.87 0.366 . . . . 1.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.28 -43.69 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.035 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 694' ' ' LEU . 11.1 mp -62.36 -41.98 99.03 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -45.32 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.743 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.1 t -63.55 -44.96 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 1.0 110.707 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.41 -43.01 99.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.644 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.92 -42.28 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 1.0 110.564 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 55.3 p -62.2 -40.05 94.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 696' ' ' VAL . 71.4 t -62.69 -45.59 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.729 0.299 . . . . 1.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.5 mtp -63.57 -39.43 94.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.33 99.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.989 -1.244 . . . . 1.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.09 -36.57 80.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.031 0.443 . . . . 1.0 110.184 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.406 HG21 ' C ' ' A' ' 976' ' ' GLY . 31.7 mm -60.97 -41.88 90.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.034 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.723 HD23 HD21 ' A' ' 980' ' ' LEU . 81.4 mt -60.56 -45.81 92.54 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.943 -0.703 . . . . 1.0 110.814 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.08 -42.91 99.75 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.276 -0.57 . . . . 1.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.2 -44.63 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.269 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.77 -40.57 75.66 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.39 -38.16 84.27 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.711 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.25 -56.77 20.84 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.908 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.6 Cg_exo -54.71 -45.3 42.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.174 1.249 . . . . 1.0 111.455 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.09 -41.6 90.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.188 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.08 -41.5 99.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.5 -44.27 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.854 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.5 t90 -62.3 -48.29 80.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.794 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -44.09 96.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.71 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.88 -43.2 99.44 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.47 -42.13 98.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.854 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.3 mt -63.56 -44.06 98.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.095 -0.642 . . . . 1.0 109.511 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.8 m -60.26 -47.44 85.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.795 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.18 -43.51 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.175 -0.61 . . . . 1.0 111.47 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.7 m80 . . . . . 0 C--N 1.328 -0.365 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 178.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.77 -52.24 50.32 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.418 -0.513 . . . . 1.0 111.615 -176.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -57.74 -37.94 74.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.963 -0.295 . . . . 1.0 111.511 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 973' ' ' VAL . 72.5 t -63.97 -44.72 97.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.39 -41.78 98.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.695 -1.139 . . . . 1.0 110.211 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.2 t -63.28 -45.08 99.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.114 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.25 -38.64 95.99 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.1 t -62.03 -45.17 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 121.167 -0.213 . . . . 1.0 110.492 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.28 -42.31 99.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.73 0.3 . . . . 1.0 111.535 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . 0.402 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -65.35 -44.43 93.46 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.323 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.464 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.0 -41.85 99.59 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.93 -41.38 99.46 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.79 -0.241 . . . . 1.0 110.353 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.99 -42.57 99.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.235 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 975' ' ' GLY . 8.6 mp -61.92 -41.51 98.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.155 -1.018 . . . . 1.0 110.081 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.9 mt -61.97 -42.18 98.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.95 -0.7 . . . . 1.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.2 m -61.83 -48.05 82.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.635 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.374 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . 0.489 HD11 ' HE2' ' A' ' 987' ' ' MET . 57.2 tp -63.01 -43.46 98.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.574 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 980' ' ' LEU . 59.7 t -62.65 -45.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.603 0.239 . . . . 1.0 111.158 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.76 -42.48 97.8 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.756 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.41 -41.84 98.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.311 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 983' ' ' LEU . 62.4 mtt -65.14 -42.3 93.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.688 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.435 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.8 t90 -63.65 -42.65 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.64 -34.02 76.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.218 0.533 . . . . 1.0 111.224 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.7 t -77.36 -2.39 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.811 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.22 68.4 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.043 -1.623 . . . . 1.0 109.043 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -56.13 -44.17 78.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.095 0.448 . . . . 1.0 109.946 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.672 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 47.3 m-85 . . . . . 0 C--O 1.232 0.148 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.6 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 C--O 1.227 -0.127 0 CA-C-O 121.142 0.496 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.35 -44.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.85 -43.78 95.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.91 -41.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.357 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 64.3 t -63.56 -45.97 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . 0.687 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.2 tt -62.98 -42.65 99.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.802 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.84 -42.43 97.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.092 0.472 . . . . 1.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 53.6 p -62.06 -37.94 86.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.181 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.7 t -63.62 -45.14 98.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.068 0.461 . . . . 1.0 110.109 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.7 mtp -61.77 -40.0 93.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.591 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.94 98.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.047 -1.221 . . . . 1.0 110.047 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.51 80.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.742 0.306 . . . . 1.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.464 HG21 ' C ' ' A' ' 976' ' ' GLY . 30.7 mm -62.54 -42.11 94.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.492 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.1 mm? -63.27 -43.93 96.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.489 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.32 -44.32 91.93 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.25 -41.76 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 119.775 -0.77 . . . . 1.0 110.775 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.74 93.12 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.99 -38.29 85.77 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.68 -56.03 27.0 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 112.408 0.522 . . . . 1.0 112.408 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.0 Cg_exo -53.37 -41.96 69.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.293 1.329 . . . . 1.0 111.594 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.672 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 93.5 mt -66.26 -41.49 89.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.381 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.47 -41.9 98.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 7.8 tt -65.69 -38.99 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 119.945 -0.702 . . . . 1.0 109.523 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.21 -49.11 79.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -42.71 99.28 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.87 -46.31 89.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.214 -0.594 . . . . 1.0 110.91 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.62 -41.83 99.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.335 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -65.74 -42.77 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 30.7 m -58.63 -45.74 88.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.501 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.89 -43.83 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.058 0.456 . . . . 1.0 111.077 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.4 m80 . . . . . 0 C--N 1.328 -0.355 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.209 178.664 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 113.315 0.858 . . . . 1.0 113.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.551 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -70.87 -54.63 10.77 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.888 -177.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -58.4 -39.41 79.61 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 970' ' ' LEU . 9.8 p -65.59 -43.19 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 119.239 -0.985 . . . . 1.0 109.241 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 969' ' ' VAL . 54.9 tp -62.39 -42.61 99.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.749 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 967' ' ' TRP . 74.5 t -62.47 -44.54 99.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.688 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.84 -39.26 95.19 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.54 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.522 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.23 -42.83 99.28 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.65 -44.86 91.82 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.101 -0.571 . . . . 1.0 111.709 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.481 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.05 -41.53 99.48 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.06 -40.79 98.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.977 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.16 -42.62 99.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.656 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.7 -40.96 96.86 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.396 -0.922 . . . . 1.0 109.729 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 984' ' ' VAL . 89.9 mt -62.77 -41.63 99.33 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.815 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -62.52 -47.6 83.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.423 -0.511 . . . . 1.0 112.007 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.49 -40.85 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.726 -0.79 . . . . 1.0 111.286 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.05 -43.81 97.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 980' ' ' LEU . 73.8 t -60.71 -45.07 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.121 -0.231 . . . . 1.0 111.064 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.68 -41.71 99.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.197 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.96 -43.63 98.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.537 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.479 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 96.2 mmm -63.9 -43.62 95.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.894 0.378 . . . . 1.0 111.804 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.415 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.7 t90 -63.16 -43.32 98.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.291 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.03 -34.35 76.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 1.0 111.593 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.3 t -76.85 -2.19 4.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.065 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.81 8.28 63.52 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.479 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -56.41 -44.86 80.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 C--N 1.329 -0.319 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.092 177.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.584 0.231 . . . . 1.0 110.436 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.8 mt -62.64 -44.02 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.478 0.547 . . . . 1.0 112.478 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.51 -43.02 99.85 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.49 -45.41 98.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.978 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.419 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.5 t -63.42 -44.23 98.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 1.0 110.172 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.41 -43.87 98.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.961 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.75 -42.23 95.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 1.0 110.814 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.0 p -61.87 -39.98 93.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.458 -0.792 . . . . 1.0 112.085 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 66.7 t -64.21 -45.03 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.076 0.465 . . . . 1.0 110.871 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . 0.439 ' O ' HD13 ' B' ' 705' ' ' LEU . 93.0 mtp -63.27 -39.09 93.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.274 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.37 -41.34 96.59 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.613 -0.995 . . . . 1.0 110.613 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.11 88.07 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 120.685 0.278 . . . . 1.0 110.677 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.481 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.6 mm -60.41 -43.21 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.651 -0.819 . . . . 1.0 109.692 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.485 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.7 mp -61.28 -43.23 99.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.467 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.81 -44.39 96.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.619 -0.832 . . . . 1.0 111.197 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.74 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.77 -39.98 65.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.491 -0.862 . . . . 1.0 111.169 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.59 -37.39 82.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.714 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.36 -56.92 19.46 Favored Pre-proline 0 N--CA 1.462 0.137 0 C-N-CA 120.04 -0.664 . . . . 1.0 111.593 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.1 Cg_exo -54.27 -44.37 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 120.837 1.024 . . . . 1.0 111.489 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.13 -42.13 94.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.64 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.59 -41.85 99.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.813 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.6 -44.05 98.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.544 -0.463 . . . . 1.0 109.964 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -62.33 -48.16 81.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.958 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -43.27 98.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.189 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.33 -44.56 96.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.133 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 84.9 mt -61.14 -42.1 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.89 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.5 -44.11 98.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 120.068 -0.653 . . . . 1.0 110.242 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.5 m -59.79 -46.95 87.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.6 -45.11 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.494 0.664 . . . . 1.0 111.198 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . 0.415 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 51.2 m80 . . . . . 0 C--N 1.321 -0.656 0 C-N-CA 119.865 -0.734 . . . . 1.0 109.438 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.731 ' O ' HG13 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -54.33 -50.27 67.78 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.857 -0.737 . . . . 1.0 111.306 -176.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -57.69 -38.07 74.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.335 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 973' ' ' VAL . 66.6 t -64.46 -46.38 93.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.964 -1.094 . . . . 1.0 109.468 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.56 -44.58 93.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.856 -1.066 . . . . 1.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 967' ' ' TRP . 3.4 m -64.88 -39.35 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 119.729 -0.788 . . . . 1.0 110.508 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.24 96.34 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.1 t -61.88 -45.28 99.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.211 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.11 -42.64 99.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 1.0 111.658 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.62 85.03 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.476 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -59.69 -42.82 98.08 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.66 -42.52 98.07 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.391 -0.476 . . . . 1.0 111.951 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.44 -44.95 93.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.426 0.528 . . . . 1.0 112.426 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.22 -42.07 99.21 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.471 -0.891 . . . . 1.0 110.988 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' B' ' 705' ' ' LEU . 2.1 mm? -63.19 -40.59 97.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.98 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.8 m -62.0 -45.29 94.26 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.569 -0.452 . . . . 1.0 110.203 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -41.34 89.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.3 99.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.963 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.8 t -61.76 -46.04 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.505 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.36 -41.81 98.86 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.334 -0.546 . . . . 1.0 110.521 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.21 -42.53 98.75 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.207 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.39 -42.88 95.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.537 -0.302 . . . . 1.0 110.815 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.452 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 9.9 t90 -61.71 -42.03 98.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.11 -33.95 75.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.078 0.466 . . . . 1.0 111.176 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 986' ' ' ALA . 51.8 t -78.27 -3.18 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.689 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.47 10.81 71.23 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.53 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.6 OUTLIER -55.29 -45.29 76.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 -178.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 51.7 m-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.645 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.901 0.381 . . . . 1.0 110.269 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.532 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.9 mt -62.6 -43.51 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 1.0 112.309 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 694' ' ' LEU . 90.1 mt -62.3 -42.47 99.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.208 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.74 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.5 t -63.26 -44.12 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.808 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.25 -43.39 98.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.06 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.8 -42.31 95.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.176 0.512 . . . . 1.0 110.812 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 35.4 p -62.27 -42.84 99.69 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.18 -42.32 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.9 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.5 mtp -62.38 -39.26 92.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.347 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.66 -40.42 97.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 1.0 110.367 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.476 HG21 ' C ' ' A' ' 976' ' ' GLY . 29.4 mm -62.36 -42.54 95.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.513 ' HA ' HD11 ' A' ' 980' ' ' LEU . 5.6 tt -61.6 -44.54 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.743 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.05 -43.2 99.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.128 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.35 -43.9 98.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.311 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.905 -0.664 . . . . 1.0 112.029 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . 0.469 HD22 HD21 ' B' ' 705' ' ' LEU . 9.6 mp -67.18 -34.89 78.51 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.598 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -58.11 10.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.347 -0.541 . . . . 1.0 112.334 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 17.8 Cg_endo -62.12 -39.83 46.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.374 1.383 . . . . 1.0 112.045 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 89.5 mt -65.6 -42.08 92.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.933 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -41.25 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.933 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.31 -44.07 98.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.382 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.855 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.1 t90 -62.72 -48.52 78.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.369 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.81 -43.62 97.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.021 -178.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.69 -43.36 99.0 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.24 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.66 -41.3 97.33 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.23 -0.588 . . . . 1.0 110.132 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.855 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.55 -44.15 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.679 -0.808 . . . . 1.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 92.1 m -59.17 -45.35 91.24 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.335 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.51 -43.92 97.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.128 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 67.4 m80 . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.076 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -55.72 -53.66 53.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -176.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.49 -39.32 79.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.419 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 69.2 t -64.18 -44.96 97.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.699 0.762 . . . . 1.0 108.971 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.53 -42.64 99.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.0 t -63.51 -45.74 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.776 0.322 . . . . 1.0 111.248 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.52 96.82 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.268 -0.733 . . . . 1.0 111.268 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.9 t -61.73 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.605 0.24 . . . . 1.0 110.447 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.21 -42.61 99.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.497 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.99 -45.13 93.27 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.079 -0.581 . . . . 1.0 111.883 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.19 99.71 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.31 -41.6 98.96 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.644 -0.327 . . . . 1.0 110.82 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.99 -42.39 99.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.47 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.91 -41.68 98.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.009 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' B' ' 705' ' ' LEU . 83.9 mt -60.57 -41.06 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.104 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -59.88 -45.65 91.84 Favored 'General case' 0 C--O 1.253 1.262 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.477 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.35 -47.69 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 119.904 -0.718 . . . . 1.0 111.344 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.92 -42.65 98.54 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.833 -0.747 . . . . 1.0 111.655 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.18 -47.11 95.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.66 -0.816 . . . . 1.0 111.459 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.12 -42.63 99.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.531 -0.467 . . . . 1.0 110.141 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.85 -43.3 99.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.987 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 98.6 mtp -65.84 -41.95 91.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 1.0 111.773 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.1 t90 -62.7 -43.6 98.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.44 -33.46 73.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.138 0.494 . . . . 1.0 110.897 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.8 t -77.33 -2.8 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.688 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.19 7.09 81.67 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.606 ' CD1' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.82 -45.16 78.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.444 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 50.4 m-85 . . . . . 0 CA--C 1.532 0.281 0 C-N-CA 119.825 -0.75 . . . . 1.0 111.231 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.271 0.558 . . . . 1.0 111.262 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.7 -43.52 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.53 -41.78 99.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.663 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.9 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.319 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.458 ' O ' HG23 ' B' ' 700' ' ' VAL . 65.5 t -63.51 -45.38 97.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.958 0.409 . . . . 1.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . 0.688 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.1 tt -62.6 -43.03 99.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.655 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.69 -42.12 98.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 1.0 110.457 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.2 p -62.01 -36.73 82.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.037 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.8 t -63.95 -44.63 97.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.061 0.458 . . . . 1.0 110.14 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.69 -39.73 92.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.134 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.89 96.9 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.017 -1.233 . . . . 1.0 110.017 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.77 89.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 1.0 110.357 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.87 -43.22 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.233 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 980' ' ' LEU . 84.6 mt -61.1 -44.22 97.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.163 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.59 -44.12 97.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.669 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 95.0 mt -63.85 -44.47 98.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.876 -0.329 . . . . 1.0 111.428 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.26 -41.14 69.56 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.87 -38.45 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.507 0.928 . . . . 1.0 113.507 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.26 -57.03 18.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.208 -0.597 . . . . 1.0 112.122 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 32.3 Cg_exo -54.63 -44.28 51.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.091 1.194 . . . . 1.0 111.359 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.29 -42.15 93.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.715 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.62 -41.77 99.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.52 -44.19 98.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.199 -0.601 . . . . 1.0 109.449 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.444 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 11.3 t90 -63.0 -48.25 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 1.0 109.783 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.606 ' NZ ' ' CD1' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.51 -44.21 96.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.729 -178.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -42.86 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.667 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . 0.498 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 83.8 mt -62.12 -42.77 99.57 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.897 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.78 -44.32 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.909 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 82.9 m -60.31 -45.8 92.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.512 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.37 -43.21 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.385 -0.526 . . . . 1.0 110.42 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 43.3 m80 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.457 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.473 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.0 -51.94 47.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.759 -176.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -58.01 -39.2 77.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.682 0.252 . . . . 1.0 111.682 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.1 -45.06 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.26 -42.64 99.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.6 t -62.79 -44.36 99.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.79 -38.26 94.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.443 -0.884 . . . . 1.0 111.155 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.8 t -61.98 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.975 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.19 -42.09 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.846 -0.341 . . . . 1.0 111.876 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.26 92.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.372 -0.691 . . . . 1.0 111.372 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.97 -42.39 99.73 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.146 -1.181 . . . . 1.0 110.146 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.44 -42.08 98.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.953 0.377 . . . . 1.0 111.999 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.76 -43.62 98.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.457 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -40.39 96.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.103 -1.039 . . . . 1.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 976' ' ' GLY . 1.8 mm? -62.5 -39.92 95.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 94.8 m -61.89 -45.53 93.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.807 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.63 -43.63 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.97 -0.692 . . . . 1.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.19 -43.45 98.79 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.379 -0.826 . . . . 1.0 111.355 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 980' ' ' LEU . 68.4 t -60.63 -44.73 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.081 -0.387 . . . . 1.0 110.82 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.45 -41.43 98.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.175 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.388 -0.525 . . . . 1.0 112.191 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.481 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 95.6 mmm -64.29 -42.81 96.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 111.201 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.457 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.1 t90 -62.53 -42.6 99.63 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.051 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.33 -34.4 76.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.832 0.349 . . . . 1.0 111.396 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -78.09 -2.49 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.792 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 68.27 12.17 62.85 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 108.548 -1.821 . . . . 1.0 108.548 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.481 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -54.9 -44.13 73.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -178.068 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 119.838 -0.745 . . . . 1.0 109.859 177.537 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 . . . . . 0 C--O 1.243 0.734 0 CA-C-O 120.917 0.389 . . . . 1.0 111.83 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.54 -42.69 96.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.856 -0.737 . . . . 1.0 112.351 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.36 -41.58 98.85 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.003 -0.436 . . . . 1.0 111.451 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.6 -45.32 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.846 0.355 . . . . 1.0 111.646 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 58.6 t -64.18 -45.23 96.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . 0.676 HD23 ' C ' ' B' ' 697' ' ' LEU . 8.2 tt -63.29 -43.03 99.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.833 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.3 -42.02 96.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 1.0 110.553 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 49.5 p -62.38 -38.26 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.361 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.2 t -63.86 -44.83 98.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.137 0.494 . . . . 1.0 110.054 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -63.03 -39.55 95.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.54 -40.54 97.72 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.94 78.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.1 mm -62.59 -42.65 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.416 ' HA ' HD21 ' A' ' 980' ' ' LEU . 13.7 mt -61.43 -44.9 96.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.833 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.28 -43.9 96.61 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.043 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.29 -44.85 97.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.52 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -70.11 -42.4 67.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.206 -0.521 . . . . 1.0 111.801 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . 0.462 ' O ' HD13 ' B' ' 713' ' ' LEU . 82.5 mt -67.12 -38.38 85.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.27 -55.56 30.31 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 44.0 Cg_exo -52.59 -41.42 68.59 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.299 1.333 . . . . 1.0 111.778 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.476 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.24 -41.89 93.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.722 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . 0.462 HD13 ' O ' ' B' ' 709' ' ' LEU . 9.4 mp -63.33 -42.37 98.97 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.29 -41.71 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.503 -0.879 . . . . 1.0 110.147 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -63.44 -48.77 76.39 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -42.7 95.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.681 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.18 -44.45 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.623 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.73 -41.91 98.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.997 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.55 -42.98 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 120.321 -0.552 . . . . 1.0 109.825 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 98.0 m -59.61 -45.88 90.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.384 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -61.73 -43.67 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.921 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.2 m80 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.679 178.625 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.028 0.381 . . . . 1.0 112.028 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.562 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -66.64 -50.86 61.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -177.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.7 m0 -58.09 -43.54 87.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 119.299 -0.381 . . . . 1.0 111.671 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 970' ' ' LEU . 28.1 m -65.78 -43.61 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 118.819 -1.152 . . . . 1.0 110.457 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . 0.444 ' N ' HG23 ' A' ' 969' ' ' VAL . 89.3 mt -63.15 -42.81 99.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.491 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.3 t -64.0 -44.98 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.707 0.289 . . . . 1.0 111.387 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.48 -38.39 94.77 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.116 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.61 -45.1 99.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 121.16 -0.216 . . . . 1.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.3 -42.14 99.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.898 0.333 . . . . 1.0 111.898 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.54 -43.43 94.64 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 120.676 -0.773 . . . . 1.0 111.735 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.1 99.95 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 120.435 -0.888 . . . . 1.0 111.133 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.8 -40.31 96.97 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.539 -0.389 . . . . 1.0 110.098 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.0 -42.7 99.43 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.48 -42.6 99.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.687 -0.805 . . . . 1.0 110.213 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 984' ' ' VAL . 24.4 mt -62.39 -42.74 99.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.824 0.345 . . . . 1.0 110.779 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 24.1 p -61.93 -45.1 95.2 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.508 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.71 -43.28 97.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.672 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.7 -42.72 97.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.394 -0.522 . . . . 1.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.617 HG22 HD21 ' B' ' 712' ' ' LEU . 69.6 t -62.45 -45.48 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.063 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.83 97.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.931 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.37 -43.28 99.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.644 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 64.4 mtt -64.77 -42.46 95.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.018 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.42 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.46 -33.79 74.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.125 0.488 . . . . 1.0 111.387 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.9 t -78.68 -3.36 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.64 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.56 11.04 72.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.333 -1.507 . . . . 1.0 109.333 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.524 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.48 -45.42 76.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.435 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 48.6 m-85 . . . . . 0 C--N 1.33 -0.248 0 C-N-CA 119.986 -0.686 . . . . 1.0 110.734 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 66.4 t0 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.879 0.371 . . . . 1.0 110.915 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.563 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 93.2 mt -61.98 -44.42 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 113.095 0.776 . . . . 1.0 113.095 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.35 99.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.717 0.294 . . . . 1.0 111.204 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.21 -45.39 98.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.819 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 700' ' ' VAL . 66.6 t -63.1 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 1.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.554 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.75 -42.88 94.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.439 . . . . 1.0 110.668 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 54.6 p -62.52 -39.56 93.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.829 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.6 t -64.24 -43.79 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.39 0.614 . . . . 1.0 109.381 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.6 mtp -63.29 -39.96 96.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.878 -1.056 . . . . 1.0 110.173 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.93 -47.12 48.74 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.07 83.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.675 0.274 . . . . 1.0 111.631 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.42 HG22 ' O ' ' B' ' 700' ' ' VAL . 10.7 tp -64.87 -37.61 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.651 -0.82 . . . . 1.0 108.849 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 62.3 tp -60.83 -44.95 96.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.31 -41.37 98.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.141 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.7 -43.85 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.43 -39.25 95.63 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.5 -37.24 82.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.694 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.11 -56.48 21.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 112.299 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.5 Cg_exo -53.66 -43.91 53.69 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.06 1.173 . . . . 1.0 112.017 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.617 HD21 HG22 ' A' ' 984' ' ' VAL . 11.1 mp -65.17 -41.99 94.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.137 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.22 -41.66 99.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.082 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.64 -44.31 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.435 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 7.9 t90 -62.16 -47.31 85.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.29 0.567 . . . . 1.0 109.578 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.53 -44.01 96.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.747 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.51 -46.28 89.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.632 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . 0.489 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 8.2 mp -63.26 -41.01 98.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.545 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 4.5 mm -63.58 -44.65 98.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.965 -0.694 . . . . 1.0 109.994 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -45.37 94.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.1 -43.53 98.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.319 -0.552 . . . . 1.0 111.366 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 44.5 m80 . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 112.433 0.531 . . . . 1.0 112.433 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -65.34 -51.94 57.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 -177.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . 0.558 ' CD1' ' N ' ' A' ' 968' ' ' TRP . 3.1 m0 -57.18 -40.81 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.143 -0.223 . . . . 1.0 110.779 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.42 -46.45 92.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 119.419 -0.912 . . . . 1.0 110.263 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.26 -42.65 99.18 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.681 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.7 t -63.93 -44.58 98.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.443 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.77 -37.91 95.07 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.292 -0.956 . . . . 1.0 111.533 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.25 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.437 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.29 -42.92 99.12 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.2 -45.08 89.24 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.88 -0.676 . . . . 1.0 111.614 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.593 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.67 -41.37 98.91 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.91 -42.78 97.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.133 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.96 -44.33 96.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.557 -0.457 . . . . 1.0 111.654 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 983' ' ' LEU . 8.4 mp -62.61 -42.12 99.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.64 -0.824 . . . . 1.0 110.366 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' B' ' 705' ' ' LEU . 4.1 mm? -63.14 -39.65 95.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.846 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 84.6 m -61.2 -45.13 95.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.515 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.82 -44.17 99.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.586 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 979' ' ' LEU . 8.5 mp -62.94 -42.0 99.67 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.349 -0.54 . . . . 1.0 110.899 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 63.8 t -62.45 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 1.0 111.011 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.24 -41.73 99.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.9 99.94 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.284 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.27 -40.54 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.373 0.606 . . . . 1.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.6 t90 -65.35 -44.7 86.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.578 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.67 -33.98 76.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.96 2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.176 -1.01 . . . . 1.0 109.296 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.16 84.5 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.38 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.417 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.9 -44.34 66.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.468 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.4 m-85 . . . . . 0 C--N 1.328 -0.355 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.857 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 CA--C 1.522 -0.108 0 N-CA-C 109.997 -0.371 . . . . 1.0 109.997 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.02 -44.46 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.88 -43.37 96.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.34 -47.24 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.91 0.707 . . . . 1.0 112.91 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' B' ' 699' ' ' SER . 11.0 p -65.26 -41.65 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . 0.42 ' N ' HG13 ' B' ' 696' ' ' VAL . 42.9 tp -61.76 -43.45 98.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.852 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.86 -41.84 95.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 1.0 110.665 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 36.8 p -62.55 -40.98 98.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.582 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.56 -45.26 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.266 0.555 . . . . 1.0 110.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -63.5 -39.76 95.3 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.035 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.44 -41.13 99.41 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.99 -0.844 . . . . 1.0 110.99 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.58 80.87 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.05 -41.27 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.673 ' HA ' HD21 ' A' ' 980' ' ' LEU . 47.5 tp -60.63 -46.26 90.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.868 -0.333 . . . . 1.0 111.166 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.24 -42.42 99.2 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.55 -44.21 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.563 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.59 -40.86 94.24 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.64 -37.57 85.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.92 -57.18 17.2 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 119.998 -0.681 . . . . 1.0 112.32 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.7 Cg_exo -54.46 -45.38 41.41 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.158 1.239 . . . . 1.0 111.934 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.493 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -65.86 -40.57 91.79 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.259 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.42 -41.32 98.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.085 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.63 -44.75 98.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.389 -0.525 . . . . 1.0 109.735 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.468 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.2 t90 -63.11 -49.19 75.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.18 0.514 . . . . 1.0 109.702 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.444 ' O ' HG23 ' B' ' 720' ' ' THR . 0.2 OUTLIER -60.64 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.104 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.35 -45.39 91.43 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.738 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . 0.455 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 82.7 mt -62.76 -42.9 99.9 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.676 0.621 . . . . 1.0 112.676 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' B' ' 720' ' ' THR . 5.6 tp -65.87 -41.26 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 119.611 -0.836 . . . . 1.0 109.871 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . 0.444 HG23 ' O ' ' B' ' 716' ' ' LYS . 30.6 p -58.69 -45.3 89.76 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.758 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' B' ' 721' ' ' ILE . 36.2 mm -62.05 -41.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 O-C-N 121.849 -0.532 . . . . 1.0 110.676 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 59.2 m80 . . . . . 0 C--N 1.327 -0.387 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.211 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.0 tt . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 113.431 0.9 . . . . 1.0 113.431 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.37 -45.4 80.54 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.272 -0.971 . . . . 1.0 110.822 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . 0.599 ' NE1' HD12 ' B' ' 693' ' ' ILE . 35.5 m0 -57.23 -46.13 83.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.78 -0.191 . . . . 1.0 110.786 -177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -63.74 -46.82 93.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 119.329 -0.948 . . . . 1.0 110.941 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.31 -44.26 95.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.113 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 967' ' ' TRP . 64.5 t -63.77 -44.95 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.07 -39.32 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.183 -1.008 . . . . 1.0 111.118 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.065 0.394 . . . . 1.0 112.065 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.72 -42.84 97.85 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.58 95.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.494 -0.86 . . . . 1.0 111.2 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.401 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.93 -42.85 99.77 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.63 -41.94 99.31 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.732 -0.275 . . . . 1.0 110.659 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.83 -41.79 98.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.47 -41.26 96.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.469 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' B' ' 705' ' ' LEU . 91.2 mt -62.61 -42.07 99.36 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.953 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 96.6 m -62.29 -48.66 78.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.01 -41.38 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.453 -0.899 . . . . 1.0 111.626 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.39 -43.48 97.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.541 -0.464 . . . . 1.0 110.696 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.2 t -62.52 -45.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.722 0.296 . . . . 1.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.08 -42.28 99.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.12 -43.64 98.38 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.336 -0.545 . . . . 1.0 111.811 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.74 -42.62 90.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.144 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -62.67 -42.79 99.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.88 -32.45 73.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.282 0.563 . . . . 1.0 110.509 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.4 t -78.37 -3.79 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.904 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.17 72.86 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.198 -1.561 . . . . 1.0 109.198 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.499 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.88 -46.09 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -178.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.658 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 39.2 m-85 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.836 177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.767 0.318 . . . . 1.0 110.507 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.599 HD12 ' NE1' ' A' ' 968' ' ' TRP . 9.4 tt -62.78 -41.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.461 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.46 -42.43 99.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.412 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.29 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 71.1 t -62.77 -44.77 99.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 1.0 110.485 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 968' ' ' TRP . 86.7 mt -62.05 -41.99 98.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.572 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.55 -43.32 94.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 1.0 110.398 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.8 p -62.47 -41.44 98.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.848 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.59 -44.88 98.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.316 0.579 . . . . 1.0 109.8 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 55.9 mtt -62.85 -39.46 94.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.499 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.25 -41.69 94.59 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.78 89.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.144 0.497 . . . . 1.0 110.759 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 980' ' ' LEU . 27.6 mm -63.24 -41.68 93.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.379 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.523 ' HA ' HD21 ' A' ' 980' ' ' LEU . 57.5 tp -59.42 -46.84 87.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.018 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.17 -43.11 99.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.602 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.88 -44.09 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.19 -41.07 92.48 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.244 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.11 -35.36 76.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.08 -56.2 24.01 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 119.588 -0.845 . . . . 1.0 111.422 -177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.8 Cg_exo -54.19 -42.43 67.36 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.296 1.331 . . . . 1.0 111.351 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 90.9 mt -64.16 -42.82 96.59 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.91 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -41.36 98.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.96 98.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.053 -0.659 . . . . 1.0 109.349 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.857 ' NE1' HD11 ' B' ' 719' ' ' ILE . 5.3 t90 -61.84 -49.27 76.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.922 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.56 -42.64 97.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.316 -0.24 . . . . 1.0 110.656 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.16 -42.62 99.45 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.48 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.91 -40.44 93.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.377 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . 0.857 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.97 -46.72 93.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.799 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 21.6 m -60.86 -48.19 82.95 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 34.1 mm -63.14 -43.78 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.788 0.662 . . . . 1.0 112.788 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . 0.455 ' CD2' ' C ' ' B' ' 722' ' ' HIS . 1.8 p-80 . . . . . 0 C--N 1.324 -0.523 0 C-N-CA 119.522 -0.871 . . . . 1.0 109.874 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -58.13 -50.71 72.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.457 -0.497 . . . . 1.0 112.285 -176.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . 0.451 ' CZ2' HD11 ' B' ' 693' ' ' ILE . 21.7 m0 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.193 -177.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 973' ' ' VAL . 65.1 t -64.36 -46.46 93.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.806 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.23 -43.74 97.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 1.0 111.686 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.0 t -63.36 -45.1 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.585 -0.279 . . . . 1.0 111.664 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.66 -37.69 94.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.095 -1.05 . . . . 1.0 111.586 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 969' ' ' VAL . 60.6 t -62.0 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.854 -0.339 . . . . 1.0 110.595 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.46 -43.08 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.85 97.58 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.746 -0.74 . . . . 1.0 111.26 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.1 -41.72 99.7 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.12 -42.95 99.63 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.139 -0.624 . . . . 1.0 111.816 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.42 -41.93 98.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.344 -0.543 . . . . 1.0 111.839 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.46 -42.45 99.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.711 -0.795 . . . . 1.0 110.234 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.66 HD11 HD12 ' B' ' 705' ' ' LEU . 3.5 mm? -64.52 -41.05 96.63 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.338 0.496 . . . . 1.0 112.338 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 20.3 m -62.14 -47.15 85.84 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.496 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 42.0 pt -63.09 -41.35 92.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.757 -0.777 . . . . 1.0 111.617 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -43.17 99.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.474 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.5 t -61.7 -45.0 99.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.87 0.367 . . . . 1.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 985' ' ' LEU . 93.0 mt -62.71 -41.5 99.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.49 -42.22 98.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 1.0 111.206 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.98 -42.03 94.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.773 0.32 . . . . 1.0 111.505 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.408 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 10.4 t90 -63.06 -43.29 99.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.47 -33.77 75.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.076 0.465 . . . . 1.0 111.587 -178.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.4 t -77.65 -3.07 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.81 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.88 9.63 71.06 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.41 -1.476 . . . . 1.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.06 -43.81 78.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.236 0.518 . . . . 1.0 109.652 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.6 m-85 . . . . . 0 N--CA 1.464 0.246 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.22 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.878 0.37 . . . . 1.0 111.269 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 693' ' ' ILE . . . . . 0.451 HD11 ' CZ2' ' A' ' 968' ' ' TRP . 86.8 mt -62.03 -43.85 98.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 1.0 112.284 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 694' ' ' LEU . . . . . 0.482 HD22 ' N ' ' B' ' 694' ' ' LEU . 3.9 mm? -62.78 -43.38 98.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.981 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.18 -45.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.328 . . . . 1.0 111.467 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.3 t -63.7 -44.75 98.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.067 0.461 . . . . 1.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.03 -43.16 99.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.781 -0.645 . . . . 1.0 112.05 -178.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.3 -42.35 96.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.1 0.476 . . . . 1.0 110.428 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 50.8 p -62.38 -41.37 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.57 -0.741 . . . . 1.0 112.871 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.45 -45.78 94.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.286 -0.565 . . . . 1.0 110.288 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.36 -39.6 94.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.565 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.24 98.0 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.002 -1.239 . . . . 1.0 110.002 177.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.76 89.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.403 0.621 . . . . 1.0 109.908 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -61.04 -41.8 90.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 118.479 -1.289 . . . . 1.0 109.053 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 705' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 980' ' ' LEU . 59.5 tp -59.36 -43.87 92.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.534 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.753 -0.779 . . . . 1.0 110.743 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.07 -44.16 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.94 -38.85 94.57 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 709' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 713' ' ' LEU . 85.7 mt -67.46 -38.19 84.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.957 1.095 . . . . 1.0 113.957 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 710' ' ' ALA . . . . . 0.667 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.97 -57.11 17.54 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.759 -177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 711' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.9 Cg_exo -55.5 -45.48 39.38 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.306 1.145 . . . . 1.0 111.448 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.308 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 713' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' B' ' 709' ' ' LEU . 33.5 mt -62.98 -41.08 99.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.784 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.18 -46.39 95.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.397 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 715' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 4.3 t90 -61.03 -49.36 77.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.648 178.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -45.83 91.17 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.786 -0.366 . . . . 1.0 111.037 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.1 -44.43 92.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.032 -0.667 . . . . 1.0 111.114 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.28 -43.42 97.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt -68.33 -40.93 83.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.579 -0.848 . . . . 1.0 109.964 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 94.6 m -59.15 -45.64 90.45 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.38 -179.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.92 -43.14 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.622 -178.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.3 m80 . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 178.105 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.885 -1.286 . . . . 11.73 109.885 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 173.14 -87.62 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.331 -2.84 . . . . 10.34 103.331 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.745 ' C ' ' H ' ' A' ' 961' ' ' GLU . 2.2 mt -85.0 108.64 17.71 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 102.328 -3.212 . . . . 10.0 102.328 171.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -54.88 -6.96 0.14 Allowed 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 106.901 -1.518 . . . . 8.5299999999999994 106.901 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . 0.792 ' O ' ' SG ' ' B' ' 690' ' ' CYS . 1.2 tt0 61.3 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.865 -2.642 . . . . 6.75 103.865 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 964' ' ' ILE . 8.5 mtm-85 -57.8 125.91 25.11 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 123.835 1.779 . . . . 7.79 113.515 -173.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.466 ' CB ' ' HA ' ' B' ' 690' ' ' CYS 0.273 73.7 m -78.52 6.82 7.77 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 110.091 -3.231 . . . . 2.6299999999999999 108.962 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.531 ' H ' ' C ' ' A' ' 962' ' ' ARG . 0.0 OUTLIER -157.46 64.71 3.25 Favored Pre-proline 0 N--CA 1.425 -1.716 0 CA-C-N 112.071 -2.332 . . . . 2.8399999999999999 107.536 -176.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.84 148.39 88.57 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 N-CA-C 106.149 -2.289 . . . . 1.52 106.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.9 -42.46 92.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 114.857 1.429 . . . . 1.45 114.857 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.56 -58.15 8.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.356 -0.538 . . . . 0.90000000000000002 111.413 -177.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -56.55 -39.4 73.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.189 0.811 . . . . 3.1899999999999999 113.189 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.89 -45.88 95.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 119.116 -1.034 . . . . 0.81999999999999995 108.375 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.47 -44.09 97.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.349 -1.296 . . . . 1.6799999999999999 110.696 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 91.4 t -63.31 -45.36 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.604 0.24 . . . . 0.68999999999999995 111.441 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.86 -37.44 92.54 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.838 -1.173 . . . . 0.23999999999999999 111.324 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.51 -44.84 99.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 121.043 -0.263 . . . . 0.28999999999999998 110.72 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.88 -42.07 95.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.374 0.509 . . . . 1.1000000000000001 112.374 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -45.84 84.27 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.132 -0.556 . . . . 0.20000000000000001 112.014 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.24 99.36 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 110.528 -1.029 . . . . 0.14999999999999999 110.528 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.6 -40.84 89.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 120.767 -0.373 . . . . 1.6299999999999999 110.513 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 63.4 tp -61.9 -43.19 99.35 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.857 -0.794 . . . . 1.5700000000000001 108.857 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.5 -41.86 95.18 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.518 -1.273 . . . . 1.51 109.752 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' B' ' 705' ' ' LEU . 60.3 mt -60.03 -38.77 83.69 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 119.843 -0.743 . . . . 1.3999999999999999 111.063 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -61.22 -47.71 84.85 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.646 -0.822 . . . . 0.60999999999999999 110.564 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.41 -42.8 95.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.341 -0.544 . . . . 1.3 110.63 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.0 -43.63 95.1 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.583 -0.447 . . . . 1.6100000000000001 110.891 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.3 t -62.32 -44.82 99.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.667 -0.413 . . . . 0.62 111.234 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.89 -43.29 99.2 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.408 -0.517 . . . . 0.76000000000000001 109.934 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.88 97.31 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.77 -0.372 . . . . 0.29999999999999999 111.743 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 44.6 mtt -64.0 -42.91 97.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.269 -0.423 . . . . 1.5900000000000001 110.472 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.549 ' HE1' ' CE ' ' A' ' 994' ' ' LYS . 17.1 t90 -63.48 -46.34 86.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.09 -0.708 . . . . 1.1699999999999999 109.09 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.18 -35.63 77.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.651 0.611 . . . . 0.78000000000000003 112.651 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 990' ' ' VAL . 71.5 t -78.04 -1.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 119.74 -0.784 . . . . 0.91000000000000003 108.965 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 74.36 5.2 71.58 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 108.18 -1.968 . . . . 0.35999999999999999 108.18 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.526 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -47.82 -44.93 29.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 120.024 1.912 . . . . 0.81000000000000005 110.444 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -84.33 -19.18 34.13 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.361 -1.29 . . . . 1.26 110.545 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.549 ' CE ' ' HE1' ' A' ' 988' ' ' TRP . 84.5 mttt -76.33 -29.95 57.48 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 104.559 -2.385 . . . . 2.6600000000000001 104.559 174.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 991' ' ' GLY . 55.6 ttt-85 -67.25 108.81 2.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.33 -2.47 . . . . 2.52 104.33 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.644 ' OD1' ' N ' ' A' ' 996' ' ' ASN . 1.7 p-10 -112.86 -18.23 12.32 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.0 -2.593 . . . . 5.1600000000000001 104.0 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 163.3 154.78 0.05 OUTLIER Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-N 110.823 -2.899 . . . . 8.3599999999999994 106.111 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 C-N-CA 121.293 1.329 . . . . 7.21 112.427 -177.316 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 119.664 -0.52 . . . . 10.539999999999999 112.017 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -120.63 17.63 12.0 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 118.214 1.007 . . . . 12.119999999999999 112.967 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . 0.5 ' O ' ' N ' ' B' ' 689' ' ' LYS . 0.0 OUTLIER 172.95 -58.38 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 102.794 -3.039 . . . . 7.4400000000000004 102.794 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . 0.696 ' C ' ' N ' ' B' ' 690' ' ' CYS . 18.7 Cg_endo -71.7 59.28 2.7 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 107.35 -1.827 . . . . 6.0800000000000001 107.35 171.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' B' ' 687' ' ' SER . 11.8 mttt -46.29 -18.35 0.05 Allowed 'General case' 0 C--N 1.351 0.65 0 N-CA-C 105.017 -2.216 . . . . 6.0499999999999998 105.017 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . 0.792 ' SG ' ' O ' ' A' ' 961' ' ' GLU . 47.0 m -109.49 103.24 52.35 Favored Pre-proline 0 N--CA 1.419 -2.004 0 CA-C-N 110.445 -3.071 . . . . 1.8 108.394 175.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.81 158.02 5.0 Favored 'Trans proline' 0 CA--C 1.507 -0.874 0 N-CA-C 108.097 -1.54 . . . . 0.90000000000000002 108.097 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.85 136.21 57.75 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.18 -1.008 . . . . 1.6000000000000001 110.074 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.73 -44.53 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.572 -0.74 . . . . 0.95999999999999996 111.865 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 69.3 mt -62.27 -41.94 98.9 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 1.29 110.428 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.49 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.72999999999999998 111.031 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 92.4 t -62.92 -45.65 98.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 1.04 110.009 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.71 -43.01 98.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 1.24 111.542 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.13 -41.59 90.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.83999999999999997 110.166 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 13.4 p -61.79 -42.59 99.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.319 -0.4 . . . . 0.27000000000000002 111.179 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.15 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 120.649 -0.421 . . . . 0.56999999999999995 109.926 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 88.1 mtp -60.79 -39.05 87.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.835 -0.62 . . . . 0.93000000000000005 109.9 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.11 -41.38 95.05 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.635 -0.986 . . . . 0.17999999999999999 110.635 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.07 89.12 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.954 0.407 . . . . 0.23999999999999999 110.021 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 24.5 mm -59.85 -42.27 88.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 118.938 -1.105 . . . . 0.5 109.366 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.473 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.3 mt -59.11 -45.99 89.47 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.64 -0.255 . . . . 1.6899999999999999 110.599 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 19.1 mt -63.29 -42.98 99.14 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.331 -0.548 . . . . 1.8100000000000001 110.561 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.63 -46.21 95.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.426 -0.51 . . . . 0.84999999999999998 110.863 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.19 -39.47 94.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.639 -0.791 . . . . 0.22 111.615 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.47 -28.68 62.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.676 1.362 . . . . 1.28 114.676 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.675 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -60.1 -54.86 51.11 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 118.969 0.804 . . . . 0.23000000000000001 111.405 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.5 Cg_exo -55.07 -44.9 45.04 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.513 1.475 . . . . 0.28999999999999998 111.333 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.59 -42.21 87.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.251 -0.886 . . . . 1.02 110.799 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.88 -41.91 99.58 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.886 -0.326 . . . . 1.04 111.092 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.91 -44.5 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 109.064 -0.717 . . . . 1.4299999999999999 109.064 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -60.81 -50.11 74.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.584 -0.525 . . . . 0.70999999999999996 109.584 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -59.84 -43.49 94.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 1.03 110.919 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 717' ' ' LEU . 19.4 tp -62.88 -47.51 83.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 1.8600000000000001 110.514 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 40.9 mt -60.85 -41.9 96.76 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.789 -0.364 . . . . 0.68999999999999995 110.836 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -45.61 98.42 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 109.522 -0.547 . . . . 1.5900000000000001 109.522 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . 0.619 ' O ' ' N ' ' B' ' 724' ' ' ARG . 18.7 m -55.01 -47.41 74.72 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.774 -0.77 . . . . 1.02 109.851 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . 0.425 ' O ' ' CB ' ' B' ' 725' ' ' LYS . 35.9 mt -64.96 -44.0 96.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.999 0.74 . . . . 1.3300000000000001 112.999 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 55.5 m80 -63.38 -34.02 76.82 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.452 -0.944 . . . . 1.3400000000000001 108.452 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.592 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 56.5 t0 -82.89 -46.98 12.33 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.244 -1.343 . . . . 1.8100000000000001 112.429 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . 0.619 ' N ' ' O ' ' B' ' 720' ' ' THR . 0.2 OUTLIER -78.58 -47.66 16.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.027 0.38 . . . . 4.6299999999999999 112.027 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.484 ' O ' ' CD1' ' B' ' 727' ' ' PHE . 5.2 tttt -43.06 109.11 0.12 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.338 -0.545 . . . . 4.9699999999999998 109.851 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.56 112.53 7.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.479 0.657 . . . . 6.8899999999999997 111.79 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' B' ' 725' ' ' LYS . 25.2 m-85 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 114.847 -1.07 . . . . 10.130000000000001 109.753 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.89 89.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.701 0.286 . . . . 1.0 110.533 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.09 126.37 55.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.486 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.94 -38.8 89.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 51.44 98.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -75.01 143.2 43.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.743 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.5 m -69.26 -36.63 77.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.748 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.51 82.56 53.42 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.609 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.61 145.89 98.05 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.051 1.834 . . . . 1.0 111.13 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt -66.97 -37.84 80.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 114.105 1.15 . . . . 1.0 114.105 -177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.498 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -53.98 -52.23 61.36 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.47 0.544 . . . . 1.0 112.47 -176.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -58.41 -40.01 81.29 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.957 -0.297 . . . . 1.0 111.765 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.7 t -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 119.796 -0.762 . . . . 1.0 109.223 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.45 -42.93 99.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.678 -1.146 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.2 t -63.17 -45.15 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.638 0.256 . . . . 1.0 111.327 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.31 -38.95 96.54 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.728 -0.749 . . . . 1.0 111.273 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 65.6 t -62.24 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 121.078 -0.249 . . . . 1.0 110.503 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.18 -42.49 99.39 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.468 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.51 -44.21 93.39 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.816 -0.707 . . . . 1.0 111.8 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.61 98.61 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.26 -41.7 99.07 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.743 -0.269 . . . . 1.0 110.723 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.89 -42.12 98.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.346 -0.542 . . . . 1.0 110.022 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.05 -40.94 95.54 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.152 -1.019 . . . . 1.0 109.764 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' B' ' 705' ' ' LEU . 87.8 mt -62.21 -39.0 91.33 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.367 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 11.5 m -63.0 -47.1 84.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.084 -0.647 . . . . 1.0 110.205 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.68 -42.5 94.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 120.919 -0.312 . . . . 1.0 111.14 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.62 -42.45 91.53 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.526 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.76 -44.29 99.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.143 0.497 . . . . 1.0 110.938 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 99.4 mt -64.87 -41.43 95.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -63.38 -42.12 98.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.776 -0.77 . . . . 1.0 111.305 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 66.2 mtt -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.322 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.425 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.5 t90 -63.0 -43.05 99.86 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.41 -34.1 76.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.136 0.493 . . . . 1.0 111.349 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.9 t -77.14 -2.74 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.78 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.97 8.73 69.64 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.336 -1.505 . . . . 1.0 109.336 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.463 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.77 -45.18 78.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.294 -1.002 . . . . 1.0 108.294 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -81.4 -22.86 37.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.355 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.83 -39.46 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 118.695 -1.202 . . . . 1.0 108.44 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' B' ' 723' ' ' ASP . 78.3 ttt-85 -66.58 121.54 15.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.87 -0.732 . . . . 1.0 110.739 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -155.94 106.83 2.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.198 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 41.25 74.17 0.78 Allowed Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.727 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo . . . . . 0 C--N 1.307 -1.655 0 C-N-CA 122.823 2.349 . . . . 1.0 112.229 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.476 -1.45 . . . . 1.0 109.476 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.89 -38.96 90.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 1.0 110.527 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . 0.415 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.4 OUTLIER -169.39 -62.98 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 1.0 111.041 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 36.5 Cg_endo -63.73 145.68 91.3 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.119 1.88 . . . . 1.0 112.19 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -44.44 96.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.642 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.55 165.68 25.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.575 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.29 156.35 63.61 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.393 2.062 . . . . 1.0 111.841 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 -61.76 138.87 58.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.294 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.3 mt -62.33 -43.56 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 1.0 111.626 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.16 -42.0 98.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.168 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 -45.19 99.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.796 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 700' ' ' VAL . 67.7 t -63.59 -45.27 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.0 110.664 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . 0.689 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.1 tt -62.64 -42.83 99.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.449 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.77 -42.37 97.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.035 0.445 . . . . 1.0 110.346 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 52.1 p -62.22 -36.82 83.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.824 -0.626 . . . . 1.0 111.032 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 696' ' ' VAL . 68.1 t -63.99 -44.87 97.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.094 0.473 . . . . 1.0 109.922 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.0 mtp -61.54 -39.51 91.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.617 -0.719 . . . . 1.0 109.992 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.1 -41.84 96.89 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.43 89.22 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.677 0.275 . . . . 1.0 110.51 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.9 mm -62.74 -43.08 98.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.025 -0.67 . . . . 1.0 109.451 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.5 mt -61.26 -44.16 97.7 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.298 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.1 -43.29 98.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.604 -0.438 . . . . 1.0 111.009 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.94 -44.24 97.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.523 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.35 -41.9 76.44 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.6 -36.17 81.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -57.84 11.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.4 0.519 . . . . 1.0 112.4 -177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 19.0 Cg_endo -60.35 -40.23 60.18 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.086 1.191 . . . . 1.0 111.901 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.17 -42.7 93.45 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.998 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.3 -41.82 98.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.858 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.63 -44.39 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.295 -0.562 . . . . 1.0 109.652 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.861 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.8 t90 -62.37 -48.17 80.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.165 0.507 . . . . 1.0 109.863 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -61.03 -42.54 98.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.004 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.24 -44.49 95.08 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.5 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.76 -41.79 98.15 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-O 121.286 0.565 . . . . 1.0 110.346 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.861 HD11 ' NE1' ' B' ' 715' ' ' TRP . 95.8 mt -62.51 -46.96 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.165 -1.014 . . . . 1.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 89.2 m -57.74 -46.01 85.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.62 -0.432 . . . . 1.0 111.454 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.57 -43.4 96.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 120.186 -0.606 . . . . 1.0 110.852 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.32 -36.33 83.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.49 ' CG ' HH12 ' A' ' 995' ' ' ARG . 8.0 m-20 -68.2 -39.79 82.33 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.173 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.38 -39.89 95.76 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.299 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.06 133.95 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.42 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.3 125.13 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.546 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.3 t80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.947 -1.025 . . . . 1.0 110.501 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.98 89.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.808 0.337 . . . . 1.0 110.589 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.96 140.81 43.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.486 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.25 135.95 54.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' B' ' 689' ' ' LYS . 97.3 mt-10 -119.03 128.13 54.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.252 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -129.09 142.72 50.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.936 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 64.0 m -116.42 151.91 35.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.888 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 964' ' ' ILE . 18.1 mt 57.01 78.96 0.35 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.419 -0.809 . . . . 1.0 111.711 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -62.25 149.68 89.73 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.52 2.147 . . . . 1.0 111.255 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.07 -42.94 98.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.165 1.172 . . . . 1.0 114.165 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.72 -52.94 54.15 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.368 -0.533 . . . . 1.0 111.73 -176.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -58.09 -39.22 78.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.839 -0.345 . . . . 1.0 111.751 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 68.6 t -64.27 -45.22 96.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.629 0.728 . . . . 1.0 109.156 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.46 -42.86 99.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.645 -1.161 . . . . 1.0 110.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.28 -44.49 99.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.649 -0.25 . . . . 1.0 110.847 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.44 93.35 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.447 -0.882 . . . . 1.0 110.913 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.46 -46.03 97.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.804 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.24 -42.62 99.24 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.8 93.34 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.807 -0.711 . . . . 1.0 111.454 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.42 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -62.13 -42.49 99.73 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.718 -0.953 . . . . 1.0 110.718 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.07 -42.12 99.6 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.837 -0.214 . . . . 1.0 110.791 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.17 -41.27 98.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.196 -0.601 . . . . 1.0 109.9 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . 0.518 ' HB3' HD21 ' B' ' 705' ' ' LEU . 89.3 mt -61.97 -41.43 98.0 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.231 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.611 HD11 ' HA3' ' B' ' 708' ' ' GLY . 0.8 OUTLIER -61.17 -43.19 99.27 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.909 -0.316 . . . . 1.0 110.981 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.2 m -61.84 -47.02 86.93 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.601 -0.44 . . . . 1.0 111.219 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.29 -43.92 98.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.515 -0.474 . . . . 1.0 111.605 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.33 -43.27 98.25 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.1 -45.72 98.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.921 -0.312 . . . . 1.0 111.351 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.21 -42.31 99.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.559 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.49 -42.47 99.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.321 -0.552 . . . . 1.0 111.566 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 65.7 mtt -65.21 -42.39 93.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.802 0.334 . . . . 1.0 111.37 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.404 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.72 -43.69 95.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.232 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -34.06 76.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.07 0.462 . . . . 1.0 111.893 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.4 t -77.28 -1.92 4.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.535 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 69.83 10.44 64.47 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.79 -1.724 . . . . 1.0 108.79 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -44.43 72.01 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.414 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 51.8 m-85 -82.81 -12.25 57.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 119.816 -0.754 . . . . 1.0 110.705 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -80.27 -11.37 59.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.756 -1.202 . . . . 1.0 107.756 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.539 HH12 ' CG ' ' B' ' 723' ' ' ASP . 78.6 ttt-85 -66.48 131.26 45.66 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.057 -0.657 . . . . 1.0 109.698 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 64.8 t30 56.39 38.32 29.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.167 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -160.48 66.86 2.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.544 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--N 1.305 -1.729 0 C-N-CA 122.803 2.335 . . . . 1.0 112.106 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.501 -1.44 . . . . 1.0 109.501 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 55.21 30.51 14.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 1.0 110.607 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 20.5 p -172.72 72.67 0.42 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.626 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.61 145.3 97.75 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.883 2.389 . . . . 1.0 111.937 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 961' ' ' GLU . 98.8 mttt -63.05 -42.01 99.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.618 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . 0.463 ' CB ' ' CD ' ' B' ' 691' ' ' PRO . 0.0 OUTLIER -85.75 -178.36 1.13 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.371 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' B' ' 690' ' ' CYS . 12.1 Cg_exo -67.58 154.46 73.47 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.545 2.163 . . . . 1.0 110.945 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.25 139.32 58.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.314 -0.554 . . . . 1.0 110.328 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.69 -43.68 98.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.803 -0.635 . . . . 1.0 112.305 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.42 -42.15 99.22 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.497 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.35 -45.2 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.4 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.6 t -63.79 -44.69 98.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.019 0.438 . . . . 1.0 110.453 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.04 -43.43 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.0 mt -64.14 -42.27 96.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.117 0.484 . . . . 1.0 110.663 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 48.6 p -62.27 -39.52 93.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 1.0 112.203 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.42 -45.87 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.135 0.493 . . . . 1.0 110.591 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.49 -39.38 94.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.797 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.14 97.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.106 -1.198 . . . . 1.0 110.106 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.04 90.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.02 0.438 . . . . 1.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.443 HG22 HD23 ' A' ' 980' ' ' LEU . 27.2 mm -60.84 -42.25 91.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.329 -0.948 . . . . 1.0 108.82 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 979' ' ' LEU . 83.4 mt -61.2 -44.18 97.69 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.831 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -44.02 95.78 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.136 -0.626 . . . . 1.0 110.227 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.26 98.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.581 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 980' ' ' LEU . . . -67.51 -41.89 89.65 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 78.8 mt -67.43 -37.82 83.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.33 -56.58 20.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 120.187 -0.605 . . . . 1.0 112.313 -176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.4 Cg_exo -53.83 -44.35 49.97 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.192 1.261 . . . . 1.0 111.734 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.482 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -64.73 -42.46 95.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.852 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.96 -39.75 94.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.633 0.73 . . . . 1.0 110.173 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -46.93 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.461 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.86 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.2 t90 -63.43 -47.29 82.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.282 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -44.12 95.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.816 0.302 . . . . 1.0 111.816 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.29 -42.09 99.04 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.473 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.0 -41.61 98.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.86 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.2 mt -63.23 -45.05 99.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.213 -0.595 . . . . 1.0 110.234 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.3 m -60.35 -47.14 87.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.864 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.53 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.388 . . . . 1.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' B' ' 725' ' ' LYS . 7.6 m80 -58.98 -41.57 87.88 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.183 -0.607 . . . . 1.0 109.519 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.539 ' CG ' HH12 ' A' ' 995' ' ' ARG . 3.0 m-20 -65.68 -38.14 88.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.136 -0.484 . . . . 1.0 112.146 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -64.78 -39.33 93.43 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.411 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' B' ' 722' ' ' HIS . 68.8 mttm -103.12 145.85 29.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.992 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 138.44 58.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.572 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.59 179.79 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.531 -1.428 . . . . 1.0 109.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.97 89.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.784 0.326 . . . . 1.0 110.536 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.97 -42.12 99.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.87 -39.38 90.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.44 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.93 138.7 58.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.943 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -128.33 145.31 51.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.436 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 85.8 m -116.46 148.43 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.579 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.418 ' O ' HG22 ' A' ' 964' ' ' ILE . 60.3 mt 56.15 79.69 0.32 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.278 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -60.77 149.25 88.89 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.445 2.097 . . . . 1.0 111.21 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.99 -39.17 82.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 113.715 1.006 . . . . 1.0 113.715 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.439 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.43 -51.84 66.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 119.699 -0.801 . . . . 1.0 111.181 -176.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -57.38 -37.9 73.4 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.244 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 68.6 t -64.11 -44.74 97.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.24 -42.49 99.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.024 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.1 t -63.27 -44.76 99.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.0 110.948 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.56 95.73 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.6 t -62.11 -45.2 99.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 110.345 -0.242 . . . . 1.0 110.345 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.03 -42.49 99.79 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.765 -0.374 . . . . 1.0 111.284 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.63 96.1 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.768 -0.73 . . . . 1.0 111.298 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -41.83 99.61 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.93 -40.94 99.15 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.746 -0.267 . . . . 1.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 88.0 mt -62.37 -42.11 99.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.202 -0.599 . . . . 1.0 110.582 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.05 -41.16 97.84 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.178 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.544 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.8 mt -61.52 -41.19 96.95 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 1.0 110.677 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.7 m -61.5 -47.13 87.02 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.471 -0.492 . . . . 1.0 111.469 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.17 -44.23 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.64 -42.44 98.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.134 -0.626 . . . . 1.0 111.468 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 980' ' ' LEU . 62.2 t -62.07 -45.65 98.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.881 -0.327 . . . . 1.0 111.105 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.14 -42.11 99.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.35 -42.52 99.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.384 -0.527 . . . . 1.0 111.55 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.1 mtt -65.17 -42.38 93.73 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 111.355 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.579 ' CD1' ' NZ ' ' A' ' 994' ' ' LYS . 10.9 t90 -63.12 -43.42 98.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 1.0 109.873 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.57 -34.7 77.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.118 0.485 . . . . 1.0 111.417 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 986' ' ' ALA . 52.1 t -76.96 -3.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 1.0 109.856 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.77 8.68 73.28 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.408 -1.477 . . . . 1.0 109.408 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.402 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.26 -45.45 76.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.277 -1.008 . . . . 1.0 108.277 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.408 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.5 m-85 -79.86 -24.31 41.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.354 177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.579 ' NZ ' ' CD1' ' A' ' 988' ' ' TRP . 56.1 mttp -64.3 -39.55 94.14 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 118.816 -1.154 . . . . 1.0 108.704 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.526 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.1 ttt-85 -66.13 132.0 47.48 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.147 -0.621 . . . . 1.0 110.555 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.57 ' CB ' HD11 ' B' ' 719' ' ' ILE . 52.3 p-10 -146.51 -28.84 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 996' ' ' ASN . 3.8 ttm180 -174.05 74.49 0.35 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.699 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 C--N 1.307 -1.622 0 C-N-CA 122.597 2.198 . . . . 1.0 112.146 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.539 -1.424 . . . . 1.0 109.539 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -134.36 147.0 50.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 1.0 110.563 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 2.7 m 42.51 70.38 1.79 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.515 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.89 -37.63 85.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.014 2.476 . . . . 1.0 112.092 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.71 -41.81 99.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.481 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.58 173.07 8.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.906 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.51 142.81 96.29 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.968 1.779 . . . . 1.0 112.047 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -67.7 140.97 56.78 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.594 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.06 -43.69 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.335 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . 0.555 ' O ' HD13 ' B' ' 698' ' ' LEU . 98.0 mt -62.97 -42.05 99.72 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.951 -0.299 . . . . 1.0 110.977 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.09 -44.95 99.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.969 0.414 . . . . 1.0 111.053 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' B' ' 699' ' ' SER . 69.2 t -64.19 -43.79 97.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.404 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.47 -43.4 98.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.751 -178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . 0.555 HD13 ' O ' ' B' ' 694' ' ' LEU . 9.3 mp -65.1 -41.34 95.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.19 0.519 . . . . 1.0 110.349 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 30.7 p -62.37 -37.11 84.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.165 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.43 -44.9 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.353 -0.539 . . . . 1.0 109.916 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.7 mtp -61.92 -40.0 93.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.197 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.04 -41.51 97.17 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.35 -38.27 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 1.0 110.409 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 980' ' ' LEU . 27.3 mm -62.95 -43.18 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.447 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.544 ' HA ' HD21 ' A' ' 980' ' ' LEU . 52.5 tp -59.5 -47.7 84.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.331 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.96 -42.5 99.84 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.206 -0.598 . . . . 1.0 111.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.56 -44.38 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.726 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.33 94.34 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.959 -0.857 . . . . 1.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 713' ' ' LEU . 86.2 mt -67.02 -37.56 84.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.65 -57.23 16.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 120.008 -0.677 . . . . 1.0 112.092 -176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 35.4 Cg_exo -55.24 -45.14 42.61 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.917 1.078 . . . . 1.0 111.331 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.35 -41.87 93.4 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.448 -0.797 . . . . 1.0 110.86 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 709' ' ' LEU . 35.6 mt -62.8 -41.43 99.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.961 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.5 -44.34 98.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.429 ' HE1' HD12 ' B' ' 719' ' ' ILE . 5.8 t90 -63.04 -48.6 78.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.095 0.474 . . . . 1.0 109.803 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.68 -45.73 93.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.555 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.81 -46.14 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.213 -0.595 . . . . 1.0 111.036 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.35 -43.11 98.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.617 0.599 . . . . 1.0 112.617 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 996' ' ' ASN . 6.9 tt -67.19 -41.37 86.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 119.896 -0.722 . . . . 1.0 109.924 -178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 88.8 m -60.66 -44.83 95.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.819 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.29 -43.43 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.062 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -60.08 -40.85 90.97 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.04 -0.664 . . . . 1.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 62.9 t0 -65.67 -41.07 92.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.973 -0.558 . . . . 1.0 111.354 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.78 -39.28 93.35 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.729 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.54 133.35 50.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.728 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.48 138.93 57.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.452 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.065 -0.969 . . . . 1.0 110.571 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.504 -1.438 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -150.88 152.17 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.713 0.292 . . . . 1.0 110.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.4 mt -109.82 130.84 55.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.359 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.35 138.52 58.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.662 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -134.26 146.76 50.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.497 . . . . 1.0 110.446 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -129.21 145.55 51.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.69 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.51 ' O ' HG23 ' A' ' 964' ' ' ILE . 1.6 m -104.86 109.79 21.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.272 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 963' ' ' CYS . 1.3 pt -159.19 70.36 3.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.39 145.9 97.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.157 1.905 . . . . 1.0 110.812 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.6 pt -70.91 -25.37 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -61.94 -49.84 74.52 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 119.573 -0.851 . . . . 1.0 111.334 -177.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -57.72 -39.12 76.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.279 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.6 t -64.19 -45.28 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 119.826 -0.749 . . . . 1.0 109.083 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.59 -42.17 99.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.652 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.1 t -63.8 -44.63 98.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.821 0.344 . . . . 1.0 110.86 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.75 -38.97 96.06 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.4 t -61.98 -45.19 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 121.158 -0.217 . . . . 1.0 110.529 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.22 -42.5 99.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.806 0.336 . . . . 1.0 111.479 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.49 -43.54 94.55 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.23 -43.02 99.69 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.45 -41.95 98.65 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.756 -0.261 . . . . 1.0 110.951 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.14 -42.11 98.92 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.517 -0.473 . . . . 1.0 109.747 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.51 -41.25 97.02 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.859 -0.736 . . . . 1.0 109.492 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.568 HD21 ' HA ' ' B' ' 705' ' ' LEU . 85.7 mt -62.05 -41.95 98.67 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.304 -0.559 . . . . 1.0 111.238 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 97.1 m -61.72 -47.4 85.45 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.896 -0.321 . . . . 1.0 111.211 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.32 -43.76 98.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.554 -0.459 . . . . 1.0 111.326 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.71 -43.05 97.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.7 t -61.89 -45.98 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.756 0.312 . . . . 1.0 111.273 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.31 -42.56 99.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.735 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.98 -45.28 94.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.022 0.378 . . . . 1.0 112.022 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 73.7 mtm -65.66 -42.45 91.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.005 0.372 . . . . 1.0 112.005 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.7 t90 -64.42 -41.92 96.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.13 -0.486 . . . . 1.0 109.869 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.59 -33.48 75.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.24 0.543 . . . . 1.0 110.44 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 986' ' ' ALA . 62.0 t -77.31 -2.6 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.261 -0.882 . . . . 1.0 109.95 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.85 8.21 72.31 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.273 -1.531 . . . . 1.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.542 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -56.11 -45.95 79.31 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 -178.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.664 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 37.8 m-85 -72.53 -32.01 65.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.76 176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.3 95.38 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 118.494 -1.282 . . . . 1.0 109.1 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.619 HH12 ' CG ' ' B' ' 723' ' ' ASP . 7.4 mmt180 -145.11 148.5 33.7 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.176 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.517 ' ND2' ' OG1' ' B' ' 720' ' ' THR . 57.4 t30 -93.46 107.63 19.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.399 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.451 ' H ' ' HD2' ' A' ' 998' ' ' PRO . 0.1 OUTLIER 178.76 -49.25 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.103 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 997' ' ' ARG . 51.9 Cg_exo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.146 1.897 . . . . 1.0 112.066 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.477 -1.449 . . . . 1.0 109.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.91 137.25 54.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.724 0.297 . . . . 1.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.5 OUTLIER 70.06 179.89 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 23.3 Cg_exo -61.84 145.16 97.26 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.289 1.993 . . . . 1.0 111.758 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.86 -42.21 97.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.701 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 48.7 t -137.69 82.01 27.85 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.363 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.22 144.79 98.99 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 122.844 2.363 . . . . 1.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -65.79 138.68 58.08 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.949 0.881 . . . . 1.0 111.995 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 88.0 mt -62.13 -44.73 99.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 119.216 -0.994 . . . . 1.0 111.199 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . 0.458 HD22 ' N ' ' B' ' 694' ' ' LEU . 4.1 mm? -61.17 -42.05 97.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.948 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.23 -43.9 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.647 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.496 ' O ' HG23 ' B' ' 700' ' ' VAL . 69.4 t -65.31 -43.71 94.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.648 0.737 . . . . 1.0 110.799 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.95 -42.7 99.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.699 0.761 . . . . 1.0 111.637 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.81 -42.71 94.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.554 0.692 . . . . 1.0 110.697 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 58.0 p -61.27 -37.67 83.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.595 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 696' ' ' VAL . 74.6 t -63.75 -45.32 97.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.293 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.8 mtp -62.07 -39.91 94.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.408 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.31 95.8 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.36 87.59 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 120.755 0.312 . . . . 1.0 110.378 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.511 HG22 HD11 ' A' ' 980' ' ' LEU . 27.0 mm -63.01 -42.78 97.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.568 ' HA ' HD21 ' A' ' 980' ' ' LEU . 53.4 tp -60.65 -45.66 93.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.493 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.11 -42.53 99.56 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.377 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.2 mt -63.68 -43.87 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.65 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.67 -38.71 93.41 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.533 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.93 -38.23 85.79 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.21 -56.96 18.83 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.242 -0.583 . . . . 1.0 112.271 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 36.9 Cg_exo -54.67 -45.49 40.52 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.067 1.178 . . . . 1.0 111.612 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.664 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 97.0 mt -65.23 -41.89 93.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.636 -0.711 . . . . 1.0 110.905 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.18 -41.71 98.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.121 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.44 -44.15 98.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.849 ' NE1' HD11 ' B' ' 719' ' ' ILE . 7.1 t90 -60.89 -48.91 79.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.332 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.38 -42.87 96.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.573 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.1 -44.06 97.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.521 -0.471 . . . . 1.0 110.373 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.36 -42.11 99.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.269 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.849 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.5 mt -62.85 -44.68 99.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.953 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . 0.517 ' OG1' ' ND2' ' A' ' 996' ' ' ASN . 99.6 m -59.64 -46.69 88.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.971 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.59 -43.82 98.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 1.0 112.23 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -64.73 -41.12 96.19 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.619 ' CG ' HH12 ' A' ' 995' ' ' ARG . 46.3 m-20 -68.05 -40.64 82.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.086 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . 0.414 ' HG2' ' H ' ' B' ' 727' ' ' PHE . 72.7 ttt180 -123.44 114.81 20.62 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.01 -0.737 . . . . 1.0 109.01 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.8 -41.01 98.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.454 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.6 -39.18 93.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.494 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . 0.414 ' H ' ' HG2' ' B' ' 724' ' ' ARG . 83.3 t80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.065 -0.969 . . . . 1.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.87 88.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.749 0.309 . . . . 1.0 110.617 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.8 mt -110.1 131.42 55.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.499 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -117.48 134.88 54.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.149 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 963' ' ' CYS . 83.6 tt0 -134.95 149.34 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.994 0.426 . . . . 1.0 110.457 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.04 -42.4 98.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.094 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 961' ' ' GLU . 1.5 m -53.54 -34.11 57.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.894 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.09 83.99 45.2 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.318 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.57 147.75 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.391 2.061 . . . . 1.0 112.334 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.42 -42.56 96.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.772 -1.104 . . . . 1.0 113.904 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.456 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.98 -52.36 50.97 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.459 -0.496 . . . . 1.0 111.532 -176.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -57.62 -39.21 76.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.848 -0.341 . . . . 1.0 111.349 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.9 t -64.1 -45.5 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 119.805 -0.758 . . . . 1.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.65 -41.8 99.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.414 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.8 t -63.14 -44.89 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.887 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.85 96.52 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.87 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.298 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.32 -43.22 98.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.15 91.58 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.894 -0.669 . . . . 1.0 111.949 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.405 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.78 -41.36 99.61 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 120.365 -0.922 . . . . 1.0 110.804 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.5 OUTLIER -62.86 -41.44 99.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 110.159 -0.312 . . . . 1.0 110.159 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.82 -41.58 99.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.052 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.35 -41.17 98.37 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.353 -0.939 . . . . 1.0 109.641 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.0 mt -61.96 -41.31 97.86 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.007 0.908 . . . . 1.0 110.972 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 37.0 m -61.37 -46.51 89.9 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 118.596 -1.242 . . . . 1.0 111.018 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.83 -42.62 97.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 120.042 -0.663 . . . . 1.0 110.555 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 983' ' ' LEU . 75.1 mt -64.03 -41.81 97.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.363 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.8 t -63.65 -44.87 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 123.328 0.393 . . . . 1.0 110.6 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.89 -42.03 97.57 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 110.14 -0.319 . . . . 1.0 110.14 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.51 -43.27 99.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.884 0.849 . . . . 1.0 111.437 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.86 -40.98 97.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.434 ' HE1' ' HE3' ' A' ' 994' ' ' LYS . 10.4 t90 -64.6 -45.44 86.96 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.349 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.88 -33.55 74.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.984 0.735 . . . . 1.0 112.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 10.9 m -85.57 0.87 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 118.668 -1.213 . . . . 1.0 108.82 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 74.19 15.07 80.15 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.347 -1.297 . . . . 1.0 110.967 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.512 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.88 -45.18 67.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.565 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 45.5 m-85 -81.82 -3.31 53.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.564 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 991' ' ' GLY . 75.5 mmtt -105.78 11.77 31.63 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.521 ' NH1' ' OD1' ' A' ' 996' ' ' ASN . 78.2 ttt-85 -66.47 130.99 45.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.061 -0.656 . . . . 1.0 109.739 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.521 ' OD1' ' NH1' ' A' ' 995' ' ' ARG . 11.8 m120 55.81 35.1 24.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.343 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -170.61 69.35 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.536 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.305 -1.739 0 C-N-CA 122.684 2.256 . . . . 1.0 112.175 179.885 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.02 138.08 58.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.825 0.345 . . . . 1.0 110.575 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.1 OUTLIER -66.25 -179.95 0.43 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.194 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 22.9 Cg_exo -61.76 145.29 97.4 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.108 1.872 . . . . 1.0 111.891 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.07 -41.92 99.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.648 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.54 171.17 6.72 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.24 143.25 98.25 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.563 1.508 . . . . 1.0 111.638 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.82 140.26 57.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.013 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.58 -43.58 98.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.0 mt -62.98 -41.7 99.63 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.053 -0.259 . . . . 1.0 111.137 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.8 -46.41 96.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.415 ' O ' HG23 ' B' ' 700' ' ' VAL . 18.9 m -65.54 -40.38 87.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.134 -0.627 . . . . 1.0 110.235 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.98 -43.97 97.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.727 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.36 -42.29 96.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.103 0.478 . . . . 1.0 110.695 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 37.5 p -62.27 -38.1 88.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.637 -0.71 . . . . 1.0 111.902 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.415 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.0 t -63.48 -45.14 98.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.125 0.488 . . . . 1.0 110.388 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 85.7 mtp -62.11 -38.98 90.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.464 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.22 -41.6 96.76 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.279 -1.129 . . . . 1.0 110.279 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.89 86.07 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.831 0.348 . . . . 1.0 110.284 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.405 HG21 ' C ' ' A' ' 976' ' ' GLY . 26.6 mm -62.61 -43.07 98.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.376 -0.601 . . . . 1.0 109.376 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.503 ' HA ' HD21 ' A' ' 980' ' ' LEU . 86.8 mt -61.16 -44.46 97.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.262 -0.427 . . . . 1.0 110.332 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.82 -43.33 99.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.908 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.67 -44.64 98.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.64 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.99 -40.13 88.89 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.431 -0.668 . . . . 1.0 111.431 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.2 mt -67.23 -38.07 84.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.769 1.025 . . . . 1.0 113.769 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.34 -57.01 18.61 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 120.309 -0.556 . . . . 1.0 112.024 -176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 33.0 Cg_exo -54.65 -44.65 47.57 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.14 1.227 . . . . 1.0 111.604 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.6 mt -64.93 -41.64 95.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.585 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.59 -41.46 98.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.196 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.12 -44.22 99.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.565 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.6 t90 -62.36 -48.77 78.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.595 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.5 OUTLIER -60.53 -45.02 95.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.446 -178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.58 -42.34 98.31 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.988 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.98 -42.46 99.84 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.706 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 3.9 mm -63.84 -44.26 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.19 -0.604 . . . . 1.0 109.709 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.6 m -60.37 -45.78 92.3 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.81 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.08 -43.69 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.868 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -62.35 -40.52 96.68 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.686 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.443 ' CG ' HH12 ' A' ' 995' ' ' ARG . 31.6 t70 -66.02 -39.82 90.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.773 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -112.32 102.29 10.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.826 0.346 . . . . 1.0 110.478 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -41.98 99.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.608 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -66.07 -38.95 89.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.976 -1.011 . . . . 1.0 110.52 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.38 142.58 56.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.0 110.611 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.94 -41.79 99.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.587 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 962' ' ' ARG . 83.3 tt0 -65.55 135.84 55.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.527 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.63 -37.67 85.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.815 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.427 ' H ' ' HG2' ' A' ' 960' ' ' GLU . 78.2 ttt-85 -61.15 -42.98 99.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.543 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 99.2 m -90.09 139.43 30.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 1.0 111.032 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 964' ' ' ILE . 7.9 mt 38.78 69.38 1.6 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 1.0 111.57 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -62.54 150.12 88.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.443 2.095 . . . . 1.0 111.544 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.24 -42.79 97.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.141 1.164 . . . . 1.0 114.141 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.432 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.26 -52.45 52.6 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.694 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -57.75 -37.76 74.19 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.956 -0.298 . . . . 1.0 111.622 -176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 973' ' ' VAL . 70.3 t -64.1 -44.74 97.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.45 -42.38 99.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.706 -1.134 . . . . 1.0 110.173 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.6 t -63.44 -44.8 99.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.071 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.11 -38.33 95.4 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 969' ' ' VAL . 67.5 t -61.86 -45.07 99.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 110.208 -0.293 . . . . 1.0 110.208 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.09 -42.68 99.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.811 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.87 -43.26 96.32 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.319 -0.713 . . . . 1.0 111.319 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.67 99.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.687 -0.965 . . . . 1.0 110.687 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.9 tp -63.45 -42.05 98.65 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.523 -0.398 . . . . 1.0 111.135 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 978' ' ' LEU . 85.5 mt -62.51 -41.33 98.77 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.196 -0.601 . . . . 1.0 110.726 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.9 -41.49 97.97 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.673 -0.811 . . . . 1.0 109.797 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 984' ' ' VAL . 87.0 mt -62.21 -41.53 98.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.359 -0.536 . . . . 1.0 111.176 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.88 -46.97 87.11 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.542 -0.463 . . . . 1.0 111.16 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.05 -43.66 99.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.27 -42.46 99.14 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.733 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.4 t -62.46 -45.57 98.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.683 0.278 . . . . 1.0 111.123 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.06 -42.24 99.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.284 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.652 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.09 -41.52 98.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.985 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.86 -41.98 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.878 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 11.0 t90 -64.11 -43.82 94.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.297 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.31 -34.3 76.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.052 0.454 . . . . 1.0 111.465 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.0 t -77.32 -1.62 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 70.57 11.59 68.85 Favored Glycine 0 N--CA 1.441 -1.033 0 N-CA-C 109.134 -1.586 . . . . 1.0 109.134 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -45.06 70.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.551 -0.907 . . . . 1.0 108.551 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.51 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 62.4 m-85 -86.99 -10.29 53.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -115.56 38.15 3.36 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.588 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 62.1 ttp180 -64.63 129.22 39.01 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.57 -0.53 . . . . 1.0 109.57 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -107.7 7.62 28.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.148 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.511 ' H ' ' HG2' ' A' ' 995' ' ' ARG . 32.7 mtp180 -78.54 156.78 77.99 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.364 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 C--N 1.312 -1.388 0 C-N-CA 122.499 2.133 . . . . 1.0 112.218 179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.97 -38.72 89.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.749 0.309 . . . . 1.0 110.4 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 6.3 m -138.38 75.57 38.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.566 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -38.13 86.17 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.749 2.299 . . . . 1.0 112.005 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -127.05 144.92 50.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.7 t 55.41 62.94 6.99 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-O 121.162 0.506 . . . . 1.0 110.544 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.85 159.66 52.51 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.856 2.371 . . . . 1.0 112.132 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.1 141.88 58.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.297 0.57 . . . . 1.0 110.767 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.9 -41.51 89.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.516 -0.766 . . . . 1.0 111.192 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . 0.528 ' N ' HD12 ' B' ' 694' ' ' LEU . 11.1 mp -63.68 -41.43 98.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.324 0.583 . . . . 1.0 110.791 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.2 t -63.27 -45.28 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.85 -0.614 . . . . 1.0 111.354 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.43 ' O ' HG23 ' B' ' 700' ' ' VAL . 77.3 t -64.04 -45.43 96.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.078 0.466 . . . . 1.0 110.707 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.5 tt -62.71 -43.4 98.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.873 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.14 -42.67 96.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.007 0.432 . . . . 1.0 110.591 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.6 p -61.85 -38.95 90.16 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.201 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.5 t -64.67 -45.41 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.231 0.539 . . . . 1.0 110.094 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . 0.435 ' O ' HD13 ' B' ' 705' ' ' LEU . 86.3 mtp -62.61 -40.28 96.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 1.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.32 -41.99 97.95 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.501 -1.04 . . . . 1.0 110.501 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.46 86.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.957 0.408 . . . . 1.0 110.174 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.496 HG22 HD11 ' A' ' 980' ' ' LEU . 26.8 mm -62.17 -42.31 94.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 119.765 -0.774 . . . . 1.0 109.576 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.0 mp -61.73 -44.05 97.65 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.135 -0.626 . . . . 1.0 110.617 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.06 -43.62 98.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 119.751 -0.779 . . . . 1.0 110.656 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.07 -47.92 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 1.0 111.673 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . 0.413 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -69.47 -39.22 80.07 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.862 -0.685 . . . . 1.0 111.546 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.13 -37.4 81.05 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.526 0.935 . . . . 1.0 113.526 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.17 -56.32 23.13 Favored Pre-proline 0 CA--C 1.531 0.231 0 C-N-CA 120.253 -0.579 . . . . 1.0 111.955 -176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.4 Cg_exo -53.29 -43.07 60.43 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.125 1.217 . . . . 1.0 112.187 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.488 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.28 -41.49 94.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.218 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.07 -41.34 99.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.38 -43.98 98.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.217 -0.66 . . . . 1.0 109.217 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.684 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.6 t90 -60.77 -48.49 81.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.314 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -45.36 94.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.587 -0.733 . . . . 1.0 111.482 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.1 -45.14 94.8 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.431 -0.507 . . . . 1.0 110.645 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . 0.518 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 87.0 mt -61.5 -42.28 98.55 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.649 -0.42 . . . . 1.0 110.683 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.684 HD11 ' NE1' ' B' ' 715' ' ' TRP . 92.0 mt -63.42 -44.11 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.513 -0.475 . . . . 1.0 110.567 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 19.5 m -59.84 -46.61 88.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.437 -0.505 . . . . 1.0 110.834 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.03 -43.04 97.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.966 -0.294 . . . . 1.0 111.621 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 47.1 m80 -58.21 -39.97 80.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 120.064 -0.654 . . . . 1.0 109.789 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.588 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 55.4 m-20 -63.69 -38.78 92.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.304 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.91 -42.71 99.4 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.21 -0.596 . . . . 1.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 57.2 75.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.434 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.86 -38.82 89.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.242 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . 0.446 ' CD2' ' OXT' ' B' ' 727' ' ' PHE . 89.2 t80 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.666 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.677 -1.369 . . . . 1.0 109.677 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . 0.435 ' O ' ' OE2' ' A' ' 961' ' ' GLU . . . -63.93 -38.26 90.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.686 0.279 . . . . 1.0 110.766 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.03 -41.7 99.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.754 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.28 -35.63 80.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.268 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 958' ' ' ALA . 80.0 mm-40 63.28 33.23 14.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.796 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -129.25 138.66 51.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.795 0.331 . . . . 1.0 110.336 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.3 m -86.41 -31.63 21.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.479 0.548 . . . . 1.0 112.479 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 964' ' ' ILE . 3.1 tt -140.96 74.04 26.33 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.353 -0.539 . . . . 1.0 112.074 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.36 149.31 91.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.632 2.222 . . . . 1.0 111.356 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.25 -42.73 97.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.44 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.76 -52.2 50.56 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.384 -176.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -57.67 -38.59 75.38 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.616 -0.433 . . . . 1.0 111.572 -176.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.1 t -64.12 -45.35 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.82 -0.752 . . . . 1.0 109.098 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.57 -42.69 99.71 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.303 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.9 t -63.28 -44.72 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.04 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.52 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.569 -0.824 . . . . 1.0 111.308 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.2 t -61.55 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 110.225 -0.287 . . . . 1.0 110.225 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.32 -42.63 99.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.769 0.319 . . . . 1.0 111.644 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.39 -45.41 90.61 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.49 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.97 -43.03 99.74 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.15 -41.89 99.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.806 -0.232 . . . . 1.0 110.518 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.11 -41.97 98.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.535 -0.466 . . . . 1.0 109.78 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.7 -41.55 97.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.756 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.4 mt -61.87 -41.65 98.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.677 -0.409 . . . . 1.0 111.074 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.1 m -61.46 -46.98 87.77 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.952 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.12 -43.84 99.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.155 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.0 -43.06 99.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.645 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 980' ' ' LEU . 69.9 t -61.79 -45.75 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.708 0.289 . . . . 1.0 111.028 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.28 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.52 -42.97 99.86 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.399 -0.52 . . . . 1.0 111.226 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.72 -42.75 95.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.877 0.37 . . . . 1.0 111.476 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.432 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 11.7 t90 -63.25 -43.55 97.71 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.23 -35.38 78.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.007 0.432 . . . . 1.0 111.569 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 986' ' ' ALA . 59.5 t -77.53 -2.57 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.441 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.33 10.87 70.73 Favored Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 109.175 -1.57 . . . . 1.0 109.175 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.47 -45.23 73.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.409 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.0 m-85 -81.26 -16.82 51.47 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.786 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.03 35.99 3.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.649 HH22 ' CB ' ' B' ' 723' ' ' ASP . 54.8 ptt85 -68.45 141.16 55.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.495 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 65.4 t30 56.55 40.93 29.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.623 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.11 162.11 0.15 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.303 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 122.755 2.303 . . . . 1.0 112.063 179.855 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 1.0 109.558 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.23 -38.58 88.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.805 0.336 . . . . 1.0 110.404 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . 0.547 ' N ' ' CD ' ' B' ' 688' ' ' PRO . 0.3 OUTLIER 178.0 -44.73 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.882 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' B' ' 687' ' ' SER . 22.6 Cg_exo -61.86 145.74 96.88 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.219 1.946 . . . . 1.0 111.986 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . 0.499 ' O ' ' SG ' ' B' ' 690' ' ' CYS . 99.2 mttt -77.61 145.88 36.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.51 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' B' ' 689' ' ' LYS . 0.5 OUTLIER 58.34 151.06 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.44 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -71.39 157.3 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.705 2.27 . . . . 1.0 113.327 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.05 157.19 38.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.623 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.0 mt -62.15 -43.66 98.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 1.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . 0.513 ' N ' HD12 ' B' ' 694' ' ' LEU . 11.1 mp -62.39 -42.14 99.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.249 -0.58 . . . . 1.0 110.399 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.43 -45.07 99.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.979 0.419 . . . . 1.0 110.604 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.435 ' O ' HG23 ' B' ' 700' ' ' VAL . 61.2 t -63.99 -44.22 97.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.07 -43.52 98.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.248 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.41 -42.4 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.231 0.539 . . . . 1.0 110.869 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 45.1 p -62.45 -37.45 85.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.645 -0.707 . . . . 1.0 111.751 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.2 t -63.64 -44.9 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.14 0.495 . . . . 1.0 110.651 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 89.9 mtp -62.97 -39.09 93.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.907 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.59 -42.2 95.69 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.435 -1.066 . . . . 1.0 110.435 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.36 -38.6 84.36 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.808 0.337 . . . . 1.0 111.02 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.49 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.5 mm -60.8 -42.4 92.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.528 -0.915 . . . . 1.0 108.528 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.531 ' HA ' HD21 ' A' ' 980' ' ' LEU . 95.4 mt -59.64 -45.71 91.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 120.104 -0.638 . . . . 1.0 110.895 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . 0.419 ' N ' HD12 ' B' ' 706' ' ' LEU . 11.1 mp -62.92 -42.31 99.75 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.884 -0.726 . . . . 1.0 111.481 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . 0.407 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 31.7 mm -63.69 -45.61 96.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.803 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.77 -41.02 84.74 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.722 -0.752 . . . . 1.0 111.448 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.49 -37.8 85.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.99 -57.13 19.27 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.201 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 43.9 Cg_exo -53.85 -43.67 55.97 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.085 1.19 . . . . 1.0 111.337 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 89.0 mt -65.28 -41.82 93.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.758 -0.656 . . . . 1.0 110.818 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.86 -41.44 99.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.928 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.75 -44.22 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.409 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.0 t90 -62.36 -48.07 81.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.644 ' O ' HG23 ' B' ' 720' ' ' THR . 0.1 OUTLIER -59.45 -44.61 92.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.16 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . 0.407 ' O ' ' OG1' ' B' ' 720' ' ' THR . 50.7 tp -64.03 -45.54 88.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.258 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.99 -43.24 99.32 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.59 -40.88 85.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.483 -0.887 . . . . 1.0 110.27 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . 0.644 HG23 ' O ' ' B' ' 716' ' ' LYS . 40.6 p -57.72 -44.34 85.91 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.319 -0.553 . . . . 1.0 110.649 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.38 -43.35 98.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.669 -0.413 . . . . 1.0 111.268 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -64.38 -40.19 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.649 ' CB ' HH22 ' A' ' 995' ' ' ARG . 34.8 t70 -65.92 -39.89 90.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.29 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -61.47 -43.0 99.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.937 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -67.99 134.5 50.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.523 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -110.61 124.13 51.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 117.995 -1.002 . . . . 1.0 110.704 -179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.554 -1.418 . . . . 1.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.27 143.22 56.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 1.0 110.643 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 959' ' ' LEU . 11.0 mp -62.77 -41.65 99.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.448 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 57.05 55.33 6.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.655 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.49 -38.74 90.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.452 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.66 146.56 50.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.541 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.2 -25.02 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.643 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 964' ' ' ILE . 93.9 mt -130.91 77.17 75.86 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.611 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -61.93 148.52 92.96 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.752 2.301 . . . . 1.0 112.7 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.7 -42.33 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.886 -1.052 . . . . 1.0 113.588 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.469 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -50.39 -51.48 45.73 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.261 -0.575 . . . . 1.0 111.074 -176.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -57.14 -37.84 72.62 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.254 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.39 -45.0 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 1.0 109.223 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.75 -41.68 99.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.744 -1.117 . . . . 1.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.9 t -63.3 -44.3 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.543 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.02 -39.73 96.07 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.86 -45.78 97.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.606 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.31 -42.78 99.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.5 -46.25 78.68 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.029 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.75 -42.17 99.33 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.649 -0.981 . . . . 1.0 110.649 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.74 -40.86 97.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.939 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.99 -42.25 98.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.18 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.0 mp -61.5 -40.78 95.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 119.058 -1.057 . . . . 1.0 109.76 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' B' ' 705' ' ' LEU . 89.6 mt -60.88 -41.31 95.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.281 -0.568 . . . . 1.0 110.508 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.4 m -60.96 -46.76 89.42 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.462 0.648 . . . . 1.0 110.629 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.79 -44.13 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 119.479 -0.888 . . . . 1.0 111.996 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.27 -41.76 99.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.315 -0.954 . . . . 1.0 111.264 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 980' ' ' LEU . 61.1 t -62.86 -46.61 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 10.5 mp -64.46 -41.7 96.37 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.369 -0.532 . . . . 1.0 110.658 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.656 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.88 -42.12 98.68 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.036 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 61.5 mtt -65.28 -42.41 93.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.137 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.695 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.7 t90 -64.26 -42.94 96.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 1.0 109.889 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.62 -34.5 77.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.117 0.484 . . . . 1.0 111.331 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.05 -1.91 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.678 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.66 8.82 68.42 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 109.113 -1.595 . . . . 1.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -56.05 -44.24 78.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 117.233 0.516 . . . . 1.0 109.785 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.495 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 36.7 m-85 -81.83 -23.07 36.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.492 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.695 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 68.5 mttm -63.65 -39.06 93.39 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 118.736 -1.185 . . . . 1.0 108.731 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 78.9 ttt-85 -65.62 120.59 13.21 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.789 -0.764 . . . . 1.0 111.125 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -119.05 -4.78 10.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.192 -0.913 . . . . 1.0 109.666 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 166.25 151.86 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 122.201 1.934 . . . . 1.0 112.098 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.74 -1.344 . . . . 1.0 109.74 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.97 125.26 53.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.836 0.351 . . . . 1.0 110.468 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 1.9 t 172.73 73.26 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.651 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -53.83 -38.61 85.64 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.891 2.394 . . . . 1.0 112.075 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.47 133.87 50.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.618 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m 53.21 78.68 0.38 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.435 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -61.36 145.38 98.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.715 2.277 . . . . 1.0 112.101 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -65.24 142.94 58.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.28 -43.49 98.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.103 -0.498 . . . . 1.0 111.792 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.34 -42.27 99.25 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.43 -0.508 . . . . 1.0 109.978 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.0 -44.81 99.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.941 0.4 . . . . 1.0 110.189 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.8 t -63.39 -44.31 98.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.24 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.63 -43.92 97.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.92 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.44 -41.89 96.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.949 0.404 . . . . 1.0 110.661 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 44.7 p -62.41 -37.91 87.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 1.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.5 t -64.06 -44.77 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.008 0.432 . . . . 1.0 110.245 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 53.6 mtt -63.19 -39.06 93.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.729 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.99 -42.23 92.75 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.32 94.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.225 0.536 . . . . 1.0 110.987 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 980' ' ' LEU . 23.8 mm -60.0 -42.18 88.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.248 -0.887 . . . . 1.0 109.553 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 980' ' ' LEU . 91.6 mt -58.94 -44.62 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.338 0.399 . . . . 1.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.35 -41.72 98.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.598 -0.441 . . . . 1.0 110.76 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.04 -45.17 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.374 -0.531 . . . . 1.0 111.188 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -68.35 -39.73 87.47 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.526 -0.845 . . . . 1.0 111.117 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.73 -37.88 85.55 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.44 -56.38 25.14 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 120.547 -0.461 . . . . 1.0 112.056 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.8 Cg_exo -53.86 -43.25 59.74 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.097 1.198 . . . . 1.0 111.379 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.8 mt -66.31 -41.21 90.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.43 -0.805 . . . . 1.0 111.169 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 37.7 mt -63.05 -42.37 99.71 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.231 0.456 . . . . 1.0 112.231 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 41.5 pt -66.28 -41.75 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.005 -0.678 . . . . 1.0 110.046 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.495 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.3 t90 -59.92 -48.84 80.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 1.0 110.109 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.16 -42.37 98.44 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.248 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.36 -44.0 96.04 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.38 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.49 -43.2 99.28 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.592 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -43.12 95.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.31 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 99.0 m -59.07 -45.8 89.88 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 119.702 -0.799 . . . . 1.0 110.612 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 95.4 mt -61.79 -43.26 97.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.975 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -64.8 -38.77 92.11 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 62.1 t0 -67.48 -41.46 84.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.658 -0.701 . . . . 1.0 110.305 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -135.04 118.19 16.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.32 -44.04 97.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 1.0 110.339 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.78 126.74 55.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.451 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . 0.487 ' OXT' ' CG ' ' B' ' 727' ' ' PHE . 89.3 t80 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.017 -0.992 . . . . 1.0 110.704 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.05 143.12 56.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 1.0 110.594 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.38 126.1 54.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.537 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -134.19 145.92 49.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.491 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -136.49 147.35 47.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.63 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -102.25 136.83 41.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.403 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 3.6 m -88.14 126.92 35.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.122 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 964' ' ' ILE . 1.3 tt -178.72 69.26 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.837 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -60.97 139.32 84.12 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.087 1.858 . . . . 1.0 111.57 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.99 -44.71 92.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -71.47 -55.67 7.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 120.175 -0.61 . . . . 1.0 112.379 -177.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . 0.65 ' CE2' HD12 ' B' ' 693' ' ' ILE . 94.5 m95 -57.64 -40.23 78.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 119.347 -0.359 . . . . 1.0 111.814 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.44 -46.2 93.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 119.446 -0.902 . . . . 1.0 110.135 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.86 -43.37 98.97 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.056 -0.974 . . . . 1.0 110.873 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.1 t -62.45 -44.3 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.71 -0.223 . . . . 1.0 110.747 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.11 92.71 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.188 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.77 -46.36 96.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.726 -0.39 . . . . 1.0 111.111 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.43 -43.15 98.27 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.592 0.589 . . . . 1.0 112.592 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.4 -45.24 91.28 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.921 -0.657 . . . . 1.0 111.734 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.415 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.87 -43.01 99.79 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 110.882 -0.887 . . . . 1.0 110.882 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.75 -41.8 99.38 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.615 -0.344 . . . . 1.0 110.632 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.26 -42.38 99.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.583 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.27 -40.33 89.97 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.754 -1.178 . . . . 1.0 109.134 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' B' ' 705' ' ' LEU . 88.5 mt -62.59 -41.52 99.0 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.645 -0.822 . . . . 1.0 112.075 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.1 m -61.96 -47.02 86.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.608 -0.437 . . . . 1.0 111.706 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 43.6 pt -64.74 -41.95 93.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.877 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.99 -42.83 99.95 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.1 t -62.22 -45.53 98.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 121.103 -0.239 . . . . 1.0 111.179 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.32 -42.26 98.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.308 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.39 -42.89 99.77 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.746 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.6 mtp -65.37 -42.35 92.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 1.0 111.252 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.619 ' HE1' ' HZ2' ' A' ' 994' ' ' LYS . 10.3 t90 -62.53 -42.5 99.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.83 -33.44 74.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.167 0.508 . . . . 1.0 110.975 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -77.45 -2.97 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.444 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 72.28 10.1 73.78 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.452 -1.459 . . . . 1.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.513 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -55.48 -45.25 77.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.795 -0.816 . . . . 1.0 108.795 -177.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.573 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 49.7 m-85 -79.19 -15.84 57.47 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.16 -0.616 . . . . 1.0 110.49 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.619 ' HZ2' ' HE1' ' A' ' 988' ' ' TRP . 99.1 mttt -112.94 33.71 4.87 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.592 -1.262 . . . . 1.0 107.592 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 991' ' ' GLY . 66.1 ttp85 -66.63 120.07 12.82 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.205 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.84 -41.5 95.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.801 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.529 ' C ' HH11 ' A' ' 995' ' ' ARG . 0.1 OUTLIER -160.43 160.16 26.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.736 -178.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . 0.526 ' N ' ' NH1' ' A' ' 995' ' ' ARG . 29.8 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 122.454 2.103 . . . . 1.0 111.953 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 N-CA-C 109.816 -1.314 . . . . 1.0 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 686' ' ' GLU . 54.9 mp0 -66.4 -38.72 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 1.0 110.146 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 8.5 m -145.8 75.08 13.32 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.534 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.43 145.08 98.43 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.596 2.197 . . . . 1.0 112.004 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.1 -41.93 99.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m -74.78 164.03 64.17 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.194 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -61.84 151.28 81.94 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.791 1.661 . . . . 1.0 110.965 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -62.0 139.39 58.42 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.911 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 968' ' ' TRP . 44.8 pt -62.66 -41.85 93.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.994 -0.548 . . . . 1.0 112.132 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.16 -42.55 99.37 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.293 -0.563 . . . . 1.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.4 t -62.32 -44.84 99.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.133 0.492 . . . . 1.0 110.266 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.413 ' O ' HG23 ' B' ' 700' ' ' VAL . 75.6 t -63.23 -43.74 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.966 -0.561 . . . . 1.0 109.642 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . 0.519 HD22 ' CE3' ' A' ' 968' ' ' TRP . 45.8 tp -61.33 -44.03 97.88 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.782 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.16 -42.42 96.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.048 0.452 . . . . 1.0 110.686 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 46.1 p -62.21 -39.05 91.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.814 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 696' ' ' VAL . 72.3 t -63.58 -44.89 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.119 0.485 . . . . 1.0 110.8 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.7 mtp -62.87 -39.35 94.17 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.33 95.47 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.62 80.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 980' ' ' LEU . 27.1 mm -61.84 -42.46 94.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.84 -0.744 . . . . 1.0 109.436 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.662 ' O ' HD13 ' B' ' 709' ' ' LEU . 92.0 mt -61.01 -45.67 93.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.092 -0.643 . . . . 1.0 110.665 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.35 -42.15 99.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.867 -0.733 . . . . 1.0 111.126 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -45.22 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.965 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.97 -38.26 64.42 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.869 -0.681 . . . . 1.0 111.984 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 705' ' ' LEU . 10.4 mp -68.66 -37.8 79.91 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.699 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.19 -55.58 32.68 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.303 -0.559 . . . . 1.0 112.24 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.1 Cg_exo -54.34 -43.14 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.283 1.322 . . . . 1.0 112.424 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.564 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 92.8 mt -64.89 -43.16 93.81 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.343 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . 0.438 HD13 ' O ' ' B' ' 709' ' ' LEU . 10.3 mp -63.75 -40.66 97.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.413 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.15 -44.48 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.129 -0.693 . . . . 1.0 109.129 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.573 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 5.5 t90 -63.43 -48.61 77.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 1.0 110.044 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.614 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . 0.418 ' O ' ' OG1' ' B' ' 720' ' ' THR . 53.3 tp -62.27 -44.36 96.7 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.583 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 86.0 mt -61.81 -42.61 99.23 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.856 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.3 mm -63.75 -44.32 98.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.25 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 717' ' ' LEU . 22.6 p -59.08 -44.19 91.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.608 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.2 mm -61.89 -44.43 98.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 119.504 -0.878 . . . . 1.0 111.203 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -61.54 -39.27 90.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.495 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 4.6 m-20 -65.77 -41.3 92.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.725 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -63.48 -39.47 94.54 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.858 0.361 . . . . 1.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.07 -44.7 96.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.618 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.28 -39.86 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.634 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.544 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 144.9 55.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.745 0.307 . . . . 1.0 110.754 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.5 mt -109.04 129.94 55.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.274 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -113.81 123.35 49.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.404 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.87 138.14 55.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.392 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -140.76 152.4 45.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.493 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 87.3 m -116.79 168.31 10.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.376 0.608 . . . . 1.0 112.174 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 11.3 pt 32.99 75.97 0.41 Allowed Pre-proline 0 N--CA 1.462 0.131 0 CA-C-N 114.706 -1.134 . . . . 1.0 111.956 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -62.15 148.52 93.05 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.782 2.322 . . . . 1.0 111.405 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.3 -42.82 97.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 114.221 1.193 . . . . 1.0 114.221 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.41 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -52.14 -53.07 47.42 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.518 -0.473 . . . . 1.0 111.691 -176.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -57.09 -39.05 74.27 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.685 -0.406 . . . . 1.0 111.586 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.75 -45.29 97.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 119.702 -0.799 . . . . 1.0 109.48 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.62 -41.66 99.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.061 -0.972 . . . . 1.0 110.479 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 967' ' ' TRP . 73.4 t -63.29 -45.12 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.616 -0.266 . . . . 1.0 111.158 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.64 96.07 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.142 -0.783 . . . . 1.0 111.142 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.82 -46.0 97.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.506 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.13 -42.78 99.57 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.791 0.329 . . . . 1.0 111.848 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.01 -46.82 78.62 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.005 -0.617 . . . . 1.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.426 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -60.09 -42.04 98.31 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.358 -1.097 . . . . 1.0 110.358 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.65 -41.43 98.23 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.97 0.414 . . . . 1.0 110.502 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.5 tp -61.88 -42.9 99.62 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.654 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 975' ' ' GLY . 9.2 mp -61.32 -40.85 95.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.623 -0.831 . . . . 1.0 109.897 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.0 mt -61.91 -40.45 95.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.711 -0.396 . . . . 1.0 111.181 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 99.3 m -60.85 -48.2 82.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.209 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.03 -44.15 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 120.275 -0.57 . . . . 1.0 111.769 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.68 -43.32 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.438 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 980' ' ' LEU . 79.1 t -61.9 -46.18 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 123.158 0.286 . . . . 1.0 111.124 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.26 -42.42 99.16 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.639 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.34 -43.85 97.87 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.336 -0.546 . . . . 1.0 111.752 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.2 mtt -64.52 -42.47 95.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.618 -0.433 . . . . 1.0 111.263 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -62.97 -44.37 96.24 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -60.95 -32.66 72.18 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.876 -0.515 . . . . 1.0 111.628 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.7 t -77.9 -1.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 68.54 12.81 64.6 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 108.828 -1.709 . . . . 1.0 108.828 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.51 -44.1 68.84 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.613 -1.254 . . . . 1.0 107.613 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.456 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 59.2 m-85 -81.97 -4.5 56.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.553 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.4 mttt -108.05 14.44 25.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 175.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.456 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 73.4 ttp85 -66.36 131.04 45.19 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.008 -0.677 . . . . 1.0 110.533 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -110.39 145.74 37.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.661 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.94 161.88 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--N 1.308 -1.563 0 C-N-CA 122.589 2.192 . . . . 1.0 112.375 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -97.16 138.04 35.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.847 0.355 . . . . 1.0 110.32 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.96 174.22 4.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.366 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.94 -39.32 79.16 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.128 1.885 . . . . 1.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.2 146.81 51.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.572 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . 0.471 ' CB ' ' CD ' ' B' ' 691' ' ' PRO . 0.0 OUTLIER -59.82 -178.54 0.14 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.394 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . 0.471 ' CD ' ' CB ' ' B' ' 690' ' ' CYS . 12.5 Cg_exo -67.96 154.27 73.19 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.286 1.99 . . . . 1.0 110.497 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.58 139.66 57.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.352 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.51 -43.63 98.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.671 -0.695 . . . . 1.0 112.112 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.36 -41.97 98.85 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.897 -0.321 . . . . 1.0 111.168 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.16 -46.19 97.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 112.069 0.396 . . . . 1.0 112.069 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.423 ' O ' HG23 ' B' ' 700' ' ' VAL . 22.3 m -65.47 -40.68 89.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.945 -0.702 . . . . 1.0 110.597 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 49.4 tp -61.92 -43.74 98.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.535 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.12 -42.19 96.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.197 0.522 . . . . 1.0 110.73 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 37.5 p -62.91 -38.89 92.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.003 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 696' ' ' VAL . 77.4 t -63.78 -45.27 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.413 -0.515 . . . . 1.0 110.306 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 91.8 mtp -62.57 -39.24 93.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.4 -41.69 97.97 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.91 86.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.831 0.348 . . . . 1.0 110.534 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.426 HG21 ' C ' ' A' ' 976' ' ' GLY . 25.8 mm -62.65 -42.45 96.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.475 ' HA ' HD21 ' A' ' 980' ' ' LEU . 87.3 mt -61.52 -43.8 98.21 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.427 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.82 -43.07 99.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.601 -0.44 . . . . 1.0 110.661 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.2 mt -63.89 -44.33 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.691 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.95 -40.4 73.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.917 -0.658 . . . . 1.0 111.459 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 80.5 mt -66.71 -38.14 86.13 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.66 0.985 . . . . 1.0 113.66 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.86 -56.96 20.0 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 120.277 -0.569 . . . . 1.0 111.909 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.3 Cg_exo -54.09 -44.97 44.52 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.908 1.072 . . . . 1.0 111.774 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.27 -41.77 93.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.595 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 35.8 mt -62.58 -41.46 98.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.8 mm -63.77 -44.1 98.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.408 -0.59 . . . . 1.0 109.408 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.887 ' NE1' HD11 ' B' ' 719' ' ' ILE . 10.4 t90 -62.36 -48.53 79.38 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -43.95 97.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.559 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.97 -42.77 99.93 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.89 -42.12 98.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.509 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.887 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.1 mt -63.9 -44.71 98.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.081 -0.648 . . . . 1.0 110.057 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . 0.407 HG22 ' NE ' ' B' ' 724' ' ' ARG . 96.7 m -59.51 -46.52 88.6 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.779 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.73 -43.58 98.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.163 0.506 . . . . 1.0 110.659 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -62.6 -38.64 90.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.927 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.456 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 7.6 m-20 -69.87 -42.65 73.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.832 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . 0.407 ' NE ' HG22 ' B' ' 720' ' ' THR . 87.7 mtm180 -64.71 -36.42 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 64.1 mttp 57.68 48.88 13.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.764 0.316 . . . . 1.0 110.252 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.03 138.52 58.39 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.145 0.497 . . . . 1.0 110.724 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.9 t80 . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.989 -1.005 . . . . 1.0 109.602 179.644 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 959' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.324 -1.51 . . . . 1.0 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 40.75 22.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 1.0 110.796 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 957' ' ' GLY . 88.0 mt -62.78 -41.85 99.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 1.0 110.47 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -36.58 82.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.72 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -88.16 14.31 9.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.725 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -62.32 -40.64 96.99 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.667 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 58.9 m -71.75 -27.11 62.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.321 -0.399 . . . . 1.0 111.012 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 964' ' ' ILE . 2.9 tt -135.94 71.27 63.2 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 120.78 -0.368 . . . . 1.0 111.456 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.35 150.3 87.66 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.797 2.331 . . . . 1.0 111.971 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.94 -42.58 97.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.458 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.6 -52.04 50.73 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.456 -0.497 . . . . 1.0 111.723 -176.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -57.96 -38.58 76.27 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 121.138 -0.225 . . . . 1.0 111.53 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.2 -45.05 97.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.813 -0.81 . . . . 1.0 108.813 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.49 -42.79 99.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.546 -1.206 . . . . 1.0 110.405 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.0 t -62.86 -44.71 99.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.205 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.55 93.05 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.614 -0.803 . . . . 1.0 111.163 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.92 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.765 -0.256 . . . . 1.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.96 -41.99 99.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.776 -0.37 . . . . 1.0 111.934 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.57 -43.84 93.85 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.785 -0.721 . . . . 1.0 111.304 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.78 -42.58 99.66 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.622 -0.991 . . . . 1.0 110.622 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.4 tp -63.84 -42.86 97.52 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.944 0.372 . . . . 1.0 111.582 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.34 -42.57 99.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 120.476 -0.49 . . . . 1.0 110.875 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.7 -41.3 97.42 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.635 -0.826 . . . . 1.0 109.904 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.723 HD21 HD23 ' B' ' 705' ' ' LEU . 1.4 mm? -62.76 -41.03 99.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.036 -0.266 . . . . 1.0 111.536 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 17.9 m -60.52 -45.81 92.47 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.625 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.85 -43.92 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.226 -0.59 . . . . 1.0 111.646 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.89 -44.32 93.38 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.6 0.592 . . . . 1.0 112.6 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.18 -40.62 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.817 -0.753 . . . . 1.0 111.027 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.0 -42.3 99.81 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.56 -42.04 99.29 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.329 -0.548 . . . . 1.0 111.513 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.64 -42.06 91.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.052 0.453 . . . . 1.0 111.17 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -64.05 -42.4 97.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.752 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.12 -33.46 75.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.032 0.444 . . . . 1.0 111.291 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.5 t -77.27 -0.42 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.476 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 70.67 10.14 66.68 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.38 -1.488 . . . . 1.0 109.38 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -44.33 65.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.733 -1.21 . . . . 1.0 107.733 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.502 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 57.6 m-85 -83.13 -5.44 59.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.428 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.6 mttt -95.03 -4.01 47.27 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.563 ' NH1' ' OD2' ' B' ' 723' ' ' ASP . 73.4 ttp85 -66.62 124.39 22.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.477 -0.889 . . . . 1.0 110.572 -178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -116.41 7.59 13.88 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.267 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.18 75.92 0.6 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.856 2.371 . . . . 1.0 112.103 -179.813 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.777 -1.329 . . . . 1.0 109.777 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.77 -39.43 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.964 -0.384 . . . . 1.0 109.964 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 16.8 p 45.14 71.4 1.54 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 -37.45 85.73 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.065 2.51 . . . . 1.0 112.177 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.74 -41.52 99.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.645 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.67 76.72 59.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.31 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.98 146.41 96.3 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.103 2.535 . . . . 1.0 112.687 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 145.63 55.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.28 -43.69 98.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 1.0 112.035 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . 0.494 ' N ' HD12 ' B' ' 694' ' ' LEU . 11.1 mp -62.36 -41.98 99.03 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.826 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.8 -45.32 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.743 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.418 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.1 t -63.55 -44.96 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 1.0 110.707 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.4 tt -62.41 -43.01 99.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.644 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.92 -42.28 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 1.0 110.564 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 55.3 p -62.2 -40.05 94.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.404 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 696' ' ' VAL . 71.4 t -62.69 -45.59 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.729 0.299 . . . . 1.0 110.209 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 90.5 mtp -63.57 -39.43 94.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.25 -42.33 99.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.989 -1.244 . . . . 1.0 109.989 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.09 -36.57 80.02 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.031 0.443 . . . . 1.0 110.184 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.406 HG21 ' C ' ' A' ' 976' ' ' GLY . 31.7 mm -60.97 -41.88 90.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.034 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.723 HD23 HD21 ' A' ' 980' ' ' LEU . 81.4 mt -60.56 -45.81 92.54 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.943 -0.703 . . . . 1.0 110.814 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.08 -42.91 99.75 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.276 -0.57 . . . . 1.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.2 -44.63 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.467 -0.493 . . . . 1.0 111.269 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -69.77 -40.57 75.66 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.39 -38.16 84.27 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 113.672 0.99 . . . . 1.0 113.672 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.711 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.25 -56.77 20.84 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.908 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 34.6 Cg_exo -54.71 -45.3 42.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.174 1.249 . . . . 1.0 111.455 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.09 -41.6 90.46 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.188 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.08 -41.5 99.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.759 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.5 -44.27 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.854 ' NE1' HD11 ' B' ' 719' ' ' ILE . 9.5 t90 -62.3 -48.29 80.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.794 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -44.09 96.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.71 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.88 -43.2 99.44 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.47 -42.13 98.31 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.701 -0.4 . . . . 1.0 110.282 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.854 HD11 ' NE1' ' B' ' 715' ' ' TRP . 94.3 mt -63.56 -44.06 98.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.095 -0.642 . . . . 1.0 109.511 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 18.8 m -60.26 -47.44 85.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.795 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 96.1 mt -62.18 -43.51 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.175 -0.61 . . . . 1.0 111.47 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -63.39 -35.79 81.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.563 ' OD2' ' NH1' ' A' ' 995' ' ' ARG . 28.4 m-20 -67.82 -42.89 80.78 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.72 -39.09 93.44 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.92 -0.312 . . . . 1.0 110.348 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.28 132.72 47.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.804 0.335 . . . . 1.0 110.552 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -117.99 131.58 56.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.561 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.084 -0.96 . . . . 1.0 110.546 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.33 143.17 56.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 1.0 110.543 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.4 mt -110.09 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.418 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.0 -39.0 89.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.584 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.63 125.94 54.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.372 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.02 134.27 50.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.341 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 96.8 m -98.67 140.99 32.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.528 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.455 HD11 ' HG2' ' B' ' 691' ' ' PRO . 5.6 mt 54.22 69.78 2.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.92 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -62.61 149.75 90.08 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.65 2.233 . . . . 1.0 112.008 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.36 -42.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.77 -52.24 50.32 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.418 -0.513 . . . . 1.0 111.615 -176.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -57.74 -37.94 74.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.963 -0.295 . . . . 1.0 111.511 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 973' ' ' VAL . 72.5 t -63.97 -44.72 97.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.39 -41.78 98.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.695 -1.139 . . . . 1.0 110.211 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 967' ' ' TRP . 72.2 t -63.28 -45.08 99.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.114 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.25 -38.64 95.99 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.1 t -62.03 -45.17 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 121.167 -0.213 . . . . 1.0 110.492 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.28 -42.31 99.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.73 0.3 . . . . 1.0 111.535 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . 0.402 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -65.35 -44.43 93.46 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.323 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.464 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.0 -41.85 99.59 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.93 -41.38 99.46 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.79 -0.241 . . . . 1.0 110.353 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.1 tp -61.99 -42.57 99.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.235 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 975' ' ' GLY . 8.6 mp -61.92 -41.51 98.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.155 -1.018 . . . . 1.0 110.081 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.9 mt -61.97 -42.18 98.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.95 -0.7 . . . . 1.0 111.228 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 98.2 m -61.83 -48.05 82.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.761 -0.375 . . . . 1.0 111.635 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.582 -0.447 . . . . 1.0 111.374 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . 0.489 HD11 ' HE2' ' A' ' 987' ' ' MET . 57.2 tp -63.01 -43.46 98.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.067 -0.253 . . . . 1.0 110.574 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 980' ' ' LEU . 59.7 t -62.65 -45.52 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.603 0.239 . . . . 1.0 111.158 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.76 -42.48 97.8 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.756 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.41 -41.84 98.99 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.311 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.489 ' HE2' HD11 ' A' ' 983' ' ' LEU . 62.4 mtt -65.14 -42.3 93.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.688 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.435 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.8 t90 -63.65 -42.65 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.884 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.64 -34.02 76.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.218 0.533 . . . . 1.0 111.224 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 986' ' ' ALA . 54.7 t -77.36 -2.39 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.811 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.48 9.22 68.4 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.043 -1.623 . . . . 1.0 109.043 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -56.13 -44.17 78.92 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 117.095 0.448 . . . . 1.0 109.946 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.672 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 47.3 m-85 -83.59 -21.06 32.71 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.6 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.76 -39.12 93.19 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 118.499 -1.281 . . . . 1.0 108.492 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -65.59 126.84 29.62 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.357 -0.937 . . . . 1.0 110.126 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.539 ' O ' HG23 ' B' ' 719' ' ' ILE . 9.5 m120 -121.04 -60.31 1.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.224 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 176.95 62.08 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.541 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.306 -1.699 0 C-N-CA 122.798 2.332 . . . . 1.0 112.112 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.0 -38.86 89.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 1.0 110.402 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 5.3 t 60.52 61.97 3.27 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.656 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -71.88 152.23 57.66 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.715 2.277 . . . . 1.0 112.473 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.658 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.97 84.24 44.66 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.444 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . 0.455 ' HG2' HD11 ' A' ' 964' ' ' ILE . 22.3 Cg_exo -61.54 147.06 96.33 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.583 2.189 . . . . 1.0 112.107 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.98 141.2 58.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.142 0.496 . . . . 1.0 110.387 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.35 -44.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.85 -43.78 95.14 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.91 -41.28 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.048 -0.661 . . . . 1.0 111.357 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 64.3 t -63.56 -45.97 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . 0.687 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.2 tt -62.98 -42.65 99.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.802 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.84 -42.43 97.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.092 0.472 . . . . 1.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 53.6 p -62.06 -37.94 86.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.181 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 67.7 t -63.62 -45.14 98.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.068 0.461 . . . . 1.0 110.109 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.7 mtp -61.77 -40.0 93.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.591 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.55 -40.94 98.03 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.047 -1.221 . . . . 1.0 110.047 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.51 80.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.742 0.306 . . . . 1.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.464 HG21 ' C ' ' A' ' 976' ' ' GLY . 30.7 mm -62.54 -42.11 94.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.618 . . . . 1.0 109.33 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.492 ' HA ' HD21 ' A' ' 980' ' ' LEU . 3.1 mm? -63.27 -43.93 96.56 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.489 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.32 -44.32 91.93 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 20.9 tt -67.25 -41.76 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 119.775 -0.77 . . . . 1.0 110.775 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.74 93.12 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 35.4 mt -66.99 -38.29 85.77 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.68 -56.03 27.0 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 112.408 0.522 . . . . 1.0 112.408 -176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 41.0 Cg_exo -53.37 -41.96 69.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.293 1.329 . . . . 1.0 111.594 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.672 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 93.5 mt -66.26 -41.49 89.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.381 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 80.3 mt -63.47 -41.9 98.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 7.8 tt -65.69 -38.99 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 119.945 -0.702 . . . . 1.0 109.523 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.21 -49.11 79.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.044 -0.724 . . . . 1.0 109.044 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -42.71 99.28 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 56.7 tp -61.87 -46.31 89.99 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.214 -0.594 . . . . 1.0 110.91 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.62 -41.83 99.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.335 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 996' ' ' ASN . 33.3 mm -65.74 -42.77 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 30.7 m -58.63 -45.74 88.61 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.339 -0.544 . . . . 1.0 110.501 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.89 -43.83 98.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.058 0.456 . . . . 1.0 111.077 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -62.25 -40.98 97.99 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.193 -0.603 . . . . 1.0 110.209 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' B' ' 725' ' ' LYS . 6.8 m-20 -65.88 -38.48 88.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 1.0 111.523 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 60.6 -4.68 0.11 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.026 0.441 . . . . 1.0 110.691 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' B' ' 723' ' ' ASP . 75.4 mmtt -63.24 -41.99 99.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.096 -0.335 . . . . 1.0 110.096 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -117.13 127.74 54.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.55 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.371 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.9 89.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.698 0.285 . . . . 1.0 110.531 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.65 130.88 55.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -114.62 126.56 55.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.36 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.7 137.33 57.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.637 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -76.28 144.92 39.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.03 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 964' ' ' ILE . 81.6 m -93.77 142.49 27.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.837 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.43 ' C ' ' O ' ' A' ' 963' ' ' CYS . 1.2 tt 34.17 69.32 1.0 Allowed Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 121.378 0.609 . . . . 1.0 110.64 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.437 ' O ' HG12 ' A' ' 969' ' ' VAL . 23.4 Cg_exo -61.71 143.35 96.31 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.924 2.416 . . . . 1.0 112.754 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.74 -43.69 93.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.315 0.858 . . . . 1.0 113.315 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.551 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -70.87 -54.63 10.77 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.042 -0.663 . . . . 1.0 111.888 -177.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -58.4 -39.41 79.61 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 970' ' ' LEU . 9.8 p -65.59 -43.19 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 119.239 -0.985 . . . . 1.0 109.241 178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 969' ' ' VAL . 54.9 tp -62.39 -42.61 99.56 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.749 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 967' ' ' TRP . 74.5 t -62.47 -44.54 99.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.56 -0.291 . . . . 1.0 110.688 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.84 -39.26 95.19 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.54 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.522 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.23 -42.83 99.28 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.65 -44.86 91.82 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.101 -0.571 . . . . 1.0 111.709 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.481 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.05 -41.53 99.48 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.36 -1.096 . . . . 1.0 110.36 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.06 -40.79 98.75 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.977 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.16 -42.62 99.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.656 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -61.7 -40.96 96.86 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.396 -0.922 . . . . 1.0 109.729 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.568 ' O ' HG23 ' A' ' 984' ' ' VAL . 89.9 mt -62.77 -41.63 99.33 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.815 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -62.52 -47.6 83.19 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.423 -0.511 . . . . 1.0 112.007 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.49 -40.85 90.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.726 -0.79 . . . . 1.0 111.286 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.05 -43.81 97.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 980' ' ' LEU . 73.8 t -60.71 -45.07 98.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.121 -0.231 . . . . 1.0 111.064 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.68 -41.71 99.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.197 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.96 -43.63 98.45 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.531 -0.467 . . . . 1.0 111.537 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.479 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 96.2 mmm -63.9 -43.62 95.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.894 0.378 . . . . 1.0 111.804 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.697 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.7 t90 -63.16 -43.32 98.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.291 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.03 -34.35 76.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.283 0.563 . . . . 1.0 111.593 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.3 t -76.85 -2.19 4.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.065 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 70.81 8.28 63.52 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 109.122 -1.591 . . . . 1.0 109.122 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.479 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -56.41 -44.86 80.74 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.224 -1.028 . . . . 1.0 108.224 -178.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -81.48 -22.98 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.092 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.697 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 68.5 mttm -63.67 -39.68 94.94 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.542 -1.263 . . . . 1.0 108.301 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.504 HH12 ' CG ' ' B' ' 723' ' ' ASP . 78.1 ttt-85 -66.45 126.89 30.24 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.086 -0.646 . . . . 1.0 110.643 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -139.34 5.84 2.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.31 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 33.4 mtt-85 -153.04 158.13 32.91 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.237 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo . . . . . 0 C--N 1.312 -1.394 0 C-N-CA 122.42 2.08 . . . . 1.0 112.193 179.688 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.24 -39.03 89.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.709 0.29 . . . . 1.0 110.506 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 2.6 p -142.42 73.14 20.98 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.625 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.72 145.71 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.879 2.386 . . . . 1.0 112.005 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.75 145.05 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.343 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.61 174.84 4.99 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.12 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -62.25 145.42 96.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.263 1.975 . . . . 1.0 112.324 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.35 143.2 57.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.8 mt -62.64 -44.02 99.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.478 0.547 . . . . 1.0 112.478 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.51 -43.02 99.85 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.49 -45.41 98.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.978 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.419 ' O ' ' OG ' ' B' ' 699' ' ' SER . 62.5 t -63.42 -44.23 98.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 1.0 110.172 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -61.41 -43.87 98.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.79 -0.641 . . . . 1.0 111.961 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.75 -42.23 95.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 1.0 110.814 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.0 p -61.87 -39.98 93.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.458 -0.792 . . . . 1.0 112.085 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 66.7 t -64.21 -45.03 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.076 0.465 . . . . 1.0 110.871 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . 0.439 ' O ' HD13 ' B' ' 705' ' ' LEU . 93.0 mtp -63.27 -39.09 93.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.579 -0.737 . . . . 1.0 111.274 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.37 -41.34 96.59 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.613 -0.995 . . . . 1.0 110.613 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.11 88.07 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-O 120.685 0.278 . . . . 1.0 110.677 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.481 HG21 ' C ' ' A' ' 976' ' ' GLY . 24.6 mm -60.41 -43.21 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 119.651 -0.819 . . . . 1.0 109.692 177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.485 ' HA ' HD21 ' A' ' 980' ' ' LEU . 9.7 mp -61.28 -43.23 99.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.467 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.81 -44.39 96.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.619 -0.832 . . . . 1.0 111.197 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.74 -45.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 112.202 0.445 . . . . 1.0 112.202 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.77 -39.98 65.38 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.491 -0.862 . . . . 1.0 111.169 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.59 -37.39 82.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.714 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.36 -56.92 19.46 Favored Pre-proline 0 N--CA 1.462 0.137 0 C-N-CA 120.04 -0.664 . . . . 1.0 111.593 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.1 Cg_exo -54.27 -44.37 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 120.837 1.024 . . . . 1.0 111.489 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 90.0 mt -65.13 -42.13 94.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.64 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.59 -41.85 99.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.813 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.6 -44.05 98.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.544 -0.463 . . . . 1.0 109.964 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -62.33 -48.16 81.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.958 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -43.27 98.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.189 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 53.7 tp -62.33 -44.56 96.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.133 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . 0.415 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 84.9 mt -61.14 -42.1 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.537 -0.465 . . . . 1.0 110.89 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.5 -44.11 98.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 120.068 -0.653 . . . . 1.0 110.242 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 93.5 m -59.79 -46.95 87.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 33.4 mm -61.6 -45.11 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.494 0.664 . . . . 1.0 111.198 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' B' ' 725' ' ' LYS . 51.2 m80 -59.79 -38.95 83.33 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.865 -0.734 . . . . 1.0 109.438 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.504 ' CG ' HH12 ' A' ' 995' ' ' ARG . 7.4 m-20 -66.33 -39.73 89.43 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 112.39 0.515 . . . . 1.0 112.39 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -64.1 -38.46 91.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.038 0.447 . . . . 1.0 111.018 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' B' ' 722' ' ' HIS . 75.6 mmtt -99.46 147.3 25.43 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -120.96 133.96 55.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.265 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 . . . . . 0 C--O 1.217 -0.624 0 CA-C-O 117.815 -1.088 . . . . 1.0 110.835 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.24 143.19 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 1.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.9 mt -110.37 130.99 55.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.467 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.69 139.1 58.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.6 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -117.62 134.04 55.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.57 ' NH1' ' CZ2' ' A' ' 967' ' ' TRP . 71.6 ttt180 -67.72 134.88 51.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.278 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 93.2 m -113.08 141.27 47.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.662 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 964' ' ' ILE . 71.5 mt 56.87 69.73 1.62 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.477 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.04 148.35 93.34 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.52 2.147 . . . . 1.0 111.577 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.8 tt -65.95 -38.04 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 114.081 1.141 . . . . 1.0 114.081 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.731 ' O ' HG13 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -54.33 -50.27 67.78 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.857 -0.737 . . . . 1.0 111.306 -176.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -57.69 -38.07 74.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.335 -177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 973' ' ' VAL . 66.6 t -64.46 -46.38 93.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 118.964 -1.094 . . . . 1.0 109.468 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.56 -44.58 93.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.856 -1.066 . . . . 1.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 967' ' ' TRP . 3.4 m -64.88 -39.35 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 119.729 -0.788 . . . . 1.0 110.508 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.24 96.34 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.1 t -61.88 -45.28 99.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.211 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.11 -42.64 99.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 1.0 111.658 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.62 85.03 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.476 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -59.69 -42.82 98.08 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 109.836 -1.305 . . . . 1.0 109.836 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.66 -42.52 98.07 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 122.391 -0.476 . . . . 1.0 111.951 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.2 tp -63.44 -44.95 93.06 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.426 0.528 . . . . 1.0 112.426 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.22 -42.07 99.21 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.471 -0.891 . . . . 1.0 110.988 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' B' ' 705' ' ' LEU . 2.1 mm? -63.19 -40.59 97.97 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.98 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 19.8 m -62.0 -45.29 94.26 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.569 -0.452 . . . . 1.0 110.203 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.31 -41.34 89.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.3 99.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.963 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.8 t -61.76 -46.04 97.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.505 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.36 -41.81 98.86 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.334 -0.546 . . . . 1.0 110.521 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.609 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.21 -42.53 98.75 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.289 -0.564 . . . . 1.0 111.207 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.39 -42.88 95.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.537 -0.302 . . . . 1.0 110.815 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.587 ' NE1' ' NZ ' ' A' ' 994' ' ' LYS . 9.9 t90 -61.71 -42.03 98.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.11 -33.95 75.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.078 0.466 . . . . 1.0 111.176 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 986' ' ' ALA . 51.8 t -78.27 -3.18 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.689 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.47 10.81 71.23 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.53 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.6 OUTLIER -55.29 -45.29 76.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 -178.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 51.7 m-85 -78.89 -17.17 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.645 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.587 ' NZ ' ' NE1' ' A' ' 988' ' ' TRP . 63.9 mttp -109.77 29.8 7.26 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 991' ' ' GLY . 75.9 ttt-85 -66.95 124.11 22.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -109.47 2.1 20.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.073 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 173.55 153.6 0.26 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.474 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . 0.452 ' CA ' HH21 ' A' ' 995' ' ' ARG . 18.0 Cg_endo . . . . . 0 N--CA 1.495 1.576 0 C-N-CA 122.133 1.889 . . . . 1.0 111.994 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.609 -1.396 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 55.2 30.63 14.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 1.0 110.624 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . 0.429 ' CB ' ' CD ' ' B' ' 688' ' ' PRO . 0.4 OUTLIER -98.19 -179.9 0.95 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.221 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' B' ' 687' ' ' SER . 22.8 Cg_exo -61.87 145.25 97.13 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.104 1.869 . . . . 1.0 112.017 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.08 -41.91 99.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 61.4 m -133.31 83.43 50.15 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.571 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -61.2 149.61 88.48 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.895 2.396 . . . . 1.0 112.011 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 67.5 t0 -61.23 139.98 58.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.269 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.532 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 92.9 mt -62.6 -43.51 98.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.045 -0.525 . . . . 1.0 112.309 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' B' ' 694' ' ' LEU . 90.1 mt -62.3 -42.47 99.39 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.208 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.74 -44.79 99.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.416 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 699' ' ' SER . 72.5 t -63.26 -44.12 99.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.197 -0.456 . . . . 1.0 109.808 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.25 -43.39 98.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 1.0 112.06 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.8 -42.31 95.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.176 0.512 . . . . 1.0 110.812 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 35.4 p -62.27 -42.84 99.69 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.286 0.847 . . . . 1.0 113.286 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.18 -42.32 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.9 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 86.5 mtp -62.38 -39.26 92.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.347 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.66 -40.42 97.49 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.021 -1.232 . . . . 1.0 110.021 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.47 -36.11 79.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 1.0 110.367 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.476 HG21 ' C ' ' A' ' 976' ' ' GLY . 29.4 mm -62.36 -42.54 95.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.513 ' HA ' HD11 ' A' ' 980' ' ' LEU . 5.6 tt -61.6 -44.54 96.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.743 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.05 -43.2 99.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.128 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.35 -43.9 98.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.311 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.69 -44.31 81.85 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.905 -0.664 . . . . 1.0 112.029 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . 0.469 HD22 HD21 ' B' ' 705' ' ' LEU . 9.6 mp -67.18 -34.89 78.51 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.598 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -49.74 -58.11 10.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.347 -0.541 . . . . 1.0 112.334 -176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 17.8 Cg_endo -62.12 -39.83 46.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.374 1.383 . . . . 1.0 112.045 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 89.5 mt -65.6 -42.08 92.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.933 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -41.25 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.933 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.31 -44.07 98.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.148 -0.621 . . . . 1.0 109.382 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.855 ' NE1' HD11 ' B' ' 719' ' ' ILE . 8.1 t90 -62.72 -48.52 78.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.369 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.3 OUTLIER -60.81 -43.62 97.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.021 -178.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.69 -43.36 99.0 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.24 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.66 -41.3 97.33 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.23 -0.588 . . . . 1.0 110.132 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.855 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.55 -44.15 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.679 -0.808 . . . . 1.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 92.1 m -59.17 -45.35 91.24 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.335 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.51 -43.92 97.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.128 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -64.32 -39.44 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.01 -38.76 86.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.954 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -61.84 -43.24 99.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.8 0.333 . . . . 1.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.44 141.13 45.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.558 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.72 127.18 54.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.481 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.002 -0.999 . . . . 1.0 110.567 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.652 -1.379 . . . . 1.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.4 142.98 56.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.323 . . . . 1.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.83 -41.95 99.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.611 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 55.67 41.48 30.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.326 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -108.19 126.66 53.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.165 0.507 . . . . 1.0 110.643 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.24 -37.67 88.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.505 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 63.3 m -66.41 -33.88 76.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.479 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.8 mt -141.99 71.13 23.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.424 -0.51 . . . . 1.0 111.59 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -62.64 149.52 90.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.595 2.197 . . . . 1.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.2 -42.89 96.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -55.72 -53.66 53.93 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.537 0.569 . . . . 1.0 112.537 -176.085 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.49 -39.32 79.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.419 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 973' ' ' VAL . 69.2 t -64.18 -44.96 97.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.699 0.762 . . . . 1.0 108.971 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.53 -42.64 99.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.0 t -63.51 -45.74 96.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.776 0.322 . . . . 1.0 111.248 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.52 96.82 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.268 -0.733 . . . . 1.0 111.268 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 969' ' ' VAL . 68.9 t -61.73 -45.41 98.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.605 0.24 . . . . 1.0 110.447 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.21 -42.61 99.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.497 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.99 -45.13 93.27 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.079 -0.581 . . . . 1.0 111.883 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.19 99.71 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.31 -41.6 98.96 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 122.644 -0.327 . . . . 1.0 110.82 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.99 -42.39 99.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.196 -0.602 . . . . 1.0 110.47 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.91 -41.68 98.2 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.009 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' B' ' 705' ' ' LEU . 83.9 mt -60.57 -41.06 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.062 -0.655 . . . . 1.0 111.104 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 18.8 m -59.88 -45.65 91.84 Favored 'General case' 0 C--O 1.253 1.262 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.477 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.35 -47.69 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 119.904 -0.718 . . . . 1.0 111.344 -178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.92 -42.65 98.54 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 119.833 -0.747 . . . . 1.0 111.655 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.18 -47.11 95.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.66 -0.816 . . . . 1.0 111.459 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.12 -42.63 99.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.531 -0.467 . . . . 1.0 110.141 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.85 -43.3 99.13 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.987 -178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 98.6 mtp -65.84 -41.95 91.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.737 0.303 . . . . 1.0 111.773 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.521 ' CD1' ' NZ ' ' A' ' 994' ' ' LYS . 10.1 t90 -62.7 -43.6 98.38 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.44 -33.46 73.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.138 0.494 . . . . 1.0 110.897 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 986' ' ' ALA . 61.8 t -77.33 -2.8 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.688 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 75.19 7.09 81.67 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.606 ' CD1' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.82 -45.16 78.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.444 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 50.4 m-85 -83.2 -17.94 41.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.825 -0.75 . . . . 1.0 111.231 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.521 ' NZ ' ' CD1' ' A' ' 988' ' ' TRP . 62.8 mttp -62.62 -37.76 87.54 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 118.353 -1.339 . . . . 1.0 108.877 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.507 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 68.3 mtp180 -65.17 126.81 29.28 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.835 -1.146 . . . . 1.0 110.385 -178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 997' ' ' ARG . 44.7 p-10 -161.95 174.54 12.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.463 -0.789 . . . . 1.0 110.065 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 996' ' ' ASN . 12.5 ttp180 80.25 92.07 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.895 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.492 1.408 0 C-N-CA 122.139 1.893 . . . . 1.0 112.028 -179.767 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.0 -39.08 89.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.743 0.306 . . . . 1.0 110.559 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 10.7 p -176.08 74.44 0.27 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.64 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.41 145.02 98.53 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.86 2.373 . . . . 1.0 112.047 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -79.51 134.19 36.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . 0.401 ' SG ' ' CD ' ' B' ' 691' ' ' PRO . 0.1 OUTLIER -120.21 175.5 2.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.877 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . 0.401 ' CD ' ' SG ' ' B' ' 690' ' ' CYS . 23.3 Cg_exo -61.35 143.8 98.07 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.86 1.706 . . . . 1.0 111.822 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -66.49 138.62 57.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.271 0.558 . . . . 1.0 111.262 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.7 -43.52 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.53 -41.78 99.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.663 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.9 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.319 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.458 ' O ' HG23 ' B' ' 700' ' ' VAL . 65.5 t -63.51 -45.38 97.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.958 0.409 . . . . 1.0 110.803 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . 0.688 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.1 tt -62.6 -43.03 99.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.655 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.69 -42.12 98.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 1.0 110.457 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 47.2 p -62.01 -36.73 82.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.037 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.458 HG23 ' O ' ' B' ' 696' ' ' VAL . 73.8 t -63.95 -44.63 97.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 121.061 0.458 . . . . 1.0 110.14 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 87.9 mtp -61.69 -39.73 92.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.134 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.89 96.9 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.017 -1.233 . . . . 1.0 110.017 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.77 89.74 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.739 0.304 . . . . 1.0 110.357 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 26.7 mm -62.87 -43.22 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.928 -0.709 . . . . 1.0 109.233 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 980' ' ' LEU . 84.6 mt -61.1 -44.22 97.69 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.163 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.59 -44.12 97.1 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.669 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . 0.408 ' O ' ' CD ' ' B' ' 711' ' ' PRO . 95.0 mt -63.85 -44.47 98.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.876 -0.329 . . . . 1.0 111.428 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -70.26 -41.14 69.56 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.87 -38.45 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.507 0.928 . . . . 1.0 113.507 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -53.26 -57.03 18.38 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.208 -0.597 . . . . 1.0 112.122 -176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 32.3 Cg_exo -54.63 -44.28 51.05 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.091 1.194 . . . . 1.0 111.359 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.29 -42.15 93.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.715 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 36.1 mt -62.62 -41.77 99.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.078 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.52 -44.19 98.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.199 -0.601 . . . . 1.0 109.449 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.444 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 11.3 t90 -63.0 -48.25 79.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 1.0 109.783 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.606 ' NZ ' ' CD1' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.51 -44.21 96.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.959 -0.564 . . . . 1.0 111.729 -178.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.0 -42.86 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.563 -0.455 . . . . 1.0 110.667 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . 0.498 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 83.8 mt -62.12 -42.77 99.57 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.897 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 31.4 mm -63.78 -44.32 98.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.248 -0.581 . . . . 1.0 109.909 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 82.9 m -60.31 -45.8 92.11 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.512 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' B' ' 724' ' ' ARG . 95.3 mt -62.37 -43.21 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.385 -0.526 . . . . 1.0 110.42 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 43.3 m80 -61.75 -37.61 84.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.457 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.507 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 47.0 m-20 -67.41 -40.12 85.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.585 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' B' ' 721' ' ' ILE . 62.1 ttp180 -127.36 116.47 20.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.109 0.48 . . . . 1.0 109.765 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.23 133.64 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -116.18 127.0 54.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.337 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 89.2 t80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.091 -0.957 . . . . 1.0 110.562 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -151.05 152.37 33.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 1.0 110.581 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 959' ' ' LEU . 94.9 mt -74.57 141.73 44.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.52 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.99 137.75 57.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.631 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.28 -37.62 85.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -64.14 -39.06 93.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.688 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 67.6 m -67.29 -36.75 82.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.83 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.77 71.21 13.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.95 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.11 148.95 92.22 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.63 2.22 . . . . 1.0 112.078 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.3 -42.51 96.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.473 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -51.0 -51.94 47.91 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.759 -176.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -58.01 -39.2 77.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.682 0.252 . . . . 1.0 111.682 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.1 -45.06 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.26 -42.64 99.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.135 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.6 t -62.79 -44.36 99.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.06 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.79 -38.26 94.96 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 120.443 -0.884 . . . . 1.0 111.155 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 67.8 t -61.98 -45.74 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.975 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.19 -42.09 99.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.846 -0.341 . . . . 1.0 111.876 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.75 -44.26 92.61 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.372 -0.691 . . . . 1.0 111.372 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.545 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.97 -42.39 99.73 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.146 -1.181 . . . . 1.0 110.146 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.44 -42.08 98.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.953 0.377 . . . . 1.0 111.999 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.76 -43.62 98.33 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.457 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.5 -40.39 96.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.103 -1.039 . . . . 1.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 976' ' ' GLY . 1.8 mm? -62.5 -39.92 95.06 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 94.8 m -61.89 -45.53 93.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.807 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.63 -43.63 98.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 119.97 -0.692 . . . . 1.0 110.329 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.19 -43.45 98.79 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.379 -0.826 . . . . 1.0 111.355 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 980' ' ' LEU . 68.4 t -60.63 -44.73 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.081 -0.387 . . . . 1.0 110.82 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.45 -41.43 98.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.175 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.388 -0.525 . . . . 1.0 112.191 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.481 ' CE ' ' CD2' ' A' ' 992' ' ' PHE . 95.6 mmm -64.29 -42.81 96.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.737 0.303 . . . . 1.0 111.201 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.457 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.1 t90 -62.53 -42.6 99.63 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.051 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.33 -34.4 76.56 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.832 0.349 . . . . 1.0 111.396 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 986' ' ' ALA . 47.9 t -78.09 -2.49 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.792 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 68.27 12.17 62.85 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 108.548 -1.821 . . . . 1.0 108.548 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.481 ' CD2' ' CE ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -54.9 -44.13 73.87 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -178.068 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -82.32 -6.39 59.22 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.838 -0.745 . . . . 1.0 109.859 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 991' ' ' GLY . 75.2 mmtt -97.85 1.03 47.76 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.57 -1.27 . . . . 1.0 107.57 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.539 HH12 ' CG ' ' B' ' 723' ' ' ASP . 77.5 ttt-85 -67.02 134.17 51.39 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.467 -0.493 . . . . 1.0 110.013 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -150.54 171.25 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.451 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -72.72 149.75 90.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.189 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.494 1.52 0 C-N-CA 122.03 1.82 . . . . 1.0 112.135 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.532 -1.427 . . . . 1.0 109.532 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.49 29.72 13.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 1.0 110.447 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.58 161.19 54.58 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.521 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.83 152.94 64.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.932 2.422 . . . . 1.0 112.027 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -128.01 144.74 51.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 21.8 m -140.16 81.77 17.93 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.799 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.74 147.51 95.14 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.357 2.038 . . . . 1.0 112.361 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.02 145.65 54.94 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.83 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.54 -42.69 96.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 119.856 -0.737 . . . . 1.0 112.351 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.36 -41.58 98.85 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.003 -0.436 . . . . 1.0 111.451 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.6 -45.32 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.846 0.355 . . . . 1.0 111.646 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.432 ' O ' HG23 ' B' ' 700' ' ' VAL . 58.6 t -64.18 -45.23 96.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . 0.676 ' C ' HD23 ' B' ' 697' ' ' LEU . 8.2 tt -63.29 -43.03 99.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.833 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.3 -42.02 96.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 1.0 110.553 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 49.5 p -62.38 -38.26 88.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.361 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.2 t -63.86 -44.83 98.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.137 0.494 . . . . 1.0 110.054 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.1 mtp -63.03 -39.55 95.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.54 -40.54 97.72 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.94 78.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 29.1 mm -62.59 -42.65 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.416 ' HA ' HD21 ' A' ' 980' ' ' LEU . 13.7 mt -61.43 -44.9 96.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.833 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.28 -43.9 96.61 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.342 -0.543 . . . . 1.0 111.043 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.29 -44.85 97.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.52 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 712' ' ' LEU . . . -70.11 -42.4 67.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.206 -0.521 . . . . 1.0 111.801 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . 0.462 ' O ' HD13 ' B' ' 713' ' ' LEU . 82.5 mt -67.12 -38.38 85.49 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.941 1.089 . . . . 1.0 113.941 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.27 -55.56 30.31 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 44.0 Cg_exo -52.59 -41.42 68.59 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.299 1.333 . . . . 1.0 111.778 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.476 ' N ' HD12 ' B' ' 712' ' ' LEU . 11.0 mp -65.24 -41.89 93.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.722 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . 0.462 HD13 ' O ' ' B' ' 709' ' ' LEU . 9.4 mp -63.33 -42.37 98.97 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 21.4 tt -67.29 -41.71 86.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.503 -0.879 . . . . 1.0 110.147 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -63.44 -48.77 76.39 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -42.7 95.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.681 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.18 -44.45 96.56 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.451 -0.5 . . . . 1.0 110.623 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.73 -41.91 98.26 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.501 -0.48 . . . . 1.0 110.997 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 33.3 mm -64.55 -42.98 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 120.321 -0.552 . . . . 1.0 109.825 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 98.0 m -59.61 -45.88 90.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.616 -0.433 . . . . 1.0 110.384 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' B' ' 724' ' ' ARG . 30.5 mm -61.73 -43.67 97.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.921 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -65.78 -36.53 83.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.679 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.539 ' CG ' HH12 ' A' ' 995' ' ' ARG . 23.7 t70 -70.94 -42.27 70.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.686 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' B' ' 721' ' ' ILE . 90.3 mtm180 -130.81 130.31 43.5 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' B' ' 727' ' ' PHE . 99.4 mttt -124.07 145.61 49.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.63 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 47.68 -88.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.677 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' B' ' 725' ' ' LYS . 96.6 m-85 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.567 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.38 143.14 56.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.742 0.306 . . . . 1.0 110.598 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.9 -41.78 99.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.428 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.33 141.74 58.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.471 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -108.9 125.08 51.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.479 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -126.07 136.9 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.354 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.581 ' SG ' ' N ' ' B' ' 685' ' ' GLY . 74.3 m -88.6 133.93 34.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 964' ' ' ILE . 1.2 tt -174.26 72.0 0.33 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.011 0.434 . . . . 1.0 110.178 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.45 ' O ' HG22 ' A' ' 969' ' ' VAL . 20.3 Cg_exo -61.27 140.84 90.73 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.881 2.387 . . . . 1.0 112.679 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.46 -61.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.972 -0.558 . . . . 1.0 112.028 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.562 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -66.64 -50.86 61.58 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -177.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . 0.549 ' N ' ' CD1' ' A' ' 968' ' ' TRP . 3.7 m0 -58.09 -43.54 87.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 119.299 -0.381 . . . . 1.0 111.671 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 965' ' ' PRO . 28.1 m -65.78 -43.61 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 118.819 -1.152 . . . . 1.0 110.457 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . 0.444 ' N ' HG23 ' A' ' 969' ' ' VAL . 89.3 mt -63.15 -42.81 99.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.491 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 967' ' ' TRP . 75.3 t -64.0 -44.98 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.707 0.289 . . . . 1.0 111.387 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.48 -38.39 94.77 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.116 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 61.9 t -61.61 -45.1 99.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 121.16 -0.216 . . . . 1.0 110.94 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.3 -42.14 99.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.898 0.333 . . . . 1.0 111.898 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.54 -43.43 94.64 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 120.676 -0.773 . . . . 1.0 111.735 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.1 99.95 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 120.435 -0.888 . . . . 1.0 111.133 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 87.0 mt -62.8 -40.31 96.97 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.539 -0.389 . . . . 1.0 110.098 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.0 -42.7 99.43 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.48 -42.6 99.6 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.687 -0.805 . . . . 1.0 110.213 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 984' ' ' VAL . 24.4 mt -62.39 -42.74 99.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.824 0.345 . . . . 1.0 110.779 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 24.1 p -61.93 -45.1 95.2 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.508 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.71 -43.28 97.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.672 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.7 -42.72 97.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.394 -0.522 . . . . 1.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.617 HG22 HD21 ' B' ' 712' ' ' LEU . 69.6 t -62.45 -45.48 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.063 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.83 97.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.931 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.37 -43.28 99.18 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.644 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 64.4 mtt -64.77 -42.46 95.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.018 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.684 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 10.4 t90 -62.0 -44.28 97.06 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.46 -33.79 74.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.125 0.488 . . . . 1.0 111.387 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.9 t -78.68 -3.36 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 115.659 -0.701 . . . . 1.0 109.64 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 995' ' ' ARG . . . 71.56 11.04 72.06 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.333 -1.507 . . . . 1.0 109.333 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.524 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.48 -45.42 76.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.435 ' CD1' ' CZ3' ' B' ' 715' ' ' TRP . 48.6 m-85 -79.79 -16.52 55.37 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.986 -0.686 . . . . 1.0 110.734 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.684 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 99.2 mttt -108.96 29.35 7.57 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.397 -1.334 . . . . 1.0 107.397 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.633 HH22 ' CB ' ' B' ' 723' ' ' ASP . 73.1 ttp85 -66.26 131.26 45.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.926 0.394 . . . . 1.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -136.28 113.86 10.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.652 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -178.91 64.2 0.16 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 C-N-CA 122.867 2.378 . . . . 1.0 112.167 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . 0.581 ' N ' ' SG ' ' A' ' 963' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.584 -1.407 . . . . 1.0 109.584 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' B' ' 686' ' ' GLU . 55.5 mp0 -66.34 -38.04 86.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.841 0.353 . . . . 1.0 110.871 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 166.66 1.9 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.783 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.77 -38.43 85.11 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.338 2.025 . . . . 1.0 112.815 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -105.99 147.67 28.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.085 0.469 . . . . 1.0 111.281 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 75.2 m -72.49 151.26 91.69 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.802 -0.635 . . . . 1.0 110.027 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.35 162.39 30.61 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.658 2.238 . . . . 1.0 113.37 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' B' ' 693' ' ' ILE . 66.4 t0 -60.88 146.15 47.56 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.915 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.563 ' N ' ' OD1' ' B' ' 692' ' ' ASP . 93.2 mt -61.98 -44.42 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 113.095 0.776 . . . . 1.0 113.095 -177.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.35 99.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.717 0.294 . . . . 1.0 111.204 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.21 -45.39 98.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.819 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 700' ' ' VAL . 66.6 t -63.1 -45.41 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 1.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 7.6 tt -61.53 -43.61 98.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.554 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.75 -42.88 94.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.023 0.439 . . . . 1.0 110.668 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . . . . . . . . . 54.6 p -62.52 -39.56 93.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.829 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 696' ' ' VAL . 69.6 t -64.24 -43.79 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.39 0.614 . . . . 1.0 109.381 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.6 mtp -63.29 -39.96 96.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.878 -1.056 . . . . 1.0 110.173 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -69.93 -47.12 48.74 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.393 -0.683 . . . . 1.0 111.393 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.86 -48.07 83.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.675 0.274 . . . . 1.0 111.631 -178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.42 HG22 ' O ' ' B' ' 700' ' ' VAL . 10.7 tp -64.87 -37.61 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 119.651 -0.82 . . . . 1.0 108.849 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . . . . . . . . . 62.3 tp -60.83 -44.95 96.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.31 -41.37 98.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.141 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.7 -43.85 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.66 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.43 -39.25 95.63 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.861 -0.896 . . . . 1.0 110.861 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 86.0 mt -67.5 -37.24 82.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.694 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.11 -56.48 21.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 112.299 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.5 Cg_exo -53.66 -43.91 53.69 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.06 1.173 . . . . 1.0 112.017 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.617 HD21 HG22 ' A' ' 984' ' ' VAL . 11.1 mp -65.17 -41.99 94.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.137 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.22 -41.66 99.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.082 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.64 -44.31 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.708 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.435 ' CZ3' ' CD1' ' A' ' 993' ' ' PHE . 7.9 t90 -62.16 -47.31 85.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.29 0.567 . . . . 1.0 109.578 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.1 OUTLIER -60.53 -44.01 96.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.747 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.51 -46.28 89.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.581 -0.448 . . . . 1.0 111.632 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . 0.489 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 8.2 mp -63.26 -41.01 98.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.545 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 4.5 mm -63.58 -44.65 98.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 119.965 -0.694 . . . . 1.0 109.994 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 17.6 m -60.66 -45.37 94.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 1.0 110.701 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.1 -43.53 98.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.319 -0.552 . . . . 1.0 111.366 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . 0.489 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 44.5 m80 -59.06 -41.11 87.15 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.633 ' CB ' HH22 ' A' ' 995' ' ' ARG . 24.8 t70 -65.24 -40.17 93.69 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.444 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -63.73 -40.98 98.07 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.573 -0.451 . . . . 1.0 110.675 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.54 -42.76 98.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.698 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.13 138.51 55.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.79 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 117.971 -1.014 . . . . 1.0 110.645 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 963' ' ' CYS . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.47 -38.41 91.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.745 0.307 . . . . 1.0 110.301 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.663 HD12 HH21 ' A' ' 962' ' ' ARG . 92.6 mt -118.88 144.77 46.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.559 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.93 -35.13 80.16 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.833 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -63.05 -39.57 95.12 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.689 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.663 HH21 HD12 ' A' ' 959' ' ' LEU . 89.9 mtm180 -101.18 134.51 44.11 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 957' ' ' GLY . 78.7 m -84.81 -66.99 0.83 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.882 -0.327 . . . . 1.0 110.542 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.447 ' C ' ' O ' ' A' ' 963' ' ' CYS . 9.2 pt 27.73 70.12 0.49 Allowed Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 123.668 0.605 . . . . 1.0 111.348 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.83 140.14 88.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.367 2.045 . . . . 1.0 112.35 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.0 -63.52 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 1.0 112.433 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -65.34 -51.94 57.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 -177.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . 0.558 ' N ' ' CD1' ' A' ' 968' ' ' TRP . 3.1 m0 -57.18 -40.81 78.1 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.143 -0.223 . . . . 1.0 110.779 -176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.42 -46.45 92.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 119.419 -0.912 . . . . 1.0 110.263 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.26 -42.65 99.18 Favored 'General case' 0 CA--C 1.526 0.028 0 CA-C-N 115.513 -0.767 . . . . 1.0 111.681 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 967' ' ' TRP . 69.7 t -63.93 -44.58 98.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.667 -0.242 . . . . 1.0 111.443 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.77 -37.91 95.07 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.292 -0.956 . . . . 1.0 111.533 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.25 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.437 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.29 -42.92 99.12 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.929 0.344 . . . . 1.0 111.929 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . 0.426 ' O ' HD13 ' A' ' 979' ' ' LEU . . . -66.2 -45.08 89.24 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.88 -0.676 . . . . 1.0 111.614 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.593 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -60.67 -41.37 98.91 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.91 -42.78 97.32 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.133 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.96 -44.33 96.36 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.557 -0.457 . . . . 1.0 111.654 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 983' ' ' LEU . 8.4 mp -62.61 -42.12 99.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.64 -0.824 . . . . 1.0 110.366 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' B' ' 705' ' ' LEU . 4.1 mm? -63.14 -39.65 95.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.846 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 84.6 m -61.2 -45.13 95.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.092 -0.643 . . . . 1.0 109.515 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 32.0 mm -62.82 -44.17 99.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.586 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 979' ' ' LEU . 8.5 mp -62.94 -42.0 99.67 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.349 -0.54 . . . . 1.0 110.899 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 980' ' ' LEU . 63.8 t -62.45 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 1.0 111.011 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.24 -41.73 99.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.233 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.9 99.94 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.284 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.27 -40.54 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.373 0.606 . . . . 1.0 110.641 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.408 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 12.6 t90 -65.35 -44.7 86.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.578 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.67 -33.98 76.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.561 0.948 . . . . 1.0 113.561 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.96 2.61 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 119.176 -1.01 . . . . 1.0 109.296 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 994' ' ' LYS . . . 75.47 11.16 84.5 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.29 -1.323 . . . . 1.0 111.38 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.417 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.4 OUTLIER -52.9 -44.34 66.86 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.536 -1.283 . . . . 1.0 107.536 -178.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.468 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 50.4 m-85 -83.54 -4.29 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.81 -0.756 . . . . 1.0 110.857 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 991' ' ' GLY . 99.0 mttt -92.57 -0.46 57.32 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.533 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 77.6 ttt-85 -65.67 133.56 51.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.768 -0.773 . . . . 1.0 109.413 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.468 ' ND2' ' NH1' ' A' ' 995' ' ' ARG . 98.9 m-20 58.4 33.72 23.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.408 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 996' ' ' ASN . 97.7 mtt180 26.85 78.94 0.24 Allowed Pre-proline 0 N--CA 1.467 0.394 0 O-C-N 123.764 0.665 . . . . 1.0 111.945 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . 0.441 ' CG ' ' O ' ' A' ' 993' ' ' PHE . 71.4 Cg_endo . . . . . 0 C--N 1.306 -1.691 0 C-N-CA 122.678 2.252 . . . . 1.0 112.071 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.628 -1.389 . . . . 1.0 109.628 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.1 -38.83 89.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.707 0.289 . . . . 1.0 110.525 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 66.0 m 44.83 72.53 1.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.444 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.69 -38.18 84.41 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.953 2.435 . . . . 1.0 111.983 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.55 144.99 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.4 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 6.5 m -82.67 161.47 58.68 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.054 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.88 147.54 95.08 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.693 1.595 . . . . 1.0 112.245 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.74 143.81 57.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.997 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.02 -44.46 98.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.88 -43.37 96.25 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.596 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.34 -47.24 90.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.91 0.707 . . . . 1.0 112.91 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' B' ' 699' ' ' SER . 11.0 p -65.26 -41.65 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . 0.42 ' N ' HG13 ' B' ' 696' ' ' VAL . 42.9 tp -61.76 -43.45 98.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.852 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.86 -41.84 95.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 1.0 110.665 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 36.8 p -62.55 -40.98 98.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.582 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.56 -45.26 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.266 0.555 . . . . 1.0 110.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 92.4 mtp -63.5 -39.76 95.3 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.035 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -63.44 -41.13 99.41 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 110.99 -0.844 . . . . 1.0 110.99 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.58 80.87 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.05 -41.27 90.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.205 -1.035 . . . . 1.0 108.205 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.673 ' HA ' HD21 ' A' ' 980' ' ' LEU . 47.5 tp -60.63 -46.26 90.96 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.868 -0.333 . . . . 1.0 111.166 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.24 -42.42 99.2 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.55 -44.21 98.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.563 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -66.59 -40.86 94.24 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.435 -0.666 . . . . 1.0 111.435 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.64 -37.57 85.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.701 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.92 -57.18 17.2 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 119.998 -0.681 . . . . 1.0 112.32 -177.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.701 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 38.7 Cg_exo -54.46 -45.38 41.41 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.158 1.239 . . . . 1.0 111.934 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.493 ' N ' HD12 ' B' ' 712' ' ' LEU . 10.9 mp -65.86 -40.57 91.79 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.259 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.42 -41.32 98.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.085 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.63 -44.75 98.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.389 -0.525 . . . . 1.0 109.735 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.468 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 6.2 t90 -63.11 -49.19 75.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.18 0.514 . . . . 1.0 109.702 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.444 ' O ' HG23 ' B' ' 720' ' ' THR . 0.2 OUTLIER -60.64 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.104 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.35 -45.39 91.43 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.738 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . 0.455 ' O ' ' ND1' ' B' ' 722' ' ' HIS . 82.7 mt -62.76 -42.9 99.9 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.676 0.621 . . . . 1.0 112.676 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' B' ' 720' ' ' THR . 5.6 tp -65.87 -41.26 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 119.611 -0.836 . . . . 1.0 109.871 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . 0.444 HG23 ' O ' ' B' ' 716' ' ' LYS . 30.6 p -58.69 -45.3 89.76 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.758 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' B' ' 721' ' ' ILE . 36.2 mm -62.05 -41.7 92.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 O-C-N 121.849 -0.532 . . . . 1.0 110.676 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . 0.455 ' ND1' ' O ' ' B' ' 718' ' ' LEU . 59.2 m80 -61.73 -39.81 92.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.211 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 995' ' ' ARG . 40.5 t0 -67.25 -37.44 83.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.959 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -62.1 -42.05 98.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 1.0 110.721 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 722' ' ' HIS . 68.9 mttm -102.92 146.66 27.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.708 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.26 -39.27 89.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.738 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.479 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 961' ' ' GLU . . . -150.72 152.26 33.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 1.0 110.602 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.95 -42.33 99.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.401 ' H ' ' H ' ' A' ' 961' ' ' GLU . 83.5 tt0 -160.25 -21.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.87 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 958' ' ' ALA . 97.5 mt-10 -95.05 120.63 35.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.857 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.539 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 p 179.85 77.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.983 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 964' ' ' ILE . 5.5 pt -152.2 73.32 7.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.126 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.11 144.39 99.2 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.801 2.334 . . . . 1.0 112.426 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.61 -31.28 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.431 0.9 . . . . 1.0 113.431 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -56.37 -45.4 80.54 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 119.272 -0.971 . . . . 1.0 110.822 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . 0.599 ' NE1' HD12 ' B' ' 693' ' ' ILE . 35.5 m0 -57.23 -46.13 83.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.78 -0.191 . . . . 1.0 110.786 -177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 65.1 t -63.74 -46.82 93.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 119.329 -0.948 . . . . 1.0 110.941 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.31 -44.26 95.48 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.113 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 967' ' ' TRP . 64.5 t -63.77 -44.95 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.07 -39.32 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.183 -1.008 . . . . 1.0 111.118 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.065 0.394 . . . . 1.0 112.065 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.72 -42.84 97.85 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.58 95.78 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.494 -0.86 . . . . 1.0 111.2 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.401 ' C ' HG21 ' B' ' 704' ' ' ILE . . . -61.93 -42.85 99.77 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.63 -41.94 99.31 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.732 -0.275 . . . . 1.0 110.659 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 54.0 tp -61.83 -41.79 98.22 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.47 -41.26 96.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.907 -0.717 . . . . 1.0 109.469 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' B' ' 705' ' ' LEU . 91.2 mt -62.61 -42.07 99.36 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.953 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 96.6 m -62.29 -48.66 78.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.01 -41.38 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.453 -0.899 . . . . 1.0 111.626 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.39 -43.48 97.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.541 -0.464 . . . . 1.0 110.696 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 980' ' ' LEU . 66.2 t -62.52 -45.7 98.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.722 0.296 . . . . 1.0 111.19 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.08 -42.28 99.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.063 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -62.12 -43.64 98.38 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.336 -0.545 . . . . 1.0 111.811 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.74 -42.62 90.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.144 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -62.67 -42.79 99.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.88 -32.45 73.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.282 0.563 . . . . 1.0 110.509 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 986' ' ' ALA . 60.4 t -78.37 -3.79 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.277 -0.874 . . . . 1.0 109.904 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 72.43 9.17 72.86 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.198 -1.561 . . . . 1.0 109.198 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.499 ' O ' ' NZ ' ' B' ' 716' ' ' LYS . 0.5 OUTLIER -55.88 -46.09 78.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 -178.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.658 ' CZ ' HD22 ' B' ' 712' ' ' LEU . 39.2 m-85 -74.26 -30.99 62.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.836 177.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.73 -42.36 95.26 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 118.663 -1.215 . . . . 1.0 108.952 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.428 ' NH2' ' OD2' ' B' ' 723' ' ' ASP . 28.6 tpt85 -146.15 148.54 32.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.624 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.11 -41.12 97.91 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -74.36 156.85 87.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.443 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 122.411 2.074 . . . . 1.0 112.025 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 -38.7 89.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.777 0.322 . . . . 1.0 110.466 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.98 160.92 8.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.523 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.54 -21.87 65.55 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.586 2.191 . . . . 1.0 111.596 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.98 -41.09 99.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.106 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.98 156.0 36.89 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.439 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -72.22 152.99 56.6 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.799 2.333 . . . . 1.0 112.442 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -65.84 143.33 57.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.599 HD12 ' NE1' ' A' ' 968' ' ' TRP . 9.4 tt -62.78 -41.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.461 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . . . . . . . . . 90.5 mt -62.46 -42.43 99.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.453 -0.499 . . . . 1.0 110.412 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.29 -44.83 99.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' B' ' 699' ' ' SER . 71.1 t -62.77 -44.77 99.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.894 0.378 . . . . 1.0 110.485 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 968' ' ' TRP . 86.7 mt -62.05 -41.99 98.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.572 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.55 -43.32 94.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 1.0 110.398 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 49.8 p -62.47 -41.44 98.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.848 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.59 -44.88 98.75 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 121.316 0.579 . . . . 1.0 109.8 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 55.9 mtt -62.85 -39.46 94.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.499 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -66.25 -41.69 94.59 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.68 -0.968 . . . . 1.0 110.68 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.78 89.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.144 0.497 . . . . 1.0 110.759 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 980' ' ' LEU . 27.6 mm -63.24 -41.68 93.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.379 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.523 ' HA ' HD21 ' A' ' 980' ' ' LEU . 57.5 tp -59.42 -46.84 87.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.018 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.17 -43.11 99.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.602 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 93.6 mt -63.88 -44.09 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.023 0.379 . . . . 1.0 112.023 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -67.19 -41.07 92.48 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.645 -0.788 . . . . 1.0 111.244 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.11 -35.36 76.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.629 0.974 . . . . 1.0 113.629 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.696 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.08 -56.2 24.01 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 119.588 -0.845 . . . . 1.0 111.422 -177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 40.8 Cg_exo -54.19 -42.43 67.36 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.296 1.331 . . . . 1.0 111.351 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 993' ' ' PHE . 90.9 mt -64.16 -42.82 96.59 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.91 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -41.36 98.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.916 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.96 98.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.053 -0.659 . . . . 1.0 109.349 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.857 ' NE1' HD11 ' B' ' 719' ' ' ILE . 5.3 t90 -61.84 -49.27 76.94 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.922 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 992' ' ' PHE . 0.2 OUTLIER -60.56 -42.64 97.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.316 -0.24 . . . . 1.0 110.656 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 82.5 mt -63.16 -42.62 99.45 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.481 -0.488 . . . . 1.0 110.48 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 78.9 mt -60.91 -40.44 93.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.377 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . 0.857 HD11 ' NE1' ' B' ' 715' ' ' TRP . 97.0 mt -63.97 -46.72 93.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.799 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . . . . . . . . . 21.6 m -60.86 -48.19 82.95 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.132 0.79 . . . . 1.0 113.132 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . . . . . . . . . 34.1 mm -63.14 -43.78 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.788 0.662 . . . . 1.0 112.788 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . 0.455 ' CD2' ' C ' ' B' ' 722' ' ' HIS . 1.8 p-80 -68.97 -39.54 79.38 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 119.522 -0.871 . . . . 1.0 109.874 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.442 ' N ' ' CG ' ' B' ' 722' ' ' HIS . 65.5 t0 -66.88 -37.97 85.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.474 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -60.84 -43.08 98.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.765 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 722' ' ' HIS . 99.3 mttt -100.9 146.67 27.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.863 0.364 . . . . 1.0 110.733 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -134.65 147.48 50.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.375 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.643 -179.978 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 960' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.12 -38.13 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.753 0.311 . . . . 1.0 110.728 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.72 -43.05 99.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.804 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.492 ' OE2' ' SG ' ' A' ' 963' ' ' CYS . 22.1 pt-20 -137.22 144.48 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.734 0.302 . . . . 1.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.36 -41.29 89.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.616 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 965' ' ' PRO . 34.9 ptt-85 -149.18 148.06 29.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 1.0 111.176 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . 0.492 ' SG ' ' OE2' ' A' ' 960' ' ' GLU . 1.1 m -76.9 -17.81 58.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.808 -0.633 . . . . 1.0 111.981 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 10.6 mt -116.48 85.52 16.53 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.063 0.394 . . . . 1.0 112.063 -178.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.449 ' HA ' ' HE ' ' A' ' 962' ' ' ARG . 23.6 Cg_exo -61.66 147.5 95.2 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.904 2.403 . . . . 1.0 111.87 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.25 -43.91 97.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 -177.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 971' ' ' VAL . 0.0 OUTLIER -58.13 -50.71 72.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.457 -0.497 . . . . 1.0 112.285 -176.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . 0.451 ' CZ2' HD11 ' B' ' 693' ' ' ILE . 21.7 m0 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 119.625 -0.226 . . . . 1.0 111.193 -177.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 973' ' ' VAL . 65.1 t -64.36 -46.46 93.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 119.667 -0.813 . . . . 1.0 110.806 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.23 -43.74 97.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 1.0 111.686 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 967' ' ' TRP . 67.0 t -63.36 -45.1 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.585 -0.279 . . . . 1.0 111.664 -178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.66 -37.69 94.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.095 -1.05 . . . . 1.0 111.586 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 969' ' ' VAL . 60.6 t -62.0 -45.97 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.854 -0.339 . . . . 1.0 110.595 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.46 -43.08 98.4 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.079 0.4 . . . . 1.0 112.079 -179.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.85 97.58 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.746 -0.74 . . . . 1.0 111.26 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD23 ' A' ' 980' ' ' LEU . . . -62.1 -41.72 99.7 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.48 -1.048 . . . . 1.0 110.48 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.2 tp -63.12 -42.95 99.63 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.139 -0.624 . . . . 1.0 111.816 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.42 -41.93 98.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 120.344 -0.543 . . . . 1.0 111.839 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.46 -42.45 99.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 119.711 -0.795 . . . . 1.0 110.234 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.66 HD11 HD12 ' B' ' 705' ' ' LEU . 3.5 mm? -64.52 -41.05 96.63 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.338 0.496 . . . . 1.0 112.338 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 20.3 m -62.14 -47.15 85.84 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.496 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 42.0 pt -63.09 -41.35 92.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 119.757 -0.777 . . . . 1.0 111.617 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.69 -43.17 99.48 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.474 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 980' ' ' LEU . 70.5 t -61.7 -45.0 99.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.87 0.367 . . . . 1.0 110.699 -179.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 985' ' ' LEU . 93.0 mt -62.71 -41.5 99.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 990' ' ' VAL . . . -61.49 -42.22 98.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.195 -0.602 . . . . 1.0 111.206 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 63.1 mtt -64.98 -42.03 94.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.773 0.32 . . . . 1.0 111.505 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.408 ' CD1' ' O ' ' A' ' 988' ' ' TRP . 10.4 t90 -63.06 -43.29 99.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.47 -33.77 75.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.076 0.465 . . . . 1.0 111.587 -178.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 986' ' ' ALA . 57.4 t -77.65 -3.07 5.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.81 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 71.88 9.63 71.06 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 109.41 -1.476 . . . . 1.0 109.41 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -56.06 -43.81 78.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.236 0.518 . . . . 1.0 109.652 -178.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.421 ' CD1' ' CH2' ' B' ' 715' ' ' TRP . 40.6 m-85 -81.28 -18.69 44.99 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.22 177.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -73.95 -10.69 59.91 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 118.715 -1.194 . . . . 1.0 108.135 177.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -66.35 131.32 45.84 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.593 -0.843 . . . . 1.0 110.058 -178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -140.27 -46.82 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.441 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.423 ' O ' ' OD1' ' B' ' 723' ' ' ASP . 7.0 mtt180 39.67 72.66 0.95 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.741 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo . . . . . 0 C--N 1.305 -1.714 0 C-N-CA 122.762 2.308 . . . . 1.0 112.131 -179.827 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 685' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 686' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.77 -38.68 89.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 687' ' ' SER . . . . . 0.403 ' OG ' ' OE1' ' A' ' 960' ' ' GLU . 54.4 m 53.04 71.4 1.44 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.636 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 688' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.37 -35.98 85.95 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.198 2.599 . . . . 1.0 112.156 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 689' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.34 -43.01 99.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.844 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 690' ' ' CYS . . . . . 0.4 ' SG ' ' CD ' ' B' ' 691' ' ' PRO . 0.1 OUTLIER -76.62 174.89 5.0 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 179.924 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 691' ' ' PRO . . . . . 0.4 ' CD ' ' SG ' ' B' ' 690' ' ' CYS . 23.9 Cg_exo -60.56 143.34 99.43 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.143 1.896 . . . . 1.0 113.141 -179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 692' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.19 153.29 39.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.569 -0.742 . . . . 1.0 111.269 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 693' ' ' ILE . . . . . 0.451 HD11 ' CZ2' ' A' ' 968' ' ' TRP . 86.8 mt -62.03 -43.85 98.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 1.0 112.284 -178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 694' ' ' LEU . . . . . 0.482 HD22 ' N ' ' B' ' 694' ' ' LEU . 3.9 mm? -62.78 -43.38 98.95 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.574 -0.45 . . . . 1.0 110.981 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 695' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.18 -45.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.328 . . . . 1.0 111.467 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 696' ' ' VAL . . . . . 0.441 ' O ' ' OG ' ' B' ' 699' ' ' SER . 70.3 t -63.7 -44.75 98.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.067 0.461 . . . . 1.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 697' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.03 -43.16 99.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.781 -0.645 . . . . 1.0 112.05 -178.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 698' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.3 -42.35 96.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.1 0.476 . . . . 1.0 110.428 179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 699' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 696' ' ' VAL . 50.8 p -62.38 -41.37 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.57 -0.741 . . . . 1.0 112.871 -179.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 700' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.45 -45.78 94.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.286 -0.565 . . . . 1.0 110.288 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 701' ' ' MET . . . . . . . . . . . . . 94.1 mtp -64.36 -39.6 94.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.565 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 702' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.24 98.0 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 110.002 -1.239 . . . . 1.0 110.002 177.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 703' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.76 89.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.403 0.621 . . . . 1.0 109.908 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 704' ' ' ILE . . . . . . . . . . . . . 33.2 mm -61.04 -41.8 90.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 118.479 -1.289 . . . . 1.0 109.053 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 705' ' ' LEU . . . . . 0.66 HD12 HD11 ' A' ' 980' ' ' LEU . 59.5 tp -59.36 -43.87 92.79 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.534 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 706' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.15 -42.25 99.43 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.753 -0.779 . . . . 1.0 110.743 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 707' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.07 -44.16 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.597 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 708' ' ' GLY . . . . . . . . . . . . . . . -65.94 -38.85 94.57 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.474 -0.65 . . . . 1.0 111.474 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 709' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 713' ' ' LEU . 85.7 mt -67.46 -38.19 84.06 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.957 1.095 . . . . 1.0 113.957 -179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 710' ' ' ALA . . . . . 0.667 ' HB3' ' HD3' ' B' ' 711' ' ' PRO . . . -52.97 -57.11 17.54 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.164 -0.614 . . . . 1.0 111.759 -177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 711' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 710' ' ' ALA . 37.9 Cg_exo -55.5 -45.48 39.38 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.306 1.145 . . . . 1.0 111.448 178.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 712' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.92 -40.61 91.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.308 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 713' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' B' ' 709' ' ' LEU . 33.5 mt -62.98 -41.08 99.45 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.784 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 714' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.18 -46.39 95.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.397 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 715' ' ' TRP . . . . . 0.421 ' CH2' ' CD1' ' A' ' 993' ' ' PHE . 4.3 t90 -61.03 -49.36 77.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.582 -0.281 . . . . 1.0 110.648 178.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 716' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -45.83 91.17 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.786 -0.366 . . . . 1.0 111.037 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 717' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.1 -44.43 92.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.032 -0.667 . . . . 1.0 111.114 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 718' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.28 -43.42 97.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.655 0.613 . . . . 1.0 112.655 -178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 719' ' ' ILE . . . . . . . . . . . . . 21.2 tt -68.33 -40.93 83.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.579 -0.848 . . . . 1.0 109.964 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 720' ' ' THR . . . . . 0.469 HG22 ' NE ' ' B' ' 724' ' ' ARG . 94.6 m -59.15 -45.64 90.45 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.38 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 721' ' ' ILE . . . . . 0.521 ' CG1' HH21 ' B' ' 724' ' ' ARG . 93.7 mt -61.92 -43.14 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.326 -0.549 . . . . 1.0 110.622 -178.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 722' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -64.01 -38.43 91.03 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 1.0 109.127 178.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 723' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 997' ' ' ARG . 29.4 t70 -66.1 -44.55 84.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.901 -0.59 . . . . 1.0 111.03 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 724' ' ' ARG . . . . . 0.521 HH21 ' CG1' ' B' ' 721' ' ' ILE . 88.6 mtm180 -66.04 -39.21 89.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.952 0.406 . . . . 1.0 110.616 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 725' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.5 133.61 49.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.536 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 726' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.389 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 727' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.553 179.832 . . . . . . . . 0 0 . 1 stop_ save_